<SEC-DOCUMENT>0000849146-23-000015.txt : 20230202
<SEC-HEADER>0000849146-23-000015.hdr.sgml : 20230202
<ACCEPTANCE-DATETIME>20230202160545
ACCESSION NUMBER:		0000849146-23-000015
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		46
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230202
DATE AS OF CHANGE:		20230202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		23580857

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lfvn-20221231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e,d:b4e76625aa6f4376962a48026c346254--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:lfvn="http://www.lifevantage.com/20221231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lfvn-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV8yLTEtMS0xLTMwMDc5_c91467a9-a56c-4b7f-b18f-e52b898f3174">false</ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV8zLTEtMS0xLTMwMDc5_ed4434d3-f1b0-470e-9f4d-8248fd1177d5">2023</ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV80LTEtMS0xLTMwMDc5_bd2cb2bd-d4df-437a-bbd0-f7fb32b43edf">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV81LTEtMS0xLTMwMDc5_d8591f4c-1277-4329-b52e-bf374360950a">0000849146</ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV82LTEtMS0xLTMwMDc5_ec066880-f5c8-4c55-bc39-3c9c8f473bf5">--06-30</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80My9mcmFnOjc3OGVmZjI3ZWY4MjRhNGRiODMzMzQ3YzU2YTNmNTE0L3RhYmxlOjJlYTk2Mzg4ZDFhMTQwYjdiMWExODRhOTNjZTA1YzVlL3RhYmxlcmFuZ2U6MmVhOTYzODhkMWExNDBiN2IxYTE4NGE5M2NlMDVjNWVfMi0xLTEtMS0zMDA3OQ_14bfa13f-ae7a-4468-977c-bdc41e528362">1</ix:nonFraction><ix:nonNumeric contextRef="iedf10ffdb3cb40b4b2656f5a5a3a2bfd_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTU4_9fa1335b-a4b3-465e-8752-be86b6f9943e">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lfvn-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d9e439d901540308c45eee487b67dbb_I20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i41ae61d037b64e21a0009d260cbf079c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="idbccf873afec4cdb9617f979dc003b3a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128e0238654a408294474d0d39084ec4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a96896801234c7496795468d40281a8_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2371d23a6db41b59f8d6c9a8fc7d8bb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7ae1865fdb9499ab7dbe0dc600b08d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c8eefdab538498c85908974d5418122_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d2b015f040948b0a4768f592202a13a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b09637258c24e2592b4ea4b2ab92d44_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f6778f50584111b9cff0df26dbdd7a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib49e08745efc40889406f68b33f56331_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d3d6e8da9e4ed9a3c7f88e35dc62cf_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ed14fa890843cf80731ee9e3925b99_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i358d6150799342838a19d83985b9c094_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cef537cf94a4e73b05136778889ad4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c9137b5588e4bbebaacb5c9c219b41c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i467f2e2e2ca04ab7aa50e61d9b8c729a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a0c5debcdaa46d09da95435056b3e42_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306813b6c9154396b5feb21edeaf07f4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i893a955d58ac413f99e2ed74e093e814_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3875e13d53482ca276a747d7b9725d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b4e14577474b4cb15b348ef3effb26_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieac90614bd08479a962bf94e61c65f4c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib14397b8bfef44ae89948965604a00cd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief068ef7f192472e8f91975a23c29a80_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7ae78d394c4168918ff53d250447b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff9d50c36eb64dd29b993c619ef8f346_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie75a84e3843a403e89bb873eb810cd5e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id81b9703907b4145915889d617a0c019_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b8685d6a4274d5d9e3e702bf84f7a19_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ab9efe3a76437eb4c7016235cc6d23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7567b5990404aa5af48351119c88dd1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8af00de260d44b2bbcf76a96be67275d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3cad9e185ac4aa2912209bb27110fd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i229fac654a6e456bae29a6583de50cb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie32dad3b31774e4ab4392448baf8d166_D20221231-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861234a92f024717aab0fcfdedc72f98_D20221231-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-31</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79ba066dbf2f4116a1bc1650082eb82d_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ffbc57f7df41d08f46fdd5af852da5_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1becdba443bf4dd4ad59c94e1d90ae27_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfvn:ShowroomsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="region"><xbrli:measure>lfvn:region</xbrli:measure></xbrli:unit><xbrli:context id="ib97c9bdb37f9443998ba3b10ca21301b_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c2b290155354c5893117c2102630e53_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic801932ee7b44766a8977bc48c61b215_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce3902b05744a2181c139ba0275d9b4_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa2a8d6f5cf24bb49ac338f8ad48ae7d_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfd00b15e7224a37bd9bc7bb7749d232_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d763462815c4c90813a80f4704429fb_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c7fc25b6b4042e0a1f3a4195fa43155_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79eb75825906423b9893fc621fe4f28f_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bd8df94500f43ff804118cdd61ee34a_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30543519b0b14ddfa6511963cf86120a_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05b0acc99f3243ed990137d764b012d6_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d87785af21d4f15924bf57416becf07_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9513ebaa9554e018d59758d829177e6_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018e46118dfa4569bee998cc12092f0e_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34e95207b834b059135ddc8c6f5335e_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i156352af4d364bd39bd40efc69390355_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifff7c281ffcb480b9728320152bb1757_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5a8c78ae114f3ba91daa81c884673a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c8407d9278411daaade025540b8362_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lfvn:segment</xbrli:measure></xbrli:unit><xbrli:context id="ifbf321362fb048e7ad989fd29aa10371_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791994c0741744289a7ca8016b475b80_D20190531-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-31</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-16</xbrli:startDate><xbrli:endDate>2019-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedf10ffdb3cb40b4b2656f5a5a3a2bfd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i264e87d680d542c1af5201533c298cd3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218031818c05468fb4b9344e8718454c_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i332a4bdda6964cf2b5071cde0a7980c7_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00032d4dfded48658f82e08c57ab4a5a_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103063363cfe4045a96bdcbbc8bb8df3_I20180503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ed07a20460f4cb1af2e73dc102582fe_D20180504-20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-04</xbrli:startDate><xbrli:endDate>2018-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78f171a4c06a433b8599b63d53f8a878_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99892b92ec614947929196e70d6cfa90_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db563e50ed340da9ad6e97e830f1de7_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02becdb52e634fce9233ae4e1d9199ab_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b53239b6d748c0b5dc0cd15c527f78_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7033d13ec1104ebcb880b911489b11e6_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aad0c75d50047d5b8215d22695bea8e_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6986876bbd06457a874cb6f112493823_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i715b8212e42447a3bcbc76261cc68d1f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24899bef054f4e1ea3689d7f8468ada1_I20171127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3600ade8ac584e599fd793f01363db8f_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04b2568d00d452ca563a93b3382040c_I20200827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa3a80900568428483190bd6fe806e89_D20220915-20220915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-15</xbrli:startDate><xbrli:endDate>2022-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f7806f4c744d4bb6f8f72a1d67d3cc_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a878dc75136466d939f36303f8f29bb_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaed23e7162044f03b895993f02f2b3ae_D20221215-20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319cb485eedd404a8b0525a42c144e5e_I20061121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2006-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124fe5e6230a4630a62ed6b5b04e0d66_I20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id39f56f005d149c1b465694988b14646_D20170216-20170216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-02-16</xbrli:startDate><xbrli:endDate>2017-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie686cd256ac841c290a740d58fa0128c_D20180202-20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-02</xbrli:startDate><xbrli:endDate>2018-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d44ad1e2f441659ef97e1de7898de2_D20181115-20181115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-15</xbrli:startDate><xbrli:endDate>2018-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14171336bf9443a9a4f5906ebea800a2_D20201112-20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-12</xbrli:startDate><xbrli:endDate>2020-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia799876fcd8d48f3a197ae9951a5a93f_D20201110-20201110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-10</xbrli:startDate><xbrli:endDate>2020-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3924c2c406d347e5ba4fdff4f8a7dadc_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a9535be90b54a28934aa4096ffa89cc_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84a6b9c61ff454ea30977fdf0b8c64f_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c455728e942439eb75adbf84a5525ff_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a2bf424c72e488582d382f0dd0a0b89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-05</xbrli:startDate><xbrli:endDate>2019-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>lfvn:claim</xbrli:measure></xbrli:unit><xbrli:context id="iab9abce091734ee090f3cba6def7ace7_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib4e76625aa6f4376962a48026c346254_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xNjQ_ac584b03-c277-42fe-b362-66e10229a4e4">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6YmU5MTcxNjZmOTdiNGFjMzk3OWQ0OWRmNTc0ZGUxOGUvdGFibGVyYW5nZTpiZTkxNzE2NmY5N2I0YWMzOTc5ZDQ5ZGY1NzRkZTE4ZV8wLTAtMS0xLTMwMDc5_8d6cb82a-69df-4e33-8983-9cf321d9aed2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yODE_2eb28b15-1fc0-4ab9-bb41-f8f09e4e3fff">DECEMBER 31, 2022</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ODg1Nzk0ZmVmYTAxNGMxZWFiNzA5Y2YxNTdjYjM5N2IvdGFibGVyYW5nZTo4ODU3OTRmZWZhMDE0YzFlYWI3MDljZjE1N2NiMzk3Yl8wLTAtMS0xLTMwMDc5_94632495-c6d3-416c-a800-72641fc75026">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8zNjY_b1ff2b79-e3db-4cb1-99bf-7d61a8b2e6df">001-35647</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV80NTE_fa0a2f11-ab3d-41e8-b40d-d46e8fc80abb">LIFEVANTAGE CORP</ix:nonNumeric>ORATION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6MDk2MTM2MjQwMDU2NGUyNGJkZDljOGY0ZTk0OWM4NGIvdGFibGVyYW5nZTowOTYxMzYyNDAwNTY0ZTI0YmRkOWM4ZjRlOTQ5Yzg0Yl8wLTAtMS0xLTMwMDc5_40cf5b0d-977b-46e7-9bf2-1dc643b2a967">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6MDk2MTM2MjQwMDU2NGUyNGJkZDljOGY0ZTk0OWM4NGIvdGFibGVyYW5nZTowOTYxMzYyNDAwNTY0ZTI0YmRkOWM4ZjRlOTQ5Yzg0Yl8wLTItMS0xLTMwMDc5_7af882f3-577c-4a69-9c47-ef8cddff8273">90-0224471</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEy_6e0d9835-a71a-4f78-99e5-7399883497b8">3300 Triumph Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEz_6ead62ab-bb8d-4483-bc60-80d995167de3">Suite 700</ix:nonNumeric>, <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDE0_e3bdef24-1de8-4de2-a151-22f4ebab74a6">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV82MzU_ac41f55f-1e98-4bd5-b5bd-1b478835c220">UT</ix:nonNumeric> <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV82Mzg_f7326132-af0b-41f3-acce-656b6c744eaa">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV83MDM_088b6d66-0409-4810-94d1-a607fd3423a5">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV83MDc_f1d8c539-f57e-4339-ad26-e5c5550c56e3">432-9000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTAtMS0xLTMwMDc5_ebb6cea5-acf2-483c-89ef-f4dc2918a6da">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTItMS0xLTMwMDc5_3e1fb42d-2539-4717-b2f1-ed2613ba8c66">LFVN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTQtMS0xLTMwMDc5_a7f2974f-d96b-4963-8d2e-9b7094a382db">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15 (d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xMjM0_fc7e1fec-7156-417b-a2ad-137b78355674">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xNTU5_eef60c84-2764-403a-8636-a37b1e2bd485">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8wLTItMS0xLTMwMDc5_02525b69-1640-4326-8ed1-cbb251b58283">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8xLTMtMS0xLTMwMDc5_a7b79d01-2c2b-4195-8ac4-9b54d7f98941">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8yLTEtMS0xLTMwMDc5_b6aa2d66-accc-4837-af4e-baed19d44c97">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes&#160;&#160;&#9744;&#160;&#160;No&#160;&#160;<ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDE1_98200e02-0626-4ace-8bf5-7a49586e430e">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The number of shares outstanding of the issuer&#8217;s common stock, par value $0.0001 per share, as of February&#160;1, 2023 was <ix:nonFraction unitRef="shares" contextRef="i9d9e439d901540308c45eee487b67dbb_I20230201" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEw_1ef75d08-d1c0-4026-bf2c-f047e88d13bd">12,717,325</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q, in particular &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and the information incorporated by reference herein contains &#8220;forward-looking statements&#8221; (as such term is defined in Section&#160;27A of the Securities Act of 1933, as amended and Section&#160;21E of the Securities Exchange Act of 1934, as amended). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding the future performance of our network marketing efforts; statements regarding our expectations regarding ongoing litigation; statements regarding international growth; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission and common law.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements may be identified in this report and the information incorporated by reference by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following factors are among those that may cause actual results to differ materially from our forward-looking statements:</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to properly manage, motivate and retain our independent distributors or to attract new customers and independent distributors on an ongoing basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">The COVID-19 pandemic or the widespread outbreak of any other illness or communicable disease or any other public health crisis, could adversely affect our business, results of operations and financial condition;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to protect against cyber security risks and to maintain the integrity of data;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to manage existing markets, open new international markets or expand our operations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Non-compliance by our independent distributors with applicable legal requirements or our policies and procedures, including making improper and/or illegal claims about our products or earnings opportunity;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability of new products and technological innovations to gain customer or independent distributor or market acceptance;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our business and stock price may be adversely affected if our internal controls over financial reporting is not effective;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to execute our product launch process due to increased pressure on our supply chain, information systems and management;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to appropriately manage our inventory;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Disruptions in our information technology systems;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">International trade or foreign exchange restrictions, increased tariffs, foreign currency exchange fluctuations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to raise additional capital or complete desired acquisitions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Inability to comply with financial covenants imposed by our credit facility and the impact of debt service obligations and restrictive debt covenants;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Dependence upon a few products for revenue;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We may be unable to retain our existing distributor force or customer base or attract additional customers and/or independent distributors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">High quality materials for our products may become difficult to obtain or expensive;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10pt">Improper actions by our independent distributors that violate laws or regulations could harm our business;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Dependence on third parties to manufacture our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Disruptions to the transportation channels used to distribute our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We may be subject to a product recall;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Unfavorable publicity on our business or products; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We are subject to risks related to Global Not For Resale programs;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our direct selling program could be found to not be in compliance with current or newly adopted laws or regulations in various markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Legal proceedings may be expensive and time consuming;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Strict government regulations on our business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our Cannabidiol (&#8220;CBD&#8221;) products are subject to varying and changing federal, state or local laws which could adversely affect our results of operations and financial condition;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Regulations governing the production or marketing of our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Risk of investigatory and enforcement action;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Government authorities may question our tax positions or transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Failure to comply with anti-corruption laws;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Loss of, or inability to attract, key personnel;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">We may be held responsible for certain taxes or assessments and other obligations relating to the activity of our independent distributors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Competition in the dietary supplement and personal care markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our inability to protect our intellectual property rights;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Third party claims that we infringe on their intellectual property;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Product liability claims against us;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Consumer discretionary spending habits factor into our economic success;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Economic, political, foreign exchange and other risks associated with international operations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Potential delisting of our common stock due to non-compliance with Nasdaq's continued listing requirements;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Volatility of the market price of our common stock; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Substantial sales of shares may negatively impact the market price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_13">PART I. Financial Information</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_16">Financial Statements:</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_19">Condensed Consolidated Balance Sheets (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_22">Condensed Consolidated Statements of Operations and Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_22"> (Loss)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_22"> (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_25">Condensed Consolidated Statement of Stockholders&#8217; Equity (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_31">Condensed Consolidated Statements of Cash Flows (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_34">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_64">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_64">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_88">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_88">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_91">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_91">27</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_94">PART II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_94">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_97">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_97">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_100">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_100">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_103">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_103">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_106">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_106">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_109">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_109">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_112">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_112">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_115">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_115">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_118">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ib4e76625aa6f4376962a48026c346254_118">30</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. Financial Information</span></div><div id="ib4e76625aa6f4376962a48026c346254_16"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="ib4e76625aa6f4376962a48026c346254_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNC0xLTEtMS0zMDA3OQ_18cc0c15-6f77-45d5-b103-ce2ca1689340">17,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNC0zLTEtMS0zMDA3OQ_b6f4951a-bb65-4410-b55b-f917677572d4">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNS0xLTEtMS0zMDA3OQ_915147ad-184b-4885-9290-6acfb7871445">2,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNS0zLTEtMS0zMDA3OQ_7dfe156b-d4cc-4770-9716-f09cd7b5b999">3,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNi0xLTEtMS0zMDA3OQ_849a3a3b-0e4f-41db-9386-349b57c140a6">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNi0zLTEtMS0zMDA3OQ_a1dd5421-5f24-430a-b5dc-5ecad3ddbc33">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNy0xLTEtMS0zMDA3OQ_09f659d0-33b9-4e6f-8965-0c86b8f40b78">20,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNy0zLTEtMS0zMDA3OQ_3daaefdc-cf9e-4cd7-9da6-78807e5709e0">16,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfOS0xLTEtMS0zMDA3OQ_6d23552a-5fa9-43ae-8a73-bdd6601a6d36">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfOS0zLTEtMS0zMDA3OQ_2dc7b883-9c48-43ca-b922-1e5a75704d2f">5,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTAtMS0xLTEtMzAwNzk_10f59140-898b-40b2-9d7f-4393d4103839">44,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTAtMy0xLTEtMzAwNzk_2cde4226-e6cc-42d7-a21a-8c9490dfc432">46,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTItMS0xLTEtMzAwNzk_d41ab259-711a-4f7d-b318-b91dec61ddde">9,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTItMy0xLTEtMzAwNzk_3882c695-7781-419d-80f4-8b9bc87af003">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTMtMS0xLTEtMzAwNzk_c8709339-f9e5-41ac-9e00-74239e055863">9,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTMtMy0xLTEtMzAwNzk_01701064-1394-4a95-adf8-0e41e9c82c8d">11,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTQtMS0xLTEtMzAwNzk_333f4c33-b992-4ffd-884a-1b0666a4d3e7">521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTQtMy0xLTEtMzAwNzk_13837815-64a5-448e-b0ff-2aba4ffde12e">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTUtMS0xLTEtMzAwNzk_42811aca-7acf-42dc-b332-eaa00760d960">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTUtMy0xLTEtMzAwNzk_49821dd4-cab3-4f14-af95-3034dbc1a96c">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTctMS0xLTEtMzAwNzk_5d294311-0311-4d2d-99f1-365e7e1f4a39">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTctMy0xLTEtMzAwNzk_d517f62c-e7a4-4dfc-a18f-51b6e6c71b90">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTgtMS0xLTEtMzAwNzk_8475bc97-1f35-499c-8aa0-aa261bd0bd03">67,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTgtMy0xLTEtMzAwNzk_c86a5736-1ddb-42c4-aef4-f28ee05b7cf7">70,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjItMS0xLTEtMzAwNzk_a71cf4eb-e936-4dea-a501-62964c35d2e7">8,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjItMy0xLTEtMzAwNzk_06b55072-1743-495f-997e-2d38d6c6bfb3">7,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjMtMS0xLTEtMzAwNzk_b11599a1-d48c-4121-ada1-5a935d153a38">6,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjMtMy0xLTEtMzAwNzk_643af364-42f0-4dc6-be27-53b5f82759e2">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjYtMS0xLTEtMzAwNzk_32abf754-f663-440d-be4c-07d57c4dfdb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjYtMy0xLTEtMzAwNzk_0a3fa36b-3819-4b43-8a54-c87247a31f33">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjctMS0xLTEtMzAwNzk_e6f09dd4-8290-4910-b1fa-c598fb95cf36">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjctMy0xLTEtMzAwNzk_1de727c0-84e0-403c-8396-7b07f09b2c3a">2,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjgtMS0xLTEtMzAwNzk_125923fd-6dd3-4d0b-ae7b-4004af47a3f6">6,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjgtMy0xLTEtMzAwNzk_e4d24dd6-6d47-4150-8eed-ea2443f8286f">7,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzAtMS0xLTEtMzAwNzk_bba6a839-de78-4e2b-916e-d559a93c4fe9">23,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzAtMy0xLTEtMzAwNzk_25845204-480a-4092-b270-563def95d901">25,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzYtMS0xLTEtMzAwNzk_985fbd1f-7abb-49dd-8200-f07733fe9d13">12,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzYtMy0xLTEtMzAwNzk_360ba19e-fe02-4e5b-b516-8d4d58a419a4">13,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzctMS0xLTEtMzAwNzk_4c449a8a-e2b8-4ad9-bcc4-d0bd0c5f6d19">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzctMy0xLTEtMzAwNzk_2856e126-a94f-4694-bc7f-254dcf2794a9">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzgtMS0xLTEtMzAwNzk_42837432-2c18-4638-a264-e0fa05eb673a">35,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzgtMy0xLTEtMzAwNzk_b4321896-41ce-4738-9d24-de978bed9011">39,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies - Note 8</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzktMS0xLTEtMzAwNzk_041eb4c0-bd10-4e53-9b00-c924964cb865"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzktMy0xLTEtMzAwNzk_b68a221d-15b7-44ae-90bf-3ea434106cf2"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl8zMg_1b24810c-bc44-4817-948a-d1907455de8e"><ix:nonFraction unitRef="usdPerShare" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl8zMg_cd95c3ce-6c23-4436-b713-e98e4cfb0312">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl80Ng_553eae4f-22da-46bb-a946-d443a8bf343b"><ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl80Ng_56def318-f263-43da-95d3-605ac0fcef77">5,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_6d0f470b-3343-476e-809f-23dc581dd9ed"><ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_85abba23-8dfa-4103-a5b0-1df46171964d"><ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_d04cd039-c483-4223-bf52-03b961cb460b"><ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_d74f952f-7c35-4172-be47-6330d5e67fc8">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMS0xLTEtMzAwNzk_3a2f2c32-f5f7-40e8-9130-704bab2b73d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMy0xLTEtMzAwNzk_73d0e337-889a-4ff3-b098-4c99c7ed7d45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV8zMA_4290a1e9-5a0d-4360-9fce-883475463d22"><ix:nonFraction unitRef="usdPerShare" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV8zMA_df43594f-87ac-4efb-8242-3ab492273ece">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV80NA_1c3f6ae2-4591-4494-9a04-9dcd38ff5fb1"><ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV80NA_82c40b78-eba3-41cb-b035-e7f0dc2d1ad8">40,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV82OQ_26f0042f-6422-4b94-b475-c150bdde160a"><ix:nonFraction unitRef="shares" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV82OQ_94005486-7376-4805-bddc-4fa13e4b68c7">12,707</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV83Ng_6b579ff3-437a-4fb9-8acf-e75be088e421"><ix:nonFraction unitRef="shares" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV83Ng_a12e670f-20cc-4462-81d8-34553284904e">12,493</ix:nonFraction></ix:nonFraction> issued and outstanding as of December 31, 2022 and June&#160;30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMS0xLTEtMzAwNzk_40a0a6f3-e9aa-43de-91ce-8bec769debb8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMy0xLTEtMzAwNzk_05e1287b-c3e3-4ac2-b8ce-723c088b325a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDMtMS0xLTEtMzAwNzk_766eabb7-b0f1-4aa2-aedc-6640363f229b">132,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDMtMy0xLTEtMzAwNzk_a5a1dd0b-f5cb-4577-b542-d82e0b0dd696">131,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDQtMS0xLTEtMzAwNzk_6ae33f5b-d721-4d9d-b1a0-90f3436b830f">99,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDQtMy0xLTEtMzAwNzk_b9a00903-3d99-4d49-b5be-309846900eb1">98,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDUtMS0xLTEtMzAwNzk_cf0959ec-fdf8-48a4-829c-89abd781fc76">993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDUtMy0xLTEtMzAwNzk_295c26ef-6032-4fe2-9861-52ae2729076d">1,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDYtMS0xLTEtMzAwNzk_d73b4b61-a5d9-4c41-80ca-1b236ede01d0">31,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDYtMy0xLTEtMzAwNzk_2405d2ae-d0a5-4653-bd47-f9e79f57d745">31,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDctMS0xLTEtMzAwNzk_d01c5f8c-3b55-49da-b74f-bedfb7b90414">67,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDctMy0xLTEtMzAwNzk_85f59ddd-db8a-4b96-b89a-5756d279a173">70,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div id="ib4e76625aa6f4376962a48026c346254_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy0xLTEtMS0zMDA3OQ_cfb80f5a-742e-4acf-acc9-12d9b7c0a722">53,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy0zLTEtMS0zMDA3OQ_017b180f-d97b-4dd1-a5ca-be0e4332d113">52,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy01LTEtMS0zMDA3OQ_acf8e245-8696-4c61-a364-e89add3f477c">105,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy03LTEtMS0zMDA3OQ_87351ac2-3bbb-4b7a-84f7-fa7a01297904">105,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC0xLTEtMS0zMDA3OQ_aa63b2e0-77e1-4cd8-a698-c2d72443b293">11,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC0zLTEtMS0zMDA3OQ_b3310898-0bb1-4d91-95d1-db7e932256ff">9,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC01LTEtMS0zMDA3OQ_e9335def-c83b-4302-b8bf-88b343502dc5">21,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC03LTEtMS0zMDA3OQ_da2cbd46-865a-484f-84fb-513213b40bba">19,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS0xLTEtMS0zMDA3OQ_6dee0bbc-03d0-41ef-b992-b6b240a31bf9">41,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS0zLTEtMS0zMDA3OQ_b3e1ebe6-c9b1-4b8b-aea4-3b7335374eea">42,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS01LTEtMS0zMDA3OQ_1238e174-9f7b-4a54-8d93-5d82c5591863">83,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS03LTEtMS0zMDA3OQ_97d49a62-6280-48b0-8385-5bbd3179a345">86,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy0xLTEtMS0zMDA3OQ_41cc3a15-1bf7-4a17-842d-3aa0b5145e70">23,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy0zLTEtMS0zMDA3OQ_d731ed40-3c6e-48f9-85f3-4338e6aba0a5">25,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy01LTEtMS0zMDA3OQ_ab82c06c-0630-429f-9d8b-52a75f1ec234">47,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy03LTEtMS0zMDA3OQ_d63f78c6-f0d6-481a-8537-0c9793df39a6">49,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC0xLTEtMS0zMDA3OQ_411e9175-4711-4394-a0ca-b58aefe1a6b8">19,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC0zLTEtMS0zMDA3OQ_8bd5fb99-04e1-414b-994a-74992d05e756">17,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC01LTEtMS0zMDA3OQ_04db144d-dd6e-4d73-9419-807594bc413d">36,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC03LTEtMS0zMDA3OQ_d5ddcbd0-14f4-4c94-b9a8-5b298d7b97c7">32,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtMS0xLTEtMzAwNzk_155902a8-abb0-477f-80e9-6e8f7a634518">43,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtMy0xLTEtMzAwNzk_5536f5ed-d858-4f1b-aab4-3aa338f20189">42,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtNS0xLTEtMzAwNzk_6ed7b698-6315-466a-b20b-5393e6db6ca2">83,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtNy0xLTEtMzAwNzk_5e2b58f4-574d-4c8e-a930-a76eb23a9f1a">82,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItMS0xLTEtMzAwNzk_38765b33-0c49-4753-841e-2f79a09ebd34">1,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItMy0xLTEtMzAwNzk_d616c722-a082-4d48-84a4-93b92cc94843">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItNS0xLTEtMzAwNzk_4dd39fa5-43b3-4d2f-aef2-cac7170ff30a">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItNy0xLTEtMzAwNzk_d92bf425-29ab-4323-8511-263534c81f21">4,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtMS0xLTEtMzAwNzk_83db4f1a-9616-45c0-b55e-59459a9a40b7">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtMy0xLTEtMzAwNzk_150ed0fa-cf89-4fb2-b543-fd0ced85acec">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtNS0xLTEtMzAwNzk_c7df721f-6a7b-4dc2-a473-126af7c371a6">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtNy0xLTEtMzAwNzk_b04e9985-a0b7-44e6-9d94-8774ff418467">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtMS0xLTEtMzAwNzk_f3a03293-0b98-48b3-be0e-a7310c8d7ac4">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtMy0xLTEtMzAwNzk_0e3c09ec-2b3e-4f7d-931b-7d3ea6cce7d2">139</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtNS0xLTEtMzAwNzk_563e6128-65ea-4cd0-b883-31291d7bf9c1">312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtNy0xLTEtMzAwNzk_6d32a871-be7e-4524-97f2-50169173ce1e">316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctMS0xLTEtMzAwNzk_966d2da9-9a96-4d37-ae87-be5d93e72933">157</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctMy0xLTEtMzAwNzk_24740a0d-4dfb-4330-8b7a-2dab3649e0da">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctNS0xLTEtMzAwNzk_0fdc83f6-111c-4b40-b3d4-6b85e206aeb5">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctNy0xLTEtMzAwNzk_12340f91-badf-4672-ad10-18d20970fea9">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtMS0xLTEtMzAwNzk_e3545bbb-e1d0-4daa-a21c-0c50b5fadc93">1,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtMy0xLTEtMzAwNzk_b8fcd040-cda9-4d8d-91b6-0cee5b461b7a">498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtNS0xLTEtMzAwNzk_29510ca7-5984-4b36-96fd-d4c6cf8da28e">223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtNy0xLTEtMzAwNzk_75bde3c3-be36-4e0f-a281-f449e136cd6c">3,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktMS0xLTEtMzAwNzk_8edd85b2-561d-4981-b69e-e9bd57efb94b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktMy0xLTEtMzAwNzk_08183752-2838-48d3-bcc6-1babd5578c9f">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktNS0xLTEtMzAwNzk_949956fb-ef4e-4bf5-b3d9-392c48c63ea5">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktNy0xLTEtMzAwNzk_bc2567ac-59e6-4f22-812d-76f342482f47">539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtMS0xLTEtMzAwNzk_c7d5b51b-add9-4b6a-ba9c-f84cb9fed4c0">1,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtMy0xLTEtMzAwNzk_e3681438-a6bb-4795-96cd-ce6fe4031626">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtNS0xLTEtMzAwNzk_7cd4fd61-17df-48f3-9643-5fecc7b06a49">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtNy0xLTEtMzAwNzk_b901daaa-9b6f-4b34-9428-7f9528eebbd4">3,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItMS0xLTEtMzAwNzk_73e8e1f5-68ff-41b4-91b1-0f166b4de54a">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItMy0xLTEtMzAwNzk_965a41e0-77b6-4711-a3d4-b06e98ee8d51">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItNS0xLTEtMzAwNzk_005507c3-823c-438b-95f4-0b33f96a20f4">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItNy0xLTEtMzAwNzk_cc393bb3-61e6-44b0-9752-b91be9d0404e">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtMS0xLTEtMzAwNzk_15074acf-720c-431a-a95a-a7263def03e5">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtMy0xLTEtMzAwNzk_01195e95-757c-4619-a101-6f999cbc3c9e">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtNS0xLTEtMzAwNzk_178fd575-8163-4f59-aa0e-a1060bdbc3ee">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtNy0xLTEtMzAwNzk_0b278813-938b-4e7a-9835-7f002d583e48">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtMS0xLTEtMzAwNzk_6c9ef1f5-ff65-4075-b7ee-cde192b2314c">12,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtMy0xLTEtMzAwNzk_7fc5d1a1-be2b-4455-9d4c-51e235fa5a3f">13,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtNS0xLTEtMzAwNzk_6f2347b8-58f6-4c93-83ae-110883b80b16">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtNy0xLTEtMzAwNzk_e281e153-d1c4-4007-b5cb-2eaaa9278e32">13,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtMS0xLTEtMzAwNzk_90a52a10-da09-4443-8d6c-01c04aacc690">12,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtMy0xLTEtMzAwNzk_14e12497-d343-4a1d-96be-5199c84b5295">13,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtNS0xLTEtMzAwNzk_7337a0f3-c568-4aef-a99e-05fc286bde94">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtNy0xLTEtMzAwNzk_3ee9733f-fbf4-4f5e-921c-96f0f39ed3b9">13,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtMS0xLTEtMzAwNzk_e9560c36-f7c6-410f-b5a0-95061b46d084">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtMy0xLTEtMzAwNzk_2049cb0b-53b0-417a-bfb6-6ad961cceb52">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtNS0xLTEtMzAwNzk_331eb429-4f0b-45ff-9eab-decb95c2a2b4">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtNy0xLTEtMzAwNzk_612cb896-dc9c-4c3c-b593-089f72adde6c">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtMS0xLTEtMzAwNzk_542147b6-7903-4dfe-a579-3d97579585e5">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtMy0xLTEtMzAwNzk_1b6e876f-1587-4f14-b651-364d25da3651">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtNS0xLTEtMzAwNzk_ace3727c-caad-4c83-b611-19c72831e1af">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtNy0xLTEtMzAwNzk_7dc66cbb-e0c2-4112-a35d-a40a1ab1d1b5">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (loss) income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtMS0xLTEtMzAwNzk_8d107aa5-0970-46fc-9ead-b2d76104661a">418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtMy0xLTEtMzAwNzk_33cf6ba4-4c3f-479c-af40-391d0943efb6">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtNS0xLTEtMzAwNzk_a6bc4ebc-a0a2-4467-9703-731d23d48ee2">318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtNy0xLTEtMzAwNzk_ea2350d7-d29d-473d-9e8a-d1b75b9a8a63">3,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i128e0238654a408294474d0d39084ec4_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0xLTEtMS0zMDA3OQ_ee3b3652-1182-4783-be5d-38d935d3c0b2">12,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128e0238654a408294474d0d39084ec4_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0zLTEtMS0zMDA3OQ_a6a7e66c-3423-443d-a619-40a3b6ae1761">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a96896801234c7496795468d40281a8_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy01LTEtMS0zMDA3OQ_1b2507e3-9118-4f11-8e20-a699c7f54a57">131,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2371d23a6db41b59f8d6c9a8fc7d8bb_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy03LTEtMS0zMDA3OQ_eff5f141-d452-4c10-b024-81d894bbdfa5">98,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7ae1865fdb9499ab7dbe0dc600b08d9_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy05LTEtMS0zMDA3OQ_eff21565-6967-41c0-9909-b56e6becb2bf">1,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0xMS0xLTEtMzAwNzk_1473db84-a041-4163-aba7-ea4c906bf91e">31,516</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNS01LTEtMS0zMDA3OQ_1f1fdf46-ed07-4bee-bef2-aa0c24750271">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNS0xMS0xLTEtMzAwNzk_7d72af77-6c01-4cdd-b587-29c6de3ec0ff">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNy0xLTEtMS0zMDA3OQ_5c1210f5-34fb-4acb-8577-1451eec9e8cf">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNy0xMS0xLTEtMzAwNzk_902241ec-63b4-417e-9058-4d82d39da5ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC0xLTEtMS0zMDA3OQ_781db2c2-fdb5-49f6-b01f-ae90a3b38a69">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC01LTEtMS0zMDA3OQ_a1a0e34b-ff06-455d-88b3-6d67127e8ce3">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC0xMS0xLTEtMzAwNzk_3db1a8d8-0a48-4006-9ab5-bbc714b6b20f">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtMS0xLTEtMzAwNzk_a3c0655e-3394-4613-89b3-80c7eed94a53">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtNS0xLTEtMzAwNzk_149b3279-f9d7-4615-9566-edb4161707f0">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtMTEtMS0xLTMwMDc5_b9466d46-f34e-483f-9a30-37c5508ff7e7">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTEtNy0xLTEtMzAwNzk_7a940e51-b08e-4ae2-94fc-3fafe0df198c">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTEtMTEtMS0xLTMwMDc5_61c89236-ed55-4b67-8749-c34d01700231">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c8eefdab538498c85908974d5418122_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTItOS0xLTEtMzAwNzk_d31b08e4-2e5d-42cc-9088-ffe64a38e059">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTItMTEtMS0xLTMwMDc5_42bf39b3-de1c-42f2-bb66-27ce5ffd8ad4">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTMtNy0xLTEtMzAwNzk_c8d4a6cb-3462-47a4-afc5-309bb30631e1">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTMtMTEtMS0xLTMwMDc5_e3136463-c359-49b5-ae1d-f35c023d2b3b">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d2b015f040948b0a4768f592202a13a_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMS0xLTEtMzAwNzk_c741d23b-79b7-4961-8607-b09afda54617">12,560</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d2b015f040948b0a4768f592202a13a_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMy0xLTEtMzAwNzk_c2801c5a-d890-48fa-ae7b-d76a3585321d">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b09637258c24e2592b4ea4b2ab92d44_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtNS0xLTEtMzAwNzk_2ea9867b-0a64-4ce2-8bb0-ab4bfd3abd90">131,726</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45f6778f50584111b9cff0df26dbdd7a_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtNy0xLTEtMzAwNzk_f6e20833-efaf-4273-a1d7-86cdb652cac1">98,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib49e08745efc40889406f68b33f56331_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtOS0xLTEtMzAwNzk_a1701377-675e-4eb2-b80d-1a5a937aeaa7">1,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d3d6e8da9e4ed9a3c7f88e35dc62cf_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMTEtMS0xLTMwMDc5_280d3c11-1bad-4f39-b53a-129c42688c5e">31,890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTYtNS0xLTEtMzAwNzk_ce1ab420-fe3a-4ac7-acc0-16fa80330854">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTYtMTEtMS0xLTMwMDc5_9787c9c8-2851-457f-a80e-27292405541f">823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTgtMS0xLTEtMzAwNzk_c48934bc-f2b7-4950-8679-42e6a0996685">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTgtMTEtMS0xLTMwMDc5_9d684c30-4125-4444-bf37-c1770b182d57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktMS0xLTEtMzAwNzk_8f6a26ca-6e8a-4b8c-a91f-08027502610c">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktNS0xLTEtMzAwNzk_242be319-abae-4147-a12a-832855f7c806">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktMTEtMS0xLTMwMDc5_0c2de28e-dc5d-4d44-acad-1798baf4d7a6">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjEtNy0xLTEtMzAwNzk_dd8405f1-4758-4d50-b619-35f7e67eaead">381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjEtMTEtMS0xLTMwMDc5_f88a0115-eb36-4f58-b0fa-f796e7c7c816">381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ed14fa890843cf80731ee9e3925b99_D20221001-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjItOS0xLTEtMzAwNzk_6500c1ed-2b25-4a6d-bd4a-ccbd82be2634">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjItMTEtMS0xLTMwMDc5_024c2466-29e2-4ba7-878b-feb68be6f380">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjMtNy0xLTEtMzAwNzk_1c664269-d5e5-4f9f-8bc0-07b18dd8d046">1,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjMtMTEtMS0xLTMwMDc5_5861262c-1e8a-45b2-a306-8f68c795312e">1,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i358d6150799342838a19d83985b9c094_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMS0xLTEtMzAwNzk_37f6c01a-47ae-4a56-b973-4ee8edc9684f">12,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i358d6150799342838a19d83985b9c094_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMy0xLTEtMzAwNzk_88bb8a9b-20f9-4ca5-9a5b-cbc475aca97e">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cef537cf94a4e73b05136778889ad4f_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtNS0xLTEtMzAwNzk_ea3fb514-0e35-4c6a-baee-e0438528d4fe">132,530</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c9137b5588e4bbebaacb5c9c219b41c_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtNy0xLTEtMzAwNzk_a770bd76-e0b4-48b2-a731-082b5154ef4a">99,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i467f2e2e2ca04ab7aa50e61d9b8c729a_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtOS0xLTEtMzAwNzk_1558e044-72c6-4dcd-82e8-e3bc9e8decc4">993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMTEtMS0xLTMwMDc5_1602b25f-e87e-4df0-b48f-1fd996445f5a">31,895</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (CONTINUED)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive (Loss) Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a0c5debcdaa46d09da95435056b3e42_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0xLTEtMS0zMDA3OQ_ea793b07-89f8-4ffe-8135-8b16e16c5b38">13,609</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a0c5debcdaa46d09da95435056b3e42_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0zLTEtMS0zMDA3OQ_19a55396-833c-433b-81b2-e643855144c7">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306813b6c9154396b5feb21edeaf07f4_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy01LTEtMS0zMDA3OQ_533de59a-7455-487d-915a-8939af8dccf3">129,048</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i893a955d58ac413f99e2ed74e093e814_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy03LTEtMS0zMDA3OQ_58a32821-2fbe-4337-8147-9a20bd0fc2d6">92,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3875e13d53482ca276a747d7b9725d_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy05LTEtMS0zMDA3OQ_519991cc-9821-4aa8-b3aa-248d1415d18c">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b4e14577474b4cb15b348ef3effb26_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0xMS0xLTEtMzAwNzk_256eb301-3c38-4081-818f-0dee43a0e892">36,807</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNS01LTEtMS0zMDA3OQ_29eb2705-5d2a-47d5-ae76-fb8e49fade60">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNS0xMS0xLTEtMzAwNzk_7d25599d-ee2a-4e26-aa82-3b1b4cb1eef3">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi0xLTEtMS0zMDA3OQ_e5052d76-70fd-43dd-bb4c-16afb09bb95a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi01LTEtMS0zMDA3OQ_7e166e41-4ba8-4b55-b9e2-52a96bf54677">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi0xMS0xLTEtMzAwNzk_73726e8a-fa5a-406d-b054-6ddef9e356bc">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNy0xLTEtMS0zMDA3OQ_869dcbad-7a18-4f1a-9f4f-97b10b34939c">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNy0xMS0xLTEtMzAwNzk_3b0aa1b3-9f92-4fe8-b9b5-715e03c536a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC0xLTEtMS0zMDA3OQ_ca075a83-0dd8-4d9e-8214-711919cd76b0">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC01LTEtMS0zMDA3OQ_10af2d9a-ad73-46d4-9b7b-29ea72b3aa68">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC0xMS0xLTEtMzAwNzk_0db63eca-1dd1-4882-a03c-23d0fe3dd2c2">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS0xLTEtMS0zMDA3OQ_952bdb81-ec42-4fc9-9f3e-c94708c04e94">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS03LTEtMS0zMDA3OQ_2344fb72-07e7-4222-8ffe-3c2414394e9b">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS0xMS0xLTEtMzAwNzk_a3b464e0-6454-4620-b82a-332723845991">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtMS0xLTEtMzAwNzk_a3b4ecb0-8df3-4d98-838e-8fdf948272ef">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtNS0xLTEtMzAwNzk_d046069b-0cc8-4bc1-b73c-ab94befc0dbc">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtMTEtMS0xLTMwMDc5_d285e3e1-0aa1-410a-aa9d-627bff57e922">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieac90614bd08479a962bf94e61c65f4c_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTEtOS0xLTEtMzAwNzk_aadcb315-f32a-4446-8e38-93a7d10512bc">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTEtMTEtMS0xLTMwMDc5_de482946-3db0-4bc7-9178-f173937241c0">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTItNy0xLTEtMzAwNzk_c0d7cc9d-02c0-4fa4-85f4-f531c62be58f">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTItMTEtMS0xLTMwMDc5_5c8b002f-bdea-4372-a127-0adbf04766e6">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib14397b8bfef44ae89948965604a00cd_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMS0xLTEtMzAwNzk_a6fe500e-26fc-45ea-a879-c188ac57bb6d">13,236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib14397b8bfef44ae89948965604a00cd_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMy0xLTEtMzAwNzk_5e2a72b7-72e6-4ea2-9a1c-fd0d6f41a1e4">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief068ef7f192472e8f91975a23c29a80_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtNS0xLTEtMzAwNzk_a7369c68-60e1-4bcc-b0ac-447aa3f19e66">129,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d7ae78d394c4168918ff53d250447b7_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtNy0xLTEtMzAwNzk_265b0383-b797-49ca-a7e1-799c756e3d23">92,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff9d50c36eb64dd29b993c619ef8f346_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtOS0xLTEtMzAwNzk_781fcd08-dfad-4c08-9155-7da40d4ad063">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75a84e3843a403e89bb873eb810cd5e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMTEtMS0xLTMwMDc5_5b0064d6-85ed-4f66-880d-5b016ba2673f">37,310</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTUtNS0xLTEtMzAwNzk_0e59cb59-1bc1-4fda-8737-ac47100bac14">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTUtMTEtMS0xLTMwMDc5_1f0b3668-d95a-42c8-b928-44dc14d5e3a6">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTctMS0xLTEtMzAwNzk_3e0e2fcf-c773-4819-8505-c7ec8094d3ea">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTctMTEtMS0xLTMwMDc5_13595b5e-d817-4438-9c18-0f264c93cf96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtMS0xLTEtMzAwNzk_d012ee11-264d-417e-b474-8af6871e5bd5">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtNS0xLTEtMzAwNzk_006d595a-6e25-4f38-90f2-6429c24ec38d">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtMTEtMS0xLTMwMDc5_25cade8f-ec47-46a7-8e96-04a5d0d1cdd3">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktMS0xLTEtMzAwNzk_1392f8a6-9fab-4097-9569-68bd54d2ebd7">454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktNy0xLTEtMzAwNzk_7f8711e8-e76a-4882-b72b-0c3bd85082d1">3,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktMTEtMS0xLTMwMDc5_b783bf43-682b-46f1-81b4-0d2bc8cb9f68">3,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b8685d6a4274d5d9e3e702bf84f7a19_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjEtOS0xLTEtMzAwNzk_968b4e48-5f1e-4f46-98d0-0421c8fb5be4">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjEtMTEtMS0xLTMwMDc5_ee67389d-001e-4ddd-a97d-4761069d251f">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjItNy0xLTEtMzAwNzk_6a87c956-abe1-4a6d-abc8-55998c5c1866">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjItMTEtMS0xLTMwMDc5_e174b73e-f42c-454a-9e90-ed1109cb8c71">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id9ab9efe3a76437eb4c7016235cc6d23_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMS0xLTEtMzAwNzk_333257a5-fbdf-4e57-b340-bd27587a3ff9">12,844</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ab9efe3a76437eb4c7016235cc6d23_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMy0xLTEtMzAwNzk_cdd277c1-2d5d-49d8-9494-a519084576c1">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7567b5990404aa5af48351119c88dd1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtNS0xLTEtMzAwNzk_3306021d-e735-49fd-bcb1-a36912ea92f3">130,586</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8af00de260d44b2bbcf76a96be67275d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtNy0xLTEtMzAwNzk_269743f2-9f9a-4084-80a9-d3b7f894f0ec">95,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3cad9e185ac4aa2912209bb27110fd8_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtOS0xLTEtMzAwNzk_c7484b2c-653f-4988-81f0-470cfd57cb89">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229fac654a6e456bae29a6583de50cb7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMTEtMS0xLTMwMDc5_5ac664b3-62f4-4fee-842b-84d765c10587">34,780</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNC0xLTEtMS0zMDA3OQ_9f56e685-e692-4abb-8864-19ca87af79cb">448</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNC0zLTEtMS0zMDA3OQ_6664df36-bcf0-414f-9899-ac1d532fee22">3,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNi0xLTEtMS0zMDA3OQ_547436b2-c618-4c42-95f1-8733449e86ce">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNi0zLTEtMS0zMDA3OQ_fe0d3f7a-16bc-4ffb-89d7-9c0bcda657bf">1,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOC0xLTEtMS0zMDA3OQ_8f3bf85e-82fc-4b98-8a72-d3bd39904bad">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOC0zLTEtMS0zMDA3OQ_d55efa87-f8f8-4888-ba42-187fe800a9b0">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOS0xLTEtMS0zMDA3OQ_bfde6403-34f2-43b8-b107-3b319d942363">761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOS0zLTEtMS0zMDA3OQ_254ac825-1174-4823-9555-50d254d0919f">1,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTAtMS0xLTEtMzAwNzk_5e2e121c-8d09-4050-b6cf-ad53970ebf47">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTAtMy0xLTEtMzAwNzk_aa0fe9b5-1d68-4640-a9a3-236abb75eb92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTQtMS0xLTEtMzAwNzk_1397cfb2-a1a9-4491-bfb4-3c078d6b4c30">1,230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTQtMy0xLTEtMzAwNzk_31b2be7c-5575-40ef-b2a2-224cf7421cbf">825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTYtMS0xLTEtMzAwNzk_67ddd9bc-357f-41d5-8d90-61556bffe569">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTYtMy0xLTEtMzAwNzk_7ff92dda-039c-4c07-94a2-0d1a9248f17e">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTctMS0xLTEtMzAwNzk_fc38c054-0753-4018-8757-54a5033ffe01">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTctMy0xLTEtMzAwNzk_e37e9fff-67c4-444d-9109-8a76ef1a3a55">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTgtMS0xLTEtMzAwNzk_5300a64d-751c-4fa9-924b-78d41ed329dc">3,915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTgtMy0xLTEtMzAwNzk_05050061-262e-4635-9a47-a04e95e7f43a">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTktMS0xLTEtMzAwNzk_b02b73fe-b8a2-413c-9231-870d859c6919">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTktMy0xLTEtMzAwNzk_20c25bf0-55ca-45e0-befa-2152bf26b900">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjAtMS0xLTEtMzAwNzk_0ac7e9ee-4945-40c3-966f-a4a231b1d24e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjAtMy0xLTEtMzAwNzk_ed6171c8-86f9-4768-a452-61e8f4262266">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjEtMS0xLTEtMzAwNzk_91c4ed47-2972-4311-9c8f-fdc873656e50">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjEtMy0xLTEtMzAwNzk_ca9efd74-f91a-48c9-b4dd-13ad1f093a9e">1,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjItMS0xLTEtMzAwNzk_eb170d01-da5e-4581-8b8c-3bd146bb0f28">453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjItMy0xLTEtMzAwNzk_58e05d31-d0f1-45c2-80fd-70182a3c3690">461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjMtMS0xLTEtMzAwNzk_7cc40816-c036-448a-87fe-3cca8f43ec48">1,858</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjMtMy0xLTEtMzAwNzk_16f2e4c2-7514-42b5-aa76-bd781f3bd6cc">1,788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjQtMS0xLTEtMzAwNzk_9be754f1-6f93-46e0-ab47-13cfc270e121">673</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjQtMy0xLTEtMzAwNzk_c8e70fb4-be3a-4d3f-9834-d58a1ff35d4d">732</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjUtMS0xLTEtMzAwNzk_92883a17-3819-4d44-81a0-20888110c715">278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjUtMy0xLTEtMzAwNzk_3fbddb92-dc56-4521-9cee-4cb0fb293194">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash (Used in) Provided by Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjYtMS0xLTEtMzAwNzk_53f5ee7c-862a-4a4a-a17e-5fda4bac63bb">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjYtMy0xLTEtMzAwNzk_568a2a4b-5868-44b7-86c0-3c03718301db">4,508</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzEtMS0xLTEtMzAwNzk_e868eaf5-b954-41c0-a3e0-d22ee739fc4f">1,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzEtMy0xLTEtMzAwNzk_389d98b1-03fa-41c8-b74a-2d9e6ba2c6d0">899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Investing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzItMS0xLTEtMzAwNzk_ac60b6f2-8085-4755-a381-bc606621b666">1,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzItMy0xLTEtMzAwNzk_b00047c8-8730-48a7-8c2e-f7701330fd2a">899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzctMS0xLTEtMzAwNzk_96adc8f1-d004-4ae9-bc98-44f7071f3dcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzctMy0xLTEtMzAwNzk_1254b8ce-6e32-4265-baba-d1e83013fba1">6,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of cash dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:PaymentsOfDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzgtMS0xLTEtMzAwNzk_eda2a431-9e98-4def-ad98-f335d28ddb68">758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzgtMy0xLTEtMzAwNzk_23410dc6-8d48-4cfd-a358-1f6cba2bcfff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzktMS0xLTEtMzAwNzk_aed66ed3-7516-49aa-86c7-aabfe8d7dbb1">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzktMy0xLTEtMzAwNzk_2c6b898a-d065-48fa-9965-561d40ca48c2">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDAtMS0xLTEtMzAwNzk_bb0d7603-6f4e-462c-bbb2-158dabc3aaad">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDAtMy0xLTEtMzAwNzk_fffd80ed-a56b-4137-924f-9236b2102407">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDEtMS0xLTEtMzAwNzk_e7cf9fc9-cfbd-4019-975e-f739a91be4ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDEtMy0xLTEtMzAwNzk_7be7e3f7-dcc4-4152-a4e6-96cd45dd4f3f">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDItMS0xLTEtMzAwNzk_354c0ec4-f21f-4a92-a977-3e8d61dd4c4b">728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDItMy0xLTEtMzAwNzk_b96f9ecc-e9a7-4401-9248-21560c7e24f1">6,508</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Effect on Cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDMtMS0xLTEtMzAwNzk_7574f78f-88c9-494f-a44c-4c7fcfeab863">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDMtMy0xLTEtMzAwNzk_4d77305d-0a9d-449e-8250-1fbcbfc90186">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Decrease in Cash and Cash Equivalents:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDQtMS0xLTEtMzAwNzk_726f2e4a-d1e5-4701-98ff-8b1520324704">2,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDQtMy0xLTEtMzAwNzk_b4322b7a-16ae-47f2-9fcd-2775b2fdc760">3,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents &#8212; beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDUtMS0xLTEtMzAwNzk_07ac22c6-4e5d-4127-98ef-9e82a3a1defb">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b4e14577474b4cb15b348ef3effb26_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDUtMy0xLTEtMzAwNzk_2d4a2956-53ab-48f4-9327-1ef3072998e8">23,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents &#8212; end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDYtMS0xLTEtMzAwNzk_0b2b5849-fb4c-45b9-ba9c-2c37c926c76d">17,370</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229fac654a6e456bae29a6583de50cb7_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDYtMy0xLTEtMzAwNzk_34838456-5cb6-4fb5-884a-a1cbec3ce340">20,174</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTEtMS0xLTEtMzAwNzk_5feec8ac-5506-4739-9da6-5224e2fa8ead">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTEtMy0xLTEtMzAwNzk_14c0792e-9171-44dd-b434-4322f3532616">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTItMS0xLTEtMzAwNzk_91853c95-d321-47bb-b681-ce1df0bf0fb1">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTItMy0xLTEtMzAwNzk_a64169b4-3a85-435b-9079-7f697602c5e4">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and notes should be read in conjunction with the audited financial statements and notes of LifeVantage Corporation (the &#8220;Company&#8221;) as of and for the year ended June&#160;30, 2022 included in the annual report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 23, 2022.</span></div><div id="ib4e76625aa6f4376962a48026c346254_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zNy9mcmFnOmQ2ZGU3YjE4NzRkNzQ1ZWJiMGVkOWEyM2RjZDBlM2RhL3RleHRyZWdpb246ZDZkZTdiMTg3NGQ3NDVlYmIwZWQ5YTIzZGNkMGUzZGFfMjgwOA_f2967bb1-72b8-4cdc-924c-b180bead93fd" continuedAt="i2407ec6d04064708bc7b489e479f44b0" escape="true">Organization and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i2407ec6d04064708bc7b489e479f44b0"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of December&#160;31, 2022, and the results of operations for the three and six months ended December&#160;31, 2022 and 2021, and the cash flows for the six months ended December&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.</span></div></ix:continuation><div id="ib4e76625aa6f4376962a48026c346254_40"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NDE_66b1116b-7dc3-48e8-b315-dacc580b6cd3" continuedAt="iabd9942b34fa44309fe8856f990a5563" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iabd9942b34fa44309fe8856f990a5563" continuedAt="ia1a0c031d1bb4f329c50e5cc6c0941f9"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTk_88e07e5e-236d-4909-af33-4e2eb72d1c52" continuedAt="iba86b5fdccb344ee825fa9bed269fa2c" escape="true">Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba86b5fdccb344ee825fa9bed269fa2c">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3Njk_8137bc73-ee13-4a5b-beb9-3111e34a691f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MjY_e3887148-b0f8-49db-a0c7-4d3cbe992203" continuedAt="i70f5707a28d84313a3039bd7c770ca94" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia1a0c031d1bb4f329c50e5cc6c0941f9" continuedAt="i07a1520c5e4249cd9e8cf70ede895a85"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i70f5707a28d84313a3039bd7c770ca94" continuedAt="icc236c6f0dc84a7581cf54abd9e1850a">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icc236c6f0dc84a7581cf54abd9e1850a">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</ix:continuation> For the three months ended December 31, 2022 and 2021, net foreign currency gains of $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjA1Ng_65f62304-9125-496e-ab97-d3fd1a2e0aec">0.2</ix:nonFraction> million and losses of $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjA2Mw_a052d872-b2e6-4e3d-8e34-f391f84a82ca">0.1</ix:nonFraction> million, respectively, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, net foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODU4_62d2b59f-d4ef-4e76-83d5-9dada4e7f3ed">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODY2_b4682971-596f-4643-bf75-d6fbfb6ca5a5">0.3</ix:nonFraction> million, respectively, are recorded in other expense, net. </span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTE_7ea06f88-6f85-44b9-a329-fd1d289ce532" continuedAt="i65578ff84d074099a43994c89180941f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i65578ff84d074099a43994c89180941f">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjc4OQ_a1c365e9-400a-49fc-b6b8-b0defaf84704">no</ix:nonFraction> realized gains or losses for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2021, realized losses of $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjg1NQ_83b99743-b81d-4a68-9cbf-761658bb36b9">34,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODkx_dce34dd3-527d-43d0-aa34-7eb3b4bfa599">0.1</ix:nonFraction> million related to forward contracts, are recorded in other expense, net, respectively.  The Company did not hold any derivative instruments at December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3MzE_8c44babe-bd0d-4bb7-94af-98a40988d9d1" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDI_88657aa0-367f-4674-b404-31f148dfd7be" continuedAt="ie3c30d4d56704e068b2729b34f9ba680" escape="true">Concentration of Credit Risk</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3c30d4d56704e068b2729b34f9ba680" continuedAt="ic73b651160314e38a2a4ab3453a8e7eb">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic73b651160314e38a2a4ab3453a8e7eb">such risk. Financial instruments with significant credit risk include cash and investments.</ix:continuation> At December&#160;31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="ie32dad3b31774e4ab4392448baf8d166_D20221231-20221231" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzQyNg_0d7199c1-33be-434a-b539-bf3133434c3f">12.4</ix:nonFraction> million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="i861234a92f024717aab0fcfdedc72f98_D20221231-20221231" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzQ3OQ_238e189f-306c-4335-8efe-6139b35b714a">5.0</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $<ix:nonFraction unitRef="usd" contextRef="i79ba066dbf2f4116a1bc1650082eb82d_D20220630-20220630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzU1MQ_87e71bb7-4061-433a-83eb-9d7da41a804c">15.4</ix:nonFraction>&#160;million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="ic6ffbc57f7df41d08f46fdd5af852da5_D20220630-20220630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzYwNA_620a4131-ea22-4ceb-8ac4-bd0d56ae6bfc">4.8</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of December&#160;31, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NzA_e3bd4195-c27e-4a08-834f-6dd14630305b" continuedAt="i2f9945ec18664af987e86468804fae5a" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2f9945ec18664af987e86468804fae5a">The Company&#8217;s accounts receivable as of December&#160;31, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December&#160;31, 2022 and June&#160;30, 2022 is not necessary.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_07bd3745-e6c1-458e-a7e6-58433ef43d57"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_30ceaf23-84a5-456a-a52d-3fe711b42638"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_8906baf7-b6dc-4eb2-82e1-23987eb3582d"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_db16faae-9761-47b2-a91a-05bdab804a94">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> bad debt expense was recorded during the three and six months ended December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MzQ_0939751a-fef5-45b4-aa9b-aade50523cf3" continuedAt="id5fa58a3357f44fe90100e25bd24b408" escape="true">As of December&#160;31, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):</ix:nonNumeric></span><ix:continuation id="id5fa58a3357f44fe90100e25bd24b408"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:31.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS0xLTEtMS0zMDA3OQ_602d9a27-f675-4bca-a7ce-91a27a8817bd">16,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS0zLTEtMS0zMDA3OQ_02692247-0b54-4bc3-8b7a-2492ea1d3b9e">80.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS01LTEtMS0zMDA3OQ_81b329f9-803b-49a6-be29-901f9e1ed56f">12,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS03LTEtMS0zMDA3OQ_214283c4-b7a8-406d-b5e0-dfecb9f2bd17">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi0xLTEtMS0zMDA3OQ_f38b3f54-2996-4195-b2c0-3a189657a58b">3,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi0zLTEtMS0zMDA3OQ_9d565f4a-13ac-4d72-85d9-6960a3c69474">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi01LTEtMS0zMDA3OQ_fc7a4053-1eb0-4d62-8f8d-236d8f2645ed">3,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi03LTEtMS0zMDA3OQ_8faade3f-2883-4354-a185-d39a5d66307c">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy0xLTEtMS0zMDA3OQ_732b9a5f-964a-4e49-803f-32088a802c60">20,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy0zLTEtMS0zMDA3OQ_5c761c3e-62de-4911-b980-6b43f3502136">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy01LTEtMS0zMDA3OQ_907aa16a-2f8e-40c8-a395-396285cc5f22">16,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy03LTEtMS0zMDA3OQ_ec650c1f-45bf-4ae1-9620-62b486a711c9">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDY_df09df0e-72c0-48d5-a616-14f39432559e" escape="true">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</ix:nonNumeric>, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDQyNg_86363757-85a3-4958-b8b8-a4b3f63ef4e8">1.2</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDQzMw_f8f4dacd-e6b4-425c-8a4d-b9489e8d9b94">1.3</ix:nonFraction> million at December 31, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.</span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NzQ_dd2595d6-bd97-469d-a671-aafbb6a06a53" continuedAt="i39c0eb44cad846dbb93b1c210f82c276" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i07a1520c5e4249cd9e8cf70ede895a85" continuedAt="ida5edbda83154d31be1714eb7ccac802"><ix:continuation id="i39c0eb44cad846dbb93b1c210f82c276"><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div></ix:continuation><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NDc_319037ba-eeda-402e-b3e1-d7e4c7b4ebe5" continuedAt="iab6a1a6c52334e6893610917be523a7d" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab6a1a6c52334e6893610917be523a7d" continuedAt="i5e3c535ef34a44c084820fe8fa6db6bd">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODEzOQ_e8cc1d53-393c-4834-9020-6bbabf132a41">30</ix:nonNumeric> days. After <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODE0OQ_e8cc1d53-393c-4834-9020-6bbabf132a41">30</ix:nonNumeric> days of purchase, only unopened product that is in a resalable and restockable condition may be returned within <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODI1OQ_872439b6-ac99-4d5e-bc23-92b460ef9c64">twelve months</ix:nonNumeric> of purchase and shall receive a <ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODI5NA_1bc72173-91a9-4ff8-b3d3-8a67a31dcfde">100</ix:nonFraction>% refund, less a <ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="INF" name="lfvn:HandlingAndRestockingFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODMxMg_d3a53259-dc54-4b04-9232-18f7ad70c0f1">10</ix:nonFraction>% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.</ix:continuation> As of&#160;December&#160;31, 2022 and June&#160;30, 2022, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODY2OA_6e8d0860-cec3-4515-a8e8-5e0e24236761">0.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODY3NQ_d1e0c47b-b002-4552-868b-5fb0034ee200">0.1</ix:nonFraction> million, respectively.</span></div><ix:continuation id="i5e3c535ef34a44c084820fe8fa6db6bd"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDM_ddaf21d9-df3f-438d-9f44-8d531ee75f3c" continuedAt="iedaf295b3836478ba2bc567de74ac931" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iedaf295b3836478ba2bc567de74ac931">The Company expenses all costs related to research and development activities, as incurred.</ix:continuation> Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended December 31, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfOTE0Ng_7d31bed0-7dbd-44be-a41a-3705ca161fbc">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfOTE1Mw_b0c0d0e1-fd04-41a3-9b97-783d527a9c06">0.2</ix:nonFraction> million, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwMDE5_5b19e108-6d16-4c7e-822c-8f9c67a42247">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwMDIz_bea13124-7669-46c9-8433-c57d744598eb">0.4</ix:nonFraction> million, respectively. </span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3ODk_fc1a003f-2480-4558-adab-c40bc3050247" continuedAt="i49a250e1783d4c529e3086e7e2eec82c" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ida5edbda83154d31be1714eb7ccac802" continuedAt="i85daa1ce3efc446384f1fd8a4be37673"><ix:continuation id="i49a250e1783d4c529e3086e7e2eec82c" continuedAt="i71910998aea94073935e37686841382e"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's strategies have resulted in operation modifications in certain Asia/Pacific markets resulting in the closure of showrooms and changes to selling models. As of December 31, 2022, the Company abandoned the ROU assets related to the Hong Kong and Singapore showroom leases. These leases were to terminate in August and September 2023, respectively. However, the Company reached agreements with each of the landlords to modify the termination date to February 2023. The remaining lease liability for these showrooms is $<ix:nonFraction unitRef="usd" contextRef="i1becdba443bf4dd4ad59c94e1d90ae27_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMzMDc3_4ddd21e5-9d62-4cd6-81c7-5db743e32735">34,000</ix:nonFraction> as of December&#160;31, 2022.  </span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i71910998aea94073935e37686841382e">Total expenses related to the abandonment of the ROU assets and costs associated with the change in operations in these markets for the three and six months ended December&#160;31, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:LossOnContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMyMTEz_45dfe20e-67d8-4b9c-b038-e2dc8b1c7ca2"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:LossOnContractTermination" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMyMTEz_a19d5c0f-b00e-408a-bfaf-2566235ea540">0.4</ix:nonFraction></ix:nonFraction>&#160;million and is included in selling, general, and administrative expenses.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4NDE_4b2fe017-86a5-4f12-88f7-0c7ca45888b0" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4NDI_3d02e816-3e8f-43ea-aa5b-288ec1b8baa7" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended December 31, 2022 and 2021, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTM2MzE_b9627e53-819d-4bee-a261-c6b85d9ba2f1">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTM2Mzg_35ef15cb-4509-412a-86e5-615818f8949b">0.5</ix:nonFraction> million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTY_83c231e4-4abb-45f0-afb8-8617c98c2873" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per common share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted (loss) income per common share is computed by dividing net (loss) income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2022 and 2021, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTQzNDQ_24630641-831e-463d-927c-17ef10c98b2b">0.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTQzNTE_11f41679-69c6-4d31-b204-c6dd478b69a6">0.1</ix:nonFraction> million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i85daa1ce3efc446384f1fd8a4be37673"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">computations as their effect was anti-dilutive. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwNjE0_f26b98b6-46a5-4a3d-89c4-14cc31d60358">0.4</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwNjE4_38b28895-7c11-4834-9dd8-d94beafddfe5">0.2</ix:nonFraction> million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MTY_2ebab501-0fb7-406d-8e7c-6fa659215bb3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net (loss) income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy0xLTEtMS0zMDA3OQ_c7d5b51b-add9-4b6a-ba9c-f84cb9fed4c0">1,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy0zLTEtMS0zMDA3OQ_713177f4-eef7-4254-a900-3738385377f4">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy01LTEtMS0zMDA3OQ_7cd4fd61-17df-48f3-9643-5fecc7b06a49">448</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy03LTEtMS0zMDA3OQ_80f7e397-c334-4eaf-b48a-c38d3da0d9e4">3,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS0xLTEtMS0zMDA3OQ_a94fb1e6-a9da-44ef-a00c-5882fe5a372b">12,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS0zLTEtMS0zMDA3OQ_0cc5ecb0-0fda-4be7-b026-d3fbe7d96f49">13,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS01LTEtMS0zMDA3OQ_ce4d70f2-997c-43de-8b4e-15c48448023a">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS03LTEtMS0zMDA3OQ_1e5bcf75-bfc6-4ece-82ae-d4822c0f1d41">13,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy0xLTEtMS0zMDA3OQ_dd634166-0047-40d5-a837-e256e64c8267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy0zLTEtMS0zMDA3OQ_bde85cad-7cb2-44e2-a097-8435042cca71">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy01LTEtMS0zMDA3OQ_a424040f-7c30-419e-a989-3d37ed48abf8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy03LTEtMS0zMDA3OQ_4b53126c-8a19-4465-94bb-372df83f477a">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS0xLTEtMS0zMDA3OQ_25569219-aba9-4a01-90be-c514eec391d6">12,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS0zLTEtMS0zMDA3OQ_d82f1691-9e7d-4320-a5ff-dd7020b9c790">13,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS01LTEtMS0zMDA3OQ_04bc57cb-2557-4daf-80f1-22c008aedf09">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS03LTEtMS0zMDA3OQ_b17b050c-4fac-4e38-8252-ca13aba7852d">13,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtMS0xLTEtMzAwNzk_780f6ce7-dea6-43ee-b590-229e0565f4f4">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtMy0xLTEtMzAwNzk_9e86005a-1cfc-4ff6-bb23-c304c7fabb7f">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtNS0xLTEtMzAwNzk_03221eea-be0b-4808-881d-e3504d1403ae">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtNy0xLTEtMzAwNzk_b0deb0ba-83e7-44bc-8081-0bb32b26f3ed">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtMS0xLTEtMzAwNzk_f9e14546-26e3-499a-9845-921cfbf07d17">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtMy0xLTEtMzAwNzk_9ce0f210-7ed5-4608-97be-07e1f261db3f">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtNS0xLTEtMzAwNzk_3f0e705d-bede-4bba-ab51-ae4e8ba3b8a4">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtNy0xLTEtMzAwNzk_03b80dd7-299f-49a3-962e-d1902d0dc486">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDQ_f1dbc1a9-3a92-42bf-a02f-e661dbdb935e" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in <ix:nonFraction unitRef="region" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTUyNjg_5ffa8785-9607-48c4-978b-dadfd1eda90e">two</ix:nonFraction>&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3Njc_f1ce8744-a494-4e35-a8e8-70ac901989eb" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these <ix:nonFraction unitRef="region" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU0MjM_5ffa8785-9607-48c4-978b-dadfd1eda90e">two</ix:nonFraction> geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib97c9bdb37f9443998ba3b10ca21301b_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi0xLTEtMS0zMDA3OQ_735835de-1dec-4d0d-ac29-d46601253763">39,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c2b290155354c5893117c2102630e53_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi0zLTEtMS0zMDA3OQ_708a6465-1651-4abc-8310-3f8fc7d4e33e">34,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic801932ee7b44766a8977bc48c61b215_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi01LTEtMS0zMDA3OQ_9c766062-bdc6-46c3-b56b-3870dfa29685">76,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ce3902b05744a2181c139ba0275d9b4_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi03LTEtMS0zMDA3OQ_5b17a31a-fd59-4f24-8eaa-c2cc4a2021ca">71,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa2a8d6f5cf24bb49ac338f8ad48ae7d_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy0xLTEtMS0zMDA3OQ_5bfc30b4-4476-4622-b789-6f6082326def">13,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd00b15e7224a37bd9bc7bb7749d232_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy0zLTEtMS0zMDA3OQ_14645efa-d983-4e6a-8ae8-fca2450ce8a3">17,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d763462815c4c90813a80f4704429fb_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy01LTEtMS0zMDA3OQ_5eb11aa9-9280-4a12-a474-1574e1532dd9">29,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c7fc25b6b4042e0a1f3a4195fa43155_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy03LTEtMS0zMDA3OQ_30d82072-b5e6-45ec-aa4f-29b144ed44db">34,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC0xLTEtMS0zMDA3OQ_4e92e082-8eb0-4f6e-8cfc-008551a28acb">53,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC0zLTEtMS0zMDA3OQ_37a72134-38b7-475a-bf16-308bb0f1f99f">52,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC01LTEtMS0zMDA3OQ_9f56b0ec-7e1b-4c1d-a519-d5757212fa8a">105,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC03LTEtMS0zMDA3OQ_fa4e93d0-4956-4fa0-944f-8f02d6ef0b8a">105,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79eb75825906423b9893fc621fe4f28f_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi0xLTEtMS0zMDA3OQ_968a8c82-9e99-4558-8075-c5cb86ee082d">37,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bd8df94500f43ff804118cdd61ee34a_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi0zLTEtMS0zMDA3OQ_d84ea607-54ed-4599-bf64-9c05edebe3db">32,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30543519b0b14ddfa6511963cf86120a_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi01LTEtMS0zMDA3OQ_0a612fdd-8220-4ab4-83fd-ecc5540a47ad">72,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b0acc99f3243ed990137d764b012d6_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi03LTEtMS0zMDA3OQ_0b68321f-b153-42cb-9e7a-b46c3298a2e2">67,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d87785af21d4f15924bf57416becf07_D20221001-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy0xLTEtMS0zMDA3OQ_e5f9fe1c-f66f-4d8e-a1ce-d848c1868469">7,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9513ebaa9554e018d59758d829177e6_D20211001-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy0zLTEtMS0zMDA3OQ_b2e095b7-566a-4966-861a-ce87532b950d">9,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018e46118dfa4569bee998cc12092f0e_D20220701-20221231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy01LTEtMS0zMDA3OQ_d76cafa2-1e34-43fb-ad56-caf75fc0cde2">15,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34e95207b834b059135ddc8c6f5335e_D20210701-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy03LTEtMS0zMDA3OQ_54850bbb-e751-4154-9ddf-11f8975fc19b">19,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTg_01fceff9-a9c5-41f8-97d8-900188830527" escape="true"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MTQ_d361000d-7ba9-4935-9150-41af1abf0a01" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i156352af4d364bd39bd40efc69390355_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMS0xLTEtMS0zMDA3OQ_c76a2271-6a48-467a-98fe-960bc61aaabc">20,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff7c281ffcb480b9728320152bb1757_I20220630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMS0zLTEtMS0zMDA3OQ_ed9ce72a-cc80-4d35-aad3-30c5d0f268fd">19,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5a8c78ae114f3ba91daa81c884673a_I20221231" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMi0xLTEtMS0zMDA3OQ_203e1829-d729-4d94-b6e6-62a23374860b">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c8407d9278411daaade025540b8362_I20220630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMi0zLTEtMS0zMDA3OQ_1c2809ff-b853-4380-bd3b-dd61d1767a2e">1,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div id="ib4e76625aa6f4376962a48026c346254_46"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMzQwMQ_d283bde4-2809-467e-9f74-6bbc999c6df9" continuedAt="ic1ed27ba63314f35a5118c6578972e5a" escape="true">Gig Economy Group Investment</ix:nonNumeric></span></div><ix:continuation id="ic1ed27ba63314f35a5118c6578972e5a" continuedAt="id6b9be3ed1c74f1dbaa0e13d422d936c"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="ifbf321362fb048e7ad989fd29aa10371_I20190531" decimals="INF" name="lfvn:NotesReceivableRelatedPartyMaximumCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMjQ3_7ab6e173-229c-499b-8fc1-43b3ff4d08fb">2.0</ix:nonFraction>&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="i791994c0741744289a7ca8016b475b80_D20190531-20190531" decimals="INF" name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfNDI5_f6384679-7981-4754-becc-d67ffe9bb682">8</ix:nonFraction>% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id6b9be3ed1c74f1dbaa0e13d422d936c"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company <ix:nonFraction unitRef="shares" contextRef="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfODAy_79b22fd8-49db-4a4c-9d88-ffffd3ec991c">1,000,000</ix:nonFraction> shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $<ix:nonFraction unitRef="usd" contextRef="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfOTcz_42b6e393-ee12-4bd1-ad95-951d963e2d03">0.0&#160;million</ix:nonFraction> in aggregate consideration).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive (loss) income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $<ix:nonFraction unitRef="usd" contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMzE3Ng_137e3eab-9ede-4138-a708-c6ba339fb180">2.2</ix:nonFraction>&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at December&#160;31, 2022 and June&#160;30, 2022.  During the three and six months ended December&#160;31, 2022 and 2021, there were no impairments recognized.</span></div></ix:continuation><div id="ib4e76625aa6f4376962a48026c346254_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQw_0574f986-51f8-486c-a61c-e1b5f8938ed9" continuedAt="i8194fabd0209436e95bd45a69e80d556" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i8194fabd0209436e95bd45a69e80d556"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTU4_9fa1335b-a4b3-465e-8752-be86b6f9943e">one</span> to <ix:nonNumeric contextRef="i264e87d680d542c1af5201533c298cd3_I20221231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTY0_71de10e4-d6d1-4ea9-855f-400f0d1a483a">nine years</ix:nonNumeric>. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was <ix:nonNumeric contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMjgw_12de90df-791a-456d-a7f8-0372a9f82e13">8.44</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMjg3_919d5fad-7ff9-4a8b-b31d-9839d03966b0">3.25</ix:nonFraction>%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2022 and 2021, operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMzUz_e7a13d1c-e82f-4c68-8723-a8e3c81d47c4">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMzYw_e7639b74-fa6e-4117-9dbb-5cba6f224e21">0.8</ix:nonFraction> million, respectively. For the six months ended December 31, 2022 and 2021, operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQ5NzU1ODE0NTI0_d2f31b4e-c630-4362-ba35-83a273ee2f16">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQ5NzU1ODE0NTI4_44fdbe01-7fee-4ab7-bb0d-e061ae1bc109">1.6</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQy_1744c0be-5e7e-4191-99bf-95a44f7b654b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi0xLTEtMS0zMDA3OQ_4b205a6a-09d2-4e27-b892-671915a20209">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi0zLTEtMS0zMDA3OQ_20bbd1d8-fc25-4192-8954-f62747c70ed5">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi01LTEtMS0zMDA3OQ_8e52d3c8-ffe8-4577-bce9-1226b2558eca">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi03LTEtMS0zMDA3OQ_b88ac42d-9443-4c95-bc62-5e395412e4ef">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQz_f2a1c221-91f5-4d87-a5e7-cab2274e855e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at December&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMS0yLTEtMS0zMDA3OQ_bb2d4003-5352-40b3-ba92-c2e78a649ebb">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMi0yLTEtMS0zMDA3OQ_46c5b7cd-ad21-4c8e-8a1d-e67eb53b36b7">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMy0yLTEtMS0zMDA3OQ_ac587a85-7b1c-4afd-8faf-7906e2071c19">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNC0yLTEtMS0zMDA3OQ_1b70cb32-51d2-4568-868e-b2af2aaa88a7">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNS0yLTEtMS0zMDA3OQ_c1fa1d87-d67e-48c1-81cb-6885d8784f34">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNi0yLTEtMS0zMDA3OQ_51a8afdd-03f4-4e58-88d3-87b053a8dd01">8,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNy0yLTEtMS0zMDA3OQ_316f9022-0bc0-4053-aaa6-aec21992194a">16,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfOC0yLTEtMS0zMDA3OQ_70467222-2135-4b2a-9a1f-a8cf0e853e14">2,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfOS0yLTEtMS0zMDA3OQ_70a90506-f502-42e3-9545-68114c9209ad">14,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcwNw_39ef4554-8c10-4be9-9688-636ad956423c" continuedAt="i2301c6385e6d46b0a376ebea4122edc8" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i2301c6385e6d46b0a376ebea4122edc8" continuedAt="i63c3f05a229a41d8bd01c5ce378c2aa1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i218031818c05468fb4b9344e8718454c_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzY1_2ab2f864-35c9-46be-b42d-f47efe6df54d">10.0</ix:nonFraction> million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNDY4_6e074b69-9de5-4a04-b6d7-4e5bc8276aaa">2.0</ix:nonFraction> million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $<ix:nonFraction unitRef="usd" contextRef="i00032d4dfded48658f82e08c57ab4a5a_D20220701-20221231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNzI1_6349dde8-4e3a-4575-a786-d4b509ee6c99">0.5</ix:nonFraction> million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from <ix:nonFraction unitRef="number" contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTE3NA_c661da5d-66c0-4906-9da5-4755aa347163">4.93</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTE4MA_243d4e07-2ef3-4793-b139-4426a721e625">5.68</ix:nonFraction>%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTM0NA_fd56083f-fcf7-40fb-bf96-fbf09dd752a8">1.50</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTM1Ng_9442230f-8c2e-4cd9-9568-a457ee0a27c7">1.25</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="i7ed07a20460f4cb1af2e73dc102582fe_D20180504-20180504" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcxMg_e6d60747-59e9-4fb3-81c3-5640227273b9">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was increased from $<ix:nonFraction unitRef="usd" contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTQ4Nw_bdff267f-1a58-4146-b5a1-e79e06ba3071">5.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTQ5Mw_6adbb0f1-c281-4d91-a3a1-a334639eb0aa">8.0</ix:nonFraction> million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than <ix:nonFraction unitRef="number" contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTY0OQ_8034cce6-2a05-44c6-8a5d-eb18f5478fed">3.00</ix:nonFraction> to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $<ix:nonFraction unitRef="usd" contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjE2Ng_dc9aca58-d9ec-4d07-b5e4-f46bd1202e67">2.0</ix:nonFraction> million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $<ix:nonFraction unitRef="usd" contextRef="i78f171a4c06a433b8599b63d53f8a878_D20190201-20190201" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjUxNA_af5927fa-1fda-47d3-a8eb-de86112cabc6">2.0</ix:nonFraction> million and increased the revolving loan facility from $<ix:nonFraction unitRef="usd" contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjU2NA_dc9aca58-d9ec-4d07-b5e4-f46bd1202e67">2.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i99892b92ec614947929196e70d6cfa90_I20190201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjU3MA_c2fe4652-f87e-404c-82a2-be7708ed0175">5.0</ix:nonFraction> million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjczNA_9442230f-8c2e-4cd9-9568-a457ee0a27c7">1.25</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="i6db563e50ed340da9ad6e97e830f1de7_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjc0Ng_6a2ae62b-128b-429b-a0db-e85b0028e71f">1.10</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="i02becdb52e634fce9233ae4e1d9199ab_D20190201-20190201" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcxMw_703deb98-11f7-415d-a1d3-6507c0b2abd4">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was decreased from $<ix:nonFraction unitRef="usd" contextRef="i09b53239b6d748c0b5dc0cd15c527f78_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjg3Nw_b6a51f82-161f-4b9d-a1c4-6dfe0ac167d3">8.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i6db563e50ed340da9ad6e97e830f1de7_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjg4Mw_3193d326-c1e1-4e07-bab2-64eeb528bbde">6.0</ix:nonFraction> million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of <ix:nonFraction unitRef="number" contextRef="i7033d13ec1104ebcb880b911489b11e6_D20210401-20210401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzE5OA_db0d5360-91ec-44dd-a934-d351195d61e0">3.00</ix:nonFraction>%, with an interest rate floor of <ix:nonFraction unitRef="number" contextRef="i1aad0c75d50047d5b8215d22695bea8e_D20210401-20210401" decimals="INF" name="lfvn:DebtInstrumentFloorInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzIzMw_f78d21e7-9078-4a3e-99c7-d0cdcf15888a">4.00</ix:nonFraction>%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of <ix:nonFraction unitRef="number" contextRef="i6986876bbd06457a874cb6f112493823_I20210401" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzQyOQ_bfab9e38-8112-42cd-aeba-588b5f1f1384">2.00</ix:nonFraction> to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $<ix:nonFraction unitRef="usd" contextRef="i715b8212e42447a3bcbc76261cc68d1f_I20221231" decimals="INF" name="lfvn:DebtInstrumentCovenantMaximumAllowedDividends" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzk1MA_f25f1a5a-b772-453c-abdd-beddba7dcaaa">500,000</ix:nonFraction> per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of December&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i63c3f05a229a41d8bd01c5ce378c2aa1">ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</ix:continuation></span></div><div id="ib4e76625aa6f4376962a48026c346254_55"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjk5Ng_a450e370-a19e-4a20-81da-9a9eab61622a" continuedAt="i345b81cc489443c29a743b7c53583fc1" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i345b81cc489443c29a743b7c53583fc1"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued $<ix:nonFraction unitRef="shares" contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3OTQx_ad5946d4-813a-4dbf-82b0-79e285ce1cef">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="shares" contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3OTUy_875b9074-62cf-4312-9dab-58be9a590632">0.1</ix:nonFraction> million shares of common stock under equity award plans, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued $<ix:nonFraction unitRef="shares" contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE4MDI3_9928a691-eced-4c8c-9405-2f00cecfb0f8">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="shares" contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE4MDMx_79357062-e41c-4d94-9b20-371b74e4ae6c">0.1</ix:nonFraction> million shares of common stock equity award plans, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued <ix:nonFraction unitRef="shares" contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjcwNA_56be68a5-6f54-4063-97c1-d852315498d1"><ix:nonFraction unitRef="shares" contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjcwNA_fa924dda-8956-43c9-b088-7d6f5825eef5">no</ix:nonFraction></ix:nonFraction> shares of common stock upon the exercise of stock options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued <ix:nonFraction unitRef="shares" contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3MDY0_6de5917d-dcfe-445f-81a4-0732a021fdc7">zero</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3MDcy_122be6e5-628e-47b6-ad17-40a6032f1859">30,000</ix:nonFraction> shares of common stock upon the exercise of stock options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE2ODk5_770bd13a-b0c0-4296-a9b5-8f1d83ea77e0">5,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NDg5_b40a0ea5-5ae4-4291-8e05-3191397c1ada">5,000</ix:nonFraction> shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NDk3_e1a9a9a5-4938-417f-ada9-5310e788aa7f">22,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTAx_5ab4263c-06c5-4112-9ed2-1e5215067b1d">24,000</ix:nonFraction> shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i24899bef054f4e1ea3689d7f8468ada1_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTY1_6200f919-f8b8-4f4b-98f2-d2689a57e581">5</ix:nonFraction> million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="i24899bef054f4e1ea3689d7f8468ada1_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTQ1NQ_ee24781b-1add-4c81-b20b-5ce795e05895">5</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i3600ade8ac584e599fd793f01363db8f_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTQ2MQ_a084339d-769c-43aa-b30a-d45f9c902f04">15</ix:nonFraction> million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="i3600ade8ac584e599fd793f01363db8f_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTYxOA_e3d88032-6700-4893-bb77-b9b279ba8d5a">15</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ib04b2568d00d452ca563a93b3382040c_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTYyNA_82175ec7-5901-4a57-a1b9-615c8d68ea2c">35</ix:nonFraction> million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="ib04b2568d00d452ca563a93b3382040c_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTg1NQ_82175ec7-5901-4a57-a1b9-615c8d68ea2c">35</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTg2MQ_5a033246-87d0-4e5f-a21f-5c2181b675aa">60</ix:nonFraction> million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended December&#160;31, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased <ix:nonFraction unitRef="shares" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjY5Ng_4bafa0d3-c7cf-43bf-94ec-8904087e770e"><ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjY5Ng_61fbc94c-8e97-4c57-95d1-bec41b01a280">no</ix:nonFraction></ix:nonFraction> shares of common stock under this repurchase program. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased <ix:nonFraction unitRef="shares" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTk5OQ_59a45c2d-0e39-46a1-981e-a97c590187c1">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTI1_6b02125b-3978-47ee-ad88-b5ef7a6872a9">0.9</ix:nonFraction> million shares of common stock at an aggregate price of $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjA1MA_ec94b493-2508-4acd-82f2-07b815840dcd">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTUw_33bdf7f9-8d63-4ed9-a620-17bdd4be6a3d">6.6</ix:nonFraction> million under this repurchase program, respectively. At&#160;December&#160;31, 2022, there is $<ix:nonFraction unitRef="usd" contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjEwMA_c32b4b2c-fb39-4097-b2bf-172301fdd0ef">27.7</ix:nonFraction> million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of December&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022 and November 2022, the board of directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa3a80900568428483190bd6fe806e89_D20220915-20220915" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_2182cfc0-338a-4f58-8f08-f49acefdcc1f"><ix:nonFraction unitRef="usdPerShare" contextRef="i81f7806f4c744d4bb6f8f72a1d67d3cc_D20221101-20221130" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_62dd3e0f-bed3-41e9-bbe0-03de3b54ac54"><ix:nonFraction unitRef="usdPerShare" contextRef="i0a878dc75136466d939f36303f8f29bb_D20220801-20220831" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_6c1baa2e-c46a-4d03-bff5-884e27c051bd"><ix:nonFraction unitRef="usdPerShare" contextRef="iaed23e7162044f03b895993f02f2b3ae_D20221215-20221215" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_6f2fd648-6571-47e4-a57f-a3947793cf18">0.03</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share of common stock to be paid on September 15, 2022 and December 15, 2022, to stockholders of record on September 2, 2022 and December 1, 2022, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends for the three and six months ended December&#160;31, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjYyNg_edafc211-2546-432f-a4e2-77cb5c52e3bf">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTYz_f44c1296-3f3f-41f1-95f8-f2adc2a94afb">0.8</ix:nonFraction> million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjYzMw_0fa0a659-fb06-4af4-8ca4-a653a1db779e">0.03</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTcz_f9bd6d69-eb7c-4e9a-8b9f-25f919c19b11">0.06</ix:nonFraction> per share, respectively</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.</span></div></ix:continuation><div id="ib4e76625aa6f4376962a48026c346254_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzNA_7aa1c3bb-1af4-474f-8de8-8e494fb1f3bb" continuedAt="iaae804f7d2c746779948c07923485f3d" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="iaae804f7d2c746779948c07923485f3d" continuedAt="i582e58ff352847d0af87622389b19cb5"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="i319cb485eedd404a8b0525a42c144e5e_I20061121" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzA1_1436d8ac-40da-4bf8-86d8-27476842ae80">1.4</ix:nonFraction> million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="i124fe5e6230a4630a62ed6b5b04e0d66_I20100927" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfODI1_21a94945-655e-4ec5-8d37-e85efb772f0c">1.0</ix:nonFraction> million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i582e58ff352847d0af87622389b19cb5" continuedAt="i2dced4393bad48d593181c20749e1af1"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, officers and directors. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2010 Plan. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants.&#160;&#160;&#160;&#160;The initial share pool approved was <ix:nonFraction unitRef="shares" contextRef="id39f56f005d149c1b465694988b14646_D20170216-20170216" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODI0MDMy_b577e3df-8301-4e30-927f-80dc03b42ed7">650,000</ix:nonFraction> shares. On February 2, 2018, November 15, 2018, November 12, 2020 and November 10, 2022, the stockholders approved amendments to the 2017 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="ie686cd256ac841c290a740d58fa0128c_D20180202-20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjExMg_7928ee0d-89d1-425f-8d39-7ec82eb46282">425,000</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="if3d44ad1e2f441659ef97e1de7898de2_D20181115-20181115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjEyMw_6f4a20d9-1596-41b0-984d-ab66d1c5d017">715,000</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i14171336bf9443a9a4f5906ebea800a2_D20201112-20201112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjEzNw_a19bb705-2bd3-43d4-bab6-6a534fa2ba2d">650,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="ia799876fcd8d48f3a197ae9951a5a93f_D20201110-20201110" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODk3_6be6f900-93e7-4070-b42d-226df9752c8c">1,052,000</ix:nonFraction> shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;December&#160;31, 2022, a maximum of <ix:nonFraction unitRef="shares" contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjI4OQ_1a837753-a89a-4a53-a1fa-8e7e30729b20">4.0</ix:nonFraction> million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) <ix:nonFraction unitRef="shares" contextRef="i3924c2c406d347e5ba4fdff4f8a7dadc_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjQ0MA_4c3708bd-da97-466c-9918-5726ec01a4b6">3,492,000</ix:nonFraction> shares and (ii) up to <ix:nonFraction unitRef="shares" contextRef="i1a9535be90b54a28934aa4096ffa89cc_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjQ2NQ_8222ba5f-57b7-415f-a610-77447de7f21a">475,000</ix:nonFraction> shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjczNA_3620bce6-e134-4da9-bf13-d4a9195db174">4.44</ix:nonFraction> per share, and vest over a <ix:nonNumeric contextRef="if84a6b9c61ff454ea30977fdf0b8c64f_D20220701-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzNg_eb73d0c9-aa4d-44ef-9f53-67e89b944092">three year</ix:nonNumeric> vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted is generally <ix:nonNumeric contextRef="i1c455728e942439eb75adbf84a5525ff_D20100927-20100927" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzMjA4_7bc4f3cd-a60e-4856-a039-577a1fb9303c">ten years</ix:nonNumeric>. As of December&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of <ix:nonFraction unitRef="shares" contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzE3NA_85c993cc-e3c7-4610-8ee4-8652f6801044">0.1</ix:nonFraction> million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved <ix:nonFraction unitRef="shares" contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzU0OQ_a4bb425b-c7b4-4d5e-946e-82f1f5516af9">0.4</ix:nonFraction> million shares of its common stock for issuance under the ESPP. As of December&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzYxOA_e7a6f7b6-82e2-4d4e-a01f-5b9899361c26">0.2</ix:nonFraction> million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to <ix:nonFraction unitRef="number" contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzk3Mg_49bc45e2-31d3-4cf0-bcac-2273a4cd90b9">85</ix:nonFraction>% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to <ix:nonFraction unitRef="number" contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDE0OA_7b51f8f8-64aa-4199-bed2-0d9984ccf75d">15</ix:nonFraction>% of their regular hourly or salary compensation, and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDIyMg_edfa94fa-eefe-4517-add8-a6b8a5b686b1">3,000</ix:nonFraction> shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $<ix:nonFraction unitRef="usd" contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDQzOA_e1055c4b-dad1-43b1-bd4f-05c385760391">25,000</ix:nonFraction> grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive <ix:nonNumeric contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzMA_fe9e9500-56da-4520-a8e9-35805f10aaf1">six-month</ix:nonNumeric> offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately <ix:nonFraction unitRef="shares" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODM4_09955f39-ec33-41f4-9317-65bddaaed97f">36,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODU0_c2f4e9af-da19-43d5-a69e-42e962713d8d">27,000</ix:nonFraction> shares of common stock were issued under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="i2dced4393bad48d593181c20749e1af1" continuedAt="ifdd2925c5b544720aa876f7d795804ef"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, compensation of $<ix:nonFraction unitRef="usd" contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5Mjg4_829f8437-2061-4739-b865-39237ca5cafa">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5MTcx_5d700bcc-58f5-462b-8dee-277a47e33fe6">0.8</ix:nonFraction> million, respectively, was reflected as an increase to additional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> paid-in capital, all of which was employee related. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended December 31, 2022 and 2021, compensation of $<ix:nonFraction unitRef="usd" contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5Mjk2_88ee42a0-043c-4876-9b33-9a86c3264b1c">1.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5MzA0_fe484e63-fca7-4fdd-ac7c-73a68fe73bc0">1.4</ix:nonFraction> million, respectively, was reflected as an increase to additional</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifdd2925c5b544720aa876f7d795804ef"> paid-in capital, all of which was employee related.</ix:continuation> </span></div><div id="ib4e76625aa6f4376962a48026c346254_61"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfODQ2Ng_75d7d1aa-8aa0-46ed-b7fa-46c21b76234e" continuedAt="i83c5ddd85c03428a8c0ce24d9c9ef390" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i83c5ddd85c03428a8c0ce24d9c9ef390" continuedAt="i0a72fe9fa352431a9ffbde33ed43373b"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  December&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0a72fe9fa352431a9ffbde33ed43373b" continuedAt="ie62410e4388b4140a294a18babc1ccd0"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing <ix:nonFraction unitRef="claim" contextRef="i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfNTQyMw_a9b96643-428b-4593-943a-f46084740d8d">three</ix:nonFraction> of the Plaintiff's <ix:nonFraction unitRef="claim" contextRef="iab9abce091734ee090f3cba6def7ace7_I20191205" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfNTQ0NQ_83e8d92c-579a-43eb-94c4-ecbc8ba11f6c">four</ix:nonFraction> claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. On December 15, 2022, the case was dismissed with prejudice, which concluded litigation.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="ie62410e4388b4140a294a18babc1ccd0" continuedAt="i68e16b0f067a4d3b834b96e6d98af0da"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i68e16b0f067a4d3b834b96e6d98af0da">In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="ib4e76625aa6f4376962a48026c346254_67"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. We are dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically-validated products to customers an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d independent distributors as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">well as a financially rewarding commission-based direct sales opportunity to our independent distributors. We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. We currently sell our products to customers and independent distributors in two geographic regions that we have classified as the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.04pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success and growth of our business is primarily based on the effectiveness of our independent distributors to attract and retain customers in order to sell our products and our ability to attract and retain independent distributors. When we are successful in attracting and retaining independent distributors and customers, it is largely because of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our products, including our flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> family of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, our line of Nrf2 enhanced TrueScience&#174; skin, hair, bath &amp; body, and targeted relief products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our smart weight management system;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our sales compensation plan and other sales initiatives and incentives; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our delivery of superior customer service.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, it is vital to our success that we leverage our product development resources to develop and introduce compelling and innovative products and provide opportunities for our independent distributors to sell these products in a variety of markets. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. In addition, we sell our products in a number of countries to customers for personal consumption only and in China through a China approved cross-border e-commerce business model. Entering a new market requires a considerable amount of time, resources and continued support. If we are unable to properly support an existing or new market, our revenue growth may be negatively impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 on Our Business</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by COVID-19 has continued to disrupt our business in certain markets in fiscal year 2023. Our independent distributors have continued to experience disruptions. Specifically, in Japan, independent distributors are required to provide a hard-copy introductory packet (gaiyoshomen) in person to each person they approach to sponsor as an independent distributor before presenting our products and business opportunity. This requirement inhibits independent distributors from connecting with potential new independent distributors virtually or through social media. Accordingly, quarantines, avoidance of public places and general concerns about physical distancing related to COVID-19 or otherwise negatively affected the ability for independent distributors to meet people in person and commence the enrollment process. To mitigate these effects and in an effort to sustain their sales volume, our independent distributors have adapted their approach for customer outreach and enrollment, including transitioning to a stronger social media presence. Our business may, in the future, experience additional disruptions and be negatively impacted by the COVID-19 pandemic, including as a result of limitations on the ability of our suppliers to manufacture, or procure from manufacturers, the products we sell or any of the raw materials or components required in the production process, or to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic or local, state, or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; limitations on the ability of our independent distributors to conduct their businesses and purchase our products; and limitations on the ability of our independent distributors or customers to continue to purchase our products due to decreased disposable income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made modifications and are continuing to evaluate additional potential modifications that may be needed, to protect our supply chain and preserve adequate liquidity to ensure that our business can continue to operate during  uncertain times. Near the end of fiscal year 2020 we transitioned all of our corporate employees to a work from home model and during July 2021 we began to implement a hybrid schedule with opportunities for employees to return back to the office. That hybrid schedule continues to be in effect today. To date, our employees are performing and adapting well with the evolving environment. With respect to liquidity, we are evaluating and taking actions to ensure that we continue to responsibly manage expenses across our organization.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to actively monitor how COVID-19 or any similar situation might affect business operations.  We may take any necessary actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees, independent distributors, customers, and stockholders.</span></div><div id="ib4e76625aa6f4376962a48026c346254_70"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+ , ProBio and Daily Wellness dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our line of skin, bath &amp; body, target relief, and hair care products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ, our smart weight management system. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is formulated to increase cellular energy and performance by boosting mitochondria production to improve cellular repair and slow cellular aging. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contains a proprietary blend of ingredients and has been shown to combat oxidative stress and enhance energy production by increasing the body&#8217;s natural antioxidant protection at the genetic level, inducing the production of naturally occurring protective antioxidant enzymes, including superoxide dismutase, catalase, and glutathione synthase. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alled NAD (nicotinamide adenine dinucleotide), and has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. Use of the three Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products together has been shown to produce synergistic benefits greater than using the single products on their own. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+ is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ProBio  is a dietary supplement designed to support optimal digestion and immune system function. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Daily Wellness  is a dietary supplement designed to support and strengthen immune health. Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of anti-aging skin and hair care, and CBD Nrf2 enhanced, bath &amp; body, targeted relief products includes TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Facial Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Eye Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Anti-Aging Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beauty Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Invigorating Shampoo, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nourishing Conditioner, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scalp Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Wash, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Butter, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deodorant, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Soothing Balm, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Rub, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen. Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our line of our nootropic energy drink mixes formulated to promote alertness and support mental performance. PhysIQ is our smart weight management system, which includes PhysIQ Fat Burn, PhysIQ Prebiotic and PhysIQ Whey Protein, all formulated to aid in weight management. IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  helps support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and may help support normal sleep patterns. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. By studying the effects of nutrients and natural compounds, we have developed scientifically-backed nutrigenomics products that promote healthy aging on the cellular level. By stacking these products together, we have created a foundation for synergy from nutrigenomic products to promote a healthier life. The Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes four of our nutrigenomics products &#8212; Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ProBio. This product stack was designed to provide a foundation for wellness, supporting healthy organs, including the brain, heart, eyes, and other vitals. With the Ultimate Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we added Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and PhysIQ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prebiotic to our Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to support gut health and increase sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of our Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and was designed to effectively and synergistically reduce oxidative stress, support mitochondria function, increase sirtuin activity, and target cell signaling pathways to fight the effects of aging. We also offer stacks that directly support the following consumer needs: immune support, heart health, energy, well-being, eye health, cognition and memory, metabolism, gut health, skin care, and hair care.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have additional products in development. Any delays or difficulties in intr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oducing compelling products or attractive initiatives or tools into our markets may have a negative impact on our revenue and our ability to attract new independent distributors and customers. </span></div><div id="ib4e76625aa6f4376962a48026c346254_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we utilize a direct selling model for the distribution of a majority of our products, the success and growth of our business is primarily based on the effectiveness of our independent distributors to attract customers and sell our products and our ability to attract new and retain existing independent distributors. Changes in our product sales typically are the result of variations in product sales volume relating to fluctuations in the number of active independent distributors and customers purchasing our products. The number of active independent distributors and customers is, therefore, used by management as a key non-financial measure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in our active accounts base by geographic region. These numbers have been rounded to the nearest thousand as of the dates indicated. For purposes of this report, we define &#8220;Active Accounts&#8221; as only those independent distributors and customers who have purchased from us at any time during the most recent three-month period, either for personal use or for resale.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change from Prior Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Independent Distributors</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Independent Distributors</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Accounts</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="ib4e76625aa6f4376962a48026c346254_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three and Six Months Ended December&#160;31, 2022 and 2021</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generated net revenue of $53.7 million and $52.2 million during the three months ended December 31, 2022 and 2021, respectively. We generated net revenue of $105.4 million and $105.4 million during the six months ended December 31, 2022 and 2021, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Foreign currency fluctuations negatively impacted our revenue $2.4 million or 4.5% and $5.0 million or 4.8% during the three and six months ended December&#160;31, 2022, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three and six months ended December&#160;31, 2022 and 2021 for the Americas region (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,074&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue in the Americas region for the three and six months ended December&#160;31, 2022 increased $5.0 million or 14.4% and $4.9 million or 6.9%, respectively, from the prior year periods. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Active Accounts decreased by 7.1% in the region compared to the prior year </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period. The decrease in total Active Accounts was offset by an increase in average revenue per account due to changes in our product sales mix, driven primarily by our new TrueScience</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen product announced during our Activate 2022 event held in June 2022. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia/Pacific &amp; Europe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three and six months ended December&#160;31, 2022 and 2021 for the Asia/Pacific &amp; Europe region and its principal markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.581%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia &amp; New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,957&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,362&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,257&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the Asia/Pacific &amp; Europe region decreased $3.5 million or 20.2% and $4.9 million or 14.3% for the three and six months ended December&#160;31, 2022, respectively, as com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pared to the prior year periods. Active Accounts in the region decreased 12.0% compared to the prior year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> period. Decreases in total Active Accounts along with negative impacts from foreign currency exchange rate fluctuations have contributed to the overall decrease in revenue within the Asia/Pacific &amp; Europe region. We continue to be encouraged by the results we are seeing from our launch of Philippines due to continued distributor leadership development and advancement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, revenue in the Asia/Pacific &amp; Europe region was negatively impacted by foreign currency exchange rate fluctuations in the amount of approximately $2.3 million or 13.3% and $4.9 million or 14.5% during the three and six months ended December&#160;31, 2022, respectively, as compared to the prior year periods, mainly due to currency fluctuations in Japan. Revenue in Japan was negatively impacted by foreign exchange rate fluctuations in the amount of approximately $1.8 million or 17.3% and $3.9 million or 19.3%, during the three and six months ended December&#160;31, 2022, respectively, as compared to the prior year periods. On a constant currency basis, revenue in Japan decreased 8.3% and 2.0% for the three and six months ended December&#160;31, 2022, respectively, as compared to the prior year periods. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Globally, our sales and marketing efforts continue to be directed toward strengthening our core business through our fiscal year initiatives and building our worldwide revenue. During fiscal year 2022, we launched our new LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> IC Bright</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> eye health product in October 2021 and TrueScience</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen in June 2022. We have plans for continued product expansion during the remaining fiscal 2023. We expect these product launches will help drive revenue growth globally through increased average order size and increased ability to attract and retain new independent distributors and customers with a compelling product lineup.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Margin. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit percentage for the three months ended December 31, 2022 and 2021 was 78.1% and 81.5%, respectively. Our gross profit percentage for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 was 79.4% and 81.9%, respectively. The decrease in gross margins, as compared to the prior year periods, is primarily due to increased shipping to customer expenses during the current year period as well as shifts in geographic and product sales mix. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commissions and Incentives.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Commissions and incentives expenses during the three months ended December 31, 2022 were $23.6 million or 43.9% of revenue as compared to $25.4 million or 48.8% of revenue for the three months ended December 31, 2021. Commissions and incentives expenses during the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were $47.4 million or 44.9% of revenue as compared to $49.6 million or 47.0% of revenue for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The decrease in commissions and incentives expenses as a percentage of revenue compared to the prior year periods is due mainly to the price increases on many of our products during the current period as well as due to the timing and magnitude of our various promotional and incentive programs. Commissions and incentives expenses, as a percentage of revenue, may fluctuate in future periods based on ability to hold incentive trips and events and the timing and magnitude of compensation, incentive and promotional programs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses during the three months ended December 31, 2022 were $19.6 million or 36.5% of revenue as compared to $17.4 million or 33.4% of revenue for the three months ended December 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses during the six months ended December 31, 2022 were $36.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 34.4% of revenue as compared to $32.5 million or 30.8% of revenue for the six months ended December 31, 2021. The increase in selling, general and administrative expenses as a percentage of revenue during the three and six months ended December&#160;31, 2022 compared to the prior year periods is primarily due to increased event and travel expenses, employee compensation, and outside professional services related to upcoming initiatives launching in the second half of fiscal 2023.  These increases have been offset by decreases in legal, accounting, and tax services. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Other Income (Expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e).</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we recognized total net other income of $0.2 million as compared to expense of $0.1 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we recognized total net other expense of $0.3 million as compared to $0.3 million for the six months ended December 31, 2021. Total net other income (expense) for the three and six months ended December&#160;31, 2022 and 2021 consisted primarily of foreign currency gains and losses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Benefit (Expense)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognized income tax benefit of $17,000 and expense of $0.2 million for the three and six months ended December&#160;31, 2022, respectively, as compared to income tax benefit of $0.6 million and expense $0.5 million for the three and six months ended December&#160;31, 2021, respectively.</span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The change in the effective tax rate for the six months ended December 31, 2022 compared to the prior year period was mainly due to a change in taxable income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our effective tax rate will fluctuate slightly during the remainder of fiscal 2023 as the impact of discrete items and other permanent differences are recognized during the year; however, our tax rate can be impacted by various book to tax differences and fluctuations in our stock price that occur during the year which are difficult to forecast.</span></div><div id="ib4e76625aa6f4376962a48026c346254_79"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary liquidity and capital resource requirements are to finance the cost of our planned operating expenses and working capital (principally inventory purchases), fund capital expenditures, and service our debt, which includes any outstanding balances under the 2016 Credit Facility. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generally relied on cash flow from operations to fund operating activities and we have, at times, incurred long-term debt in order to fund stock repurchases and strategic transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, our available liquidity was $17.4 million, which consisted of available cash and cash equivalents. This represents a decrease of $2.8 million from the $20.2 million in cash and cash equivalents as of June&#160;30, 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended December&#160;31, 2022, our net cash used in operating activities was $0.4 million as compared to our net cash provided by operating activities of $4.5 million during the six months ended December&#160;31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended December&#160;31, 2022, our net cash used in investing activities was $1.6 million, as a result of the purchase of fixed assets. During the six months ended December&#160;31, 2021, our net cash used in investing activities was $0.9 million, as a result of the purchase of fixed assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities during the six months ended December&#160;31, 2022 was $0.7 million as a result of our payment of a cash dividend and shares purchased as payment of tax withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan. Cash used in financing activities during the six months ended December&#160;31, 2021 was $6.5 million as a result of our repurchas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e of common stock, and shares purchased as payment of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan and stock option exercises.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and June&#160;30, 2022, the total amount of our foreign subsidiary cash </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $6.4 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $7.0 million, respectively. The federal tax reform legislation that was passed into law during December 2017 enacted a 100% dividend deduction for greater than 10% owned foreign corporations. Therefore, in the future, if needed, we expect to be able to repatriate cash from foreign subsidiaries without paying additional U.S. taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had working capital (current assets minus current liabilities) of $21.0 million, compared to working capital of $21.2 million at June&#160;30, 2022. We believe that our cash and cash equivalents balances and our ongoing cash flow from operations will be sufficient to satisfy our cash requirements for at least the next 12 months. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow needs. In the event that our current cash balances and future cash flow from operations are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds, which may not be available on terms that are acceptable to us, or at all. Our credit facility, however, contains covenants that restrict our ability to raise additional funds in the debt markets and repurchase our equity securities without prior approval from the lender. Additionally, our credit facility, as amended, provides for a revolving loan facility in an aggregate principal amount up to $5.0 million. We would also consider realigning our strategic plans including a reduction in capital spending and expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2020, we filed a shelf registration statement (the "Shelf Registration") on Form S-3 with the SEC that was declared effective April 3, 2020, which permits us to offer up to $75 million of common stock, preferred stock, debt securities and warrants in one or more offerings and in any combination, including in units from time to time. Our Shelf Registration is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intended to provide us with additional flexibility to access capital markets for general corporate purposes, which may include, among other purposes, working capital, capital expenditures, other corporate expenses and acquisitions of assets, licenses, products, technologies or businesses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, we entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance our outstanding debt. In connection with the 2016 Loan Agreement and on the same date, we entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan was payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If we borrow under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, we entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, we entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, we made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, we entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that we maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility amount as set forth in Amendment No. 2.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows us to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict our ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of our equity interests, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of our assets. As of December&#160;31, 2022, we were in compliance with all applicable non-financial and restrictive covenants under the 2016 Credit Facility, as amended. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, also contains various financial covenants that require us to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Specifically, we must:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a minimum fixed charge coverage ratio (as defined in the 2016 Loan Agreement, as amended) of at least 1.10 to 1.00 at the end of each fiscal quarter, measured on a trailing twelve month basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain minimum consolidated working capital (as defined in the 2016 Loan Agreement, as amended) at the end of each fiscal quarter of at least $6.0&#160;million; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a ratio of debt (total liabilities) to tangible net worth (as defined in the 2016 Loan Agreement, as amended) of not greater than 2.00 to 1.00 at the end of each quarter, measured on a trailing twelve month basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we were in compliance with all applicable financial covenants under the 2016 Credit Facility, as amended. Additionally, management anticipates that in the normal course of operations we will be in compliance with the financial covenants during the ensuing year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2020, we repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments and Obligations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual payment obligations and commitments as of&#160;December&#160;31, 2022&#160;(in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than<br/>1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-3&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3-5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,594&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,338&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,374&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other operating obligations represent contractual obligations primarily related to marketing and sponsorship commitments and purchases of inventory.</span></div><div id="ib4e76625aa6f4376962a48026c346254_82"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we did not have any off-balance sheet arrangements.</span></div><div id="ib4e76625aa6f4376962a48026c346254_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our financial statements in conformity with accounting principles generally accepted in the United States of America. As such, we are required to make certain estimates, judgments, and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from these estimates. Our significant accounting policies are described in Note 2 to our unaudited condensed consolidated financial statements. Certain of these significant accounting policies require us to make difficult, subjective, or complex judgments or estimates. We consider an accounting estimate to be critical if (1)&#160;the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and (2)&#160;changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are other items within our financial statements that require estimation, but are not deemed critical as defined above. Changes in estimates used in these and other items could have a material impact on our financial statements. Management has discussed the development and selection of these critical accounting estimates with our board of directors, and the audit committee has reviewed the disclosures noted below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Allowances for Product Returns</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record allowances for product returns at the time we ship the product based on estimated return rates. Subject to some exceptions based on local regulations, our return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. As of December&#160;31, 2022, our shipments of products sold totaling approxi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mately $17.5 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were subject to the return policy. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor our product returns estimate on an ongoing basis and revise the allowances to reflect our experience. Our allowance for product returns was $0.2 million at December&#160;31, 2022, compared with $0.1 million at June&#160;30, 2022. To date, product expiration dates have not played any role in product returns, and we do not expect that they will in the future as it is unlikely that we will ship product with an expiration date earlier than the latest allowable product return date. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory Valuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value our inventory at the lower of cost or net realizable value on a first-in first-out basis. Accordingly, we reduce our inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equal to the difference between the cost of the inventory and its net realizable value. Factors utilized in the determination of net realizable value include: (i)&#160;current sales data and historical return rates, (ii)&#160;estimates of future demand, (iii)&#160;competitive pricing pressures, (iv)&#160;new production introductions, (v)&#160;product expiration dates, and (vi)&#160;component and packaging obsolescence.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2022 we recognized expenses of approximately $0.3 million and $0.5 million, respectively, related to obsolete and slow-moving inventory. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2021 we recognized expenses of approximately $0.3 million and $0.5 million, respectively, related to obsolete and slow-moving inventory.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes that we collect concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the fair value approach to account for stock-based compensation in accordance with current accounting guidance. We recognize compensation costs for awards with performance conditions when we conclude it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each balance sheet date and adjust compensation costs based on our probability assessment. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by the employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all of our costs related to research and development activities as incurred.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are occasionally involved in lawsuits and disputes arising in the normal course of business. Management regularly reviews all pending litigation matters in which we are involved and establishes accruals as we deem appropriate for these litigation matters when a probable loss estimate can be made. Estimated accruals require management judgment about future events. The results of lawsuits are inherently unpredictable and unfavorable resolutions could occur. As such, the amount of loss may differ from management estimates.</span></div><div id="ib4e76625aa6f4376962a48026c346254_88"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks during the quarter ended December&#160;31, 2022 when compared to the disclosures in &#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Annual Report on Form 10-K for the year ended June 30, 2022.</span></div><div id="ib4e76625aa6f4376962a48026c346254_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act of 1934, as amended) that are designed to ensure that the information required to be disclosed in the reports we file or submit under the Exchange Act of 1934, as amended, is (a)&#160;recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and (b)&#160;accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As of the end of the period covered by this quarterly report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness and design and operation of such disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were designed and operating effectively as of December&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting during the quarter ended December&#160;31, 2022 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation required by paragraph (d)&#160;of Rules 13a-15 and 15d-15 of the Exchange Act of 1934, as amended, was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter. That evaluation did not identify any changes in our internal control over financial reporting during the three months ended December&#160;31, 2022&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div id="ib4e76625aa6f4376962a48026c346254_94"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. Other Information</span></div><div id="ib4e76625aa6f4376962a48026c346254_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 to our unaudited condensed consolidated financial statements contained within this quarterly report on Form 10-Q for a discussion of our legal proceedings.</span></div><div id="ib4e76625aa6f4376962a48026c346254_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in &#8220;Part I. Item 1A &#8212; Risk Factors&#8221; in our annual report on Form 10-K for the fiscal year ended June 30, 2022, filed on August 23, 2022. The risks and uncertainties described in such risk factors and elsewhere in this report have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results and future prospects. We do not believe that there have been any material changes to the risk factors previously disclosed in our recent SEC filings, including our most recently filed Form 10-K, as referenced above.</span></div><div id="ib4e76625aa6f4376962a48026c346254_103"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, our Board of Directors approved a stock repurchase plan, as amended on February 1, 2019, August 27, 2020, and February 17, 2022. Under the plan, we are authorized to repurchase up to $60.0 million of our outstanding shares through November 30, 2023. The repurchase program permits us to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by our management, in accordance with applicable securities laws. As part of the repurchase program, we have entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. During the three months ended December 31, 2022, we repurchased no shares of our common stock under this repurchase program.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;December&#160;31, 2022, there is $27.7 million remaining under this repurchase program.</span></div><div id="ib4e76625aa6f4376962a48026c346254_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ib4e76625aa6f4376962a48026c346254_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ib4e76625aa6f4376962a48026c346254_112"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:8.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporate by Reference From</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914618000046/ex31-certificateofincorpor.htm">Certificate of Incorporation, as filed with the Delaware Secretary of State on March 9, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on March 13, 2018.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914619000066/lifevantage-amendedandrest.htm">Amended and Restated Bylaws, August 9, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on August 15, 2019</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_123122xex311.htm">Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_123122xex312.htm">Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_123122xex321.htm">Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_123122xex322.htm">Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from the Company&#8217;s quarterly report on Form 10-Q for the quarter ended December 31, 2022 formatted in Inline XBRL (extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets at December 31, 2022 and June&#160;30, 2022; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three and six months ended December 31, 2022 and 2021; (iii) Unaudited Condensed Consolidated Statement of Stockholders&#8217; Equity for the three and six months ended December 31, 2022 and 2021; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended December 31, 2022 and 2021; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section&#160;18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ib4e76625aa6f4376962a48026c346254_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFEVANTAGE CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven R. Fife</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carl A. Aure</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure<br/>Chief Financial Officer<br/>(Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lfvn_123122xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i702c767833c6461197a6ef2db5676562_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Steven R. Fife, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;2, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lfvn_123122xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifc45b370d6c74d94914d2791294a7c94_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carl A. Aure, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;2, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lfvn_123122xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i97e0ab1643d84d349d4fce0de0d85672_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended December&#160;31, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Steven R. Fife, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;2, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>lfvn_123122xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib7da2a47d20740eb8b49821cb417cbe0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended December&#160;31, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Carl A. Aure, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;2, 2023</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>lfvn-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfvn="http://www.lifevantage.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lifevantage.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lifevantage.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBasisofPresentation" roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation">
        <link:definition>0000007 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestment" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment">
        <link:definition>0000009 - Disclosure - Gig Economy Group Investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.lifevantage.com/role/Leases">
        <link:definition>0000010 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.lifevantage.com/role/LongTermDebt">
        <link:definition>0000011 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.lifevantage.com/role/StockholdersEquity">
        <link:definition>0000012 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.lifevantage.com/role/StockBasedCompensation">
        <link:definition>0000013 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.lifevantage.com/role/LeasesTables">
        <link:definition>0000017 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails">
        <link:definition>0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestmentDetails" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails">
        <link:definition>0000022 - Disclosure - Gig Economy Group Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails">
        <link:definition>0000023 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails">
        <link:definition>0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails">
        <link:definition>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails" roleURI="http://www.lifevantage.com/role/LongTermDebtDetails">
        <link:definition>0000026 - Disclosure - Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails">
        <link:definition>0000027 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails">
        <link:definition>0000028 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails">
        <link:definition>0000029 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" abstract="true" name="CashAccountsHeldatOtherFinancialInstitutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_InventoryPercentOfTotalInventory" abstract="false" name="InventoryPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_CommissionAndIncentives" abstract="false" name="CommissionAndIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" abstract="false" name="ContractsWithCustomersRefundPercentForResalableAndRestockableItems" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_March2016TermLoanMember" abstract="true" name="March2016TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_March2016RevolvingLoanMember" abstract="true" name="March2016RevolvingLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_ShowroomsMember" abstract="true" name="ShowroomsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" abstract="false" name="DebtInstrumentCovenantFixedChargeCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" abstract="false" name="ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_HandlingAndRestockingFeePercentage" abstract="false" name="HandlingAndRestockingFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_NotesReceivableRelatedPartyMaximumCommitment" abstract="false" name="NotesReceivableRelatedPartyMaximumCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" abstract="false" name="ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" abstract="true" name="CashAccountsHeldPrimarilyAtFinancialInstitutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_IncreaseDecreaseInLeaseLiabilities" abstract="false" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_DebtInstrumentTrailingPeriod" abstract="false" name="DebtInstrumentTrailingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_InventoryFinishedGoodsPercentOfTotalInventory" abstract="false" name="InventoryFinishedGoodsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" abstract="false" name="DebtInstrumentCovenantRequiredMinimumWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndSevenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_RawMaterialsPercentOfTotalInventory" abstract="false" name="RawMaterialsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_AsiaPacificAndEuropeMember" abstract="true" name="AsiaPacificAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_MoneyBackGuaranteePeriod" abstract="false" name="MoneyBackGuaranteePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" abstract="false" name="DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_DebtInstrumentFloorInterestRate" abstract="false" name="DebtInstrumentFloorInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ReturnLiabilityReserve" abstract="false" name="ReturnLiabilityReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_NumberOfGeographicSegments" abstract="false" name="NumberOfGeographicSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantMaximumAllowedDividends" abstract="false" name="DebtInstrumentCovenantMaximumAllowedDividends" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>lfvn-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_45123772-3950-461a-8458-a2c793a0a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_677cfdae-471f-4546-a2b7-b491f14700da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_45123772-3950-461a-8458-a2c793a0a8cc" xlink:to="loc_us-gaap_Liabilities_677cfdae-471f-4546-a2b7-b491f14700da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fbdbbd4c-3969-465e-9dcc-413e9d5382c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_45123772-3950-461a-8458-a2c793a0a8cc" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fbdbbd4c-3969-465e-9dcc-413e9d5382c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fd011c82-2249-45f7-ad21-026615e83812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_45123772-3950-461a-8458-a2c793a0a8cc" xlink:to="loc_us-gaap_StockholdersEquity_fd011c82-2249-45f7-ad21-026615e83812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1d38231c-866d-4870-ab0c-c3ad85ea84cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:to="loc_us-gaap_PreferredStockValue_1d38231c-866d-4870-ab0c-c3ad85ea84cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2850f336-4b8c-41b8-a689-66b8d277cf34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:to="loc_us-gaap_CommonStockValue_2850f336-4b8c-41b8-a689-66b8d277cf34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_74314803-1a6a-4a29-8119-6f27970229e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_74314803-1a6a-4a29-8119-6f27970229e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05b61857-043c-442b-938a-bfaa77ae24a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_05b61857-043c-442b-938a-bfaa77ae24a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3838ae9a-fd19-4a02-b557-4b45fef5c2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9d5e0390-c2e1-4014-9c72-b02dd88f21d2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3838ae9a-fd19-4a02-b557-4b45fef5c2e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_52d1f357-bb1b-4ab7-ac59-65be6f288c42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_085bd2ab-e1ed-451e-b896-64bb45714a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_52d1f357-bb1b-4ab7-ac59-65be6f288c42" xlink:to="loc_us-gaap_LiabilitiesCurrent_085bd2ab-e1ed-451e-b896-64bb45714a39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_313f9a30-17c2-4482-a6cf-48a5ee95a3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_52d1f357-bb1b-4ab7-ac59-65be6f288c42" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_313f9a30-17c2-4482-a6cf-48a5ee95a3a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1dbc4bc2-55ad-4de5-9d57-7dc41caa687b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_52d1f357-bb1b-4ab7-ac59-65be6f288c42" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1dbc4bc2-55ad-4de5-9d57-7dc41caa687b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ddffd546-2342-4bc8-8319-9000d1e6a227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_AssetsCurrent_ddffd546-2342-4bc8-8319-9000d1e6a227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ba30828b-3226-4ab2-b217-c3a7a57665f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ba30828b-3226-4ab2-b217-c3a7a57665f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6b387901-22a3-4d7c-addf-7575b84ad8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6b387901-22a3-4d7c-addf-7575b84ad8a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2ecd1d27-9de9-474e-81d0-7cbc01a7f391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2ecd1d27-9de9-474e-81d0-7cbc01a7f391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_765e866d-cba3-45f5-b9f9-4e626f2d296f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_765e866d-cba3-45f5-b9f9-4e626f2d296f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_fed2b289-ebfd-4726-8e74-00665b42a3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4528e47f-5584-43db-8207-3f114f9c0dbc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_fed2b289-ebfd-4726-8e74-00665b42a3d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a8104c01-6cf5-4b4c-b8a1-8398d3dabfbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:to="loc_us-gaap_AccountsPayableCurrent_a8104c01-6cf5-4b4c-b8a1-8398d3dabfbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_83a08d2f-8bef-498a-8f56-c3666015bd53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_83a08d2f-8bef-498a-8f56-c3666015bd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_03860ea8-fe68-4497-8446-3adf0e248589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_03860ea8-fe68-4497-8446-3adf0e248589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e201f263-294b-4ed5-98a1-c9256f3f19cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e201f263-294b-4ed5-98a1-c9256f3f19cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c868878-f1dc-400c-9192-ff13832c3798" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75078431-c8b8-4e44-bddd-2ecf5f4f6502" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4c868878-f1dc-400c-9192-ff13832c3798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cc0d2fa-72c0-4704-a7dc-ff2e07d2bf49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1cc0d2fa-72c0-4704-a7dc-ff2e07d2bf49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d0e353fd-a1fb-4bff-94cb-b4960e60317f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d0e353fd-a1fb-4bff-94cb-b4960e60317f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_185bd5ab-d859-4018-abd6-8bd4fb21909a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:to="loc_us-gaap_IncomeTaxesReceivable_185bd5ab-d859-4018-abd6-8bd4fb21909a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cec46b2f-5e27-496b-a543-7cbfe9e1c844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:to="loc_us-gaap_InventoryNet_cec46b2f-5e27-496b-a543-7cbfe9e1c844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b6d50a25-0982-433f-aec7-772975c05b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_feada8d1-1323-4db0-b3f8-4f0bf6f80561" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b6d50a25-0982-433f-aec7-772975c05b6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_297bf842-f222-457b-83a9-0c052ad09229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1c38a61-77f4-4a98-8a61-107b730ccc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_297bf842-f222-457b-83a9-0c052ad09229" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a1c38a61-77f4-4a98-8a61-107b730ccc91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c704671f-13f2-4a0e-8b9a-d72bfc8c4e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_297bf842-f222-457b-83a9-0c052ad09229" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c704671f-13f2-4a0e-8b9a-d72bfc8c4e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d96d3b5a-36e7-4d11-adb7-110ba048d6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_df71935a-142f-4785-a914-4d2eacc97d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d96d3b5a-36e7-4d11-adb7-110ba048d6c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_df71935a-142f-4785-a914-4d2eacc97d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9dae6387-ac50-4668-9df5-277846693e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_96dcb8f1-cd70-4213-840d-bd1279705f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9dae6387-ac50-4668-9df5-277846693e6f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_96dcb8f1-cd70-4213-840d-bd1279705f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e82122c8-dc71-42f0-bfbc-7c6260c23c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9dae6387-ac50-4668-9df5-277846693e6f" xlink:to="loc_us-gaap_OperatingIncomeLoss_e82122c8-dc71-42f0-bfbc-7c6260c23c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d0bae9b3-6f44-404f-ab20-dd268801a8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d17bf726-9b62-4100-a47c-01d206ef7d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0bae9b3-6f44-404f-ab20-dd268801a8f5" xlink:to="loc_us-gaap_GrossProfit_d17bf726-9b62-4100-a47c-01d206ef7d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a3c8095e-8170-455a-839e-2d8363771048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d0bae9b3-6f44-404f-ab20-dd268801a8f5" xlink:to="loc_us-gaap_OperatingExpenses_a3c8095e-8170-455a-839e-2d8363771048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_5050348d-00fe-4bc5-b0d7-f7215527bd88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_cfcfc345-3138-4ac0-a05c-9510e6e9f548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5050348d-00fe-4bc5-b0d7-f7215527bd88" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_cfcfc345-3138-4ac0-a05c-9510e6e9f548" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d34b87c9-06c8-4a5e-8265-02d7f5a3e275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_5050348d-00fe-4bc5-b0d7-f7215527bd88" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d34b87c9-06c8-4a5e-8265-02d7f5a3e275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_da774f3e-0db7-4d0e-a4c6-b708e8ae193c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8d3fd57c-cefa-4754-9ac8-1c18efc160ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_da774f3e-0db7-4d0e-a4c6-b708e8ae193c" xlink:to="loc_us-gaap_NetIncomeLoss_8d3fd57c-cefa-4754-9ac8-1c18efc160ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3a32f222-b898-46ad-a8af-a5ced3a8104f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_da774f3e-0db7-4d0e-a4c6-b708e8ae193c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3a32f222-b898-46ad-a8af-a5ced3a8104f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_95a5e58c-f604-4ab5-bc69-c2cf19f2848d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f14bad9-528c-497c-b153-06525ba38f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_95a5e58c-f604-4ab5-bc69-c2cf19f2848d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f14bad9-528c-497c-b153-06525ba38f3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7b7dc523-4a28-45d2-84f1-3523ee5baadc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_95a5e58c-f604-4ab5-bc69-c2cf19f2848d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7b7dc523-4a28-45d2-84f1-3523ee5baadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_33f5abda-0bea-4fe9-9e49-0075de579763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_ab8711d3-962e-4272-9e45-87fffa0809c0" xlink:href="lfvn-20221231.xsd#lfvn_CommissionAndIncentives"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_33f5abda-0bea-4fe9-9e49-0075de579763" xlink:to="loc_lfvn_CommissionAndIncentives_ab8711d3-962e-4272-9e45-87fffa0809c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8f36b72f-4192-4842-bbce-3c9625f2dac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_33f5abda-0bea-4fe9-9e49-0075de579763" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8f36b72f-4192-4842-bbce-3c9625f2dac2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_618f2abe-f152-4541-8f24-eb89df380f56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3c8e28c7-a12e-4ed0-b189-9a376c150b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_618f2abe-f152-4541-8f24-eb89df380f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3c8e28c7-a12e-4ed0-b189-9a376c150b2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35e4181d-a7ed-40a6-bc7f-83c8f1b0d265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_618f2abe-f152-4541-8f24-eb89df380f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35e4181d-a7ed-40a6-bc7f-83c8f1b0d265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_010cca40-bef8-4fb1-8e97-c352abba6f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_618f2abe-f152-4541-8f24-eb89df380f56" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_010cca40-bef8-4fb1-8e97-c352abba6f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9ab192e-8e45-4f08-8e2a-1ddc532651c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_618f2abe-f152-4541-8f24-eb89df380f56" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9ab192e-8e45-4f08-8e2a-1ddc532651c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_60e1aec2-9a8a-435d-bbd3-ac64906cdd4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_60e1aec2-9a8a-435d-bbd3-ac64906cdd4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_390aab0f-c680-4faa-a5e4-9fd2490f1757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_390aab0f-c680-4faa-a5e4-9fd2490f1757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2e3e5c8f-c548-4ff1-aea0-cce838a7376f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2e3e5c8f-c548-4ff1-aea0-cce838a7376f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_57707994-1818-409c-b92c-d1f87df5864a" xlink:href="lfvn-20221231.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_57707994-1818-409c-b92c-d1f87df5864a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_f75c9c3f-8cc8-4cd5-84e9-3b3da1bd760b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cb3f8742-1c7e-404b-9f7a-bfcea06ce596" xlink:to="loc_us-gaap_PaymentsOfDividends_f75c9c3f-8cc8-4cd5-84e9-3b3da1bd760b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb58f13e-3a0a-44c6-8916-4606163bfff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9eeaa5a4-8878-4f4c-86fe-48ae2d7c67be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_eb58f13e-3a0a-44c6-8916-4606163bfff0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9eeaa5a4-8878-4f4c-86fe-48ae2d7c67be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1dea271b-bc1a-4374-8111-74b5768b6cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_NetIncomeLoss_1dea271b-bc1a-4374-8111-74b5768b6cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_29c23361-d396-4693-ac7d-048acf0db64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_29c23361-d396-4693-ac7d-048acf0db64c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5a5858e4-44cb-4990-bbd6-bca5ab132be4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_ShareBasedCompensation_5a5858e4-44cb-4990-bbd6-bca5ab132be4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64788005-81ed-4e52-9045-5e67e8843b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_64788005-81ed-4e52-9045-5e67e8843b88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0af849a4-2e96-4f90-b489-2fa7aeb5315a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_0af849a4-2e96-4f90-b489-2fa7aeb5315a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0bd2e7ee-1767-4658-bb16-05761cfeea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_0bd2e7ee-1767-4658-bb16-05761cfeea99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_c204de4d-1ed4-4532-8189-4b5f0960ebde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_c204de4d-1ed4-4532-8189-4b5f0960ebde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f7e62216-877c-410d-abf3-29fef4d23baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f7e62216-877c-410d-abf3-29fef4d23baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7c4bd466-4c43-457c-9198-508a06558e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_7c4bd466-4c43-457c-9198-508a06558e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_52b41567-abd5-4043-b17c-f44270038d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_52b41567-abd5-4043-b17c-f44270038d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7f2d976d-4fa8-4e87-82d2-259ce92e4995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7f2d976d-4fa8-4e87-82d2-259ce92e4995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_16d5ced1-3e7d-446d-8b01-65f6f1cff9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_16d5ced1-3e7d-446d-8b01-65f6f1cff9a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e3daadac-c495-45d8-9d8a-acd473e45871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_e3daadac-c495-45d8-9d8a-acd473e45871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_2aaeea7a-1c70-49b8-9356-ff5dd0856355" xlink:href="lfvn-20221231.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_2aaeea7a-1c70-49b8-9356-ff5dd0856355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_92efd921-17ec-40c6-9277-a4a207a280e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_92efd921-17ec-40c6-9277-a4a207a280e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_b89225b3-e226-48c9-b161-41fd12e92784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1d4602ab-61d2-45ba-abaf-5b2b38935eee" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_b89225b3-e226-48c9-b161-41fd12e92784" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b984e6a2-4bc7-4356-972b-7c3a1b853baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_771e1943-2e98-442d-a686-a1d35e965c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b984e6a2-4bc7-4356-972b-7c3a1b853baf" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_771e1943-2e98-442d-a686-a1d35e965c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_44e9648f-9447-4e93-add5-50f7550b846b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b984e6a2-4bc7-4356-972b-7c3a1b853baf" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_44e9648f-9447-4e93-add5-50f7550b846b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_bda4a341-8ea8-4f7c-b2fe-e245c331ffcf" xlink:href="lfvn-20221231.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_dbd34247-64be-4d94-b840-33abe7e177ed" xlink:href="lfvn-20221231.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_bda4a341-8ea8-4f7c-b2fe-e245c331ffcf" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_dbd34247-64be-4d94-b840-33abe7e177ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_2037b42c-cbdd-412c-a13e-f186794ffd60" xlink:href="lfvn-20221231.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_bda4a341-8ea8-4f7c-b2fe-e245c331ffcf" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_2037b42c-cbdd-412c-a13e-f186794ffd60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70c295c4-26aa-4d66-b417-07da25f47cca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e3c7ee77-dea3-492e-ba6e-4d6aac3317f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70c295c4-26aa-4d66-b417-07da25f47cca" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e3c7ee77-dea3-492e-ba6e-4d6aac3317f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0241dda1-7810-4323-bc3c-4d0f8ef37971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_70c295c4-26aa-4d66-b417-07da25f47cca" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0241dda1-7810-4323-bc3c-4d0f8ef37971" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_79f21ef3-8d90-46b5-b2da-ed23f78e2104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_79f21ef3-8d90-46b5-b2da-ed23f78e2104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1c4b6ca8-f5e4-4544-aa1a-de7b26c71fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1c4b6ca8-f5e4-4544-aa1a-de7b26c71fce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc068e62-5faa-4551-a6e1-e4c74b09ca41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bc068e62-5faa-4551-a6e1-e4c74b09ca41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_90576a21-19cb-4a95-8857-e089383432f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_90576a21-19cb-4a95-8857-e089383432f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_455cff6d-5298-48f6-935e-dd0f41b5df58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_455cff6d-5298-48f6-935e-dd0f41b5df58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_b677f4ab-26b4-41ab-842a-78214dadaa20" xlink:href="lfvn-20221231.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_816e84ac-2991-472e-a2c3-3ec9c4058453" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_b677f4ab-26b4-41ab-842a-78214dadaa20" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf716eca-4977-49db-a12a-b10b56278ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dd2fd409-1a8f-453d-9248-b86144aa7b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf716eca-4977-49db-a12a-b10b56278ad8" xlink:to="loc_us-gaap_OperatingLeaseLiability_dd2fd409-1a8f-453d-9248-b86144aa7b5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a672822-87da-4da5-bb0e-5638e0afa2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bf716eca-4977-49db-a12a-b10b56278ad8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a672822-87da-4da5-bb0e-5638e0afa2b1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>lfvn-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="iaf1c714a769e4054b22e6e279944cf46_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c78db090-efb3-4f5d-8dac-dd0462a40ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c78db090-efb3-4f5d-8dac-dd0462a40ae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9b4a83d-6168-4975-bdb2-15cc2981e07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockholdersEquity_a9b4a83d-6168-4975-bdb2-15cc2981e07b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a5610a7d-4eb6-4a81-9220-d233a34c1ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a5610a7d-4eb6-4a81-9220-d233a34c1ddf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d807800c-15d4-4813-8bee-e00e47af3031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d807800c-15d4-4813-8bee-e00e47af3031" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1b00453f-f4a7-4a1d-9f74-88d3b764c886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1b00453f-f4a7-4a1d-9f74-88d3b764c886" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e61cd222-9ad2-48a3-93cc-28470d6cee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e61cd222-9ad2-48a3-93cc-28470d6cee74" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_95adee7d-7aaa-4735-91ce-d510bb65f2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_95adee7d-7aaa-4735-91ce-d510bb65f2e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97cb763d-c88c-4b1f-a8ae-a0c3b290e510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97cb763d-c88c-4b1f-a8ae-a0c3b290e510" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_893d1dcf-2471-429c-91c2-19345ea11644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_893d1dcf-2471-429c-91c2-19345ea11644" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd68ea1f-0218-47bc-bf5e-87322c538277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd68ea1f-0218-47bc-bf5e-87322c538277" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_12e44052-5ad8-4811-b372-69e08b7b7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_12e44052-5ad8-4811-b372-69e08b7b7da2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3c06556-cffd-42f8-9794-128965126bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3c06556-cffd-42f8-9794-128965126bcc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bb97f0c4-b470-40d3-8dcd-ae500c00e559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bb97f0c4-b470-40d3-8dcd-ae500c00e559" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_16490315-ec66-4e11-ba0b-144837d6a445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_DividendsCash_16490315-ec66-4e11-ba0b-144837d6a445" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f512556b-bd04-4acf-b4f8-55a6822dad92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f512556b-bd04-4acf-b4f8-55a6822dad92" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4f6a6f9-5c96-44ba-b782-c14cadf00000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_NetIncomeLoss_b4f6a6f9-5c96-44ba-b782-c14cadf00000" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ac7354bc-9559-4812-a7ab-2fda350fd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77382d38-2f2a-4e78-b083-109ce6235ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:to="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:to="loc_us-gaap_EquityComponentDomain_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:to="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8f1b17ad-113d-404b-b316-e2c631eae508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_CommonStockMember_8f1b17ad-113d-404b-b316-e2c631eae508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9e26c739-8488-4092-a0a3-5bbecd24f1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9e26c739-8488-4092-a0a3-5bbecd24f1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c1c17e7c-050c-40fe-8ffe-69e1130b7a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_RetainedEarningsMember_c1c17e7c-050c-40fe-8ffe-69e1130b7a75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2090f534-0ac1-46d6-81dc-87f0b7d454d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2090f534-0ac1-46d6-81dc-87f0b7d454d8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i9654af01678f4029b80ab50617cf779e_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_570eef95-570c-42aa-b058-60e2f0996f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_570eef95-570c-42aa-b058-60e2f0996f2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a5c36d0e-07fc-431f-bd11-22b242fd548a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a5c36d0e-07fc-431f-bd11-22b242fd548a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_ff82f227-887d-49ed-b927-bef03e6630f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_ff82f227-887d-49ed-b927-bef03e6630f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e376296c-4eb9-4470-ab22-50718ed92544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e376296c-4eb9-4470-ab22-50718ed92544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_f36b592a-e2ba-4089-ba2d-1d0698b97379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_InventoryValuationReserves_f36b592a-e2ba-4089-ba2d-1d0698b97379" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_9404e23c-6ef9-410b-9fd2-9e478113fe80" xlink:href="lfvn-20221231.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_9404e23c-6ef9-410b-9fd2-9e478113fe80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_98fac256-7200-41de-85f7-0d27c121b1a7" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_98fac256-7200-41de-85f7-0d27c121b1a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_40e24339-8b94-40ad-9c8a-2e5f5cade979" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_40e24339-8b94-40ad-9c8a-2e5f5cade979" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_abd77668-d0ae-4594-b9d3-56988291c4cd" xlink:href="lfvn-20221231.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_abd77668-d0ae-4594-b9d3-56988291c4cd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_34f8db53-0ef8-49a7-a4e8-a3d1aa32c7b1" xlink:href="lfvn-20221231.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ReturnLiabilityReserve_34f8db53-0ef8-49a7-a4e8-a3d1aa32c7b1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1d60f19b-f412-421f-82dd-7a8795ed5625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1d60f19b-f412-421f-82dd-7a8795ed5625" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c8e1a129-b478-472d-acdc-ec0336ac0be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_OperatingLeaseLiability_c8e1a129-b478-472d-acdc-ec0336ac0be3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnContractTermination_a46c821b-a2ba-4829-be5b-b32edf0378a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_LossOnContractTermination_a46c821b-a2ba-4829-be5b-b32edf0378a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cf3b487d-61c3-47fa-9f3e-ca6cf029d970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cf3b487d-61c3-47fa-9f3e-ca6cf029d970" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e32b149c-68bc-4828-8653-8cc371162ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e32b149c-68bc-4828-8653-8cc371162ad7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_3bcee16f-30d8-467e-a299-70ecdaae56c9" xlink:href="lfvn-20221231.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_NumberOfGeographicSegments_3bcee16f-30d8-467e-a299-70ecdaae56c9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_55c4995a-786e-41d3-b1d2-571fec4ba69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_NumberOfOperatingSegments_55c4995a-786e-41d3-b1d2-571fec4ba69c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e46ee790-446c-41b3-9041-558ffa61dffa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e46ee790-446c-41b3-9041-558ffa61dffa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_c0f876a2-3497-472d-852a-5b61a00c3f89" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_c0f876a2-3497-472d-852a-5b61a00c3f89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_84b3db29-4793-4c26-bb8b-734339293f46" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_84b3db29-4793-4c26-bb8b-734339293f46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fac9b58f-b5ff-474a-ae44-036af670e11b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_fac9b58f-b5ff-474a-ae44-036af670e11b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShowroomsMember_6a65adaf-cf21-4e60-a1b4-bea1ebba4a67" xlink:href="lfvn-20221231.xsd#lfvn_ShowroomsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:to="loc_lfvn_ShowroomsMember_6a65adaf-cf21-4e60-a1b4-bea1ebba4a67" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended" id="i86e0234684cb4c96878b95b87e11d4ef_SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30ae72d5-2a2b-43be-b168-7ac2540527fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30ae72d5-2a2b-43be-b168-7ac2540527fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_93d1166f-5a42-4a6b-b81d-ea4a65263fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:to="loc_us-gaap_NoncurrentAssets_93d1166f-5a42-4a6b-b81d-ea4a65263fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:to="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_eed82766-7efe-4025-801f-f6b45b3b5ca3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:to="loc_srt_SegmentGeographicalDomain_eed82766-7efe-4025-801f-f6b45b3b5ca3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:to="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2016ebdd-94df-47ee-8ac9-7f4b6e9a54e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_srt_AmericasMember_2016ebdd-94df-47ee-8ac9-7f4b6e9a54e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_4015de96-8150-4333-95a5-06bf50132608" xlink:href="lfvn-20221231.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_4015de96-8150-4333-95a5-06bf50132608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8d15f713-211c-4184-a373-fe2d016102c5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_country_US_8d15f713-211c-4184-a373-fe2d016102c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_2e0c7496-ac81-4e2d-bae3-6a2c7074e4c8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_country_JP_2e0c7496-ac81-4e2d-bae3-6a2c7074e4c8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended" id="iff076d7bb15e4443be521e711b8f258b_GigEconomyGroupInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_b5a11ae5-815c-4b2d-8b67-5801891b6ede" xlink:href="lfvn-20221231.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_b5a11ae5-815c-4b2d-8b67-5801891b6ede" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_60f91e44-a4b2-4828-a8c5-d9dadbfc76f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_60f91e44-a4b2-4828-a8c5-d9dadbfc76f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1147ef15-c8d3-42aa-929a-01fbaea04812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1147ef15-c8d3-42aa-929a-01fbaea04812" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_6344764e-a906-4e28-b6c8-0cb47968e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_6344764e-a906-4e28-b6c8-0cb47968e2ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0ac00ff3-5158-414e-9dd3-d8ffae8803d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0ac00ff3-5158-414e-9dd3-d8ffae8803d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_83e6fae0-590c-4f3e-bb24-25da7abb39ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:to="loc_us-gaap_RelatedPartyDomain_83e6fae0-590c-4f3e-bb24-25da7abb39ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:to="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_2e8fe593-1610-4a53-bf47-eb6d2f017ea6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:to="loc_srt_AffiliatedEntityMember_2e8fe593-1610-4a53-bf47-eb6d2f017ea6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_38382214-0db0-4865-bb86-8887663ad6a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_38382214-0db0-4865-bb86-8887663ad6a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_72fa9504-c60a-4826-ac7f-195017c2285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:to="loc_us-gaap_CommonStockMember_72fa9504-c60a-4826-ac7f-195017c2285a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i9a11f950e95c46288f9129526c73eccd_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd92b7ad-c540-47ee-a4b9-ce2bf7760467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd92b7ad-c540-47ee-a4b9-ce2bf7760467" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b62122aa-14f3-4c20-aa08-6a220eb54dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b62122aa-14f3-4c20-aa08-6a220eb54dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_29577571-d10b-48c1-9927-f3c1dcdfc923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_29577571-d10b-48c1-9927-f3c1dcdfc923" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2f3b5ebc-adbb-45fb-b7e4-ab19106f36fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseExpense_2f3b5ebc-adbb-45fb-b7e4-ab19106f36fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:to="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:to="loc_srt_RangeMember_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:to="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5488d208-0deb-4008-a453-f5364c6d816b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:to="loc_srt_MinimumMember_5488d208-0deb-4008-a453-f5364c6d816b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca1d40b2-8040-4c71-acde-915d12097a95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:to="loc_srt_MaximumMember_ca1d40b2-8040-4c71-acde-915d12097a95" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="extended" id="ibc6b014ce4e64e7ebe1a94edd58e74ec_LongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ba5fcb18-395e-471f-8564-6696ab99ee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ba5fcb18-395e-471f-8564-6696ab99ee8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_968fb463-cc18-4510-a42a-46bb2dbf5b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_968fb463-cc18-4510-a42a-46bb2dbf5b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_598489c9-1b98-495f-a1a8-0f12ad0241f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_598489c9-1b98-495f-a1a8-0f12ad0241f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_2bfc8ad9-a3c7-4a65-bf3e-7d1711fea18c" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_2bfc8ad9-a3c7-4a65-bf3e-7d1711fea18c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_c16736d7-e99a-4bd9-9253-0ce0e3ac063c" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_c16736d7-e99a-4bd9-9253-0ce0e3ac063c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_156a8ae0-8d99-43e5-8726-c19ad198d4f8" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_156a8ae0-8d99-43e5-8726-c19ad198d4f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_d24b1a7b-8b11-40ed-844b-fc3e53633807" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_d24b1a7b-8b11-40ed-844b-fc3e53633807" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f7ee9601-60c7-43a1-823f-3a35d282f757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f7ee9601-60c7-43a1-823f-3a35d282f757" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_80b87ff2-5a28-4f58-8478-5df36a44dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_80b87ff2-5a28-4f58-8478-5df36a44dcc8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_97235c7b-4438-426b-8804-df5be3298853" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_97235c7b-4438-426b-8804-df5be3298853" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_d1f52ea8-0f4b-494a-9610-0af70fe8fbcc" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_d1f52ea8-0f4b-494a-9610-0af70fe8fbcc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e1d9cb4-458d-49c6-aca4-1faa74b1b733_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e1d9cb4-458d-49c6-aca4-1faa74b1b733_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_2fa47ca5-45de-4ad4-83c5-56d1b81202a0" xlink:href="lfvn-20221231.xsd#lfvn_March2016TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:to="loc_lfvn_March2016TermLoanMember_2fa47ca5-45de-4ad4-83c5-56d1b81202a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_20e58d27-97c3-4b80-a953-980cf66a5ab3" xlink:href="lfvn-20221231.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:to="loc_lfvn_March2016RevolvingLoanMember_20e58d27-97c3-4b80-a953-980cf66a5ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e191ecb1-a831-47ea-8c14-b4c77c04286d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:to="loc_us-gaap_CreditFacilityDomain_e191ecb1-a831-47ea-8c14-b4c77c04286d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:to="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_27c906e7-c3aa-4d2a-8363-f802394af87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:to="loc_us-gaap_SecuredDebtMember_27c906e7-c3aa-4d2a-8363-f802394af87e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bec3e106-c8f4-4684-9600-7b2de0cbce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bec3e106-c8f4-4684-9600-7b2de0cbce0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:to="loc_us-gaap_VariableRateDomain_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:to="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_81334942-56df-433d-8fe9-a6f23ebf84ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_81334942-56df-433d-8fe9-a6f23ebf84ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1043c2bb-958c-4c39-818c-35c83b4a0f8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1043c2bb-958c-4c39-818c-35c83b4a0f8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5af6136d-aa4f-4359-ae7a-d69cd6398d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:to="loc_us-gaap_LineOfCreditMember_5af6136d-aa4f-4359-ae7a-d69cd6398d31" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended" id="i4aa74c697ca24defa6f71504f3601adb_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1225872d-5257-4e73-a00c-196895f7c657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1225872d-5257-4e73-a00c-196895f7c657" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3050b128-fa36-4a85-98bf-0a7e13c59f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3050b128-fa36-4a85-98bf-0a7e13c59f01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a84e1d2a-fe56-4935-8a3c-60437af2d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a84e1d2a-fe56-4935-8a3c-60437af2d7c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_444cd996-50bc-48df-8cbf-8c1268701790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_444cd996-50bc-48df-8cbf-8c1268701790" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7ced7ffa-07c2-4993-a54a-6275a02c4ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7ced7ffa-07c2-4993-a54a-6275a02c4ac7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad0c04bf-24f5-420b-b141-94b0335eb1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad0c04bf-24f5-420b-b141-94b0335eb1b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_609eb097-8948-46a4-9035-5d5c5b5784ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_609eb097-8948-46a4-9035-5d5c5b5784ca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b0230376-a956-400a-bdf5-9441a2458eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b0230376-a956-400a-bdf5-9441a2458eb4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5f337239-14f7-417c-8048-37d9dcaf4f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_DividendsCommonStockCash_5f337239-14f7-417c-8048-37d9dcaf4f4e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_6d9eae56-37f8-4ed3-9598-21986cf8fd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_6d9eae56-37f8-4ed3-9598-21986cf8fd2c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_5fdbffde-e5d7-4fee-977a-72e3230bfc87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:to="loc_us-gaap_ClassOfStockDomain_5fdbffde-e5d7-4fee-977a-72e3230bfc87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:to="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6399722a-9a2c-4c91-8643-9d5e1091af99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:to="loc_us-gaap_CommonStockMember_6399722a-9a2c-4c91-8643-9d5e1091af99" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended" id="i5f31c34d2bfa4dc4ac0a683d58d00915_StockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a352337e-ce57-48cf-bc1a-db75a5526194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a352337e-ce57-48cf-bc1a-db75a5526194" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_20e77576-499f-443b-86dd-60279ad9d840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_20e77576-499f-443b-86dd-60279ad9d840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9806b42b-9eec-4a0d-b881-97de4054c916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9806b42b-9eec-4a0d-b881-97de4054c916" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b09a7d2f-edc1-4c3f-b0b9-8912aa413eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b09a7d2f-edc1-4c3f-b0b9-8912aa413eca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_4ffa5144-6449-40cf-bbb8-1eccb1f31029" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_4ffa5144-6449-40cf-bbb8-1eccb1f31029" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4893d6b-19a1-4a71-a698-8fa131013bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4893d6b-19a1-4a71-a698-8fa131013bb7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d3628be-0fb0-445b-85e4-19f2265f2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d3628be-0fb0-445b-85e4-19f2265f2d4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_343a26fb-ec33-451e-9550-0189cb12c56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_343a26fb-ec33-451e-9550-0189cb12c56b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd8d8ebf-be9b-407a-9f08-32e86e136e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd8d8ebf-be9b-407a-9f08-32e86e136e9d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d7821294-6bfe-4158-a5ac-3519f06f346b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d7821294-6bfe-4158-a5ac-3519f06f346b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_4c10095e-4290-4d3b-a95e-ea6876318e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_4c10095e-4290-4d3b-a95e-ea6876318e9a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_18d431ab-1fca-4fc0-8879-a1861239a2d7" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_18d431ab-1fca-4fc0-8879-a1861239a2d7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8158a6cf-9025-4b4f-86d3-d32becf78978" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8158a6cf-9025-4b4f-86d3-d32becf78978" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dfd9df1c-1c26-4e9d-aea0-ba49837c4ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dfd9df1c-1c26-4e9d-aea0-ba49837c4ec4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_e68c0db3-a489-4b73-bfe8-d0103051a2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_e68c0db3-a489-4b73-bfe8-d0103051a2f3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:to="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_00d87d75-df88-4e82-a29f-31015dd3e67d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:to="loc_us-gaap_PlanNameDomain_00d87d75-df88-4e82-a29f-31015dd3e67d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:to="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f70f918e-d46b-44d4-b540-02f4c6dfba96" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f70f918e-d46b-44d4-b540-02f4c6dfba96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_a8ccc3e0-95d6-46cb-896c-60568cd8021d" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_a8ccc3e0-95d6-46cb-896c-60568cd8021d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_45e6338e-94e1-4194-a1c6-048c82be1f97" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_45e6338e-94e1-4194-a1c6-048c82be1f97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_57e8fe3f-3c3b-40de-adb7-064ad5f39124" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_57e8fe3f-3c3b-40de-adb7-064ad5f39124" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_aaffeebf-5f21-477d-9a44-d32cbd113ec1" xlink:href="lfvn-20221231.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_aaffeebf-5f21-477d-9a44-d32cbd113ec1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:to="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b277e3f-046d-4cd0-8b78-bfad78d09960_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:to="loc_srt_RangeMember_1b277e3f-046d-4cd0-8b78-bfad78d09960_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:to="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_13023894-c688-4048-980c-e55e5e0dce62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:to="loc_srt_MinimumMember_13023894-c688-4048-980c-e55e5e0dce62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e4505fd-7246-4431-a878-41f9f7d6275e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:to="loc_srt_MaximumMember_9e4505fd-7246-4431-a878-41f9f7d6275e" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>lfvn-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49bb548e-2d15-4194-9b97-9bf7e92b6378_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_795e21e7-0a1e-4c89-85f5-361411329d3b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_352f2ccc-5da3-4c55-8957-dea3a8bf595f_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_449a3022-c145-4593-bbbc-8ac5b0253d36_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7d6fd800-0455-4eb0-902d-d4eb44683d74_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_75d4d609-17d3-4ec2-9f38-072be303b9c4_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_7a0e751e-2e57-434c-ac2a-ee9ae032bc70_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_58070d1f-3d55-4f24-a008-dcba74d91801_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_ed75ea5c-39bd-484a-a87e-51b3e4b1325e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_90ce5d30-21f5-4933-a15a-4dfc89da4ed5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3a9832df-a628-4be8-a950-cf952a10d073_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit (expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_64588d89-5789-4aa8-afac-447f6c918d6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_4cf73e50-b637-4fd2-95e8-9020eaf3553d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_80124421-e606-4f86-aa06-f8c67fa42f40_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_8d40159b-f82e-47e8-b034-a32a93608b57_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_da0c4023-4729-4e11-bf7b-4ff81120a693_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f0a9f2c1-cb31-4834-bb12-44979d297278_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_44cdac72-ff26-4a51-bd15-c60ff3c0054d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_25973f12-2603-40f0-a729-c7d6716df4f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_83847368-a46b-441a-be60-a4a2c2a47dee_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4869f0d0-89d7-4b91-a7ce-e2c5fc803c7f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_455631fe-217a-4b64-b354-2a92c1d1a283_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1ae959ab-1faf-481f-bd17-99f3da8527ec_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_081fbf63-c751-4864-94fc-a76f5be91555_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_5efae0c3-5861-477e-9f74-3422554bf866_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1dde17e0-b586-4f36-9439-cf4690e3f32c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_b7724ca4-c4be-4e25-8b19-00dcc4f960b6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_b9d134e1-2540-4983-abf4-791353125914_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_157a2839-8957-4649-b822-c3b6b5805da8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum capacity on draw</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_9b810896-7bf8-41d0-9613-a25bacaf8ea0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_595ea35b-e76a-4a76-a0c9-1d9e20cedcdf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f7bff5fe-c0e0-41a0-9d4c-644dfd2c5b72_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,707 and 12,493 issued and outstanding as of December 31, 2022 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_a3253955-cbf3-44bb-8ef2-81e19c87e831_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gig Economy Group Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_426e4581-e4c6-48b2-9a3f-20804778a1c5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2c63313f-d45d-4546-a708-d882f29dbc54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0459ce1f-71ca-4a47-9d1d-ce8fb88e3adb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_83d20a76-368f-4cdc-8084-e0f3021a8c0d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_9282c6c4-1b48-4eaa-ab50-c24f12e4c99b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9fe13e04-71ed-478c-95fe-a71b5e8fc3ea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a6d7f891-bd1b-4922-ac68-67477243ffa0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_2e029fcd-6ac5-429a-aec0-1fba72875727_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_457c50b7-d402-49dd-9b6f-f497d6a30677_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_e2d30b83-ec3f-4693-86da-6d40ec913a54_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, maximum allowed dividends</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Allowed Dividends</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Allowed Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:to="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_c9e11907-5edb-4937-9ca1-0a7dd8a404c0_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c01445e-d0bc-4fd8-aca6-8043a9bb6cba_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3078c752-33d3-4c37-a335-057f69ba9bb4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2f3a2a53-d232-40a0-9621-221cb532192f_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_dfa26bf9-ab9a-45ae-9e47-54a906a8a066_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_0716693e-ca07-4c54-911d-06d27be882bc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_35a12a2a-740f-4e73-bade-9bd698683d89_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_1ee466ed-d832-498b-ad75-310292d60c1d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_42676620-817f-4a72-bd75-12ea6c1daf4d_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, fixed charge coverage ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ced67948-d898-488b-bf76-2dc69a761650_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_fcf21bc8-a42b-4cee-9728-f5eb88961d24_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShowroomsMember_931a3e3e-294b-48a7-9e98-43f0c3bb7bdf_terseLabel_en-US" xlink:label="lab_lfvn_ShowroomsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Showrooms</link:label>
    <link:label id="lab_lfvn_ShowroomsMember_label_en-US" xlink:label="lab_lfvn_ShowroomsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Showrooms [Member]</link:label>
    <link:label id="lab_lfvn_ShowroomsMember_documentation_en-US" xlink:label="lab_lfvn_ShowroomsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Showrooms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShowroomsMember" xlink:href="lfvn-20221231.xsd#lfvn_ShowroomsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShowroomsMember" xlink:to="lab_lfvn_ShowroomsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d0ee6f40-4803-40f8-b357-2f0a9e203c91_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a143b57f-e5d8-42fc-8cbb-2c88c92fb5d2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_006bb361-a1d6-480e-8c92-e6acdd895d28_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_437f9e76-e355-40e9-8481-5b23eb881d36_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e21fc703-1923-4261-827e-7770a160afe0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from EPS calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_48abff16-f7e1-4f8d-8374-1ff9fcb0ea29_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_be7e9294-0885-4f85-a900-bbcb24922088_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, required minimum working capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:to="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_70405b22-ce13-4324-a211-23fc9d2d2dce_terseLabel_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:href="lfvn-20221231.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:to="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_8da85d83-71c2-4070-a68f-705c1ea38794_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seven Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and seven long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5aa90e6c-808b-43a5-8105-b033fea661f4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f8d459ac-67e6-4cd5-b04f-758239433791_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_fc2d9e25-0915-4cd5-8c9d-5cfc766563dd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_4e18af71-3e4c-4719-84bb-9217bdaaab92_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ecb1c0ce-ca23-4584-a9ca-2772e16d9216_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_462a9e12-9422-486f-9ae7-adaad562b851_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_2ccf2a09-c7a0-41f0-897a-25480e8b2a76_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CommissionAndIncentives_e90dafa1-5768-4982-b1d6-3f503cc881bc_terseLabel_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions and incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_label_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission And Incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_documentation_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives" xlink:href="lfvn-20221231.xsd#lfvn_CommissionAndIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CommissionAndIncentives" xlink:to="lab_lfvn_CommissionAndIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_753369bc-277e-4059-a260-b13104b69e83_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_2e703275-5484-4e0f-a054-11a48a1948f5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0e651b24-af22-4796-82df-85b3b248e686_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dfa5a056-472c-4fd9-92db-d09790f41cea_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_77696b31-d28a-4dbf-b7e4-d92607b4ecca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_49af4954-e607-41b1-ba23-6a6a00cf3a2b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_727af35f-0390-496b-a6cc-eb99a9f393ed_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2d0c6c44-76c9-405e-a20f-7e5899aa0449_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_ae997e1e-f37b-4886-aeda-154352851c97_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2803d69a-0d19-403d-97ab-effdb1986ad9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d97a4a69-35aa-4265-b4a3-0e8d0cef5988_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (remaining six months ending June 30, 2023)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_0b967072-1455-4214-a034-92a511a23e75_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_3ea65894-a22c-44c2-9729-577a3ab2f948_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_34f62f32-5913-45db-8879-6586c814a518_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_334a185d-dea9-4289-a14f-ca10d9b6dd94_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floor interest rate (as a percent)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_label_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:to="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_2e23a6dc-23ab-4910-b1e6-015d22b88861_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c2da4186-28dd-418e-b560-07b922a5ad2f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_4fbdbef8-515c-4971-b435-3555d8009299_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount in excess of fair market value of stock for option not to be granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_4f2249e8-857e-4b57-be1a-444cd3a58595_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91004b3f-b4fc-45eb-8eeb-dab83b64b2be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, net of awards expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_db427e36-cc1c-4e0e-8551-6239b6c4a3ec_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash accounts held primarily at One Financial Institution</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:to="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_fe4caf63-3d85-4020-837c-976809d1586b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_54282da6-8d3a-4a10-9f37-c577bfbd61eb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_6fb96a5b-5a17-4aa4-932a-95573d01a282_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_11911ca1-bfc8-400b-a4f8-c03764cd50d1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash (Used in) Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bc610cc4-a201-4f9d-8d4c-c06b7b93c3f9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_0bc5380f-3aad-409a-82fb-46066e5fb387_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_deeae13e-17b1-4470-ab16-ee2b3a41886c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Effect on Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d464c866-bb4d-4e22-a8db-0a0d047c189d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_8bf8ea84-2492-4ed1-b7f6-ff93b6cee00d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cace966b-e2be-4d34-b52c-f45f47a402ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_55c470eb-9b78-4813-8350-1c8f65ab3a49_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of cash dividends</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5e066b34-ceaa-49f3-b5ee-499b294e13b4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7df2d2db-1eb2-4ec0-a6d8-3ae402b30f3c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_38ea0bec-5868-47d8-81ee-01436cb8c82a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_980a9095-2fec-4c23-aef0-f12062af0fce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_3e48b194-372e-46bc-8fa8-b79a64f1e1d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_beb8788b-a58c-4284-89ae-b123f65d1d60_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_c75b35a2-de1c-46c8-9cde-358be6023a57_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments, realized loss</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2dd3ab51-47ea-4e23-b8af-01a459abf58d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_b5af8f0a-71fd-46bc-ad94-4ded3e776b47_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_65cc4211-2325-466b-b676-ddd164ed8e16_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3cdd952f-0b22-4bb8-bad4-3851aa907ff6_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_dacdab0d-882b-40ed-9aa2-27fabd01368c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1df0db34-60d1-4997-9a21-5ca260bb63e9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_51f9b8dc-cf6d-406c-bfff-b622ff68305f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_32347ae1-d40b-4604-b5a8-f77be7043fa6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0fd10620-6065-471f-8cee-461d85bf1744_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_fbbc11e6-2ab1-4fa2-8a40-39ac19a48bd1_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_05e35615-1eb7-4c99-9985-5711d6ede5d0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6a1a2caa-5ebb-424e-a74d-f2bedfd6d0e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition &amp; Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6dd92c19-9817-4ad9-8516-80a1a9752c32_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d3b16a20-decb-479f-a28c-598b9a71371d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7a5823ff-b225-46fb-a16d-6e094667d199_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_05ad092d-4e61-4fc2-8968-bd8fbfca17f8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_cb37480d-702b-41cd-ac34-8feb9c0f4986_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_eb8074e5-ac62-480e-a641-e11d0bdb49f9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend, common stock declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_e90a0470-158c-4e02-b21e-e96a1ea07aad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under equity award plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_70f99779-438b-455d-a86a-c70558cc0a29_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_50ea91a8-56e5-4052-946f-5e94101d0bab_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_db1fabb7-47fb-41fc-a200-f5836554150c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_f8474692-2677-4512-bab4-846f42a11ce7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gain (loss), realized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_b86f7e7b-0240-47f5-abc5-f05fc602e18b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_b78dd3c1-d016-4ad2-b7db-0c5f219df26e_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_label_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Geographic Segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_documentation_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments" xlink:href="lfvn-20221231.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfGeographicSegments" xlink:to="lab_lfvn_NumberOfGeographicSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_50327776-8e18-4dc4-80b7-10fde6a14032_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9926f552-4c54-4c6a-ad27-c47ed95187f2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_b85079be-16bf-4a5a-a327-7e0e9836eba6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_82a16d80-8c46-4b8b-abf1-04c700cdc377_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2a52b08d-6c8c-46df-9a54-797a36d815c6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_18f2e14f-1990-4afb-8de3-71d0dfdcdd97_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_291e7f2a-812c-4340-815b-7153a924b601_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8738c1af-8094-4f47-8167-80691ab6bd16_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6a05aec2-634c-44c6-b212-bf7b3caf0a50_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_7ccbf40a-bd47-408c-b754-6c1aa1dffcb4_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEG</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_c3e26f0f-ae52-48a4-8651-4ae0f4bc1882_terseLabel_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and restocking fee, percentage (as a percent)</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_label_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_documentation_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:href="lfvn-20221231.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:to="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_159bc9b3-46c6-4362-a24f-85d52360f070_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_2ebe5efc-0d7f-4e3d-98f9-7829eefc398d_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_e0c7b7ae-c8b2-436e-b04a-415a6ab98918_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b958807a-67c3-4ccc-9698-568f03216288_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8bdc87df-8a22-4c5b-b1b3-c750a209f13c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_7eb552a6-f21d-4eb1-9e35-cbdd72c89679_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2fb33088-b326-46d0-8786-4e01c52c7760_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_b437550f-ed25-42b0-a2d7-9a1c8833d3cd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f8be68a2-1e8d-4bd7-a989-b1655b181c4c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e4b2ee9d-0442-408e-a498-8483a4b29692_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_bac1b3de-f054-429e-a12d-26f47d06486c_terseLabel_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:href="lfvn-20221231.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:to="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_cb4750ce-5536-4337-8771-7ba45acf7a16_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_de308fbe-c62c-4dca-b4eb-2b32130d1852_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_480cd2c5-0b69-4dfc-aaab-b64cad63868d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_90ffa1a6-6cf6-4337-917a-eb58d1805714_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase common stock amount authorized (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f3caaba2-7b51-46d6-bcfa-a94565b04aec_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_266fe312-5654-471d-90e6-af3a5294c348_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_a1916c79-dd88-4f22-851b-f85feb69103d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_6f0e129c-08a9-4e68-9a8f-3a35ff30496c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_81ba650d-c56a-4c0a-9aa8-15f992be40c8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_959ddfb9-2de6-4e1c-a53d-d754c3d4e1c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2df31278-348a-4c07-b071-e3572c3921c0_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_b9cb7c3d-a552-485c-8a6a-35b07888b393_terseLabel_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:href="lfvn-20221231.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_0e3eacc0-101c-45ca-9e68-f49f0025f527_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions payable</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_d7979550-f88d-4877-aa66-80259a4fcbe3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_08265aa3-22e1-44cb-b1f6-38efa3071c2e_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_a19e1056-ad59-4384-92a2-90375ef2abb3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9c336b4-a1b3-45c5-80c8-ea5db6570f2d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a870bc8-f8e5-4ae1-88de-19946b11036d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_dbff4ac8-f7ef-458d-b269-52546bb7d692_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_0a62ed8f-8c25-4d7d-a081-375e38033704_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_42aa214f-8c18-44e8-85ba-e69300825068_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_979570a8-11f9-4eca-a119-319699eb025d_terseLabel_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_label_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Back Guarantee Period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_documentation_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod" xlink:href="lfvn-20221231.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MoneyBackGuaranteePeriod" xlink:to="lab_lfvn_MoneyBackGuaranteePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4b80b44d-69fc-43d3-90eb-095646fc7f2c_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_122454c9-4d25-4939-90e1-aea0c542d1c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies - Note 8</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ab99be86-b749-4775-af63-3c9f1c0e6db1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_9b799b71-9bb6-407e-949c-21076f4a7aa4_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_c467d244-e699-49da-a247-2bc4ca3ac398_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_2f6d45a2-5851-4a1e-a056-a3473205b1bf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_6057a8d9-7c12-4773-8e89-1883a6413533_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossOnContractTermination_5722d181-edc2-4fe8-8007-6df37c3a8ffb_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on contract termination</link:label>
    <link:label id="lab_us-gaap_LossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_LossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnContractTermination" xlink:to="lab_us-gaap_LossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_55193d6a-ea73-4254-bbc8-74f75bc6df57_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_00baf1bb-129a-49a5-9d28-a9f28f913c3c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_03d48dc7-938c-45fe-ab91-f1a3ea4bf5ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c96fe64e-e2b4-40ff-8d8b-6e2a98f08e19_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_bab36b62-0241-4fea-9c88-d29844a39073_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_60e131cb-7c28-4b63-b868-710755e5ea27_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term of stock options granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c3f349e5-ce24-4fbb-9190-faa1f545cd87_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_501dbb65-c42c-4cd4-bcdc-70c5954bac09_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_b9bff464-fada-4661-80cf-aceacc0011bb_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b36073f2-ac38-4cb0-a97e-c4feb00185de_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_b026d16b-0d61-4119-a2b8-de63973dc697_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_b668bc45-7092-4703-9ddd-5d3ce77f3556_terseLabel_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, related party, maximum commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_label_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_documentation_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:href="lfvn-20221231.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:to="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_4c768a12-fdf1-4551-b69d-d7e67b9ece42_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_34fafcba-ec0a-41ab-8e81-0555488459ad_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_635f20cb-23cb-4549-9e2d-ef360537cb0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_00320141-eaf1-4f60-8f72-f9e08f94e38e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5dde470-1556-4561-9af0-700cd21dc415_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_1279e830-d8fd-476f-b946-fa0b60da59bb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_52faabe9-93cd-4164-910f-ecc8d333eede_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c26f93d1-3396-494d-b91b-a9ae37d7dc6f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5003953a-920b-417d-aaf5-3845a20794d2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f6e4b464-e04e-40b2-b5c5-9cf2d3082a9f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_24b34fa0-35a0-4534-8b0c-77d43673102c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_58340bce-2ea8-42f0-ba05-9d8b89afd842_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f4c2a028-2bfa-47a6-954a-b40bdaaf2f9a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7f47e564-5dd1-4dd5-b91b-149e15b04190_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a50a5ba4-4a18-4f52-a65d-3fd870e40050_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards and options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_857c5809-e330-4197-b051-38094fc4e754_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_39509184-1672-452c-bb2d-171afa865cd2_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a5900ea0-4801-4ab1-8652-0494c794ce58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aabe296a-18dd-4c45-8540-f1b56e5155e0_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_19305a81-763b-44bc-9b8d-afdbe0107a45_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed rate interest on debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_f026a872-390b-4bf8-b775-4bb84aedd45e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e305e891-5d2f-4181-8a01-20ebc3c87066_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1b8f36e4-3b46-4d48-a711-ac08dcaff0b2_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_2232d284-e261-4f16-8cff-0b24434aae8e_terseLabel_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_label_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember" xlink:href="lfvn-20221231.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016RevolvingLoanMember" xlink:to="lab_lfvn_March2016RevolvingLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8511cbd5-682b-4006-82d3-50a6ab1a8c74_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5db21bef-a767-4f91-b414-94ec4f8668ca_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c701003-ef59-45f8-a826-de91ab69aeb7_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_80af0abf-e0ad-46a1-b6d7-84867c34b4e9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_07d111f1-e3ae-4123-8a0f-5db4089c4272_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based payment award, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_612b91fd-3e4b-43ef-a9c6-daa683ce7fe8_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held primarily at Other Financial Institutions</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held at Other Financial Institutions [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held At Other Financial Institutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:to="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_a4c26681-f48d-487f-8982-74f7f1c7586c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_08964414-8a11-4e15-b4ff-3abf394826ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_57f0640f-c66c-4e69-bd4c-e0edbd285882_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_7e3bbd2f-e26c-491d-b016-7bb0ad796205_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_1b82e5ce-ce40-403c-88e2-140cfe384ed6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_47976d7e-289e-41d0-937e-d96767b708cc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_47f3347e-4c1c-4ba5-a498-960f5b7e6381_terseLabel_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:href="lfvn-20221231.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:to="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_d00e0137-a561-4ffa-99b2-390e9ee66b23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b3bf7870-0450-4fba-95bf-e4296fe42803_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_bba01850-289f-4556-8170-52d7807b2af1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_33ad1199-0f49-4a1e-a59e-80dc31c8177a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_46ca221a-8b77-4268-bed4-a304a7db0474_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7628888b-7ce2-4715-b97a-3c91a516d9b5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8c6df766-6d27-4357-aafa-470a165e9565_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_d3e32d0a-d31f-4f5f-9af6-6e30aacd8f79_terseLabel_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return liability reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_label_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_documentation_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve" xlink:href="lfvn-20221231.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ReturnLiabilityReserve" xlink:to="lab_lfvn_ReturnLiabilityReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_388fde6e-46c7-4cc2-aa01-bfe641e496d7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_d8d5127f-8cc6-4d59-9ac8-3780fcb42eab_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_e49622d8-66a8-4779-ad02-513aba4a79dc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_a3d2f413-73de-4723-a678-a02c54ba68cf_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_67a11095-5234-4378-972f-11e7bb4c2518_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_f9c6d7a6-dc71-4727-aabc-625eed176178_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_089c924d-1b95-4a3f-b410-868dc8524903_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_0c608d21-ee9e-4a1e-a704-5b6e56787cba_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_dbae48ba-0315-4639-bf44-ce74d3db1612_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_31ad7732-9fdc-4b49-a684-4d23ec1c9051_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8f25264e-0e3f-489d-aacd-4b17c440b24b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_98a52393-bdb3-469b-84c1-c2303410c1c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_cfb33436-aef6-497d-9a24-9e0a5e81f431_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_dd717d09-b4ac-4df3-83cd-19f95eee793f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_2e09583c-837e-40e9-8a35-1e11597b3ba8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_22422262-0852-42e0-ac0e-f3947cd6b027_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_7b1ee9e3-f40c-45ee-ad8a-1e6c4b2f66d3_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_e7ce44d8-24ce-4570-af91-29c18426428d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e7d689c3-294d-4fd0-8956-30b626f3f0a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_57e92dc6-6a48-4109-a869-7bf4dea02490_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_deffa9ba-f36f-42fd-b6d0-181bf9f71935_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_ea51b8b1-3145-4d01-9fc6-ffa7a046cc11_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c852acc7-59fe-406a-8c68-7d73f4633c0f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_91126d95-3b2b-4f26-b2b7-ffb8048547f2_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, common stock, cash</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_3af95b37-183b-42e6-9d57-743d39ad8dd5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_ee231a73-cbf5-439e-8913-7cd76fd78235_terseLabel_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return period for resalable and restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_label_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Return Period For Resalable And Restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_documentation_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Return Period For Resalable And Restockable Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:to="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_747f8095-baae-471d-b267-b993a5c4d8dd_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_9772eee4-4743-4e97-b523-c7146f0a9ac7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_4612d748-9806-47a2-918e-1aa884045a49_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_9206074e-bc70-41c7-9f74-fc39aa1ed890_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_64a50383-e003-44e3-88c3-a9f1d1aec475_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_21bbb718-a2c2-463e-b20f-b1a6ba50522b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_6b8f8a78-36f8-4676-85b1-9eb94e8b6125_terseLabel_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="lfvn-20221231.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_850fb311-5fe8-4e07-a37d-8ea60a89a48b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c2522d8f-8c5c-486b-a3bb-c1120baf07be_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_8df0124b-087b-44e4-bfe8-b5582a9c8fbe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_1d03b5a7-26f5-4f7c-8df1-15b9bb956d21_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_16fe9b65-bb28-447a-9677-6c6094cd674b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_f1699821-c1d1-482c-95f8-cc9517db1357_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_397db018-69e6-4f0c-a5fc-85434d83d845_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d1df6d8e-4ad2-46e9-bc56-c82645da678b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_015fbdd2-7815-4131-9337-8440abea7207_terseLabel_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund percent for resalable and restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_label_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Refund Percent For Resalable And Restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_documentation_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Refund Percent For Resalable And Restockable Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:to="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_fb97bd46-4c20-4885-8a8b-95b34487f4c3_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation reflected in additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_cf507c33-3d25-46ce-9e43-e6be7b094c7c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_14113ebb-8f13-4f60-aed0-cb68e19310db_terseLabel_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_label_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:href="lfvn-20221231.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:to="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_499bc533-b576-447e-a234-1a2cda082d37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c889437a-95e6-46b6-b3aa-8d1dce81ec0a_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_d17d9ebb-dd99-4bf3-9927-6cffc5c5948e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bf8fa3f1-f605-4d7a-ab41-66f519d51607_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a5bb7f21-1f95-469a-9e2a-3ab3c4b8e377_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_247cd30d-c91b-4019-b7dc-954234d8ee55_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Cash and Cash Equivalents:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_72d14d50-e338-48e7-bc6c-a0ee635b1ec7_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and ten long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_b6230a68-d680-431d-a1a0-23664cbb2ef6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue Disaggregated by Geographic Regions</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_cd2663c3-6a1e-4e98-9e70-a11ecb226800_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_91decccc-dca9-4065-8972-afcbfdb51a93_totalLabel_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory" xlink:href="lfvn-20221231.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_66811f1a-c02d-4ee5-8436-bd2652f42894_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_05127c01-9ba2-4381-a1a1-e51dd6b77764_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c743b76a-dc28-4e03-888a-3a7825fff285_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7dc6d383-7ef7-476f-b64e-08dd9d190d1e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_eda4949a-9204-4fca-91a6-3cc44eab5896_terseLabel_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia/Pacific &amp; Europe</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_label_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_documentation_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember" xlink:href="lfvn-20221231.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AsiaPacificAndEuropeMember" xlink:to="lab_lfvn_AsiaPacificAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_65a61636-3637-43c8-8947-8b4ed66281cb_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016TermLoanMember_e7d2aacc-331c-4a61-b793-c29023ae293f_terseLabel_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_label_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember" xlink:href="lfvn-20221231.xsd#lfvn_March2016TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016TermLoanMember" xlink:to="lab_lfvn_March2016TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_52b733f4-2c53-42e9-916f-1f742a453fb4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cc7188e4-9dc9-4c07-a51c-486a8610bbf3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_878e695d-c43c-48be-b8da-9d80da4fc711_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_53bb603d-8ff4-4cd1-8d96-6ea5cad67406_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_ddce4d51-1d2e-4e39-af30-0abc33632f08_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b1f34009-f508-4e14-9090-6920566bebd8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_67c1979d-c609-4f87-8f33-aae8e347ce16_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7c6933f0-60a7-4313-846f-57b9a2df70e6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_10cc3e7d-98ed-4a5c-9474-9b013031988b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e551e818-e6f9-4387-9fc9-e32793d8c961_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b0e383fa-0265-4caa-be18-6da442a3c872_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_873ebb5b-ac39-4d83-9225-8c7c168fa9aa_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_cca75471-d78b-4c9f-99f0-518885885553_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e38005c9-587a-43db-981e-00fe9547fefc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_eb3ce68f-18c0-4230-a26c-388d7f8b1712_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, original debt, interest rate of debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Interest Rate of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_49852224-9f2e-49ac-8988-4cf04ace137e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_57e54b54-d352-4882-9fc9-1f0cecea924a_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_label_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:to="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_61adf3db-0a98-46c3-ac5d-7493e03dcd83_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_24854db0-4f44-4c10-ba5c-23d20aa29a93_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_fe4bd6a6-d47d-4b8e-9597-20aed793ec51_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_802426c9-7e0b-48f3-829e-6840c38befb5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_5b84964b-0318-437b-951b-1a0f6cc2a0a3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_f690bd47-6ffc-4907-a4ee-7e3c3ff6d855_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_db6d03aa-e3a2-4c4a-a520-b8b7c0144c4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_e56a18dd-757f-4675-813e-b718a653f786_terseLabel_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate</link:label>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_label_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:to="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_7198a551-312b-421b-a74c-1894c196f48c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_407f31ba-499e-49a9-9a4e-6a70350300b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_839117b9-ff20-47ff-85bb-de88671dfcd1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_483f8ea2-aca0-4a26-b560-c512213ab95e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9654c361-07ff-4290-8e49-4103278ab1b9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_23214940-2286-46ba-9cef-c267e87a57b2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_a41e906b-468d-46ec-9da5-810d4a5889df_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_65560741-1f6b-4ead-aab9-90d5f349ec9a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_83759a29-0643-46d5-9b7a-1bc6d56c02f1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2b1b0a1c-2ad5-4374-ba1a-37884ce2cf07_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_76268811-463b-4d53-9067-b8e32cf328a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Net (Loss) Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_9e42a663-9b25-4c93-9454-ef6acbe8e798_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities held without readily determinable value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_c47cd85e-767e-4043-a0a0-a45cd150b454_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9b02c66b-54a7-4097-bf48-9645f393994d_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3d65064e-98d1-4856-afac-60a826b8fd14_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5ac8d7cc-e55f-4b8d-8e63-bbd624d3067d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>lfvn-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:05c63f19-c700-4e08-9efe-fee41111e327,g:bc879b91-edcc-4072-a1cf-bbd43641676e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0b568e68-ab86-4dd3-8954-5e1e4d947a5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentType_0b568e68-ab86-4dd3-8954-5e1e4d947a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_04afa984-9cb7-4c38-8e5f-6e5bfd1641b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentQuarterlyReport_04afa984-9cb7-4c38-8e5f-6e5bfd1641b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_05392bf5-9a59-4e6d-b64a-f79308f22b69" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentPeriodEndDate_05392bf5-9a59-4e6d-b64a-f79308f22b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3d236c04-dd37-4f9f-80ad-bc1a51c11461" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentTransitionReport_3d236c04-dd37-4f9f-80ad-bc1a51c11461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ccf29d2e-67af-4413-bf8c-e599eb461f96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityFileNumber_ccf29d2e-67af-4413-bf8c-e599eb461f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_aad7beae-db33-49e2-b416-2f8f34626e29" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityRegistrantName_aad7beae-db33-49e2-b416-2f8f34626e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_68ab2049-8aaf-42be-a520-58029d94fb6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityIncorporationStateCountryCode_68ab2049-8aaf-42be-a520-58029d94fb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b46c4c62-dd42-46c2-ae51-bbb31e6312e7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityTaxIdentificationNumber_b46c4c62-dd42-46c2-ae51-bbb31e6312e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dedcca7d-0ff8-4a9c-9928-960dae551f22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityAddressAddressLine1_dedcca7d-0ff8-4a9c-9928-960dae551f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_fd86c9d6-f36f-4376-811a-b30ea6ff30f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityAddressAddressLine2_fd86c9d6-f36f-4376-811a-b30ea6ff30f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_25f7b0ff-9b1b-4547-9f5f-fc6abfa7805e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityAddressCityOrTown_25f7b0ff-9b1b-4547-9f5f-fc6abfa7805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0bc4241e-3b93-42f2-b809-a48c38cba0b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityAddressStateOrProvince_0bc4241e-3b93-42f2-b809-a48c38cba0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_0eb69bb8-85ff-478d-94d0-4eee5894e9a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityAddressPostalZipCode_0eb69bb8-85ff-478d-94d0-4eee5894e9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4dc86735-4272-4f62-82f5-7ba6b8b18878" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_CityAreaCode_4dc86735-4272-4f62-82f5-7ba6b8b18878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ccac923a-1a95-42be-9e8e-dc4e17cf0f9b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_LocalPhoneNumber_ccac923a-1a95-42be-9e8e-dc4e17cf0f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f6b5945c-cff6-47cd-9458-2a95d58046cc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_Security12bTitle_f6b5945c-cff6-47cd-9458-2a95d58046cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a6c3e2e6-c448-4e3a-a2c1-c23338fec62f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_TradingSymbol_a6c3e2e6-c448-4e3a-a2c1-c23338fec62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c1117748-0083-4038-97b0-933a9e30daa5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_SecurityExchangeName_c1117748-0083-4038-97b0-933a9e30daa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_40d802ca-419e-4237-8a0f-4fb660040002" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityCurrentReportingStatus_40d802ca-419e-4237-8a0f-4fb660040002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_21869066-71f6-4c7c-9404-035b01894ed7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityInteractiveDataCurrent_21869066-71f6-4c7c-9404-035b01894ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ef7063ab-6415-4a66-8ff7-288feeaf11f4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityFilerCategory_ef7063ab-6415-4a66-8ff7-288feeaf11f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1f59bc85-8ef9-44ed-a4f4-7ec40d16cc2d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntitySmallBusiness_1f59bc85-8ef9-44ed-a4f4-7ec40d16cc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3628b58e-a1e7-4c9b-a22f-ff6a53282bf3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityEmergingGrowthCompany_3628b58e-a1e7-4c9b-a22f-ff6a53282bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_15c5fd9d-1417-434d-866a-82c27d00938a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityShellCompany_15c5fd9d-1417-434d-866a-82c27d00938a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0a61e281-cfe1-4d27-b4e9-5b52dcc73c46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0a61e281-cfe1-4d27-b4e9-5b52dcc73c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fb0801f9-a8c4-4a14-8af2-9a259b6e3bdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_AmendmentFlag_fb0801f9-a8c4-4a14-8af2-9a259b6e3bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0d3b6358-113d-4295-9e64-8fb0d14766a6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentFiscalYearFocus_0d3b6358-113d-4295-9e64-8fb0d14766a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_b6993e85-4039-4abc-af30-ced5cc48b6a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_DocumentFiscalPeriodFocus_b6993e85-4039-4abc-af30-ced5cc48b6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_067bfcab-9318-4882-bcc3-ce7da10b5e0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_EntityCentralIndexKey_067bfcab-9318-4882-bcc3-ce7da10b5e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_841eef2b-0eb2-47a1-ad47-672f8524c835" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9597bb11-7851-4a09-a489-eddf28ebe612" xlink:to="loc_dei_CurrentFiscalYearEndDate_841eef2b-0eb2-47a1-ad47-672f8524c835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ced3d447-b64d-457b-a0fc-aa9c954e3c19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2e21abbb-8c0f-4dd5-acdf-ba1aa4cd054d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ced3d447-b64d-457b-a0fc-aa9c954e3c19" xlink:to="loc_us-gaap_AssetsAbstract_2e21abbb-8c0f-4dd5-acdf-ba1aa4cd054d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2e21abbb-8c0f-4dd5-acdf-ba1aa4cd054d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fe43607-ecfa-42a7-86de-b1745381ee01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fe43607-ecfa-42a7-86de-b1745381ee01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5bc5d05c-8ac2-41a3-98ce-0ca5691f6325" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5bc5d05c-8ac2-41a3-98ce-0ca5691f6325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_3f88b21d-4205-4d68-90a9-e468c13ad8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_IncomeTaxesReceivable_3f88b21d-4205-4d68-90a9-e468c13ad8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_432eb4ed-c207-4335-a0ed-6aecde01e1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_InventoryNet_432eb4ed-c207-4335-a0ed-6aecde01e1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_79078e68-3556-4c2d-bdcc-77bbadc9f43c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_79078e68-3556-4c2d-bdcc-77bbadc9f43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c96bb0c1-749a-4bb7-adb9-19fef6f839cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e3189b38-d758-49c8-b457-e7ca132919d4" xlink:to="loc_us-gaap_AssetsCurrent_c96bb0c1-749a-4bb7-adb9-19fef6f839cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2e21abbb-8c0f-4dd5-acdf-ba1aa4cd054d" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b5c471e-5a8e-4ba0-afd0-b98fb4fb76d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5b5c471e-5a8e-4ba0-afd0-b98fb4fb76d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a3f7bebe-4500-4d40-950d-c318029b2de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a3f7bebe-4500-4d40-950d-c318029b2de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cceab97a-b623-4dfe-a39a-5a95126f4e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cceab97a-b623-4dfe-a39a-5a95126f4e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2844bf36-df19-4b40-afa9-3decf0a38e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2844bf36-df19-4b40-afa9-3decf0a38e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_89edb799-7ed8-4b96-adc7-64156f66afb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_48d9e0a0-ce95-48eb-b209-e9dc32f96db7" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_89edb799-7ed8-4b96-adc7-64156f66afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_75ce9c76-d691-45ba-a3f7-3e51f5ba7740" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2e21abbb-8c0f-4dd5-acdf-ba1aa4cd054d" xlink:to="loc_us-gaap_Assets_75ce9c76-d691-45ba-a3f7-3e51f5ba7740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ced3d447-b64d-457b-a0fc-aa9c954e3c19" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8205dc0f-29c1-4531-848d-a4e9406b9b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_AccountsPayableCurrent_8205dc0f-29c1-4531-848d-a4e9406b9b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_086b5ccc-a5ac-4dfa-9b69-e45661516618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_086b5ccc-a5ac-4dfa-9b69-e45661516618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_0bff1e7d-f098-4bc5-b022-4ab94b6d0e42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_0bff1e7d-f098-4bc5-b022-4ab94b6d0e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_44eb2d27-89a8-402f-82ca-3848de0b9ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_44eb2d27-89a8-402f-82ca-3848de0b9ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4bb4ce4e-f758-4e39-90f5-16bcb9ba2bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4bb4ce4e-f758-4e39-90f5-16bcb9ba2bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5e0bf412-670b-4314-ad13-d1b32211ebbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6a12b794-e57f-49be-ba19-a3825eff74c1" xlink:to="loc_us-gaap_LiabilitiesCurrent_5e0bf412-670b-4314-ad13-d1b32211ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_85914d14-148c-492f-a9ae-69f76fccc2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_85914d14-148c-492f-a9ae-69f76fccc2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_dc420845-85be-4acb-86d8-9ad88d1c592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_dc420845-85be-4acb-86d8-9ad88d1c592f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a5971ce9-10d4-432f-8b34-b6fb4f573d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_Liabilities_a5971ce9-10d4-432f-8b34-b6fb4f573d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e4dbfc01-e0df-4aa7-bb04-6611f82eef8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e4dbfc01-e0df-4aa7-bb04-6611f82eef8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_846f748b-ff7a-428f-b521-9a775a3e42d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_PreferredStockValue_846f748b-ff7a-428f-b521-9a775a3e42d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fbb42942-8af2-4752-a3fd-23344f936d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_CommonStockValue_fbb42942-8af2-4752-a3fd-23344f936d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f3d11095-9d63-4171-9661-5e70059541eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_f3d11095-9d63-4171-9661-5e70059541eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cd73cc73-08d9-4b1e-86df-048b1c09aa67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cd73cc73-08d9-4b1e-86df-048b1c09aa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_357f97ed-4089-469b-9392-176651d9fcbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_357f97ed-4089-469b-9392-176651d9fcbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f00ef739-28fd-4c60-855c-ccc756492690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe312c36-2390-4f6f-a91b-449ef755f848" xlink:to="loc_us-gaap_StockholdersEquity_f00ef739-28fd-4c60-855c-ccc756492690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c62910ca-b4e0-40b9-9cce-7da670dfa6e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e4218e67-4759-412c-b59d-36a9d222cd22" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c62910ca-b4e0-40b9-9cce-7da670dfa6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_490e1725-6315-4ab9-820f-23a45856f3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_490e1725-6315-4ab9-820f-23a45856f3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0f0eed6d-6652-49ff-9363-fa7524f5547b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0f0eed6d-6652-49ff-9363-fa7524f5547b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_985253a0-daa4-4ac5-bafa-476c9e520f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_985253a0-daa4-4ac5-bafa-476c9e520f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5c443f04-3862-4e91-b94d-2312cafd36ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5c443f04-3862-4e91-b94d-2312cafd36ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a6ab1e8-bc00-428b-8277-cc5306cac61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9a6ab1e8-bc00-428b-8277-cc5306cac61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bd71d182-731f-49a8-bc8c-d8699d5424c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bd71d182-731f-49a8-bc8c-d8699d5424c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_37b9b9ee-6e50-422b-b32a-89b1cb58b354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_CommonStockSharesIssued_37b9b9ee-6e50-422b-b32a-89b1cb58b354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d40fdd1d-d4eb-4e17-abac-a2f4896bdd41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2c619edf-4383-4cb3-b565-69bbb6d954c4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d40fdd1d-d4eb-4e17-abac-a2f4896bdd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b406c786-2549-49d1-9fdd-3b3dec0628cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b406c786-2549-49d1-9fdd-3b3dec0628cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e16b9075-1d72-4178-a7d8-958389ca2671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e16b9075-1d72-4178-a7d8-958389ca2671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dc333792-2496-488a-a338-48ec46468e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_GrossProfit_dc333792-2496-488a-a338-48ec46468e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_3405ce53-108c-4665-9bc0-11478c82ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_OperatingExpensesAbstract_3405ce53-108c-4665-9bc0-11478c82ded0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_2444b914-68ae-49b5-89fb-24b84e4930a2" xlink:href="lfvn-20221231.xsd#lfvn_CommissionAndIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3405ce53-108c-4665-9bc0-11478c82ded0" xlink:to="loc_lfvn_CommissionAndIncentives_2444b914-68ae-49b5-89fb-24b84e4930a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3d4b89f-ede4-4958-bfd2-10e1b7299522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3405ce53-108c-4665-9bc0-11478c82ded0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a3d4b89f-ede4-4958-bfd2-10e1b7299522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e24ef38a-6c05-4857-9cf8-b48dd6be0026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_3405ce53-108c-4665-9bc0-11478c82ded0" xlink:to="loc_us-gaap_OperatingExpenses_e24ef38a-6c05-4857-9cf8-b48dd6be0026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_081d86a4-408c-4aff-9566-cea1e0840d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_OperatingIncomeLoss_081d86a4-408c-4aff-9566-cea1e0840d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_82b64f7e-0554-4571-8d08-5bcbe7adbc8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_82b64f7e-0554-4571-8d08-5bcbe7adbc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_9afe3d7e-5c0a-4ace-a316-b68bc32b9242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_82b64f7e-0554-4571-8d08-5bcbe7adbc8a" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_9afe3d7e-5c0a-4ace-a316-b68bc32b9242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_790b70c3-b2d3-4732-a407-7f31a3fa61e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_82b64f7e-0554-4571-8d08-5bcbe7adbc8a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_790b70c3-b2d3-4732-a407-7f31a3fa61e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_06b96f05-90f3-403f-92c8-8775f09a61d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_82b64f7e-0554-4571-8d08-5bcbe7adbc8a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_06b96f05-90f3-403f-92c8-8775f09a61d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6561455-bd08-4e83-8239-d76775b085ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6561455-bd08-4e83-8239-d76775b085ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8c3e777f-9188-4c7a-b0d2-08f27be1ec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8c3e777f-9188-4c7a-b0d2-08f27be1ec44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6da5e9b3-a16b-4835-8a74-2ebd3cf9874d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_NetIncomeLoss_6da5e9b3-a16b-4835-8a74-2ebd3cf9874d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_86db020b-c928-43dc-86dc-21d3811045a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_EarningsPerShareAbstract_86db020b-c928-43dc-86dc-21d3811045a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_738f90aa-8356-4972-bdd2-1e080f80e163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86db020b-c928-43dc-86dc-21d3811045a0" xlink:to="loc_us-gaap_EarningsPerShareBasic_738f90aa-8356-4972-bdd2-1e080f80e163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fdf0dff3-b779-43f8-8d0b-fc959a4b4274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86db020b-c928-43dc-86dc-21d3811045a0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fdf0dff3-b779-43f8-8d0b-fc959a4b4274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ac1dd92-cb25-4f37-acf0-b313ee1c6b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ac1dd92-cb25-4f37-acf0-b313ee1c6b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1cd5584-d044-47c0-a13b-90de9d5eab79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ac1dd92-cb25-4f37-acf0-b313ee1c6b38" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a1cd5584-d044-47c0-a13b-90de9d5eab79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19629c4d-a44f-4585-938a-8489ed03b753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ac1dd92-cb25-4f37-acf0-b313ee1c6b38" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_19629c4d-a44f-4585-938a-8489ed03b753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18c130e0-3b56-41fb-be68-4d726384321e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18c130e0-3b56-41fb-be68-4d726384321e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6cc89af1-7437-40e4-ada3-ee73423416b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18c130e0-3b56-41fb-be68-4d726384321e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_6cc89af1-7437-40e4-ada3-ee73423416b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e7a413f2-7667-4ce9-8e56-24ff4177c5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_18c130e0-3b56-41fb-be68-4d726384321e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e7a413f2-7667-4ce9-8e56-24ff4177c5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ac62c74e-b1b7-4fc0-abe2-96af8d283450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a1eecdf-95c7-45f8-a1dc-9df1e30273b4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ac62c74e-b1b7-4fc0-abe2-96af8d283450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_95ecf05b-cd22-433d-bd4d-076db7ebec8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_95ecf05b-cd22-433d-bd4d-076db7ebec8a" xlink:to="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d7ededc5-f2df-43d1-97bf-feaf2f2e7b0c" xlink:to="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8f1b17ad-113d-404b-b316-e2c631eae508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_CommonStockMember_8f1b17ad-113d-404b-b316-e2c631eae508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9e26c739-8488-4092-a0a3-5bbecd24f1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9e26c739-8488-4092-a0a3-5bbecd24f1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c1c17e7c-050c-40fe-8ffe-69e1130b7a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_RetainedEarningsMember_c1c17e7c-050c-40fe-8ffe-69e1130b7a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2090f534-0ac1-46d6-81dc-87f0b7d454d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5598d76d-79c3-4454-824b-780a348fb9ca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2090f534-0ac1-46d6-81dc-87f0b7d454d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93c0ff44-7131-4791-956c-dc591a45263c" xlink:to="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e9311153-7a81-4e17-80c7-375d5098ee26" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c78db090-efb3-4f5d-8dac-dd0462a40ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c78db090-efb3-4f5d-8dac-dd0462a40ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a9b4a83d-6168-4975-bdb2-15cc2981e07b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockholdersEquity_a9b4a83d-6168-4975-bdb2-15cc2981e07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a5610a7d-4eb6-4a81-9220-d233a34c1ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a5610a7d-4eb6-4a81-9220-d233a34c1ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d807800c-15d4-4813-8bee-e00e47af3031" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d807800c-15d4-4813-8bee-e00e47af3031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1b00453f-f4a7-4a1d-9f74-88d3b764c886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1b00453f-f4a7-4a1d-9f74-88d3b764c886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e61cd222-9ad2-48a3-93cc-28470d6cee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_e61cd222-9ad2-48a3-93cc-28470d6cee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_95adee7d-7aaa-4735-91ce-d510bb65f2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_95adee7d-7aaa-4735-91ce-d510bb65f2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97cb763d-c88c-4b1f-a8ae-a0c3b290e510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97cb763d-c88c-4b1f-a8ae-a0c3b290e510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_893d1dcf-2471-429c-91c2-19345ea11644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_893d1dcf-2471-429c-91c2-19345ea11644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd68ea1f-0218-47bc-bf5e-87322c538277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_cd68ea1f-0218-47bc-bf5e-87322c538277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_12e44052-5ad8-4811-b372-69e08b7b7da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_12e44052-5ad8-4811-b372-69e08b7b7da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3c06556-cffd-42f8-9794-128965126bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3c06556-cffd-42f8-9794-128965126bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bb97f0c4-b470-40d3-8dcd-ae500c00e559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_bb97f0c4-b470-40d3-8dcd-ae500c00e559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_16490315-ec66-4e11-ba0b-144837d6a445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_DividendsCash_16490315-ec66-4e11-ba0b-144837d6a445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f512556b-bd04-4acf-b4f8-55a6822dad92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f512556b-bd04-4acf-b4f8-55a6822dad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4f6a6f9-5c96-44ba-b782-c14cadf00000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_NetIncomeLoss_b4f6a6f9-5c96-44ba-b782-c14cadf00000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ac7354bc-9559-4812-a7ab-2fda350fd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ac7354bc-9559-4812-a7ab-2fda350fd8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_77382d38-2f2a-4e78-b083-109ce6235ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_193c00e9-ab68-4672-9e3e-ebd92985f7b4" xlink:to="loc_us-gaap_StockholdersEquity_77382d38-2f2a-4e78-b083-109ce6235ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2bebd2f0-7a73-4333-9ef3-731ada12a598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2bebd2f0-7a73-4333-9ef3-731ada12a598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5106f3c2-9b04-4a77-8930-f664e35acbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2bebd2f0-7a73-4333-9ef3-731ada12a598" xlink:to="loc_us-gaap_NetIncomeLoss_5106f3c2-9b04-4a77-8930-f664e35acbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2bebd2f0-7a73-4333-9ef3-731ada12a598" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_15e7a3f5-0bf7-4e90-b62d-2310c7e8322b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_15e7a3f5-0bf7-4e90-b62d-2310c7e8322b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a8d14d42-eb9f-4ac9-b037-461722d65225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_ShareBasedCompensation_a8d14d42-eb9f-4ac9-b037-461722d65225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e77c38ff-1616-422b-ba5a-1d9fe25561e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_e77c38ff-1616-422b-ba5a-1d9fe25561e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_03061319-79cb-4360-9c60-5c70c4be12a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_03061319-79cb-4360-9c60-5c70c4be12a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a7b1fb44-12cc-45c7-9420-55b91a342341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a7b1fb44-12cc-45c7-9420-55b91a342341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c19125c7-9e91-4813-84dc-3bec7b623677" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9e606a1f-13ee-4df6-819e-172141a9aabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9e606a1f-13ee-4df6-819e-172141a9aabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_3ba9f561-b331-49ca-9d8a-26950c414307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_3ba9f561-b331-49ca-9d8a-26950c414307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_406da15c-59d5-4625-8b96-3fac9289a5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_406da15c-59d5-4625-8b96-3fac9289a5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_da5f8f5f-86cd-4f73-a8d5-b5fe440c681b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_da5f8f5f-86cd-4f73-a8d5-b5fe440c681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_27ff3764-1073-4176-be2a-c3db620a86b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_27ff3764-1073-4176-be2a-c3db620a86b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2b39018c-6d62-4e87-8b80-e6ff85d0ccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2b39018c-6d62-4e87-8b80-e6ff85d0ccd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5734b343-1e77-48b7-8747-969a989441e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5734b343-1e77-48b7-8747-969a989441e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fab68509-dcf8-48a8-b898-7e4e53c45488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fab68509-dcf8-48a8-b898-7e4e53c45488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_9a739dac-88fa-4ad0-a3c3-dc3465efd937" xlink:href="lfvn-20221231.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_9a739dac-88fa-4ad0-a3c3-dc3465efd937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e0aeac36-895d-4023-af6f-e8dec3e74128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1d4925d6-71f5-4ce8-b333-aa9ef66c5419" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e0aeac36-895d-4023-af6f-e8dec3e74128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_74aa0e3d-de98-4367-92bf-719ee93df34e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2bebd2f0-7a73-4333-9ef3-731ada12a598" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_74aa0e3d-de98-4367-92bf-719ee93df34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a7700f1-b6f8-44e0-839d-aa072cf48b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a7700f1-b6f8-44e0-839d-aa072cf48b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf38f442-4908-43e7-a6ca-08a2dd4e54f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a7700f1-b6f8-44e0-839d-aa072cf48b0d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf38f442-4908-43e7-a6ca-08a2dd4e54f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ba849f0-6014-4042-9948-20eff71575b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a7700f1-b6f8-44e0-839d-aa072cf48b0d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ba849f0-6014-4042-9948-20eff71575b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f7934d8c-c636-447d-a59c-ff94578a1aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f7934d8c-c636-447d-a59c-ff94578a1aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_67f0bd47-4d7d-4619-af56-21ebfcd4b67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_us-gaap_PaymentsOfDividends_67f0bd47-4d7d-4619-af56-21ebfcd4b67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cbb0102b-34bd-4504-ad01-75bef768b01f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cbb0102b-34bd-4504-ad01-75bef768b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_6a64687d-977d-4c01-8315-68556ea4dacb" xlink:href="lfvn-20221231.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_6a64687d-977d-4c01-8315-68556ea4dacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_533624f4-3d70-4848-8e85-f00bddbbb766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_533624f4-3d70-4848-8e85-f00bddbbb766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a2acb49-c23e-4845-84d3-ef4eb2f07dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6d0fd312-64cc-488a-bf04-58b53bf14c45" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a2acb49-c23e-4845-84d3-ef4eb2f07dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_43d027fb-adc5-47b3-93b0-fa27519d55b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_43d027fb-adc5-47b3-93b0-fa27519d55b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_061189d7-310f-497d-b95d-2892953869ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_061189d7-310f-497d-b95d-2892953869ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c2973f8-a025-48f9-ae52-ccc7a2c2b3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c2973f8-a025-48f9-ae52-ccc7a2c2b3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b503d2f4-19c1-48b9-b3eb-5c5d28746542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b503d2f4-19c1-48b9-b3eb-5c5d28746542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_bc004d33-0122-4425-abd2-efc14b461fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a8bd246b-4ec6-4a88-99ff-108fecf26d0a" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_bc004d33-0122-4425-abd2-efc14b461fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_815b19c1-6589-4be3-8e89-d55e0169ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bc004d33-0122-4425-abd2-efc14b461fc4" xlink:to="loc_us-gaap_InterestPaidNet_815b19c1-6589-4be3-8e89-d55e0169ce0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_e189fdda-a140-45b1-8bc7-cb99247be8af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_bc004d33-0122-4425-abd2-efc14b461fc4" xlink:to="loc_us-gaap_IncomeTaxesPaid_e189fdda-a140-45b1-8bc7-cb99247be8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="lfvn-20221231.xsd#OrganizationandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de41f1a7-6989-4372-9127-f11ec6ba8d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5b8351ba-c864-42d5-8a5d-a6c9392779d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_de41f1a7-6989-4372-9127-f11ec6ba8d3a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5b8351ba-c864-42d5-8a5d-a6c9392779d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_346c6965-7bd5-4003-bcf7-239499dac3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c646efe1-cbc7-4aae-ab88-81d8f8ebffe3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_346c6965-7bd5-4003-bcf7-239499dac3d5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c646efe1-cbc7-4aae-ab88-81d8f8ebffe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="simple" xlink:href="lfvn-20221231.xsd#GigEconomyGroupInvestment"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_15cad81d-60e0-45b7-9d22-086197dcff0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_36ff6ada-d690-43a8-bc2f-459f619a7e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_15cad81d-60e0-45b7-9d22-086197dcff0e" xlink:to="loc_us-gaap_InvestmentTextBlock_36ff6ada-d690-43a8-bc2f-459f619a7e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/Leases" xlink:type="simple" xlink:href="lfvn-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9e49f847-4e7f-497e-8279-2be96a8086fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_608503cc-5f90-405d-a5d8-19461d0cd73a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9e49f847-4e7f-497e-8279-2be96a8086fe" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_608503cc-5f90-405d-a5d8-19461d0cd73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebt" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4b3529d8-4f1d-4057-9f73-69c368465732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d2e1ffb9-3442-4050-b794-389ab7d9eb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4b3529d8-4f1d-4057-9f73-69c368465732" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d2e1ffb9-3442-4050-b794-389ab7d9eb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b2158c79-dd8a-4df4-bfbc-e4214a3db151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_342a1bc8-2899-4c25-a0cf-01f69594a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b2158c79-dd8a-4df4-bfbc-e4214a3db151" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_342a1bc8-2899-4c25-a0cf-01f69594a1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_60e3c159-05b8-4e8c-a1be-ab4605fc5b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_61d2ed7d-672a-4dbf-ab55-c3dea48e255c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_60e3c159-05b8-4e8c-a1be-ab4605fc5b2f" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_61d2ed7d-672a-4dbf-ab55-c3dea48e255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29ee9196-a794-4e37-bd71-907c17b0eab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_904bfbb6-aaee-4982-b41e-a337fc5268a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_29ee9196-a794-4e37-bd71-907c17b0eab9" xlink:to="loc_us-gaap_LossContingencyDisclosures_904bfbb6-aaee-4982-b41e-a337fc5268a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_72d3bd93-2952-42c7-942e-adc02cf5144e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_72d3bd93-2952-42c7-942e-adc02cf5144e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_47f84627-603e-4221-8057-10f05fd76e68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_UseOfEstimates_47f84627-603e-4221-8057-10f05fd76e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3dc212fe-d24d-43c2-b5eb-f53233e215d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_3dc212fe-d24d-43c2-b5eb-f53233e215d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_49693213-c39b-4f6b-9a00-93720ebad753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_49693213-c39b-4f6b-9a00-93720ebad753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_998438a2-3a64-4833-9ba3-d15ac270d0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_998438a2-3a64-4833-9ba3-d15ac270d0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_a515d4c9-e2dd-4e94-a0f8-6f9fb953658e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_a515d4c9-e2dd-4e94-a0f8-6f9fb953658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_73a7bd09-db58-4851-a7b4-cb9583b11ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_73a7bd09-db58-4851-a7b4-cb9583b11ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_9dc12a49-624d-4d8e-b734-25e15efe3710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_9dc12a49-624d-4d8e-b734-25e15efe3710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12ac4adf-1c92-4c2b-93c5-43cbf6c272a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12ac4adf-1c92-4c2b-93c5-43cbf6c272a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_27b97b90-77b8-4c32-a559-099111290f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_27b97b90-77b8-4c32-a559-099111290f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1e4d48d5-e08b-4897-a2b0-ad3023fda924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_1e4d48d5-e08b-4897-a2b0-ad3023fda924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_fb5e4996-633a-4cc5-9c6b-c4117cb0e15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_fb5e4996-633a-4cc5-9c6b-c4117cb0e15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ba485548-5a9a-45fb-8c13-dd546a91f116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ba485548-5a9a-45fb-8c13-dd546a91f116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_a7c85696-63dc-4e52-b3e8-84552ee65d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_a7c85696-63dc-4e52-b3e8-84552ee65d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_617d0c7c-9e9b-4c44-8210-3af29b9ab096" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_617d0c7c-9e9b-4c44-8210-3af29b9ab096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5f20fb28-4f97-42a0-adb7-9ddcbf53f049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6a436c93-41f2-48dc-ae2f-7435433de92e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_5f20fb28-4f97-42a0-adb7-9ddcbf53f049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b2cfb97b-5ae6-41ea-874c-9820a144b20e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7e75a447-26b6-4c3b-beb0-f3d59f467cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2cfb97b-5ae6-41ea-874c-9820a144b20e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7e75a447-26b6-4c3b-beb0-f3d59f467cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3d39779c-7ac1-4e04-9e76-8cb69efa3151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2cfb97b-5ae6-41ea-874c-9820a144b20e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3d39779c-7ac1-4e04-9e76-8cb69efa3151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_b7c75e1c-dbe6-49c3-9a32-3f92844b849f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2cfb97b-5ae6-41ea-874c-9820a144b20e" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_b7c75e1c-dbe6-49c3-9a32-3f92844b849f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_1962e9b3-ea76-48e6-8918-a3d737433f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2cfb97b-5ae6-41ea-874c-9820a144b20e" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_1962e9b3-ea76-48e6-8918-a3d737433f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesTables" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a51b449d-de9d-4884-b2de-c1915789c4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_3082a719-e645-43b9-b0bf-84ce12633e72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a51b449d-de9d-4884-b2de-c1915789c4fe" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_3082a719-e645-43b9-b0bf-84ce12633e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_58a751fc-7694-4033-a11a-eb9315ec1cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a51b449d-de9d-4884-b2de-c1915789c4fe" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_58a751fc-7694-4033-a11a-eb9315ec1cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_edba5901-1847-4c06-80e7-0ebbfd3096bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_edba5901-1847-4c06-80e7-0ebbfd3096bc" xlink:to="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e46ee790-446c-41b3-9041-558ffa61dffa" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_c0f876a2-3497-472d-852a-5b61a00c3f89" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_c0f876a2-3497-472d-852a-5b61a00c3f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_84b3db29-4793-4c26-bb8b-734339293f46" xlink:href="lfvn-20221231.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e80e0cdd-5477-4b82-a0c9-cdcb0ef04039" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_84b3db29-4793-4c26-bb8b-734339293f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_fac9b58f-b5ff-474a-ae44-036af670e11b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShowroomsMember_6a65adaf-cf21-4e60-a1b4-bea1ebba4a67" xlink:href="lfvn-20221231.xsd#lfvn_ShowroomsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f7d55fc-5e39-4d90-b987-a54145ecebee" xlink:to="loc_lfvn_ShowroomsMember_6a65adaf-cf21-4e60-a1b4-bea1ebba4a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_298eccde-22b0-4ba5-81af-1e1c55aa6e02" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_570eef95-570c-42aa-b058-60e2f0996f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_570eef95-570c-42aa-b058-60e2f0996f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a5c36d0e-07fc-431f-bd11-22b242fd548a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_a5c36d0e-07fc-431f-bd11-22b242fd548a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_ff82f227-887d-49ed-b927-bef03e6630f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_ff82f227-887d-49ed-b927-bef03e6630f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e376296c-4eb9-4470-ab22-50718ed92544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e376296c-4eb9-4470-ab22-50718ed92544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_f36b592a-e2ba-4089-ba2d-1d0698b97379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_InventoryValuationReserves_f36b592a-e2ba-4089-ba2d-1d0698b97379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_9404e23c-6ef9-410b-9fd2-9e478113fe80" xlink:href="lfvn-20221231.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_9404e23c-6ef9-410b-9fd2-9e478113fe80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_98fac256-7200-41de-85f7-0d27c121b1a7" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_98fac256-7200-41de-85f7-0d27c121b1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_40e24339-8b94-40ad-9c8a-2e5f5cade979" xlink:href="lfvn-20221231.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_40e24339-8b94-40ad-9c8a-2e5f5cade979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_abd77668-d0ae-4594-b9d3-56988291c4cd" xlink:href="lfvn-20221231.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_abd77668-d0ae-4594-b9d3-56988291c4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_34f8db53-0ef8-49a7-a4e8-a3d1aa32c7b1" xlink:href="lfvn-20221231.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_ReturnLiabilityReserve_34f8db53-0ef8-49a7-a4e8-a3d1aa32c7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1d60f19b-f412-421f-82dd-7a8795ed5625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1d60f19b-f412-421f-82dd-7a8795ed5625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c8e1a129-b478-472d-acdc-ec0336ac0be3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_OperatingLeaseLiability_c8e1a129-b478-472d-acdc-ec0336ac0be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnContractTermination_a46c821b-a2ba-4829-be5b-b32edf0378a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnContractTermination"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_LossOnContractTermination_a46c821b-a2ba-4829-be5b-b32edf0378a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cf3b487d-61c3-47fa-9f3e-ca6cf029d970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cf3b487d-61c3-47fa-9f3e-ca6cf029d970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e32b149c-68bc-4828-8653-8cc371162ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e32b149c-68bc-4828-8653-8cc371162ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_3bcee16f-30d8-467e-a299-70ecdaae56c9" xlink:href="lfvn-20221231.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_lfvn_NumberOfGeographicSegments_3bcee16f-30d8-467e-a299-70ecdaae56c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_55c4995a-786e-41d3-b1d2-571fec4ba69c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6fc4ac12-4e35-478b-a64e-4982b894f7a4" xlink:to="loc_us-gaap_NumberOfOperatingSegments_55c4995a-786e-41d3-b1d2-571fec4ba69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9a221d5b-206c-4fdc-ac59-5e9494eeffb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9a221d5b-206c-4fdc-ac59-5e9494eeffb7" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_31b7649c-1315-4115-8693-483c175cc516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_31b7649c-1315-4115-8693-483c175cc516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_58cd9893-3c5f-4191-83f4-bc028c4570be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_58cd9893-3c5f-4191-83f4-bc028c4570be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_36ac6094-1963-4f67-963c-1f2017441e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_us-gaap_InventoryNet_36ac6094-1963-4f67-963c-1f2017441e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_d11ba3d3-39d4-49fb-b35e-1bdb4b099bd0" xlink:href="lfvn-20221231.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_d11ba3d3-39d4-49fb-b35e-1bdb4b099bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_5ab9ed45-8736-49de-80bc-5e6dd1465dc0" xlink:href="lfvn-20221231.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_5ab9ed45-8736-49de-80bc-5e6dd1465dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_6341ec6d-2f2d-497b-abb8-85cf7a43f090" xlink:href="lfvn-20221231.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_16460d33-1211-4eaf-b6ac-fcc0db6098fa" xlink:to="loc_lfvn_InventoryPercentOfTotalInventory_6341ec6d-2f2d-497b-abb8-85cf7a43f090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d45afb35-5e26-4d0d-8988-68041a26eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d45afb35-5e26-4d0d-8988-68041a26eddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e429fc91-a7ed-4c15-8aa5-fe95e797f7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_d45afb35-5e26-4d0d-8988-68041a26eddd" xlink:to="loc_us-gaap_NetIncomeLoss_e429fc91-a7ed-4c15-8aa5-fe95e797f7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_dd36dc60-716b-4bfa-9d24-22733ac8d3ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_dd36dc60-716b-4bfa-9d24-22733ac8d3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aae74077-29b1-433e-83b9-fcdae1a87d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_dd36dc60-716b-4bfa-9d24-22733ac8d3ec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aae74077-29b1-433e-83b9-fcdae1a87d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_e4388937-c09f-4c49-92fa-a8d3f866a4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_e4388937-c09f-4c49-92fa-a8d3f866a4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_200b38c7-8cb2-4d28-9555-dd9ad69459ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_e4388937-c09f-4c49-92fa-a8d3f866a4c7" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_200b38c7-8cb2-4d28-9555-dd9ad69459ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e9b1476c-8787-4659-8308-75276cdc63a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e9b1476c-8787-4659-8308-75276cdc63a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_53e25809-3600-4784-9ed0-7930fb1f2e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_EarningsPerShareBasic_53e25809-3600-4784-9ed0-7930fb1f2e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_96971563-6907-427a-9536-3db50f31f471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_34ae355d-d3f6-4f5c-843a-ac0b3f17a3d7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_96971563-6907-427a-9536-3db50f31f471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_295edbfd-8935-4c95-af52-1df8a3b8f5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_295edbfd-8935-4c95-af52-1df8a3b8f5f7" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:to="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_eed82766-7efe-4025-801f-f6b45b3b5ca3" xlink:to="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2016ebdd-94df-47ee-8ac9-7f4b6e9a54e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_srt_AmericasMember_2016ebdd-94df-47ee-8ac9-7f4b6e9a54e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_4015de96-8150-4333-95a5-06bf50132608" xlink:href="lfvn-20221231.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_4015de96-8150-4333-95a5-06bf50132608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8d15f713-211c-4184-a373-fe2d016102c5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_country_US_8d15f713-211c-4184-a373-fe2d016102c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_2e0c7496-ac81-4e2d-bae3-6a2c7074e4c8" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4db02f80-4501-4ee3-b04c-e677fc7b726d" xlink:to="loc_country_JP_2e0c7496-ac81-4e2d-bae3-6a2c7074e4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5691b473-f12a-4fdf-9ff7-f9c7353cb2ea" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30ae72d5-2a2b-43be-b168-7ac2540527fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_30ae72d5-2a2b-43be-b168-7ac2540527fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_93d1166f-5a42-4a6b-b81d-ea4a65263fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_c5e0c8ff-eab5-4b3d-b7d4-a8cb48c6a7e8" xlink:to="loc_us-gaap_NoncurrentAssets_93d1166f-5a42-4a6b-b81d-ea4a65263fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_ca239363-9de8-4f96-ae65-75b72f26c994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_ca239363-9de8-4f96-ae65-75b72f26c994" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_83e6fae0-590c-4f3e-bb24-25da7abb39ee" xlink:to="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_2e8fe593-1610-4a53-bf47-eb6d2f017ea6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_8247feda-10c6-49b7-9066-bc681ad46522" xlink:to="loc_srt_AffiliatedEntityMember_2e8fe593-1610-4a53-bf47-eb6d2f017ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_38382214-0db0-4865-bb86-8887663ad6a0" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_72fa9504-c60a-4826-ac7f-195017c2285a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_57a90aef-a656-46db-9e4f-7a4f839acf7f" xlink:to="loc_us-gaap_CommonStockMember_72fa9504-c60a-4826-ac7f-195017c2285a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_11a4fad3-462c-4a0c-a334-e7c6cc222fea" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_b5a11ae5-815c-4b2d-8b67-5801891b6ede" xlink:href="lfvn-20221231.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_b5a11ae5-815c-4b2d-8b67-5801891b6ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_60f91e44-a4b2-4828-a8c5-d9dadbfc76f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_60f91e44-a4b2-4828-a8c5-d9dadbfc76f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1147ef15-c8d3-42aa-929a-01fbaea04812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_1147ef15-c8d3-42aa-929a-01fbaea04812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_6344764e-a906-4e28-b6c8-0cb47968e2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_6344764e-a906-4e28-b6c8-0cb47968e2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0ac00ff3-5158-414e-9dd3-d8ffae8803d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6617ba13-5c04-4aff-bcfa-b7d68680bf0c" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0ac00ff3-5158-414e-9dd3-d8ffae8803d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_150681df-9b08-4b7c-98a1-069fab6aa6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_150681df-9b08-4b7c-98a1-069fab6aa6be" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:to="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6b5111a2-e1f3-4a70-b3a0-dd7670ab9361" xlink:to="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5488d208-0deb-4008-a453-f5364c6d816b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:to="loc_srt_MinimumMember_5488d208-0deb-4008-a453-f5364c6d816b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca1d40b2-8040-4c71-acde-915d12097a95" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3d136e7b-82dd-4229-be6f-b0723ab7c7cd" xlink:to="loc_srt_MaximumMember_ca1d40b2-8040-4c71-acde-915d12097a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_7dd7c0da-a9c9-4eca-a3e8-2fb6d18c42fe" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd92b7ad-c540-47ee-a4b9-ce2bf7760467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_fd92b7ad-c540-47ee-a4b9-ce2bf7760467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b62122aa-14f3-4c20-aa08-6a220eb54dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b62122aa-14f3-4c20-aa08-6a220eb54dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_29577571-d10b-48c1-9927-f3c1dcdfc923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_29577571-d10b-48c1-9927-f3c1dcdfc923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2f3b5ebc-adbb-45fb-b7e4-ab19106f36fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a143adf0-46ed-4b53-b3cb-f73e56791690" xlink:to="loc_us-gaap_OperatingLeaseExpense_2f3b5ebc-adbb-45fb-b7e4-ab19106f36fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3b3d70ca-c14d-4d60-8a4f-1e0a651aae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2962a915-aec1-425a-8f60-fc7800cef7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b3d70ca-c14d-4d60-8a4f-1e0a651aae2e" xlink:to="loc_us-gaap_OperatingLeasePayments_2962a915-aec1-425a-8f60-fc7800cef7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_80d8516c-9ecc-4968-b15e-871ff0da0767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_80d8516c-9ecc-4968-b15e-871ff0da0767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_14338e09-9dbb-48f0-8459-f73c0d5deb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_14338e09-9dbb-48f0-8459-f73c0d5deb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d9da18c9-65f8-48e2-848a-023c5dce4cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d9da18c9-65f8-48e2-848a-023c5dce4cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9151053f-9d8a-4aac-be19-e9ae497df67e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9151053f-9d8a-4aac-be19-e9ae497df67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2dad8f0-d444-40a7-8ca2-3d1579fa4735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a2dad8f0-d444-40a7-8ca2-3d1579fa4735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_18d62022-541b-4bc7-974d-46ac8897a722" xlink:href="lfvn-20221231.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_18d62022-541b-4bc7-974d-46ac8897a722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cb6c725-19e0-46e5-9df7-250448ba8bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cb6c725-19e0-46e5-9df7-250448ba8bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_882716eb-b0b2-4c0f-801c-f8c58cfbd671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_882716eb-b0b2-4c0f-801c-f8c58cfbd671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ba3165f5-0b83-4115-b863-7ef52fd80d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_505e8fb8-4d5c-4a89-9e59-4725f0f88c70" xlink:to="loc_us-gaap_OperatingLeaseLiability_ba3165f5-0b83-4115-b863-7ef52fd80d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#LongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e32128a4-e751-4711-9ac2-f9a380ecfa8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e32128a4-e751-4711-9ac2-f9a380ecfa8e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7e1d9cb4-458d-49c6-aca4-1faa74b1b733" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_2fa47ca5-45de-4ad4-83c5-56d1b81202a0" xlink:href="lfvn-20221231.xsd#lfvn_March2016TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:to="loc_lfvn_March2016TermLoanMember_2fa47ca5-45de-4ad4-83c5-56d1b81202a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_20e58d27-97c3-4b80-a953-980cf66a5ab3" xlink:href="lfvn-20221231.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81abd718-e18a-45a5-b939-a81a041b23b0" xlink:to="loc_lfvn_March2016RevolvingLoanMember_20e58d27-97c3-4b80-a953-980cf66a5ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e191ecb1-a831-47ea-8c14-b4c77c04286d" xlink:to="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_27c906e7-c3aa-4d2a-8363-f802394af87e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:to="loc_us-gaap_SecuredDebtMember_27c906e7-c3aa-4d2a-8363-f802394af87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_bec3e106-c8f4-4684-9600-7b2de0cbce0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ef1a0a4d-3a50-488f-8cc3-bc246c72b322" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_bec3e106-c8f4-4684-9600-7b2de0cbce0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_7aaf4ec4-f28a-4462-a5b8-0872d4d25dec" xlink:to="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_81334942-56df-433d-8fe9-a6f23ebf84ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_30765bdb-6c3e-45da-b8f0-b76f160557e1" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_81334942-56df-433d-8fe9-a6f23ebf84ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1043c2bb-958c-4c39-818c-35c83b4a0f8a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_5af6136d-aa4f-4359-ae7a-d69cd6398d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_cda1d642-ee84-4377-9b31-7379cd640c7d" xlink:to="loc_us-gaap_LineOfCreditMember_5af6136d-aa4f-4359-ae7a-d69cd6398d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e71d4bdc-7934-4170-927b-fadc2d7465e2" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ba5fcb18-395e-471f-8564-6696ab99ee8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ba5fcb18-395e-471f-8564-6696ab99ee8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_968fb463-cc18-4510-a42a-46bb2dbf5b64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_968fb463-cc18-4510-a42a-46bb2dbf5b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_598489c9-1b98-495f-a1a8-0f12ad0241f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_598489c9-1b98-495f-a1a8-0f12ad0241f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_2bfc8ad9-a3c7-4a65-bf3e-7d1711fea18c" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_2bfc8ad9-a3c7-4a65-bf3e-7d1711fea18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_c16736d7-e99a-4bd9-9253-0ce0e3ac063c" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_c16736d7-e99a-4bd9-9253-0ce0e3ac063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_156a8ae0-8d99-43e5-8726-c19ad198d4f8" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_156a8ae0-8d99-43e5-8726-c19ad198d4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_d24b1a7b-8b11-40ed-844b-fc3e53633807" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_d24b1a7b-8b11-40ed-844b-fc3e53633807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f7ee9601-60c7-43a1-823f-3a35d282f757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f7ee9601-60c7-43a1-823f-3a35d282f757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_80b87ff2-5a28-4f58-8478-5df36a44dcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_80b87ff2-5a28-4f58-8478-5df36a44dcc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_97235c7b-4438-426b-8804-df5be3298853" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_97235c7b-4438-426b-8804-df5be3298853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_d1f52ea8-0f4b-494a-9610-0af70fe8fbcc" xlink:href="lfvn-20221231.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c976375d-b78c-461a-ac0d-dc1b5c52665e" xlink:to="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_d1f52ea8-0f4b-494a-9610-0af70fe8fbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_31b4ba2c-ebd7-49a6-8a5f-8c9fc27d4267" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_31b4ba2c-ebd7-49a6-8a5f-8c9fc27d4267" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_5fdbffde-e5d7-4fee-977a-72e3230bfc87" xlink:to="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6399722a-9a2c-4c91-8643-9d5e1091af99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_45e90503-7365-43c2-a98c-428cb6a51e6c" xlink:to="loc_us-gaap_CommonStockMember_6399722a-9a2c-4c91-8643-9d5e1091af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_14655006-e4ad-46da-b76b-22255653b9fa" xlink:to="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1225872d-5257-4e73-a00c-196895f7c657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1225872d-5257-4e73-a00c-196895f7c657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3050b128-fa36-4a85-98bf-0a7e13c59f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3050b128-fa36-4a85-98bf-0a7e13c59f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a84e1d2a-fe56-4935-8a3c-60437af2d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a84e1d2a-fe56-4935-8a3c-60437af2d7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_444cd996-50bc-48df-8cbf-8c1268701790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_444cd996-50bc-48df-8cbf-8c1268701790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_7ced7ffa-07c2-4993-a54a-6275a02c4ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_7ced7ffa-07c2-4993-a54a-6275a02c4ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad0c04bf-24f5-420b-b141-94b0335eb1b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ad0c04bf-24f5-420b-b141-94b0335eb1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_609eb097-8948-46a4-9035-5d5c5b5784ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_609eb097-8948-46a4-9035-5d5c5b5784ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b0230376-a956-400a-bdf5-9441a2458eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b0230376-a956-400a-bdf5-9441a2458eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5f337239-14f7-417c-8048-37d9dcaf4f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_DividendsCommonStockCash_5f337239-14f7-417c-8048-37d9dcaf4f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_6d9eae56-37f8-4ed3-9598-21986cf8fd2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_9de515b2-63d6-4bb8-b9f2-18a0c39d9ae2" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_6d9eae56-37f8-4ed3-9598-21986cf8fd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_322eee41-c8bd-4864-a1d7-3960731ef922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_322eee41-c8bd-4864-a1d7-3960731ef922" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:to="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_00d87d75-df88-4e82-a29f-31015dd3e67d" xlink:to="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f70f918e-d46b-44d4-b540-02f4c6dfba96" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f70f918e-d46b-44d4-b540-02f4c6dfba96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_a8ccc3e0-95d6-46cb-896c-60568cd8021d" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_a8ccc3e0-95d6-46cb-896c-60568cd8021d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_45e6338e-94e1-4194-a1c6-048c82be1f97" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_45e6338e-94e1-4194-a1c6-048c82be1f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_57e8fe3f-3c3b-40de-adb7-064ad5f39124" xlink:href="lfvn-20221231.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_57e8fe3f-3c3b-40de-adb7-064ad5f39124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_aaffeebf-5f21-477d-9a44-d32cbd113ec1" xlink:href="lfvn-20221231.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_14799761-ce8a-4341-93ac-7691e9d623f8" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_aaffeebf-5f21-477d-9a44-d32cbd113ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:to="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1b277e3f-046d-4cd0-8b78-bfad78d09960" xlink:to="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_13023894-c688-4048-980c-e55e5e0dce62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:to="loc_srt_MinimumMember_13023894-c688-4048-980c-e55e5e0dce62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e4505fd-7246-4431-a878-41f9f7d6275e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_abab888b-8ea1-41bc-9fbd-7a263b742ff7" xlink:to="loc_srt_MaximumMember_9e4505fd-7246-4431-a878-41f9f7d6275e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8c46e0cf-057e-4afc-a8b2-933ce840c9b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a352337e-ce57-48cf-bc1a-db75a5526194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_a352337e-ce57-48cf-bc1a-db75a5526194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_20e77576-499f-443b-86dd-60279ad9d840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_20e77576-499f-443b-86dd-60279ad9d840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9806b42b-9eec-4a0d-b881-97de4054c916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_9806b42b-9eec-4a0d-b881-97de4054c916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b09a7d2f-edc1-4c3f-b0b9-8912aa413eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b09a7d2f-edc1-4c3f-b0b9-8912aa413eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_4ffa5144-6449-40cf-bbb8-1eccb1f31029" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_4ffa5144-6449-40cf-bbb8-1eccb1f31029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4893d6b-19a1-4a71-a698-8fa131013bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d4893d6b-19a1-4a71-a698-8fa131013bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d3628be-0fb0-445b-85e4-19f2265f2d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9d3628be-0fb0-445b-85e4-19f2265f2d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_343a26fb-ec33-451e-9550-0189cb12c56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_343a26fb-ec33-451e-9550-0189cb12c56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd8d8ebf-be9b-407a-9f08-32e86e136e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_cd8d8ebf-be9b-407a-9f08-32e86e136e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d7821294-6bfe-4158-a5ac-3519f06f346b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_d7821294-6bfe-4158-a5ac-3519f06f346b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_4c10095e-4290-4d3b-a95e-ea6876318e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_4c10095e-4290-4d3b-a95e-ea6876318e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_18d431ab-1fca-4fc0-8879-a1861239a2d7" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_18d431ab-1fca-4fc0-8879-a1861239a2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8158a6cf-9025-4b4f-86d3-d32becf78978" xlink:href="lfvn-20221231.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_8158a6cf-9025-4b4f-86d3-d32becf78978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dfd9df1c-1c26-4e9d-aea0-ba49837c4ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dfd9df1c-1c26-4e9d-aea0-ba49837c4ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_e68c0db3-a489-4b73-bfe8-d0103051a2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c14564fc-665b-4b2f-a2f2-bd6e1c9b2999" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_e68c0db3-a489-4b73-bfe8-d0103051a2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="lfvn-20221231.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59b4e8a1-9985-4758-b08f-a3fab9f6e702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_f5b5e2a1-f090-4315-9469-45e2915ed868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59b4e8a1-9985-4758-b08f-a3fab9f6e702" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_f5b5e2a1-f090-4315-9469-45e2915ed868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_6f5f46b2-7ef5-403e-8461-8e26dd02dd84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_59b4e8a1-9985-4758-b08f-a3fab9f6e702" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_6f5f46b2-7ef5-403e-8461-8e26dd02dd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962041680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEVANTAGE CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0224471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300 Triumph Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,717,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000849146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962209200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 17,370<span></span>
</td>
<td class="nump">$ 20,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,407<span></span>
</td>
<td class="nump">3,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">891<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">20,435<span></span>
</td>
<td class="nump">16,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">3,254<span></span>
</td>
<td class="nump">5,205<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">44,357<span></span>
</td>
<td class="nump">46,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">9,315<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">9,744<span></span>
</td>
<td class="nump">11,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax asset</a></td>
<td class="nump">2,519<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,376<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">67,832<span></span>
</td>
<td class="nump">70,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,228<span></span>
</td>
<td class="nump">7,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions payable</a></td>
<td class="nump">6,691<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income tax payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">2,010<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">6,405<span></span>
</td>
<td class="nump">7,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">23,334<span></span>
</td>
<td class="nump">25,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">12,282<span></span>
</td>
<td class="nump">13,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">35,937<span></span>
</td>
<td class="nump">39,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 8</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,707 and 12,493 issued and outstanding as of December 31, 2022 and June&#160;30, 2022, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">132,530<span></span>
</td>
<td class="nump">131,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(99,643)<span></span>
</td>
<td class="num">(98,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(993)<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">31,895<span></span>
</td>
<td class="nump">31,516<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 67,832<span></span>
</td>
<td class="nump">$ 70,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139926045386176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">12,707,000<span></span>
</td>
<td class="nump">12,493,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">12,707,000<span></span>
</td>
<td class="nump">12,493,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925960795008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 53,662<span></span>
</td>
<td class="nump">$ 52,189<span></span>
</td>
<td class="nump">$ 105,436<span></span>
</td>
<td class="nump">$ 105,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">11,758<span></span>
</td>
<td class="nump">9,677<span></span>
</td>
<td class="nump">21,700<span></span>
</td>
<td class="nump">19,108<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">41,904<span></span>
</td>
<td class="nump">42,512<span></span>
</td>
<td class="nump">83,736<span></span>
</td>
<td class="nump">86,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CommissionAndIncentives', window );">Commissions and incentives</a></td>
<td class="nump">23,556<span></span>
</td>
<td class="nump">25,449<span></span>
</td>
<td class="nump">47,369<span></span>
</td>
<td class="nump">49,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">19,580<span></span>
</td>
<td class="nump">17,421<span></span>
</td>
<td class="nump">36,310<span></span>
</td>
<td class="nump">32,497<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">43,136<span></span>
</td>
<td class="nump">42,870<span></span>
</td>
<td class="nump">83,679<span></span>
</td>
<td class="nump">82,052<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(1,232)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">4,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense), net</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">125<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="num">(312)<span></span>
</td>
<td class="num">(316)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">157<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">(Loss) income before income taxes</a></td>
<td class="num">(1,075)<span></span>
</td>
<td class="num">(498)<span></span>
</td>
<td class="num">(223)<span></span>
</td>
<td class="nump">3,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit (expense)</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="num">(539)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (1,058)<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="num">$ (448)<span></span>
</td>
<td class="nump">$ 3,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net (loss) income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">12,543<span></span>
</td>
<td class="nump">13,195<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">13,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">12,543<span></span>
</td>
<td class="nump">13,285<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">13,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive gain (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="num">$ (179)<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive gain (loss), net of tax</a></td>
<td class="nump">640<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">$ (418)<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (318)<span></span>
</td>
<td class="nump">$ 3,081<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommissionAndIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommissionAndIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925959901904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 36,807<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 129,048<span></span>
</td>
<td class="num">$ (92,346)<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">(3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">37,310<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,862<span></span>
</td>
<td class="num">(92,522)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 36,807<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,048<span></span>
</td>
<td class="num">(92,346)<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 3,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">34,780<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">130,586<span></span>
</td>
<td class="num">(95,597)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 30, 2021</a></td>
<td class="nump">37,310<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,862<span></span>
</td>
<td class="num">(92,522)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (3,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 34,780<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">130,586<span></span>
</td>
<td class="num">(95,597)<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">12,493<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">$ 31,516<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">131,075<span></span>
</td>
<td class="num">(98,437)<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends</a></td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(510)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 31,890<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">131,726<span></span>
</td>
<td class="num">(98,204)<span></span>
</td>
<td class="num">(1,633)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">12,493<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">$ 31,516<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">131,075<span></span>
</td>
<td class="num">(98,437)<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (448)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">12,707<span></span>
</td>
<td class="nump">12,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,895<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">132,530<span></span>
</td>
<td class="num">(99,643)<span></span>
</td>
<td class="num">(993)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 30, 2022</a></td>
<td class="nump">31,890<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">131,726<span></span>
</td>
<td class="num">(98,204)<span></span>
</td>
<td class="num">(1,633)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends</a></td>
<td class="num">$ (381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="nump">640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (1,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">12,707<span></span>
</td>
<td class="nump">12,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 31,895<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 132,530<span></span>
</td>
<td class="num">$ (99,643)<span></span>
</td>
<td class="num">$ (993)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925960758144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (448)<span></span>
</td>
<td class="nump">$ 3,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">1,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">761<span></span>
</td>
<td class="nump">1,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="num">(1,230)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="num">(3,915)<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other</a></td>
<td class="nump">1,941<span></span>
</td>
<td class="nump">894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">761<span></span>
</td>
<td class="num">(1,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(453)<span></span>
</td>
<td class="num">(461)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other accrued expenses</a></td>
<td class="num">(1,858)<span></span>
</td>
<td class="num">(1,788)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_IncreaseDecreaseInLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(673)<span></span>
</td>
<td class="num">(732)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(278)<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash (Used in) Provided by Operating Activities</a></td>
<td class="num">(378)<span></span>
</td>
<td class="nump">4,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(899)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(1,564)<span></span>
</td>
<td class="num">(899)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of cash dividends</a></td>
<td class="num">(758)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(91)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan', window );">Proceeds from common stock issued under employee stock purchase plan</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(728)<span></span>
</td>
<td class="num">(6,508)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign Currency Effect on Cash</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in Cash and Cash Equivalents:</a></td>
<td class="num">(2,820)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; beginning of period</a></td>
<td class="nump">20,190<span></span>
</td>
<td class="nump">23,174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; end of period</a></td>
<td class="nump">17,370<span></span>
</td>
<td class="nump">20,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 932<span></span>
</td>
<td class="nump">$ 1,566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_IncreaseDecreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_IncreaseDecreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925961001024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text">Organization and Basis of Presentation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of December&#160;31, 2022, and the results of operations for the three and six months ended December&#160;31, 2022 and 2021, and the cash flows for the six months ended December&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925964103456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended December 31, 2022 and 2021, net foreign currency gains of $0.2 million and losses of $0.1 million, respectively, are recorded in other expense, net. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, net foreign currency losses of $0.3 million and $0.3 million, respectively, are recorded in other expense, net. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December&#160;31, 2021, realized losses of $34,000 and $0.1 million related to forward contracts, are recorded in other expense, net, respectively.  The Company did not hold any derivative instruments at December&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such risk. Financial instruments with significant credit risk include cash and investments. At December&#160;31, 2022, the Company had $12.4 million in cash accounts at one financial institution and $5.0 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $15.4&#160;million in cash accounts at one financial institution and $4.8 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of December&#160;31, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable as of December&#160;31, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December&#160;31, 2022 and June&#160;30, 2022 is not necessary. No bad debt expense was recorded during the three and six months ended December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $1.2 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $1.3 million at December 31, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;December&#160;31, 2022 and June&#160;30, 2022, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.1 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all costs related to research and development activities, as incurred. Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended December 31, 2022 and 2021 were $0.2 million and $0.2 million, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021 were $0.3 million and $0.4 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's strategies have resulted in operation modifications in certain Asia/Pacific markets resulting in the closure of showrooms and changes to selling models. As of December 31, 2022, the Company abandoned the ROU assets related to the Hong Kong and Singapore showroom leases. These leases were to terminate in August and September 2023, respectively. However, the Company reached agreements with each of the landlords to modify the termination date to February 2023. The remaining lease liability for these showrooms is $34,000 as of December&#160;31, 2022.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total expenses related to the abandonment of the ROU assets and costs associated with the change in operations in these markets for the three and six months ended December&#160;31, 2022 is $0.4&#160;million and is included in selling, general, and administrative expenses. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended December 31, 2022 and 2021, the Company recognized income tax expense of $0.2 million and $0.5 million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per common share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted (loss) income per common share is computed by dividing net (loss) income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2022 and 2021, the effects of approximately 0.2 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">computations as their effect was anti-dilutive. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, the effects of approximately 0.4 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net (loss) income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925961007600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Gig Economy Group Investment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Gig Economy Group Investment</a></td>
<td class="text">Gig Economy Group Investment<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $0.0&#160;million in aggregate consideration).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive (loss) income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $2.2&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at December&#160;31, 2022 and June&#160;30, 2022.  During the three and six months ended December&#160;31, 2022 and 2021, there were no impairments recognized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925974016336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTU4_9fa1335b-a4b3-465e-8752-be86b6f9943e">one</span> to nine years. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.44 years and 3.25%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2022 and 2021, operating lease expense was $0.8 million and $0.8 million, respectively. For the six months ended December 31, 2022 and 2021, operating lease expense was $1.5 million and $1.6 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at December&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925965184624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of December&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year </span></div>ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925965103280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued $0.2 million and $0.1 million shares of common stock under equity award plans, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued $0.2 million and $0.1 million shares of common stock equity award plans, respectively. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued no shares of common stock upon the exercise of stock options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the company issued zero and 30,000 shares of common stock upon the exercise of stock options. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000 and 5,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,000 and 24,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended December&#160;31, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased no shares of common stock under this repurchase program. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three and six months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased 0.5 million and 0.9 million shares of common stock at an aggregate price of $3.2 million and $6.6 million under this repurchase program, respectively. At&#160;December&#160;31, 2022, there is $27.7 million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of December&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022 and November 2022, the board of directors declared a quarterly cash dividend of $0.03 per share of common stock to be paid on September 15, 2022 and December 15, 2022, to stockholders of record on September 2, 2022 and December 1, 2022, respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash dividends for the three and six months ended December&#160;31, 2022 totaled $0.4 million and $0.8 million, or $0.03 and $0.06 per share, respectively</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925965103280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, officers and directors. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2010 Plan. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants.&#160;&#160;&#160;&#160;The initial share pool approved was 650,000 shares. On February 2, 2018, November 15, 2018, November 12, 2020 and November 10, 2022, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares, 650,000 shares and 1,052,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;December&#160;31, 2022, a maximum of 4.0 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 3,492,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted is generally ten years. As of December&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of December&#160;31, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">six months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately 36,000 and 27,000 shares of common stock were issued under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended December 31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021, compensation of $0.8 million and $0.8 million, respectively, was reflected as an increase to additional</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> paid-in capital, all of which was employee related. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended December 31, 2022 and 2021, compensation of $1.4 million and $1.4 million, respectively, was reflected as an increase to additional</span> paid-in capital, all of which was employee related.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925965103280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  December&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. On December 15, 2022, the case was dismissed with prejudice, which concluded litigation.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139926045401152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div>as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div>To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableThe Company&#8217;s accounts receivable as of December&#160;31, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December&#160;31, 2022 and June&#160;30, 2022 is not necessary.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition &amp; Shipping and Handling</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div>Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company's strategies have resulted in operation modifications in certain Asia/Pacific markets resulting in the closure of showrooms and changes to selling models. As of December 31, 2022, the Company abandoned the ROU assets related to the Hong Kong and Singapore showroom leases. These leases were to terminate in August and September 2023, respectively. However, the Company reached agreements with each of the landlords to modify the termination date to February 2023. The remaining lease liability for these showrooms is $34,000 as of December&#160;31, 2022.  </span></div>Total expenses related to the abandonment of the ROU assets and costs associated with the change in operations in these markets for the three and six months ended December&#160;31, 2022 is $0.4&#160;million and is included in selling, general, and administrative expenses.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic (loss) income per common share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted (loss) income per common share is computed by dividing net (loss) income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925964093504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Inventory</a></td>
<td class="text">As of December&#160;31, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Net (Loss) Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net (loss) income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,359&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue Disaggregated by Geographic Regions</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,074&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,189&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,632&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962127200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at December&#160;31, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining six months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925959590400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment </div>
<div>region </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction gain (loss), realized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
<td class="num">$ (300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments, realized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_MoneyBackGuaranteePeriod', window );">Money back guarantee period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems', window );">Return period for resalable and restockable Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems', window );">Refund percent for resalable and restockable Items</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_HandlingAndRestockingFeePercentage', window );">Handling and restocking fee, percentage (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ReturnLiabilityReserve', window );">Return liability reserve</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">14,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,292,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossOnContractTermination', window );">Loss on contract termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (17,000)<span></span>
</td>
<td class="num">$ (577,000)<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="nump">$ 539,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from EPS calculation (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfvn_ShowroomsMember', window );">Showrooms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember', window );">Cash accounts held primarily at One Financial Institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">12,400,000<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember', window );">Cash held primarily at Other Financial Institutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts With Customers, Refund Percent For Resalable And Restockable Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts With Customers, Return Period For Resalable And Restockable Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_HandlingAndRestockingFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Handling and Restocking Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_HandlingAndRestockingFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_MoneyBackGuaranteePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Money back guarantee period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_MoneyBackGuaranteePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ReturnLiabilityReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return Liability Reserve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ReturnLiabilityReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The loss recognized on termination of a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 275<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126938061&amp;loc=d3e54681-109401<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfvn_ShowroomsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=lfvn_ShowroomsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925960756624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Components of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 16,447<span></span>
</td>
<td class="nump">$ 12,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials</a></td>
<td class="nump">3,988<span></span>
</td>
<td class="nump">3,798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 20,435<span></span>
</td>
<td class="nump">$ 16,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory', window );">Finished goods, percent of inventory (in percentage)</a></td>
<td class="nump">80.50%<span></span>
</td>
<td class="nump">76.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_RawMaterialsPercentOfTotalInventory', window );">Raw materials, percent of inventory (in percentage)</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryPercentOfTotalInventory', window );">Percent of total inventory (in percentage)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Finished Goods, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryFinishedGoodsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_RawMaterialsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Raw Materials, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_RawMaterialsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962188960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (1,058)<span></span>
</td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
<td class="num">$ (448)<span></span>
</td>
<td class="nump">$ 3,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">13,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock awards and options (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">13,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share, basic (in USD per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share, diluted (in USD per share)</a></td>
<td class="num">$ (0.08)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925888101168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 53,662<span></span>
</td>
<td class="nump">$ 52,189<span></span>
</td>
<td class="nump">$ 105,436<span></span>
</td>
<td class="nump">$ 105,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">39,705<span></span>
</td>
<td class="nump">34,708<span></span>
</td>
<td class="nump">76,074<span></span>
</td>
<td class="nump">71,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember', window );">Asia/Pacific &amp; Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">13,957<span></span>
</td>
<td class="nump">17,481<span></span>
</td>
<td class="nump">29,362<span></span>
</td>
<td class="nump">34,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">37,972<span></span>
</td>
<td class="nump">32,897<span></span>
</td>
<td class="nump">72,630<span></span>
</td>
<td class="nump">67,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">20,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">7,365<span></span>
</td>
<td class="nump">$ 9,991<span></span>
</td>
<td class="nump">15,533<span></span>
</td>
<td class="nump">$ 19,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925961630928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Gig Economy Group Investment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 16, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities held without readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment', window );">Notes receivable, related party, maximum commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt', window );">Debt conversion, original debt, interest rate of debt (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted instrument, shares issued (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted instrument, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Related Party, Maximum Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NotesReceivableRelatedPartyMaximumCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtInterestRateOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925959072176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">8 years 5 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 5 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (as a percent)</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925961557424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease, Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 524<span></span>
</td>
<td class="nump">$ 1,506<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962027424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (remaining six months ending June 30, 2023)</a></td>
<td class="nump">$ 1,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">1,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">8,123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">16,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 14,292<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments Due, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925959482832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th">
<div>Feb. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 04, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 03, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentFloorInterestRate', window );">Floor interest rate (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | US Treasury (UST) Interest Rate | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember', window );">March 2016 Term Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Quarterly installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Fixed rate interest on debt (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentTrailingPeriod', window );">Trailing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of cash dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantMaximumAllowedDividends', window );">Debt instrument, covenant, maximum allowed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantMaximumAllowedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Allowed Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantMaximumAllowedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Required Minimum Working Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Floor Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentTrailingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Trailing Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentTrailingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925962237504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Aug. 27, 2020</div></th>
<th class="th"><div>Feb. 01, 2019</div></th>
<th class="th"><div>Nov. 27, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase common stock amount authorized (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,646,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend, common stock declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends, common stock, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividend paid (in dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued under equity award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925955306432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2020</div></th>
<th class="th"><div>Nov. 10, 2020</div></th>
<th class="th"><div>Nov. 15, 2018</div></th>
<th class="th"><div>Feb. 02, 2018</div></th>
<th class="th"><div>Feb. 16, 2017</div></th>
<th class="th"><div>Sep. 27, 2010</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 21, 2006</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock based compensation reflected in additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember', window );">2007 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm', window );">Contractual term of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">1,052,000<span></span>
</td>
<td class="nump">715,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, net of awards expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,492,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted', window );">Amount in excess of fair market value of stock for option not to be granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139925961001024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Claims dismissed</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>lfvn-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lfvn="http://www.lifevantage.com/20221231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lfvn-20221231.xsd" xlink:type="simple"/>
    <context id="i8d21455c9aa149998ae44b714c894031_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d9e439d901540308c45eee487b67dbb_I20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="i41ae61d037b64e21a0009d260cbf079c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idbccf873afec4cdb9617f979dc003b3a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i521dab2d24b34aebb658e4110516048b_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i128e0238654a408294474d0d39084ec4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9a96896801234c7496795468d40281a8_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib2371d23a6db41b59f8d6c9a8fc7d8bb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie7ae1865fdb9499ab7dbe0dc600b08d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c8eefdab538498c85908974d5418122_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9d2b015f040948b0a4768f592202a13a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9b09637258c24e2592b4ea4b2ab92d44_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i45f6778f50584111b9cff0df26dbdd7a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib49e08745efc40889406f68b33f56331_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i96d3d6e8da9e4ed9a3c7f88e35dc62cf_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib3ed14fa890843cf80731ee9e3925b99_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i358d6150799342838a19d83985b9c094_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cef537cf94a4e73b05136778889ad4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6c9137b5588e4bbebaacb5c9c219b41c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i467f2e2e2ca04ab7aa50e61d9b8c729a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a0c5debcdaa46d09da95435056b3e42_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i306813b6c9154396b5feb21edeaf07f4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i893a955d58ac413f99e2ed74e093e814_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d3875e13d53482ca276a747d7b9725d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19b4e14577474b4cb15b348ef3effb26_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieac90614bd08479a962bf94e61c65f4c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib14397b8bfef44ae89948965604a00cd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief068ef7f192472e8f91975a23c29a80_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5d7ae78d394c4168918ff53d250447b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iff9d50c36eb64dd29b993c619ef8f346_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie75a84e3843a403e89bb873eb810cd5e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id81b9703907b4145915889d617a0c019_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b8685d6a4274d5d9e3e702bf84f7a19_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9ab9efe3a76437eb4c7016235cc6d23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7567b5990404aa5af48351119c88dd1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8af00de260d44b2bbcf76a96be67275d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia3cad9e185ac4aa2912209bb27110fd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i229fac654a6e456bae29a6583de50cb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie32dad3b31774e4ab4392448baf8d166_D20221231-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i861234a92f024717aab0fcfdedc72f98_D20221231-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-31</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79ba066dbf2f4116a1bc1650082eb82d_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic6ffbc57f7df41d08f46fdd5af852da5_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1becdba443bf4dd4ad59c94e1d90ae27_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">lfvn:ShowroomsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib97c9bdb37f9443998ba3b10ca21301b_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4c2b290155354c5893117c2102630e53_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic801932ee7b44766a8977bc48c61b215_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5ce3902b05744a2181c139ba0275d9b4_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa2a8d6f5cf24bb49ac338f8ad48ae7d_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idfd00b15e7224a37bd9bc7bb7749d232_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d763462815c4c90813a80f4704429fb_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c7fc25b6b4042e0a1f3a4195fa43155_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79eb75825906423b9893fc621fe4f28f_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5bd8df94500f43ff804118cdd61ee34a_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30543519b0b14ddfa6511963cf86120a_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05b0acc99f3243ed990137d764b012d6_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d87785af21d4f15924bf57416becf07_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia9513ebaa9554e018d59758d829177e6_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i018e46118dfa4569bee998cc12092f0e_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic34e95207b834b059135ddc8c6f5335e_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i156352af4d364bd39bd40efc69390355_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifff7c281ffcb480b9728320152bb1757_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6e5a8c78ae114f3ba91daa81c884673a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7c8407d9278411daaade025540b8362_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifbf321362fb048e7ad989fd29aa10371_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="i791994c0741744289a7ca8016b475b80_D20190531-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-31</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-16</startDate>
            <endDate>2019-12-16</endDate>
        </period>
    </context>
    <context id="iedf10ffdb3cb40b4b2656f5a5a3a2bfd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i264e87d680d542c1af5201533c298cd3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i218031818c05468fb4b9344e8718454c_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i332a4bdda6964cf2b5071cde0a7980c7_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i00032d4dfded48658f82e08c57ab4a5a_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i103063363cfe4045a96bdcbbc8bb8df3_I20180503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-03</instant>
        </period>
    </context>
    <context id="i77b08e3f041d46a8b9cb04c7918e661e_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="i7ed07a20460f4cb1af2e73dc102582fe_D20180504-20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-04</startDate>
            <endDate>2018-05-04</endDate>
        </period>
    </context>
    <context id="i78f171a4c06a433b8599b63d53f8a878_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i99892b92ec614947929196e70d6cfa90_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="i6db563e50ed340da9ad6e97e830f1de7_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="i02becdb52e634fce9233ae4e1d9199ab_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i09b53239b6d748c0b5dc0cd15c527f78_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="i7033d13ec1104ebcb880b911489b11e6_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i1aad0c75d50047d5b8215d22695bea8e_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i6986876bbd06457a874cb6f112493823_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i715b8212e42447a3bcbc76261cc68d1f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i24899bef054f4e1ea3689d7f8468ada1_I20171127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2017-11-27</instant>
        </period>
    </context>
    <context id="i3600ade8ac584e599fd793f01363db8f_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="ib04b2568d00d452ca563a93b3382040c_I20200827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-08-27</instant>
        </period>
    </context>
    <context id="ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="iaa3a80900568428483190bd6fe806e89_D20220915-20220915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-09-15</startDate>
            <endDate>2022-09-15</endDate>
        </period>
    </context>
    <context id="i81f7806f4c744d4bb6f8f72a1d67d3cc_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i0a878dc75136466d939f36303f8f29bb_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="iaed23e7162044f03b895993f02f2b3ae_D20221215-20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="i319cb485eedd404a8b0525a42c144e5e_I20061121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2006-11-21</instant>
        </period>
    </context>
    <context id="i124fe5e6230a4630a62ed6b5b04e0d66_I20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-09-27</instant>
        </period>
    </context>
    <context id="id39f56f005d149c1b465694988b14646_D20170216-20170216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-02-16</startDate>
            <endDate>2017-02-16</endDate>
        </period>
    </context>
    <context id="ie686cd256ac841c290a740d58fa0128c_D20180202-20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-02</startDate>
            <endDate>2018-02-02</endDate>
        </period>
    </context>
    <context id="if3d44ad1e2f441659ef97e1de7898de2_D20181115-20181115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-15</startDate>
            <endDate>2018-11-15</endDate>
        </period>
    </context>
    <context id="i14171336bf9443a9a4f5906ebea800a2_D20201112-20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-12</startDate>
            <endDate>2020-11-12</endDate>
        </period>
    </context>
    <context id="ia799876fcd8d48f3a197ae9951a5a93f_D20201110-20201110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-10</startDate>
            <endDate>2020-11-10</endDate>
        </period>
    </context>
    <context id="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3924c2c406d347e5ba4fdff4f8a7dadc_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="i1a9535be90b54a28934aa4096ffa89cc_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="if84a6b9c61ff454ea30977fdf0b8c64f_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1c455728e942439eb75adbf84a5525ff_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="i2a2bf424c72e488582d382f0dd0a0b89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2019-12-05</startDate>
            <endDate>2019-12-05</endDate>
        </period>
    </context>
    <context id="iab9abce091734ee090f3cba6def7ace7_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="region">
        <measure>lfvn:region</measure>
    </unit>
    <unit id="segment">
        <measure>lfvn:segment</measure>
    </unit>
    <unit id="claim">
        <measure>lfvn:claim</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV8yLTEtMS0xLTMwMDc5_c91467a9-a56c-4b7f-b18f-e52b898f3174">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV8zLTEtMS0xLTMwMDc5_ed4434d3-f1b0-470e-9f4d-8248fd1177d5">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV80LTEtMS0xLTMwMDc5_bd2cb2bd-d4df-437a-bbd0-f7fb32b43edf">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV81LTEtMS0xLTMwMDc5_d8591f4c-1277-4329-b52e-bf374360950a">0000849146</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80L2ZyYWc6YmYwMjI0ZjcyM2QwNDYzYzgzOTYyMjY2YzdjYjFjMmYvdGFibGU6ZTQ3Y2NkMGY0N2U3NDcyZDkyMmRlNzJiNjY5OWViYjEvdGFibGVyYW5nZTplNDdjY2QwZjQ3ZTc0NzJkOTIyZGU3MmI2Njk5ZWJiMV82LTEtMS0xLTMwMDc5_ec066880-f5c8-4c55-bc39-3c9c8f473bf5">--06-30</dei:CurrentFiscalYearEndDate>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80My9mcmFnOjc3OGVmZjI3ZWY4MjRhNGRiODMzMzQ3YzU2YTNmNTE0L3RhYmxlOjJlYTk2Mzg4ZDFhMTQwYjdiMWExODRhOTNjZTA1YzVlL3RhYmxlcmFuZ2U6MmVhOTYzODhkMWExNDBiN2IxYTE4NGE5M2NlMDVjNWVfMi0xLTEtMS0zMDA3OQ_14bfa13f-ae7a-4468-977c-bdc41e528362"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iedf10ffdb3cb40b4b2656f5a5a3a2bfd_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTU4_9fa1335b-a4b3-465e-8752-be86b6f9943e">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xNjQ_ac584b03-c277-42fe-b362-66e10229a4e4">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6YmU5MTcxNjZmOTdiNGFjMzk3OWQ0OWRmNTc0ZGUxOGUvdGFibGVyYW5nZTpiZTkxNzE2NmY5N2I0YWMzOTc5ZDQ5ZGY1NzRkZTE4ZV8wLTAtMS0xLTMwMDc5_8d6cb82a-69df-4e33-8983-9cf321d9aed2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yODE_2eb28b15-1fc0-4ab9-bb41-f8f09e4e3fff">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ODg1Nzk0ZmVmYTAxNGMxZWFiNzA5Y2YxNTdjYjM5N2IvdGFibGVyYW5nZTo4ODU3OTRmZWZhMDE0YzFlYWI3MDljZjE1N2NiMzk3Yl8wLTAtMS0xLTMwMDc5_94632495-c6d3-416c-a800-72641fc75026">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8zNjY_b1ff2b79-e3db-4cb1-99bf-7d61a8b2e6df">001-35647</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV80NTE_fa0a2f11-ab3d-41e8-b40d-d46e8fc80abb">LIFEVANTAGE CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6MDk2MTM2MjQwMDU2NGUyNGJkZDljOGY0ZTk0OWM4NGIvdGFibGVyYW5nZTowOTYxMzYyNDAwNTY0ZTI0YmRkOWM4ZjRlOTQ5Yzg0Yl8wLTAtMS0xLTMwMDc5_40cf5b0d-977b-46e7-9bf2-1dc643b2a967">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6MDk2MTM2MjQwMDU2NGUyNGJkZDljOGY0ZTk0OWM4NGIvdGFibGVyYW5nZTowOTYxMzYyNDAwNTY0ZTI0YmRkOWM4ZjRlOTQ5Yzg0Yl8wLTItMS0xLTMwMDc5_7af882f3-577c-4a69-9c47-ef8cddff8273">90-0224471</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEy_6e0d9835-a71a-4f78-99e5-7399883497b8">3300 Triumph Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEz_6ead62ab-bb8d-4483-bc60-80d995167de3">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDE0_e3bdef24-1de8-4de2-a151-22f4ebab74a6">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV82MzU_ac41f55f-1e98-4bd5-b5bd-1b478835c220">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV82Mzg_f7326132-af0b-41f3-acce-656b6c744eaa">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV83MDM_088b6d66-0409-4810-94d1-a607fd3423a5">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV83MDc_f1d8c539-f57e-4339-ad26-e5c5550c56e3">432-9000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTAtMS0xLTMwMDc5_ebb6cea5-acf2-483c-89ef-f4dc2918a6da">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTItMS0xLTMwMDc5_3e1fb42d-2539-4717-b2f1-ed2613ba8c66">LFVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZGZhMmExZDE2ZDY4NGRlODg3YTk5ODVmNjAxMzY1ODkvdGFibGVyYW5nZTpkZmEyYTFkMTZkNjg0ZGU4ODdhOTk4NWY2MDEzNjU4OV8wLTQtMS0xLTMwMDc5_a7f2974f-d96b-4963-8d2e-9b7094a382db">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xMjM0_fc7e1fec-7156-417b-a2ad-137b78355674">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8xNTU5_eef60c84-2764-403a-8636-a37b1e2bd485">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8wLTItMS0xLTMwMDc5_02525b69-1640-4326-8ed1-cbb251b58283">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8xLTMtMS0xLTMwMDc5_a7b79d01-2c2b-4195-8ac4-9b54d7f98941">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGFibGU6ZTlmMDExMmE1Y2Y5NDg0MDlkODc4MjNjMTZiZTRjOGQvdGFibGVyYW5nZTplOWYwMTEyYTVjZjk0ODQwOWQ4NzgyM2MxNmJlNGM4ZF8yLTEtMS0xLTMwMDc5_b6aa2d66-accc-4837-af4e-baed19d44c97">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDE1_98200e02-0626-4ace-8bf5-7a49586e430e">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i9d9e439d901540308c45eee487b67dbb_I20230201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xL2ZyYWc6MjQ1NTA0ZGZmY2EzNDU0ZThiNjYwOTFiODUyOWQ0NjUvdGV4dHJlZ2lvbjoyNDU1MDRkZmZjYTM0NTRlOGI2NjA5MWI4NTI5ZDQ2NV8yNDEw_1ef75d08-d1c0-4026-bf2c-f047e88d13bd"
      unitRef="shares">12717325</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNC0xLTEtMS0zMDA3OQ_18cc0c15-6f77-45d5-b103-ce2ca1689340"
      unitRef="usd">17370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNC0zLTEtMS0zMDA3OQ_b6f4951a-bb65-4410-b55b-f917677572d4"
      unitRef="usd">20190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNS0xLTEtMS0zMDA3OQ_915147ad-184b-4885-9290-6acfb7871445"
      unitRef="usd">2407000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNS0zLTEtMS0zMDA3OQ_7dfe156b-d4cc-4770-9716-f09cd7b5b999"
      unitRef="usd">3338000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNi0xLTEtMS0zMDA3OQ_849a3a3b-0e4f-41db-9386-349b57c140a6"
      unitRef="usd">891000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNi0zLTEtMS0zMDA3OQ_a1dd5421-5f24-430a-b5dc-5ecad3ddbc33"
      unitRef="usd">1752000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:InventoryNet
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNy0xLTEtMS0zMDA3OQ_09f659d0-33b9-4e6f-8965-0c86b8f40b78"
      unitRef="usd">20435000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNy0zLTEtMS0zMDA3OQ_3daaefdc-cf9e-4cd7-9da6-78807e5709e0"
      unitRef="usd">16472000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfOS0xLTEtMS0zMDA3OQ_6d23552a-5fa9-43ae-8a73-bdd6601a6d36"
      unitRef="usd">3254000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfOS0zLTEtMS0zMDA3OQ_2dc7b883-9c48-43ca-b922-1e5a75704d2f"
      unitRef="usd">5205000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTAtMS0xLTEtMzAwNzk_10f59140-898b-40b2-9d7f-4393d4103839"
      unitRef="usd">44357000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTAtMy0xLTEtMzAwNzk_2cde4226-e6cc-42d7-a21a-8c9490dfc432"
      unitRef="usd">46957000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTItMS0xLTEtMzAwNzk_d41ab259-711a-4f7d-b318-b91dec61ddde"
      unitRef="usd">9315000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTItMy0xLTEtMzAwNzk_3882c695-7781-419d-80f4-8b9bc87af003"
      unitRef="usd">9500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTMtMS0xLTEtMzAwNzk_c8709339-f9e5-41ac-9e00-74239e055863"
      unitRef="usd">9744000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTMtMy0xLTEtMzAwNzk_01701064-1394-4a95-adf8-0e41e9c82c8d"
      unitRef="usd">11040000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTQtMS0xLTEtMzAwNzk_333f4c33-b992-4ffd-884a-1b0666a4d3e7"
      unitRef="usd">521000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTQtMy0xLTEtMzAwNzk_13837815-64a5-448e-b0ff-2aba4ffde12e"
      unitRef="usd">587000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTUtMS0xLTEtMzAwNzk_42811aca-7acf-42dc-b332-eaa00760d960"
      unitRef="usd">2519000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTUtMy0xLTEtMzAwNzk_49821dd4-cab3-4f14-af95-3034dbc1a96c"
      unitRef="usd">1289000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTctMS0xLTEtMzAwNzk_5d294311-0311-4d2d-99f1-365e7e1f4a39"
      unitRef="usd">1376000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTctMy0xLTEtMzAwNzk_d517f62c-e7a4-4dfc-a18f-51b6e6c71b90"
      unitRef="usd">1333000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTgtMS0xLTEtMzAwNzk_8475bc97-1f35-499c-8aa0-aa261bd0bd03"
      unitRef="usd">67832000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMTgtMy0xLTEtMzAwNzk_c86a5736-1ddb-42c4-aef4-f28ee05b7cf7"
      unitRef="usd">70706000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjItMS0xLTEtMzAwNzk_a71cf4eb-e936-4dea-a501-62964c35d2e7"
      unitRef="usd">8228000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjItMy0xLTEtMzAwNzk_06b55072-1743-495f-997e-2d38d6c6bfb3"
      unitRef="usd">7462000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjMtMS0xLTEtMzAwNzk_b11599a1-d48c-4121-ada1-5a935d153a38"
      unitRef="usd">6691000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjMtMy0xLTEtMzAwNzk_643af364-42f0-4dc6-be27-53b5f82759e2"
      unitRef="usd">7285000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjYtMS0xLTEtMzAwNzk_32abf754-f663-440d-be4c-07d57c4dfdb7"
      unitRef="usd">0</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjYtMy0xLTEtMzAwNzk_0a3fa36b-3819-4b43-8a54-c87247a31f33"
      unitRef="usd">453000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjctMS0xLTEtMzAwNzk_e6f09dd4-8290-4910-b1fa-c598fb95cf36"
      unitRef="usd">2010000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjctMy0xLTEtMzAwNzk_1de727c0-84e0-403c-8396-7b07f09b2c3a"
      unitRef="usd">2601000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjgtMS0xLTEtMzAwNzk_125923fd-6dd3-4d0b-ae7b-4004af47a3f6"
      unitRef="usd">6405000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMjgtMy0xLTEtMzAwNzk_e4d24dd6-6d47-4150-8eed-ea2443f8286f"
      unitRef="usd">7927000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzAtMS0xLTEtMzAwNzk_bba6a839-de78-4e2b-916e-d559a93c4fe9"
      unitRef="usd">23334000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzAtMy0xLTEtMzAwNzk_25845204-480a-4092-b270-563def95d901"
      unitRef="usd">25728000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzYtMS0xLTEtMzAwNzk_985fbd1f-7abb-49dd-8200-f07733fe9d13"
      unitRef="usd">12282000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzYtMy0xLTEtMzAwNzk_360ba19e-fe02-4e5b-b516-8d4d58a419a4"
      unitRef="usd">13154000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzctMS0xLTEtMzAwNzk_4c449a8a-e2b8-4ad9-bcc4-d0bd0c5f6d19"
      unitRef="usd">321000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzctMy0xLTEtMzAwNzk_2856e126-a94f-4694-bc7f-254dcf2794a9"
      unitRef="usd">308000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzgtMS0xLTEtMzAwNzk_42837432-2c18-4638-a264-e0fa05eb673a"
      unitRef="usd">35937000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzgtMy0xLTEtMzAwNzk_b4321896-41ce-4738-9d24-de978bed9011"
      unitRef="usd">39190000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzktMS0xLTEtMzAwNzk_041eb4c0-bd10-4e53-9b00-c924964cb865"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfMzktMy0xLTEtMzAwNzk_b68a221d-15b7-44ae-90bf-3ea434106cf2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl8zMg_1b24810c-bc44-4817-948a-d1907455de8e"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl8zMg_cd95c3ce-6c23-4436-b713-e98e4cfb0312"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl80Ng_553eae4f-22da-46bb-a946-d443a8bf343b"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl80Ng_56def318-f263-43da-95d3-605ac0fcef77"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_6d0f470b-3343-476e-809f-23dc581dd9ed"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_85abba23-8dfa-4103-a5b0-1df46171964d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_d04cd039-c483-4223-bf52-03b961cb460b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjpjNTBhMDU2MjIzYWY0NjRiODljNjJlMzc0ZWU4MTk3Nl82OA_d74f952f-7c35-4172-be47-6330d5e67fc8"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMS0xLTEtMzAwNzk_3a2f2c32-f5f7-40e8-9130-704bab2b73d3"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDEtMy0xLTEtMzAwNzk_73d0e337-889a-4ff3-b098-4c99c7ed7d45"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV8zMA_4290a1e9-5a0d-4360-9fce-883475463d22"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV8zMA_df43594f-87ac-4efb-8242-3ab492273ece"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV80NA_1c3f6ae2-4591-4494-9a04-9dcd38ff5fb1"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV80NA_82c40b78-eba3-41cb-b035-e7f0dc2d1ad8"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV82OQ_26f0042f-6422-4b94-b475-c150bdde160a"
      unitRef="shares">12707000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV82OQ_94005486-7376-4805-bddc-4fa13e4b68c7"
      unitRef="shares">12707000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV83Ng_6b579ff3-437a-4fb9-8acf-e75be088e421"
      unitRef="shares">12493000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMC0xLTEtMzAwNzkvdGV4dHJlZ2lvbjo2NGRmN2ZmMWY3YmM0NjJmODgwZWMzZGViMjI4Njk3OV83Ng_a12e670f-20cc-4462-81d8-34553284904e"
      unitRef="shares">12493000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMS0xLTEtMzAwNzk_40a0a6f3-e9aa-43de-91ce-8bec769debb8"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDItMy0xLTEtMzAwNzk_05e1287b-c3e3-4ac2-b8ce-723c088b325a"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDMtMS0xLTEtMzAwNzk_766eabb7-b0f1-4aa2-aedc-6640363f229b"
      unitRef="usd">132530000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDMtMy0xLTEtMzAwNzk_a5a1dd0b-f5cb-4577-b542-d82e0b0dd696"
      unitRef="usd">131075000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDQtMS0xLTEtMzAwNzk_6ae33f5b-d721-4d9d-b1a0-90f3436b830f"
      unitRef="usd">-99643000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDQtMy0xLTEtMzAwNzk_b9a00903-3d99-4d49-b5be-309846900eb1"
      unitRef="usd">-98437000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDUtMS0xLTEtMzAwNzk_cf0959ec-fdf8-48a4-829c-89abd781fc76"
      unitRef="usd">-993000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDUtMy0xLTEtMzAwNzk_295c26ef-6032-4fe2-9861-52ae2729076d"
      unitRef="usd">-1123000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDYtMS0xLTEtMzAwNzk_d73b4b61-a5d9-4c41-80ca-1b236ede01d0"
      unitRef="usd">31895000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDYtMy0xLTEtMzAwNzk_2405d2ae-d0a5-4653-bd47-f9e79f57d745"
      unitRef="usd">31516000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDctMS0xLTEtMzAwNzk_d01c5f8c-3b55-49da-b74f-bedfb7b90414"
      unitRef="usd">67832000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8xOS9mcmFnOjgxM2IzZTNiNmZlOTQ1MjJhNGY0YjJlNGQ1YjkxZDFlL3RhYmxlOmM4NzM1NjVmNjQyNjRjNThiZjMwYzRhMzA1N2NkZmNlL3RhYmxlcmFuZ2U6Yzg3MzU2NWY2NDI2NGM1OGJmMzBjNGEzMDU3Y2RmY2VfNDctMy0xLTEtMzAwNzk_85f59ddd-db8a-4b96-b89a-5756d279a173"
      unitRef="usd">70706000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy0xLTEtMS0zMDA3OQ_cfb80f5a-742e-4acf-acc9-12d9b7c0a722"
      unitRef="usd">53662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy0zLTEtMS0zMDA3OQ_017b180f-d97b-4dd1-a5ca-be0e4332d113"
      unitRef="usd">52189000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy01LTEtMS0zMDA3OQ_acf8e245-8696-4c61-a364-e89add3f477c"
      unitRef="usd">105436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMy03LTEtMS0zMDA3OQ_87351ac2-3bbb-4b7a-84f7-fa7a01297904"
      unitRef="usd">105414000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC0xLTEtMS0zMDA3OQ_aa63b2e0-77e1-4cd8-a698-c2d72443b293"
      unitRef="usd">11758000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC0zLTEtMS0zMDA3OQ_b3310898-0bb1-4d91-95d1-db7e932256ff"
      unitRef="usd">9677000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC01LTEtMS0zMDA3OQ_e9335def-c83b-4302-b8bf-88b343502dc5"
      unitRef="usd">21700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNC03LTEtMS0zMDA3OQ_da2cbd46-865a-484f-84fb-513213b40bba"
      unitRef="usd">19108000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS0xLTEtMS0zMDA3OQ_6dee0bbc-03d0-41ef-b992-b6b240a31bf9"
      unitRef="usd">41904000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS0zLTEtMS0zMDA3OQ_b3e1ebe6-c9b1-4b8b-aea4-3b7335374eea"
      unitRef="usd">42512000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS01LTEtMS0zMDA3OQ_1238e174-9f7b-4a54-8d93-5d82c5591863"
      unitRef="usd">83736000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNS03LTEtMS0zMDA3OQ_97d49a62-6280-48b0-8385-5bbd3179a345"
      unitRef="usd">86306000</us-gaap:GrossProfit>
    <lfvn:CommissionAndIncentives
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy0xLTEtMS0zMDA3OQ_41cc3a15-1bf7-4a17-842d-3aa0b5145e70"
      unitRef="usd">23556000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy0zLTEtMS0zMDA3OQ_d731ed40-3c6e-48f9-85f3-4338e6aba0a5"
      unitRef="usd">25449000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy01LTEtMS0zMDA3OQ_ab82c06c-0630-429f-9d8b-52a75f1ec234"
      unitRef="usd">47369000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfNy03LTEtMS0zMDA3OQ_d63f78c6-f0d6-481a-8537-0c9793df39a6"
      unitRef="usd">49555000</lfvn:CommissionAndIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC0xLTEtMS0zMDA3OQ_411e9175-4711-4394-a0ca-b58aefe1a6b8"
      unitRef="usd">19580000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC0zLTEtMS0zMDA3OQ_8bd5fb99-04e1-414b-994a-74992d05e756"
      unitRef="usd">17421000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC01LTEtMS0zMDA3OQ_04db144d-dd6e-4d73-9419-807594bc413d"
      unitRef="usd">36310000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfOC03LTEtMS0zMDA3OQ_d5ddcbd0-14f4-4c94-b9a8-5b298d7b97c7"
      unitRef="usd">32497000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtMS0xLTEtMzAwNzk_155902a8-abb0-477f-80e9-6e8f7a634518"
      unitRef="usd">43136000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtMy0xLTEtMzAwNzk_5536f5ed-d858-4f1b-aab4-3aa338f20189"
      unitRef="usd">42870000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtNS0xLTEtMzAwNzk_6ed7b698-6315-466a-b20b-5393e6db6ca2"
      unitRef="usd">83679000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTEtNy0xLTEtMzAwNzk_5e2b58f4-574d-4c8e-a930-a76eb23a9f1a"
      unitRef="usd">82052000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItMS0xLTEtMzAwNzk_38765b33-0c49-4753-841e-2f79a09ebd34"
      unitRef="usd">-1232000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItMy0xLTEtMzAwNzk_d616c722-a082-4d48-84a4-93b92cc94843"
      unitRef="usd">-358000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItNS0xLTEtMzAwNzk_4dd39fa5-43b3-4d2f-aef2-cac7170ff30a"
      unitRef="usd">57000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTItNy0xLTEtMzAwNzk_d92bf425-29ab-4323-8511-263534c81f21"
      unitRef="usd">4254000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtMS0xLTEtMzAwNzk_83db4f1a-9616-45c0-b55e-59459a9a40b7"
      unitRef="usd">32000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtMy0xLTEtMzAwNzk_150ed0fa-cf89-4fb2-b543-fd0ced85acec"
      unitRef="usd">-1000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtNS0xLTEtMzAwNzk_c7df721f-6a7b-4dc2-a473-126af7c371a6"
      unitRef="usd">32000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTQtNy0xLTEtMzAwNzk_b04e9985-a0b7-44e6-9d94-8774ff418467"
      unitRef="usd">-4000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtMS0xLTEtMzAwNzk_f3a03293-0b98-48b3-be0e-a7310c8d7ac4"
      unitRef="usd">125000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtMy0xLTEtMzAwNzk_0e3c09ec-2b3e-4f7d-931b-7d3ea6cce7d2"
      unitRef="usd">-139000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtNS0xLTEtMzAwNzk_563e6128-65ea-4cd0-b883-31291d7bf9c1"
      unitRef="usd">-312000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTUtNy0xLTEtMzAwNzk_6d32a871-be7e-4524-97f2-50169173ce1e"
      unitRef="usd">-316000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctMS0xLTEtMzAwNzk_966d2da9-9a96-4d37-ae87-be5d93e72933"
      unitRef="usd">157000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctMy0xLTEtMzAwNzk_24740a0d-4dfb-4330-8b7a-2dab3649e0da"
      unitRef="usd">-140000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctNS0xLTEtMzAwNzk_0fdc83f6-111c-4b40-b3d4-6b85e206aeb5"
      unitRef="usd">-280000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTctNy0xLTEtMzAwNzk_12340f91-badf-4672-ad10-18d20970fea9"
      unitRef="usd">-320000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtMS0xLTEtMzAwNzk_e3545bbb-e1d0-4daa-a21c-0c50b5fadc93"
      unitRef="usd">-1075000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtMy0xLTEtMzAwNzk_b8fcd040-cda9-4d8d-91b6-0cee5b461b7a"
      unitRef="usd">-498000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtNS0xLTEtMzAwNzk_29510ca7-5984-4b36-96fd-d4c6cf8da28e"
      unitRef="usd">-223000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTgtNy0xLTEtMzAwNzk_75bde3c3-be36-4e0f-a281-f449e136cd6c"
      unitRef="usd">3934000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktMS0xLTEtMzAwNzk_8edd85b2-561d-4981-b69e-e9bd57efb94b"
      unitRef="usd">-17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktMy0xLTEtMzAwNzk_08183752-2838-48d3-bcc6-1babd5578c9f"
      unitRef="usd">-577000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktNS0xLTEtMzAwNzk_949956fb-ef4e-4bf5-b3d9-392c48c63ea5"
      unitRef="usd">225000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMTktNy0xLTEtMzAwNzk_bc2567ac-59e6-4f22-812d-76f342482f47"
      unitRef="usd">539000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtMS0xLTEtMzAwNzk_c7d5b51b-add9-4b6a-ba9c-f84cb9fed4c0"
      unitRef="usd">-1058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtMy0xLTEtMzAwNzk_e3681438-a6bb-4795-96cd-ce6fe4031626"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtNS0xLTEtMzAwNzk_7cd4fd61-17df-48f3-9643-5fecc7b06a49"
      unitRef="usd">-448000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjAtNy0xLTEtMzAwNzk_b901daaa-9b6f-4b34-9428-7f9528eebbd4"
      unitRef="usd">3395000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItMS0xLTEtMzAwNzk_73e8e1f5-68ff-41b4-91b1-0f166b4de54a"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItMy0xLTEtMzAwNzk_965a41e0-77b6-4711-a3d4-b06e98ee8d51"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItNS0xLTEtMzAwNzk_005507c3-823c-438b-95f4-0b33f96a20f4"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjItNy0xLTEtMzAwNzk_cc393bb3-61e6-44b0-9752-b91be9d0404e"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtMS0xLTEtMzAwNzk_15074acf-720c-431a-a95a-a7263def03e5"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtMy0xLTEtMzAwNzk_01195e95-757c-4619-a101-6f999cbc3c9e"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtNS0xLTEtMzAwNzk_178fd575-8163-4f59-aa0e-a1060bdbc3ee"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjMtNy0xLTEtMzAwNzk_0b278813-938b-4e7a-9835-7f002d583e48"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtMS0xLTEtMzAwNzk_6c9ef1f5-ff65-4075-b7ee-cde192b2314c"
      unitRef="shares">12543000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtMy0xLTEtMzAwNzk_7fc5d1a1-be2b-4455-9d4c-51e235fa5a3f"
      unitRef="shares">13195000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtNS0xLTEtMzAwNzk_6f2347b8-58f6-4c93-83ae-110883b80b16"
      unitRef="shares">12500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjUtNy0xLTEtMzAwNzk_e281e153-d1c4-4007-b5cb-2eaaa9278e32"
      unitRef="shares">13294000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtMS0xLTEtMzAwNzk_90a52a10-da09-4443-8d6c-01c04aacc690"
      unitRef="shares">12543000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtMy0xLTEtMzAwNzk_14e12497-d343-4a1d-96be-5199c84b5295"
      unitRef="shares">13285000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtNS0xLTEtMzAwNzk_7337a0f3-c568-4aef-a99e-05fc286bde94"
      unitRef="shares">12500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjYtNy0xLTEtMzAwNzk_3ee9733f-fbf4-4f5e-921c-96f0f39ed3b9"
      unitRef="shares">13359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtMS0xLTEtMzAwNzk_e9560c36-f7c6-410f-b5a0-95061b46d084"
      unitRef="usd">640000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtMy0xLTEtMzAwNzk_2049cb0b-53b0-417a-bfb6-6ad961cceb52"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtNS0xLTEtMzAwNzk_331eb429-4f0b-45ff-9eab-decb95c2a2b4"
      unitRef="usd">130000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMjgtNy0xLTEtMzAwNzk_612cb896-dc9c-4c3c-b593-089f72adde6c"
      unitRef="usd">-314000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtMS0xLTEtMzAwNzk_542147b6-7903-4dfe-a579-3d97579585e5"
      unitRef="usd">640000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtMy0xLTEtMzAwNzk_1b6e876f-1587-4f14-b651-364d25da3651"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtNS0xLTEtMzAwNzk_ace3727c-caad-4c83-b611-19c72831e1af"
      unitRef="usd">130000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzAtNy0xLTEtMzAwNzk_7dc66cbb-e0c2-4112-a35d-a40a1ab1d1b5"
      unitRef="usd">-314000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtMS0xLTEtMzAwNzk_8d107aa5-0970-46fc-9ead-b2d76104661a"
      unitRef="usd">-418000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtMy0xLTEtMzAwNzk_33cf6ba4-4c3f-479c-af40-391d0943efb6"
      unitRef="usd">-100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtNS0xLTEtMzAwNzk_a6bc4ebc-a0a2-4467-9703-731d23d48ee2"
      unitRef="usd">-318000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yMi9mcmFnOmIwNmU4NzdjOGQyZjQyZmRhZjVlM2IxOWM5MWZlYWE0L3RhYmxlOjZiYTg0ZjA3MGRmNDQyNzU4YjQ2ZDFhNzc4NDMxMGUwL3RhYmxlcmFuZ2U6NmJhODRmMDcwZGY0NDI3NThiNDZkMWE3Nzg0MzEwZTBfMzEtNy0xLTEtMzAwNzk_ea2350d7-d29d-473d-9e8a-d1b75b9a8a63"
      unitRef="usd">3081000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i128e0238654a408294474d0d39084ec4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0xLTEtMS0zMDA3OQ_ee3b3652-1182-4783-be5d-38d935d3c0b2"
      unitRef="shares">12493000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i128e0238654a408294474d0d39084ec4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0zLTEtMS0zMDA3OQ_a6a7e66c-3423-443d-a619-40a3b6ae1761"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9a96896801234c7496795468d40281a8_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy01LTEtMS0zMDA3OQ_1b2507e3-9118-4f11-8e20-a699c7f54a57"
      unitRef="usd">131075000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib2371d23a6db41b59f8d6c9a8fc7d8bb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy03LTEtMS0zMDA3OQ_eff5f141-d452-4c10-b024-81d894bbdfa5"
      unitRef="usd">-98437000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7ae1865fdb9499ab7dbe0dc600b08d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy05LTEtMS0zMDA3OQ_eff21565-6967-41c0-9909-b56e6becb2bf"
      unitRef="usd">-1123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMy0xMS0xLTEtMzAwNzk_1473db84-a041-4163-aba7-ea4c906bf91e"
      unitRef="usd">31516000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNS01LTEtMS0zMDA3OQ_1f1fdf46-ed07-4bee-bef2-aa0c24750271"
      unitRef="usd">602000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNS0xMS0xLTEtMzAwNzk_7d72af77-6c01-4cdd-b587-29c6de3ec0ff"
      unitRef="usd">602000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNy0xLTEtMS0zMDA3OQ_5c1210f5-34fb-4acb-8577-1451eec9e8cf"
      unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfNy0xMS0xLTEtMzAwNzk_902241ec-63b4-417e-9058-4d82d39da5ac"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC0xLTEtMS0zMDA3OQ_781db2c2-fdb5-49f6-b01f-ae90a3b38a69"
      unitRef="shares">17000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC01LTEtMS0zMDA3OQ_a1a0e34b-ff06-455d-88b3-6d67127e8ce3"
      unitRef="usd">72000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfOC0xMS0xLTEtMzAwNzk_3db1a8d8-0a48-4006-9ab5-bbc714b6b20f"
      unitRef="usd">72000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i5245214ddcae40e9a0969a4a45a5c406_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtMS0xLTEtMzAwNzk_a3c0655e-3394-4613-89b3-80c7eed94a53"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic3ae38c6a30d4b53bcb0442d8a9a1276_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtNS0xLTEtMzAwNzk_149b3279-f9d7-4615-9566-edb4161707f0"
      unitRef="usd">121000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTAtMTEtMS0xLTMwMDc5_b9466d46-f34e-483f-9a30-37c5508ff7e7"
      unitRef="usd">121000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:DividendsCash
      contextRef="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTEtNy0xLTEtMzAwNzk_7a940e51-b08e-4ae2-94fc-3fafe0df198c"
      unitRef="usd">377000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTEtMTEtMS0xLTMwMDc5_61c89236-ed55-4b67-8749-c34d01700231"
      unitRef="usd">377000</us-gaap:DividendsCash>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6c8eefdab538498c85908974d5418122_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTItOS0xLTEtMzAwNzk_d31b08e4-2e5d-42cc-9088-ffe64a38e059"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTItMTEtMS0xLTMwMDc5_42bf39b3-de1c-42f2-bb66-27ce5ffd8ad4"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i42f6b8937cba40a6b8c7d1e6aed8e205_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTMtNy0xLTEtMzAwNzk_c8d4a6cb-3462-47a4-afc5-309bb30631e1"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaaa1969f87e94ae38dca3aede38e2ba3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTMtMTEtMS0xLTMwMDc5_e3136463-c359-49b5-ae1d-f35c023d2b3b"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9d2b015f040948b0a4768f592202a13a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMS0xLTEtMzAwNzk_c741d23b-79b7-4961-8607-b09afda54617"
      unitRef="shares">12560000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9d2b015f040948b0a4768f592202a13a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMy0xLTEtMzAwNzk_c2801c5a-d890-48fa-ae7b-d76a3585321d"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9b09637258c24e2592b4ea4b2ab92d44_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtNS0xLTEtMzAwNzk_2ea9867b-0a64-4ce2-8bb0-ab4bfd3abd90"
      unitRef="usd">131726000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i45f6778f50584111b9cff0df26dbdd7a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtNy0xLTEtMzAwNzk_f6e20833-efaf-4273-a1d7-86cdb652cac1"
      unitRef="usd">-98204000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib49e08745efc40889406f68b33f56331_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtOS0xLTEtMzAwNzk_a1701377-675e-4eb2-b80d-1a5a937aeaa7"
      unitRef="usd">-1633000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96d3d6e8da9e4ed9a3c7f88e35dc62cf_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTQtMTEtMS0xLTMwMDc5_280d3c11-1bad-4f39-b53a-129c42688c5e"
      unitRef="usd">31890000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTYtNS0xLTEtMzAwNzk_ce1ab420-fe3a-4ac7-acc0-16fa80330854"
      unitRef="usd">823000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTYtMTEtMS0xLTMwMDc5_9787c9c8-2851-457f-a80e-27292405541f"
      unitRef="usd">823000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTgtMS0xLTEtMzAwNzk_c48934bc-f2b7-4950-8679-42e6a0996685"
      unitRef="shares">152000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTgtMTEtMS0xLTMwMDc5_9d684c30-4125-4444-bf37-c1770b182d57"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic3ae7ee4928b458b8a273421de3c18c3_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktMS0xLTEtMzAwNzk_8f6a26ca-6e8a-4b8c-a91f-08027502610c"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3eafd1cbe2fc4e7ea472d156c91e7f83_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktNS0xLTEtMzAwNzk_242be319-abae-4147-a12a-832855f7c806"
      unitRef="usd">19000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMTktMTEtMS0xLTMwMDc5_0c2de28e-dc5d-4d44-acad-1798baf4d7a6"
      unitRef="usd">19000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:DividendsCash
      contextRef="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjEtNy0xLTEtMzAwNzk_dd8405f1-4758-4d50-b619-35f7e67eaead"
      unitRef="usd">381000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjEtMTEtMS0xLTMwMDc5_f88a0115-eb36-4f58-b0fa-f796e7c7c816"
      unitRef="usd">381000</us-gaap:DividendsCash>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib3ed14fa890843cf80731ee9e3925b99_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjItOS0xLTEtMzAwNzk_6500c1ed-2b25-4a6d-bd4a-ccbd82be2634"
      unitRef="usd">640000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjItMTEtMS0xLTMwMDc5_024c2466-29e2-4ba7-878b-feb68be6f380"
      unitRef="usd">640000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i250bd1ad4c994f539148d4cfdd26d6e3_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjMtNy0xLTEtMzAwNzk_1c664269-d5e5-4f9f-8bc0-07b18dd8d046"
      unitRef="usd">-1058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjMtMTEtMS0xLTMwMDc5_5861262c-1e8a-45b2-a306-8f68c795312e"
      unitRef="usd">-1058000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i358d6150799342838a19d83985b9c094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMS0xLTEtMzAwNzk_37f6c01a-47ae-4a56-b973-4ee8edc9684f"
      unitRef="shares">12707000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i358d6150799342838a19d83985b9c094_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMy0xLTEtMzAwNzk_88bb8a9b-20f9-4ca5-9a5b-cbc475aca97e"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4cef537cf94a4e73b05136778889ad4f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtNS0xLTEtMzAwNzk_ea3fb514-0e35-4c6a-baee-e0438528d4fe"
      unitRef="usd">132530000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c9137b5588e4bbebaacb5c9c219b41c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtNy0xLTEtMzAwNzk_a770bd76-e0b4-48b2-a731-082b5154ef4a"
      unitRef="usd">-99643000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i467f2e2e2ca04ab7aa50e61d9b8c729a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtOS0xLTEtMzAwNzk_1558e044-72c6-4dcd-82e8-e3bc9e8decc4"
      unitRef="usd">-993000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yNS9mcmFnOjJlODYwM2UwOWQyYTRkMTY5YTg5Y2EzYWIxNzNkOWI3L3RhYmxlOjk1OTJlMjVmMTM1ODRjYzg4ZWZkOWViMWJlMDdmNzU4L3RhYmxlcmFuZ2U6OTU5MmUyNWYxMzU4NGNjODhlZmQ5ZWIxYmUwN2Y3NThfMjQtMTEtMS0xLTMwMDc5_1602b25f-e87e-4df0-b48f-1fd996445f5a"
      unitRef="usd">31895000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5a0c5debcdaa46d09da95435056b3e42_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0xLTEtMS0zMDA3OQ_ea793b07-89f8-4ffe-8135-8b16e16c5b38"
      unitRef="shares">13609000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5a0c5debcdaa46d09da95435056b3e42_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0zLTEtMS0zMDA3OQ_19a55396-833c-433b-81b2-e643855144c7"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i306813b6c9154396b5feb21edeaf07f4_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy01LTEtMS0zMDA3OQ_533de59a-7455-487d-915a-8939af8dccf3"
      unitRef="usd">129048000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i893a955d58ac413f99e2ed74e093e814_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy03LTEtMS0zMDA3OQ_58a32821-2fbe-4337-8147-9a20bd0fc2d6"
      unitRef="usd">-92346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d3875e13d53482ca276a747d7b9725d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy05LTEtMS0zMDA3OQ_519991cc-9821-4aa8-b3aa-248d1415d18c"
      unitRef="usd">104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i19b4e14577474b4cb15b348ef3effb26_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMy0xMS0xLTEtMzAwNzk_256eb301-3c38-4081-818f-0dee43a0e892"
      unitRef="usd">36807000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNS01LTEtMS0zMDA3OQ_29eb2705-5d2a-47d5-ae76-fb8e49fade60"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNS0xMS0xLTEtMzAwNzk_7d25599d-ee2a-4e26-aa82-3b1b4cb1eef3"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi0xLTEtMS0zMDA3OQ_e5052d76-70fd-43dd-bb4c-16afb09bb95a"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi01LTEtMS0zMDA3OQ_7e166e41-4ba8-4b55-b9e2-52a96bf54677"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNi0xMS0xLTEtMzAwNzk_73726e8a-fa5a-406d-b054-6ddef9e356bc"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNy0xLTEtMS0zMDA3OQ_869dcbad-7a18-4f1a-9f4f-97b10b34939c"
      unitRef="shares">49000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfNy0xMS0xLTEtMzAwNzk_3b0aa1b3-9f92-4fe8-b9b5-715e03c536a8"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC0xLTEtMS0zMDA3OQ_ca075a83-0dd8-4d9e-8214-711919cd76b0"
      unitRef="shares">19000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC01LTEtMS0zMDA3OQ_10af2d9a-ad73-46d4-9b7b-29ea72b3aa68"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOC0xMS0xLTEtMzAwNzk_0db63eca-1dd1-4882-a03c-23d0fe3dd2c2"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS0xLTEtMS0zMDA3OQ_952bdb81-ec42-4fc9-9f3e-c94708c04e94"
      unitRef="shares">460000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS03LTEtMS0zMDA3OQ_2344fb72-07e7-4222-8ffe-3c2414394e9b"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfOS0xMS0xLTEtMzAwNzk_a3b464e0-6454-4620-b82a-332723845991"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie3ac2156eb494961b809a464a1fcbdd0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtMS0xLTEtMzAwNzk_a3b4ecb0-8df3-4d98-838e-8fdf948272ef"
      unitRef="shares">27000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i546fcbaf6e2d490d970d3ba7bcfb5595_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtNS0xLTEtMzAwNzk_d046069b-0cc8-4bc1-b73c-ab94befc0dbc"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTAtMTEtMS0xLTMwMDc5_d285e3e1-0aa1-410a-aa9d-627bff57e922"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ieac90614bd08479a962bf94e61c65f4c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTEtOS0xLTEtMzAwNzk_aadcb315-f32a-4446-8e38-93a7d10512bc"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTEtMTEtMS0xLTMwMDc5_de482946-3db0-4bc7-9178-f173937241c0"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i8a5183e3faa74a16897c432c3fa28844_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTItNy0xLTEtMzAwNzk_c0d7cc9d-02c0-4fa4-85f4-f531c62be58f"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2e78919c31bd44d69859fb3ece814814_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTItMTEtMS0xLTMwMDc5_5c8b002f-bdea-4372-a127-0adbf04766e6"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib14397b8bfef44ae89948965604a00cd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMS0xLTEtMzAwNzk_a6fe500e-26fc-45ea-a879-c188ac57bb6d"
      unitRef="shares">13236000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib14397b8bfef44ae89948965604a00cd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMy0xLTEtMzAwNzk_5e2a72b7-72e6-4ea2-9a1c-fd0d6f41a1e4"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief068ef7f192472e8f91975a23c29a80_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtNS0xLTEtMzAwNzk_a7369c68-60e1-4bcc-b0ac-447aa3f19e66"
      unitRef="usd">129862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d7ae78d394c4168918ff53d250447b7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtNy0xLTEtMzAwNzk_265b0383-b797-49ca-a7e1-799c756e3d23"
      unitRef="usd">-92522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iff9d50c36eb64dd29b993c619ef8f346_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtOS0xLTEtMzAwNzk_781fcd08-dfad-4c08-9155-7da40d4ad063"
      unitRef="usd">-31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie75a84e3843a403e89bb873eb810cd5e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTMtMTEtMS0xLTMwMDc5_5b0064d6-85ed-4f66-880d-5b016ba2673f"
      unitRef="usd">37310000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTUtNS0xLTEtMzAwNzk_0e59cb59-1bc1-4fda-8737-ac47100bac14"
      unitRef="usd">755000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTUtMTEtMS0xLTMwMDc5_1f0b3668-d95a-42c8-b928-44dc14d5e3a6"
      unitRef="usd">755000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTctMS0xLTEtMzAwNzk_3e0e2fcf-c773-4819-8505-c7ec8094d3ea"
      unitRef="shares">67000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTctMTEtMS0xLTMwMDc5_13595b5e-d817-4438-9c18-0f264c93cf96"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtMS0xLTEtMzAwNzk_d012ee11-264d-417e-b474-8af6871e5bd5"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i75f6686669cf4ea1a3ed6de2e31a985f_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtNS0xLTEtMzAwNzk_006d595a-6e25-4f38-90f2-6429c24ec38d"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTgtMTEtMS0xLTMwMDc5_25cade8f-ec47-46a7-8e96-04a5d0d1cdd3"
      unitRef="usd">31000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id81b9703907b4145915889d617a0c019_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktMS0xLTEtMzAwNzk_1392f8a6-9fab-4097-9569-68bd54d2ebd7"
      unitRef="shares">454000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktNy0xLTEtMzAwNzk_7f8711e8-e76a-4882-b72b-0c3bd85082d1"
      unitRef="usd">3154000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMTktMTEtMS0xLTMwMDc5_b783bf43-682b-46f1-81b4-0d2bc8cb9f68"
      unitRef="usd">3154000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5b8685d6a4274d5d9e3e702bf84f7a19_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjEtOS0xLTEtMzAwNzk_968b4e48-5f1e-4f46-98d0-0421c8fb5be4"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjEtMTEtMS0xLTMwMDc5_ee67389d-001e-4ddd-a97d-4761069d251f"
      unitRef="usd">-179000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib2fdf1026c544e9c89213bdb89f153b9_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjItNy0xLTEtMzAwNzk_6a87c956-abe1-4a6d-abc8-55998c5c1866"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjItMTEtMS0xLTMwMDc5_e174b73e-f42c-454a-9e90-ed1109cb8c71"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id9ab9efe3a76437eb4c7016235cc6d23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMS0xLTEtMzAwNzk_333257a5-fbdf-4e57-b340-bd27587a3ff9"
      unitRef="shares">12844000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id9ab9efe3a76437eb4c7016235cc6d23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMy0xLTEtMzAwNzk_cdd277c1-2d5d-49d8-9494-a519084576c1"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7567b5990404aa5af48351119c88dd1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtNS0xLTEtMzAwNzk_3306021d-e735-49fd-bcb1-a36912ea92f3"
      unitRef="usd">130586000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8af00de260d44b2bbcf76a96be67275d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtNy0xLTEtMzAwNzk_269743f2-9f9a-4084-80a9-d3b7f894f0ec"
      unitRef="usd">-95597000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia3cad9e185ac4aa2912209bb27110fd8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtOS0xLTEtMzAwNzk_c7484b2c-653f-4988-81f0-470cfd57cb89"
      unitRef="usd">-210000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i229fac654a6e456bae29a6583de50cb7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8yOC9mcmFnOjY5NjRmNGEyMjM3MDRmOWZhMWM2NjEyYTljYzBiM2I3L3RhYmxlOjcyMTY1Y2U4YjFhYzRhYjY4MDliNWUwNzIwMWU1MjBlL3RhYmxlcmFuZ2U6NzIxNjVjZThiMWFjNGFiNjgwOWI1ZTA3MjAxZTUyMGVfMjMtMTEtMS0xLTMwMDc5_5ac664b3-62f4-4fee-842b-84d765c10587"
      unitRef="usd">34780000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNC0xLTEtMS0zMDA3OQ_9f56e685-e692-4abb-8864-19ca87af79cb"
      unitRef="usd">-448000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNC0zLTEtMS0zMDA3OQ_6664df36-bcf0-414f-9899-ac1d532fee22"
      unitRef="usd">3395000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNi0xLTEtMS0zMDA3OQ_547436b2-c618-4c42-95f1-8733449e86ce"
      unitRef="usd">1809000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNi0zLTEtMS0zMDA3OQ_fe0d3f7a-16bc-4ffb-89d7-9c0bcda657bf"
      unitRef="usd">1605000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOC0xLTEtMS0zMDA3OQ_8f3bf85e-82fc-4b98-8a72-d3bd39904bad"
      unitRef="usd">1425000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOC0zLTEtMS0zMDA3OQ_d55efa87-f8f8-4888-ba42-187fe800a9b0"
      unitRef="usd">1400000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOS0xLTEtMS0zMDA3OQ_bfde6403-34f2-43b8-b107-3b319d942363"
      unitRef="usd">761000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfOS0zLTEtMS0zMDA3OQ_254ac825-1174-4823-9555-50d254d0919f"
      unitRef="usd">1079000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTAtMS0xLTEtMzAwNzk_5e2e121c-8d09-4050-b6cf-ad53970ebf47"
      unitRef="usd">-7000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTAtMy0xLTEtMzAwNzk_aa0fe9b5-1d68-4640-a9a3-236abb75eb92"
      unitRef="usd">0</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTQtMS0xLTEtMzAwNzk_1397cfb2-a1a9-4491-bfb4-3c078d6b4c30"
      unitRef="usd">-1230000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTQtMy0xLTEtMzAwNzk_31b2be7c-5575-40ef-b2a2-224cf7421cbf"
      unitRef="usd">-825000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTYtMS0xLTEtMzAwNzk_67ddd9bc-357f-41d5-8d90-61556bffe569"
      unitRef="usd">-913000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTYtMy0xLTEtMzAwNzk_7ff92dda-039c-4c07-94a2-0d1a9248f17e"
      unitRef="usd">-448000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTctMS0xLTEtMzAwNzk_fc38c054-0753-4018-8757-54a5033ffe01"
      unitRef="usd">-861000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTctMy0xLTEtMzAwNzk_e37e9fff-67c4-444d-9109-8a76ef1a3a55"
      unitRef="usd">-141000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTgtMS0xLTEtMzAwNzk_5300a64d-751c-4fa9-924b-78d41ed329dc"
      unitRef="usd">3915000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTgtMy0xLTEtMzAwNzk_05050061-262e-4635-9a47-a04e95e7f43a"
      unitRef="usd">-523000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTktMS0xLTEtMzAwNzk_b02b73fe-b8a2-413c-9231-870d859c6919"
      unitRef="usd">-1941000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMTktMy0xLTEtMzAwNzk_20c25bf0-55ca-45e0-befa-2152bf26b900"
      unitRef="usd">-894000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjAtMS0xLTEtMzAwNzk_0ac7e9ee-4945-40c3-966f-a4a231b1d24e"
      unitRef="usd">1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjAtMy0xLTEtMzAwNzk_ed6171c8-86f9-4768-a452-61e8f4262266"
      unitRef="usd">-12000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjEtMS0xLTEtMzAwNzk_91c4ed47-2972-4311-9c8f-fdc873656e50"
      unitRef="usd">761000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjEtMy0xLTEtMzAwNzk_ca9efd74-f91a-48c9-b4dd-13ad1f093a9e"
      unitRef="usd">-1853000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjItMS0xLTEtMzAwNzk_eb170d01-da5e-4581-8b8c-3bd146bb0f28"
      unitRef="usd">-453000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjItMy0xLTEtMzAwNzk_58e05d31-d0f1-45c2-80fd-70182a3c3690"
      unitRef="usd">-461000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjMtMS0xLTEtMzAwNzk_7cc40816-c036-448a-87fe-3cca8f43ec48"
      unitRef="usd">-1858000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjMtMy0xLTEtMzAwNzk_16f2e4c2-7514-42b5-aa76-bd781f3bd6cc"
      unitRef="usd">-1788000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjQtMS0xLTEtMzAwNzk_9be754f1-6f93-46e0-ab47-13cfc270e121"
      unitRef="usd">-673000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjQtMy0xLTEtMzAwNzk_c8e70fb4-be3a-4d3f-9834-d58a1ff35d4d"
      unitRef="usd">-732000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjUtMS0xLTEtMzAwNzk_92883a17-3819-4d44-81a0-20888110c715"
      unitRef="usd">-278000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjUtMy0xLTEtMzAwNzk_3fbddb92-dc56-4521-9cee-4cb0fb293194"
      unitRef="usd">670000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjYtMS0xLTEtMzAwNzk_53f5ee7c-862a-4a4a-a17e-5fda4bac63bb"
      unitRef="usd">-378000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMjYtMy0xLTEtMzAwNzk_568a2a4b-5868-44b7-86c0-3c03718301db"
      unitRef="usd">4508000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzEtMS0xLTEtMzAwNzk_e868eaf5-b954-41c0-a3e0-d22ee739fc4f"
      unitRef="usd">1564000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzEtMy0xLTEtMzAwNzk_389d98b1-03fa-41c8-b74a-2d9e6ba2c6d0"
      unitRef="usd">899000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzItMS0xLTEtMzAwNzk_ac60b6f2-8085-4755-a381-bc606621b666"
      unitRef="usd">-1564000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzItMy0xLTEtMzAwNzk_b00047c8-8730-48a7-8c2e-f7701330fd2a"
      unitRef="usd">-899000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzctMS0xLTEtMzAwNzk_96adc8f1-d004-4ae9-bc98-44f7071f3dcd"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzctMy0xLTEtMzAwNzk_1254b8ce-6e32-4265-baba-d1e83013fba1"
      unitRef="usd">6646000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzgtMS0xLTEtMzAwNzk_eda2a431-9e98-4def-ad98-f335d28ddb68"
      unitRef="usd">758000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzgtMy0xLTEtMzAwNzk_23410dc6-8d48-4cfd-a358-1f6cba2bcfff"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzktMS0xLTEtMzAwNzk_aed66ed3-7516-49aa-86c7-aabfe8d7dbb1"
      unitRef="usd">91000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfMzktMy0xLTEtMzAwNzk_2c6b898a-d065-48fa-9965-561d40ca48c2"
      unitRef="usd">170000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDAtMS0xLTEtMzAwNzk_bb0d7603-6f4e-462c-bbb2-158dabc3aaad"
      unitRef="usd">121000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDAtMy0xLTEtMzAwNzk_fffd80ed-a56b-4137-924f-9236b2102407"
      unitRef="usd">175000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDEtMS0xLTEtMzAwNzk_e7cf9fc9-cfbd-4019-975e-f739a91be4ce"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDEtMy0xLTEtMzAwNzk_7be7e3f7-dcc4-4152-a4e6-96cd45dd4f3f"
      unitRef="usd">133000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDItMS0xLTEtMzAwNzk_354c0ec4-f21f-4a92-a977-3e8d61dd4c4b"
      unitRef="usd">-728000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDItMy0xLTEtMzAwNzk_b96f9ecc-e9a7-4401-9248-21560c7e24f1"
      unitRef="usd">-6508000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDMtMS0xLTEtMzAwNzk_7574f78f-88c9-494f-a44c-4c7fcfeab863"
      unitRef="usd">-150000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDMtMy0xLTEtMzAwNzk_4d77305d-0a9d-449e-8250-1fbcbfc90186"
      unitRef="usd">-101000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDQtMS0xLTEtMzAwNzk_726f2e4a-d1e5-4701-98ff-8b1520324704"
      unitRef="usd">-2820000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDQtMy0xLTEtMzAwNzk_b4322b7a-16ae-47f2-9fcd-2775b2fdc760"
      unitRef="usd">-3000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDUtMS0xLTEtMzAwNzk_07ac22c6-4e5d-4127-98ef-9e82a3a1defb"
      unitRef="usd">20190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i19b4e14577474b4cb15b348ef3effb26_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDUtMy0xLTEtMzAwNzk_2d4a2956-53ab-48f4-9327-1ef3072998e8"
      unitRef="usd">23174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDYtMS0xLTEtMzAwNzk_0b2b5849-fb4c-45b9-ba9c-2c37c926c76d"
      unitRef="usd">17370000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i229fac654a6e456bae29a6583de50cb7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNDYtMy0xLTEtMzAwNzk_34838456-5cb6-4fb5-884a-a1cbec3ce340"
      unitRef="usd">20174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTEtMS0xLTEtMzAwNzk_5feec8ac-5506-4739-9da6-5224e2fa8ead"
      unitRef="usd">3000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTEtMy0xLTEtMzAwNzk_14c0792e-9171-44dd-b434-4322f3532616"
      unitRef="usd">4000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTItMS0xLTEtMzAwNzk_91853c95-d321-47bb-b681-ce1df0bf0fb1"
      unitRef="usd">932000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zMS9mcmFnOjkzMTI1YjQ0OTQwZDQzMGQ4MDlkMTQxY2UwYTlmMjY1L3RhYmxlOmIwMTY3ODhlNTA0ODQ2NTlhNzdjZjFjM2RmOTE0ZDdlL3RhYmxlcmFuZ2U6YjAxNjc4OGU1MDQ4NDY1OWE3N2NmMWMzZGY5MTRkN2VfNTItMy0xLTEtMzAwNzk_a64169b4-3a85-435b-9079-7f697602c5e4"
      unitRef="usd">1566000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF8zNy9mcmFnOmQ2ZGU3YjE4NzRkNzQ1ZWJiMGVkOWEyM2RjZDBlM2RhL3RleHRyZWdpb246ZDZkZTdiMTg3NGQ3NDVlYmIwZWQ5YTIzZGNkMGUzZGFfMjgwOA_f2967bb1-72b8-4cdc-924c-b180bead93fd">Organization and Basis of Presentation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp;amp; body, and targeted relief products. The Company&#x2019;s line of scientifically-validated dietary supplements includes its flagship Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; family of products, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; dietary supplements. TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; is the Company's line of skin, hair, bath &amp;amp; body, and targeted relief products. The Company also markets and sells Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; its nootropic energy drink mixes, and PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its smart weight management system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements included herein have been prepared by the Company&#x2019;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#x2019;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of December&#160;31, 2022, and the results of operations for the three and six months ended December&#160;31, 2022 and 2021, and the cash flows for the six months ended December&#160;31, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#x2019;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NDE_66b1116b-7dc3-48e8-b315-dacc580b6cd3">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of com&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended December 31, 2022 and 2021, net foreign currency gains of $0.2 million and losses of $0.1 million, respectively, are recorded in other expense, net. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, net foreign currency losses of $0.3 million and $0.3 million, respectively, are recorded in other expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; December&#160;31, 2021, realized losses of $34,000 and $0.1 million related to forward contracts, are recorded in other expense, net, respectively.  The Company did not hold any derivative instruments at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;such risk. Financial instruments with significant credit risk include cash and investments. At December&#160;31, 2022, the Company had $12.4 million in cash accounts at one financial institution and $5.0 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions.  At June&#160;30, 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company had $15.4&#160;million in cash accounts at one financial institution and $4.8 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions. As of December&#160;31, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#x2019;s cash balances exceeded federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable as of December&#160;31, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December&#160;31, 2022 and June&#160;30, 2022 is not necessary. No bad debt expense was recorded during the three and six months ended December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of December&#160;31, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of $1.2 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $1.3 million at December 31, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;December&#160;31, 2022 and June&#160;30, 2022, the returns liability reserve, net was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses all costs related to research and development activities, as incurred. Research and development expens&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es for the three months ended December 31, 2022 and 2021 were $0.2 million and $0.2 million, respectively. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expens&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021 were $0.3 million and $0.4 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company's strategies have resulted in operation modifications in certain Asia/Pacific markets resulting in the closure of showrooms and changes to selling models. As of December 31, 2022, the Company abandoned the ROU assets related to the Hong Kong and Singapore showroom leases. These leases were to terminate in August and September 2023, respectively. However, the Company reached agreements with each of the landlords to modify the termination date to February 2023. The remaining lease liability for these showrooms is $34,000 as of December&#160;31, 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total expenses related to the abandonment of the ROU assets and costs associated with the change in operations in these markets for the three and six months ended December&#160;31, 2022 is $0.4&#160;million and is included in selling, general, and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended December 31, 2022 and 2021, the Company recognized income tax expense of $0.2 million and $0.5 million, respectively, which is reflective of the Company&#x2019;s current estimated federal, state and foreign effective tax rate. Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic (loss) income per common share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted (loss) income per common share is computed by dividing net (loss) income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended December 31, 2022 and 2021, the effects of approximately 0.2 million and 0.1 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;computations as their effect was anti-dilutive. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, the effects of approximately 0.4 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net (loss) income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTk_88e07e5e-236d-4909-af33-4e2eb72d1c52">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3Njk_8137bc73-ee13-4a5b-beb9-3111e34a691f">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MjY_e3887148-b0f8-49db-a0c7-4d3cbe992203">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjA1Ng_65f62304-9125-496e-ab97-d3fd1a2e0aec"
      unitRef="usd">200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjA2Mw_a052d872-b2e6-4e3d-8e34-f391f84a82ca"
      unitRef="usd">-100000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODU4_62d2b59f-d4ef-4e76-83d5-9dada4e7f3ed"
      unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODY2_b4682971-596f-4643-bf75-d6fbfb6ca5a5"
      unitRef="usd">-300000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTE_7ea06f88-6f85-44b9-a329-fd1d289ce532">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjc4OQ_a1c365e9-400a-49fc-b6b8-b0defaf84704"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMjg1NQ_83b99743-b81d-4a68-9cbf-761658bb36b9"
      unitRef="usd">-34000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODI5ODkx_dce34dd3-527d-43d0-aa34-7eb3b4bfa599"
      unitRef="usd">-100000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3MzE_8c44babe-bd0d-4bb7-94af-98a40988d9d1">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDI_88657aa0-367f-4674-b404-31f148dfd7be">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="ie32dad3b31774e4ab4392448baf8d166_D20221231-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzQyNg_0d7199c1-33be-434a-b539-bf3133434c3f"
      unitRef="usd">12400000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i861234a92f024717aab0fcfdedc72f98_D20221231-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzQ3OQ_238e189f-306c-4335-8efe-6139b35b714a"
      unitRef="usd">5000000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i79ba066dbf2f4116a1bc1650082eb82d_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzU1MQ_87e71bb7-4061-433a-83eb-9d7da41a804c"
      unitRef="usd">15400000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="ic6ffbc57f7df41d08f46fdd5af852da5_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMzYwNA_620a4131-ea22-4ceb-8ac4-bd0d56ae6bfc"
      unitRef="usd">4800000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NzA_e3bd4195-c27e-4a08-834f-6dd14630305b">Accounts ReceivableThe Company&#x2019;s accounts receivable as of December&#160;31, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of December&#160;31, 2022 and June&#160;30, 2022 is not necessary.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_07bd3745-e6c1-458e-a7e6-58433ef43d57"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_30ceaf23-84a5-456a-a52d-3fe711b42638"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_8906baf7-b6dc-4eb2-82e1-23987eb3582d"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDE0Mg_db16faae-9761-47b2-a91a-05bdab804a94"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MzQ_0939751a-fef5-45b4-aa9b-aade50523cf3">As of December&#160;31, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS0xLTEtMS0zMDA3OQ_602d9a27-f675-4bca-a7ce-91a27a8817bd"
      unitRef="usd">16447000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS0zLTEtMS0zMDA3OQ_02692247-0b54-4bc3-8b7a-2492ea1d3b9e"
      unitRef="number">0.805</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS01LTEtMS0zMDA3OQ_81b329f9-803b-49a6-be29-901f9e1ed56f"
      unitRef="usd">12674000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMS03LTEtMS0zMDA3OQ_214283c4-b7a8-406d-b5e0-dfecb9f2bd17"
      unitRef="number">0.769</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi0xLTEtMS0zMDA3OQ_f38b3f54-2996-4195-b2c0-3a189657a58b"
      unitRef="usd">3988000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi0zLTEtMS0zMDA3OQ_9d565f4a-13ac-4d72-85d9-6960a3c69474"
      unitRef="number">0.195</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi01LTEtMS0zMDA3OQ_fc7a4053-1eb0-4d62-8f8d-236d8f2645ed"
      unitRef="usd">3798000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMi03LTEtMS0zMDA3OQ_8faade3f-2883-4354-a185-d39a5d66307c"
      unitRef="number">0.231</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy0xLTEtMS0zMDA3OQ_732b9a5f-964a-4e49-803f-32088a802c60"
      unitRef="usd">20435000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy0zLTEtMS0zMDA3OQ_5c761c3e-62de-4911-b980-6b43f3502136"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy01LTEtMS0zMDA3OQ_907aa16a-2f8e-40c8-a395-396285cc5f22"
      unitRef="usd">16472000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmUwYTEwODE1M2FiZTQ3NmY4YTExOWZhZTgwN2EyNGM0L3RhYmxlcmFuZ2U6ZTBhMTA4MTUzYWJlNDc2ZjhhMTE5ZmFlODA3YTI0YzRfMy03LTEtMS0zMDA3OQ_ec650c1f-45bf-4ae1-9620-62b486a711c9"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDY_df09df0e-72c0-48d5-a616-14f39432559e">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDQyNg_86363757-85a3-4958-b8b8-a4b3f63ef4e8"
      unitRef="usd">1200000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNDQzMw_f8f4dacd-e6b4-425c-8a4d-b9489e8d9b94"
      unitRef="usd">1300000</us-gaap:InventoryValuationReserves>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NzQ_dd2595d6-bd97-469d-a671-aafbb6a06a53">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NDc_319037ba-eeda-402e-b3e1-d7e4c7b4ebe5">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <lfvn:MoneyBackGuaranteePeriod
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODEzOQ_e8cc1d53-393c-4834-9020-6bbabf132a41">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:MoneyBackGuaranteePeriod
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODE0OQ_e8cc1d53-393c-4834-9020-6bbabf132a41">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODI1OQ_872439b6-ac99-4d5e-bc23-92b460ef9c64">P12M</lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems>
    <lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODI5NA_1bc72173-91a9-4ff8-b3d3-8a67a31dcfde"
      unitRef="number">1</lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems>
    <lfvn:HandlingAndRestockingFeePercentage
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODMxMg_d3a53259-dc54-4b04-9232-18f7ad70c0f1"
      unitRef="number">0.10</lfvn:HandlingAndRestockingFeePercentage>
    <lfvn:ReturnLiabilityReserve
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODY2OA_6e8d0860-cec3-4515-a8e8-5e0e24236761"
      unitRef="usd">200000</lfvn:ReturnLiabilityReserve>
    <lfvn:ReturnLiabilityReserve
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfODY3NQ_d1e0c47b-b002-4552-868b-5fb0034ee200"
      unitRef="usd">100000</lfvn:ReturnLiabilityReserve>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDM_ddaf21d9-df3f-438d-9f44-8d531ee75f3c">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfOTE0Ng_7d31bed0-7dbd-44be-a41a-3705ca161fbc"
      unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfOTE1Mw_b0c0d0e1-fd04-41a3-9b97-783d527a9c06"
      unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwMDE5_5b19e108-6d16-4c7e-822c-8f9c67a42247"
      unitRef="usd">300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwMDIz_bea13124-7669-46c9-8433-c57d744598eb"
      unitRef="usd">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3ODk_fc1a003f-2480-4558-adab-c40bc3050247">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company's strategies have resulted in operation modifications in certain Asia/Pacific markets resulting in the closure of showrooms and changes to selling models. As of December 31, 2022, the Company abandoned the ROU assets related to the Hong Kong and Singapore showroom leases. These leases were to terminate in August and September 2023, respectively. However, the Company reached agreements with each of the landlords to modify the termination date to February 2023. The remaining lease liability for these showrooms is $34,000 as of December&#160;31, 2022.  &lt;/span&gt;&lt;/div&gt;Total expenses related to the abandonment of the ROU assets and costs associated with the change in operations in these markets for the three and six months ended December&#160;31, 2022 is $0.4&#160;million and is included in selling, general, and administrative expenses.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1becdba443bf4dd4ad59c94e1d90ae27_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMzMDc3_4ddd21e5-9d62-4cd6-81c7-5db743e32735"
      unitRef="usd">34000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LossOnContractTermination
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMyMTEz_45dfe20e-67d8-4b9c-b038-e2dc8b1c7ca2"
      unitRef="usd">400000</us-gaap:LossOnContractTermination>
    <us-gaap:LossOnContractTermination
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMyMTEz_a19d5c0f-b00e-408a-bfaf-2566235ea540"
      unitRef="usd">400000</us-gaap:LossOnContractTermination>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4NDE_4b2fe017-86a5-4f12-88f7-0c7ca45888b0">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4NDI_3d02e816-3e8f-43ea-aa5b-288ec1b8baa7">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTM2MzE_b9627e53-819d-4bee-a261-c6b85d9ba2f1"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTM2Mzg_35ef15cb-4509-412a-86e5-615818f8949b"
      unitRef="usd">500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTY_83c231e4-4abb-45f0-afb8-8617c98c2873">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic (loss) income per common share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted (loss) income per common share is computed by dividing net (loss) income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTQzNDQ_24630641-831e-463d-927c-17ef10c98b2b"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTQzNTE_11f41679-69c6-4d31-b204-c6dd478b69a6"
      unitRef="shares">100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwNjE0_f26b98b6-46a5-4a3d-89c4-14cc31d60358"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfNTQ5NzU1ODMwNjE4_38b28895-7c11-4834-9dd8-d94beafddfe5"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MTY_2ebab501-0fb7-406d-8e7c-6fa659215bb3">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net (loss) income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,058)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy0xLTEtMS0zMDA3OQ_c7d5b51b-add9-4b6a-ba9c-f84cb9fed4c0"
      unitRef="usd">-1058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy0zLTEtMS0zMDA3OQ_713177f4-eef7-4254-a900-3738385377f4"
      unitRef="usd">79000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy01LTEtMS0zMDA3OQ_7cd4fd61-17df-48f3-9643-5fecc7b06a49"
      unitRef="usd">-448000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMy03LTEtMS0zMDA3OQ_80f7e397-c334-4eaf-b48a-c38d3da0d9e4"
      unitRef="usd">3395000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS0xLTEtMS0zMDA3OQ_a94fb1e6-a9da-44ef-a00c-5882fe5a372b"
      unitRef="shares">12543000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS0zLTEtMS0zMDA3OQ_0cc5ecb0-0fda-4be7-b026-d3fbe7d96f49"
      unitRef="shares">13195000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS01LTEtMS0zMDA3OQ_ce4d70f2-997c-43de-8b4e-15c48448023a"
      unitRef="shares">12500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNS03LTEtMS0zMDA3OQ_1e5bcf75-bfc6-4ece-82ae-d4822c0f1d41"
      unitRef="shares">13294000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy0xLTEtMS0zMDA3OQ_dd634166-0047-40d5-a837-e256e64c8267"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy0zLTEtMS0zMDA3OQ_bde85cad-7cb2-44e2-a097-8435042cca71"
      unitRef="shares">90000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy01LTEtMS0zMDA3OQ_a424040f-7c30-419e-a989-3d37ed48abf8"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfNy03LTEtMS0zMDA3OQ_4b53126c-8a19-4465-94bb-372df83f477a"
      unitRef="shares">65000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS0xLTEtMS0zMDA3OQ_25569219-aba9-4a01-90be-c514eec391d6"
      unitRef="shares">12543000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS0zLTEtMS0zMDA3OQ_d82f1691-9e7d-4320-a5ff-dd7020b9c790"
      unitRef="shares">13285000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS01LTEtMS0zMDA3OQ_04bc57cb-2557-4daf-80f1-22c008aedf09"
      unitRef="shares">12500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfOS03LTEtMS0zMDA3OQ_b17b050c-4fac-4e38-8252-ca13aba7852d"
      unitRef="shares">13359000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtMS0xLTEtMzAwNzk_780f6ce7-dea6-43ee-b590-229e0565f4f4"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtMy0xLTEtMzAwNzk_9e86005a-1cfc-4ff6-bb23-c304c7fabb7f"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtNS0xLTEtMzAwNzk_03221eea-be0b-4808-881d-e3504d1403ae"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTAtNy0xLTEtMzAwNzk_b0deb0ba-83e7-44bc-8081-0bb32b26f3ed"
      unitRef="usdPerShare">0.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtMS0xLTEtMzAwNzk_f9e14546-26e3-499a-9845-921cfbf07d17"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtMy0xLTEtMzAwNzk_9ce0f210-7ed5-4608-97be-07e1f261db3f"
      unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtNS0xLTEtMzAwNzk_3f0e705d-bede-4bba-ab51-ae4e8ba3b8a4"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmZmYWRjYTVmNDc1NDQzYjJiZThlMjhhOGQ4NDRmZDVhL3RhYmxlcmFuZ2U6ZmZhZGNhNWY0NzU0NDNiMmJlOGUyOGE4ZDg0NGZkNWFfMTEtNy0xLTEtMzAwNzk_03b80dd7-299f-49a3-962e-d1902d0dc486"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MDQ_f1dbc1a9-3a92-42bf-a02f-e661dbdb935e">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTUyNjg_5ffa8785-9607-48c4-978b-dadfd1eda90e"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3Njc_f1ce8744-a494-4e35-a8e8-70ac901989eb">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU0MjM_5ffa8785-9607-48c4-978b-dadfd1eda90e"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib97c9bdb37f9443998ba3b10ca21301b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi0xLTEtMS0zMDA3OQ_735835de-1dec-4d0d-ac29-d46601253763"
      unitRef="usd">39705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c2b290155354c5893117c2102630e53_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi0zLTEtMS0zMDA3OQ_708a6465-1651-4abc-8310-3f8fc7d4e33e"
      unitRef="usd">34708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic801932ee7b44766a8977bc48c61b215_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi01LTEtMS0zMDA3OQ_9c766062-bdc6-46c3-b56b-3870dfa29685"
      unitRef="usd">76074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ce3902b05744a2181c139ba0275d9b4_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMi03LTEtMS0zMDA3OQ_5b17a31a-fd59-4f24-8eaa-c2cc4a2021ca"
      unitRef="usd">71157000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa2a8d6f5cf24bb49ac338f8ad48ae7d_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy0xLTEtMS0zMDA3OQ_5bfc30b4-4476-4622-b789-6f6082326def"
      unitRef="usd">13957000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfd00b15e7224a37bd9bc7bb7749d232_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy0zLTEtMS0zMDA3OQ_14645efa-d983-4e6a-8ae8-fca2450ce8a3"
      unitRef="usd">17481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d763462815c4c90813a80f4704429fb_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy01LTEtMS0zMDA3OQ_5eb11aa9-9280-4a12-a474-1574e1532dd9"
      unitRef="usd">29362000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c7fc25b6b4042e0a1f3a4195fa43155_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfMy03LTEtMS0zMDA3OQ_30d82072-b5e6-45ec-aa4f-29b144ed44db"
      unitRef="usd">34257000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC0xLTEtMS0zMDA3OQ_4e92e082-8eb0-4f6e-8cfc-008551a28acb"
      unitRef="usd">53662000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC0zLTEtMS0zMDA3OQ_37a72134-38b7-475a-bf16-308bb0f1f99f"
      unitRef="usd">52189000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC01LTEtMS0zMDA3OQ_9f56b0ec-7e1b-4c1d-a519-d5757212fa8a"
      unitRef="usd">105436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOmU4ZmVmODZmNjJkMzQ2ODVhOWQ1ZDc5MzdjNzAzNGE0L3RhYmxlcmFuZ2U6ZThmZWY4NmY2MmQzNDY4NWE5ZDVkNzkzN2M3MDM0YTRfNC03LTEtMS0zMDA3OQ_fa4e93d0-4956-4fa0-944f-8f02d6ef0b8a"
      unitRef="usd">105414000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79eb75825906423b9893fc621fe4f28f_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi0xLTEtMS0zMDA3OQ_968a8c82-9e99-4558-8075-c5cb86ee082d"
      unitRef="usd">37972000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bd8df94500f43ff804118cdd61ee34a_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi0zLTEtMS0zMDA3OQ_d84ea607-54ed-4599-bf64-9c05edebe3db"
      unitRef="usd">32897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30543519b0b14ddfa6511963cf86120a_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi01LTEtMS0zMDA3OQ_0a612fdd-8220-4ab4-83fd-ecc5540a47ad"
      unitRef="usd">72630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05b0acc99f3243ed990137d764b012d6_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMi03LTEtMS0zMDA3OQ_0b68321f-b153-42cb-9e7a-b46c3298a2e2"
      unitRef="usd">67195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d87785af21d4f15924bf57416becf07_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy0xLTEtMS0zMDA3OQ_e5f9fe1c-f66f-4d8e-a1ce-d848c1868469"
      unitRef="usd">7365000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9513ebaa9554e018d59758d829177e6_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy0zLTEtMS0zMDA3OQ_b2e095b7-566a-4966-861a-ce87532b950d"
      unitRef="usd">9991000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i018e46118dfa4569bee998cc12092f0e_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy01LTEtMS0zMDA3OQ_d76cafa2-1e34-43fb-ad56-caf75fc0cde2"
      unitRef="usd">15533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic34e95207b834b059135ddc8c6f5335e_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjAyNTI4ZjgzY2FhOTRmOWZhZTI2NjE0NGUzMzhjNmI0L3RhYmxlcmFuZ2U6MDI1MjhmODNjYWE5NGY5ZmFlMjY2MTQ0ZTMzOGM2YjRfMy03LTEtMS0zMDA3OQ_54850bbb-e751-4154-9ddf-11f8975fc19b"
      unitRef="usd">19834000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU3NTg_01fceff9-a9c5-41f8-97d8-900188830527">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RleHRyZWdpb246N2MwZGFiNTY3ZGE0NGNjOThhYWVkOTc1MGQ4NDFlNjJfMTU4MTQ_d361000d-7ba9-4935-9150-41af1abf0a01">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i156352af4d364bd39bd40efc69390355_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMS0xLTEtMS0zMDA3OQ_c76a2271-6a48-467a-98fe-960bc61aaabc"
      unitRef="usd">20632000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ifff7c281ffcb480b9728320152bb1757_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMS0zLTEtMS0zMDA3OQ_ed9ce72a-cc80-4d35-aad3-30c5d0f268fd"
      unitRef="usd">19790000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6e5a8c78ae114f3ba91daa81c884673a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMi0xLTEtMS0zMDA3OQ_203e1829-d729-4d94-b6e6-62a23374860b"
      unitRef="usd">1480000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="if7c8407d9278411daaade025540b8362_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80MC9mcmFnOjdjMGRhYjU2N2RhNDRjYzk4YWFlZDk3NTBkODQxZTYyL3RhYmxlOjM0ZWE3YzhiMDA2NTRiZDJiY2VlMzU1Y2ZhMmQxNTcwL3RhYmxlcmFuZ2U6MzRlYTdjOGIwMDY1NGJkMmJjZWUzNTVjZmEyZDE1NzBfMi0zLTEtMS0zMDA3OQ_1c2809ff-b853-4380-bd3b-dd61d1767a2e"
      unitRef="usd">1869000</us-gaap:NoncurrentAssets>
    <us-gaap:InvestmentTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMzQwMQ_d283bde4-2809-467e-9f74-6bbc999c6df9">Gig Economy Group Investment&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Note Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#x2019;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $0.0&#160;million in aggregate consideration).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities under ASC 321&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive (loss) income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $2.2&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at December&#160;31, 2022 and June&#160;30, 2022.  During the three and six months ended December&#160;31, 2022 and 2021, there were no impairments recognized.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <lfvn:NotesReceivableRelatedPartyMaximumCommitment
      contextRef="ifbf321362fb048e7ad989fd29aa10371_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMjQ3_7ab6e173-229c-499b-8fc1-43b3ff4d08fb"
      unitRef="usd">2000000</lfvn:NotesReceivableRelatedPartyMaximumCommitment>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="i791994c0741744289a7ca8016b475b80_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfNDI5_f6384679-7981-4754-becc-d67ffe9bb682"
      unitRef="number">0.08</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfODAy_79b22fd8-49db-4a4c-9d88-ffffd3ec991c"
      unitRef="shares">1000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i0d7135dbf3ec4f1aa265be0b60d27d30_D20191216-20191216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfOTcz_42b6e393-ee12-4bd1-ad95-951d963e2d03"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="idbccf873afec4cdb9617f979dc003b3a_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80Ni9mcmFnOjczM2MwYTk3NjY2ODQxMDg5YzZjMjlhMTBmMzc1MDVhL3RleHRyZWdpb246NzMzYzBhOTc2NjY4NDEwODljNmMyOWExMGYzNzUwNWFfMzE3Ng_137e3eab-9ede-4138-a708-c6ba339fb180"
      unitRef="usd">2200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQw_0574f986-51f8-486c-a61c-e1b5f8938ed9">Leases&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTU4_9fa1335b-a4b3-465e-8752-be86b6f9943e"&gt;one&lt;/span&gt; to nine years. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.44 years and 3.25%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended December 31, 2022 and 2021, operating lease expense was $0.8 million and $0.8 million, respectively. For the six months ended December 31, 2022 and 2021, operating lease expense was $1.5 million and $1.6 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at December&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ending June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i264e87d680d542c1af5201533c298cd3_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMTY0_71de10e4-d6d1-4ea9-855f-400f0d1a483a">P9Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMjgw_12de90df-791a-456d-a7f8-0372a9f82e13">P8Y5M8D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMjg3_919d5fad-7ff9-4a8b-b31d-9839d03966b0"
      unitRef="number">0.0325</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMzUz_e7a13d1c-e82f-4c68-8723-a8e3c81d47c4"
      unitRef="usd">800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfMzYw_e7639b74-fa6e-4117-9dbb-5cba6f224e21"
      unitRef="usd">800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQ5NzU1ODE0NTI0_d2f31b4e-c630-4362-ba35-83a273ee2f16"
      unitRef="usd">1500000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQ5NzU1ODE0NTI4_44fdbe01-7fee-4ab7-bb0d-e061ae1bc109"
      unitRef="usd">1600000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQy_1744c0be-5e7e-4191-99bf-95a44f7b654b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi0xLTEtMS0zMDA3OQ_4b205a6a-09d2-4e27-b892-671915a20209"
      unitRef="usd">755000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi0zLTEtMS0zMDA3OQ_20bbd1d8-fc25-4192-8954-f62747c70ed5"
      unitRef="usd">524000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi01LTEtMS0zMDA3OQ_8e52d3c8-ffe8-4577-bce9-1226b2558eca"
      unitRef="usd">1506000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOjBiODdjODA0MmY3MjQxYmJhNGM4ZmQ3OWMyMWUxNzhkL3RhYmxlcmFuZ2U6MGI4N2M4MDQyZjcyNDFiYmE0YzhmZDc5YzIxZTE3OGRfMi03LTEtMS0zMDA3OQ_b88ac42d-9443-4c95-bc62-5e395412e4ef"
      unitRef="usd">1054000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RleHRyZWdpb246OTc2ZmVhNTc1OWQ3NGU0YThhOWE1ODZhMWQ1MTgyMzNfNTQz_f2a1c221-91f5-4d87-a5e7-cab2274e855e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at December&#160;31, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining six months ending June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMS0yLTEtMS0zMDA3OQ_bb2d4003-5352-40b3-ba92-c2e78a649ebb"
      unitRef="usd">1404000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMi0yLTEtMS0zMDA3OQ_46c5b7cd-ad21-4c8e-8a1d-e67eb53b36b7"
      unitRef="usd">1926000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfMy0yLTEtMS0zMDA3OQ_ac587a85-7b1c-4afd-8faf-7906e2071c19"
      unitRef="usd">1606000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNC0yLTEtMS0zMDA3OQ_1b70cb32-51d2-4568-868e-b2af2aaa88a7"
      unitRef="usd">1646000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNS0yLTEtMS0zMDA3OQ_c1fa1d87-d67e-48c1-81cb-6885d8784f34"
      unitRef="usd">1687000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNi0yLTEtMS0zMDA3OQ_51a8afdd-03f4-4e58-88d3-87b053a8dd01"
      unitRef="usd">8123000</lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfNy0yLTEtMS0zMDA3OQ_316f9022-0bc0-4053-aaa6-aec21992194a"
      unitRef="usd">16392000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfOC0yLTEtMS0zMDA3OQ_70467222-2135-4b2a-9a1f-a8cf0e853e14"
      unitRef="usd">2100000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF80OS9mcmFnOjk3NmZlYTU3NTlkNzRlNGE4YTlhNTg2YTFkNTE4MjMzL3RhYmxlOmI3NTFhN2YwMWQ4YjQwYmE4MDhiOTgyNTczMjc3OGIxL3RhYmxlcmFuZ2U6Yjc1MWE3ZjAxZDhiNDBiYTgwOGI5ODI1NzMyNzc4YjFfOS0yLTEtMS0zMDA3OQ_70a90506-f502-42e3-9545-68114c9209ad"
      unitRef="usd">14292000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcwNw_39ef4554-8c10-4be9-9688-636ad956423c">Long-Term Debt&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;30, 2016, the Company entered into a loan agreement (the &#x201c;2016 Loan Agreement&#x201d;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#x201c;Security Agreement&#x201d;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#x201c;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#x201c;2016 Revolving Loan,&#x201d; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#x201c;2016 Credit Facility&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#x201c;Amendment No. 1&#x201d;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#x2019;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#x2019;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#x2019;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of December&#160;31, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year &lt;/span&gt;&lt;/div&gt;ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i218031818c05468fb4b9344e8718454c_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzY1_2ab2f864-35c9-46be-b42d-f47efe6df54d"
      unitRef="usd">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNDY4_6e074b69-9de5-4a04-b6d7-4e5bc8276aaa"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i00032d4dfded48658f82e08c57ab4a5a_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNzI1_6349dde8-4e3a-4575-a786-d4b509ee6c99"
      unitRef="usd">500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTE3NA_c661da5d-66c0-4906-9da5-4755aa347163"
      unitRef="number">0.0493</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTE4MA_243d4e07-2ef3-4793-b139-4426a721e625"
      unitRef="number">0.0568</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTM0NA_fd56083f-fcf7-40fb-bf96-fbf09dd752a8"
      unitRef="number">1.50</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTM1Ng_9442230f-8c2e-4cd9-9568-a457ee0a27c7"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="i7ed07a20460f4cb1af2e73dc102582fe_D20180504-20180504"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcxMg_e6d60747-59e9-4fb3-81c3-5640227273b9">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i103063363cfe4045a96bdcbbc8bb8df3_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTQ4Nw_bdff267f-1a58-4146-b5a1-e79e06ba3071"
      unitRef="usd">5000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTQ5Mw_6adbb0f1-c281-4d91-a3a1-a334639eb0aa"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMTY0OQ_8034cce6-2a05-44c6-8a5d-eb18f5478fed"
      unitRef="number">3.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjE2Ng_dc9aca58-d9ec-4d07-b5e4-f46bd1202e67"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i78f171a4c06a433b8599b63d53f8a878_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjUxNA_af5927fa-1fda-47d3-a8eb-de86112cabc6"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i332a4bdda6964cf2b5071cde0a7980c7_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjU2NA_dc9aca58-d9ec-4d07-b5e4-f46bd1202e67"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i99892b92ec614947929196e70d6cfa90_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjU3MA_c2fe4652-f87e-404c-82a2-be7708ed0175"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i77b08e3f041d46a8b9cb04c7918e661e_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjczNA_9442230f-8c2e-4cd9-9568-a457ee0a27c7"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i6db563e50ed340da9ad6e97e830f1de7_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjc0Ng_6a2ae62b-128b-429b-a0db-e85b0028e71f"
      unitRef="number">1.10</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="i02becdb52e634fce9233ae4e1d9199ab_D20190201-20190201"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfNTcxMw_703deb98-11f7-415d-a1d3-6507c0b2abd4">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i09b53239b6d748c0b5dc0cd15c527f78_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjg3Nw_b6a51f82-161f-4b9d-a1c4-6dfe0ac167d3"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i6db563e50ed340da9ad6e97e830f1de7_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMjg4Mw_3193d326-c1e1-4e07-bab2-64eeb528bbde"
      unitRef="usd">6000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7033d13ec1104ebcb880b911489b11e6_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzE5OA_db0d5360-91ec-44dd-a934-d351195d61e0"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <lfvn:DebtInstrumentFloorInterestRate
      contextRef="i1aad0c75d50047d5b8215d22695bea8e_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzIzMw_f78d21e7-9078-4a3e-99c7-d0cdcf15888a"
      unitRef="number">0.0400</lfvn:DebtInstrumentFloorInterestRate>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="i6986876bbd06457a874cb6f112493823_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzQyOQ_bfab9e38-8112-42cd-aeba-588b5f1f1384"
      unitRef="number">2.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <lfvn:DebtInstrumentCovenantMaximumAllowedDividends
      contextRef="i715b8212e42447a3bcbc76261cc68d1f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81Mi9mcmFnOjZhN2M3MDAyZjY5NzQ1ZWVhYzgxNGViNTQyNjY0NWUwL3RleHRyZWdpb246NmE3YzcwMDJmNjk3NDVlZWFjODE0ZWI1NDI2NjQ1ZTBfMzk1MA_f25f1a5a-b772-453c-abdd-beddba7dcaaa"
      unitRef="usd">500000</lfvn:DebtInstrumentCovenantMaximumAllowedDividends>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjk5Ng_a450e370-a19e-4a20-81da-9a9eab61622a">Stockholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the company issued $0.2 million and $0.1 million shares of common stock under equity award plans, respectively. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the company issued $0.2 million and $0.1 million shares of common stock equity award plans, respectively. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the company issued no shares of common stock upon the exercise of stock options. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the company issued zero and 30,000 shares of common stock upon the exercise of stock options. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended December 31, 2022 and 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,000 and 5,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022 and 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,000 and 24,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23 and, on February 17, 2022, the Board of Directors approved an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended December&#160;31, 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company purchased no shares of common stock under this repurchase program. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three and six months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company purchased 0.5 million and 0.9 million shares of common stock at an aggregate price of $3.2 million and $6.6 million under this repurchase program, respectively. At&#160;December&#160;31, 2022, there is $27.7 million remaining under this repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Certificate of Incorporation authorizes the issuance of preferred stock. However&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as of December&#160;31, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022 and November 2022, the board of directors declared a quarterly cash dividend of $0.03 per share of common stock to be paid on September 15, 2022 and December 15, 2022, to stockholders of record on September 2, 2022 and December 1, 2022, respectively. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash dividends for the three and six months ended December&#160;31, 2022 totaled $0.4 million and $0.8 million, or $0.03 and $0.06 per share, respectively&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3OTQx_ad5946d4-813a-4dbf-82b0-79e285ce1cef"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3OTUy_875b9074-62cf-4312-9dab-58be9a590632"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE4MDI3_9928a691-eced-4c8c-9405-2f00cecfb0f8"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE4MDMx_79357062-e41c-4d94-9b20-371b74e4ae6c"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjcwNA_56be68a5-6f54-4063-97c1-d852315498d1"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjcwNA_fa924dda-8956-43c9-b088-7d6f5825eef5"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3MDY0_6de5917d-dcfe-445f-81a4-0732a021fdc7"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3MDcy_122be6e5-628e-47b6-ad17-40a6032f1859"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ic70d9bc9925c4491aff31728b8478d2c_D20221001-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE2ODk5_770bd13a-b0c0-4296-a9b5-8f1d83ea77e0"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="iccfeea01a94f4cd184543fd5d9074dd8_D20211001-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NDg5_b40a0ea5-5ae4-4291-8e05-3191397c1ada"
      unitRef="shares">5000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ib3a072d9a2b342a09531d6da3ea4a819_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NDk3_e1a9a9a5-4938-417f-ada9-5310e788aa7f"
      unitRef="shares">22000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i9d88473a774f415ea3b215eb60f49668_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTAx_5ab4263c-06c5-4112-9ed2-1e5215067b1d"
      unitRef="shares">24000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i24899bef054f4e1ea3689d7f8468ada1_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTY1_6200f919-f8b8-4f4b-98f2-d2689a57e581"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i24899bef054f4e1ea3689d7f8468ada1_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTQ1NQ_ee24781b-1add-4c81-b20b-5ce795e05895"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i3600ade8ac584e599fd793f01363db8f_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTQ2MQ_a084339d-769c-43aa-b30a-d45f9c902f04"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i3600ade8ac584e599fd793f01363db8f_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTYxOA_e3d88032-6700-4893-bb77-b9b279ba8d5a"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib04b2568d00d452ca563a93b3382040c_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTYyNA_82175ec7-5901-4a57-a1b9-615c8d68ea2c"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib04b2568d00d452ca563a93b3382040c_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTg1NQ_82175ec7-5901-4a57-a1b9-615c8d68ea2c"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTg2MQ_5a033246-87d0-4e5f-a21f-5c2181b675aa"
      unitRef="usd">60000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjY5Ng_4bafa0d3-c7cf-43bf-94ec-8904087e770e"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE0MjY5Ng_61fbc94c-8e97-4c57-95d1-bec41b01a280"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMTk5OQ_59a45c2d-0e39-46a1-981e-a97c590187c1"
      unitRef="shares">500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTI1_6b02125b-3978-47ee-ad88-b5ef7a6872a9"
      unitRef="shares">900000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjA1MA_ec94b493-2508-4acd-82f2-07b815840dcd"
      unitRef="usd">3200000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTUw_33bdf7f9-8d63-4ed9-a620-17bdd4be6a3d"
      unitRef="usd">6600000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i41ae61d037b64e21a0009d260cbf079c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjEwMA_c32b4b2c-fb39-4097-b2bf-172301fdd0ef"
      unitRef="usd">27700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iaa3a80900568428483190bd6fe806e89_D20220915-20220915"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_2182cfc0-338a-4f58-8f08-f49acefdcc1f"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i81f7806f4c744d4bb6f8f72a1d67d3cc_D20221101-20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_62dd3e0f-bed3-41e9-bbe0-03de3b54ac54"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0a878dc75136466d939f36303f8f29bb_D20220801-20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_6c1baa2e-c46a-4d03-bff5-884e27c051bd"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iaed23e7162044f03b895993f02f2b3ae_D20221215-20221215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjQ2OA_6f2fd648-6571-47e4-a57f-a3947793cf18"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjYyNg_edafc211-2546-432f-a4e2-77cb5c52e3bf"
      unitRef="usd">400000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTYz_f44c1296-3f3f-41f1-95f8-f2adc2a94afb"
      unitRef="usd">800000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfMjYzMw_0fa0a659-fb06-4af4-8ca4-a653a1db779e"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81NS9mcmFnOjQ4ZWY0MmFjMmM4MTQzZjc5ZDUxN2Q0NGMwODhhNmI3L3RleHRyZWdpb246NDhlZjQyYWMyYzgxNDNmNzlkNTE3ZDQ0YzA4OGE2YjdfNTQ5NzU1ODE3NTcz_f9bd6d69-eb7c-4e9a-8b9f-25f919c19b11"
      unitRef="usdPerShare">0.06</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzNA_7aa1c3bb-1af4-474f-8de8-8e494fb1f3bb">Stock-Based Compensation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Term Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity-Settled Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#x201c;2007 Plan&#x201d;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2007 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#x201c;2010 Plan&#x201d;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;employees, officers and directors. As of December&#160;31, 2022, there were no stock option awards outstanding under the 2010 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#x201c;2017 Plan&#x201d;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants.&#160;&#160;&#160;&#160;The initial share pool approved was 650,000 shares. On February 2, 2018, November 15, 2018, November 12, 2020 and November 10, 2022, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares, 650,000 shares and 1,052,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;December&#160;31, 2022, a maximum of 4.0 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 3,492,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted is generally ten years. As of December&#160;31, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;General.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Reserve.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of December&#160;31, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Offering Periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Duri&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ng the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;six months ended December 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately 36,000 and 27,000 shares of common stock were issued under the ESPP, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended December 31, 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2021, compensation of $0.8 million and $0.8 million, respectively, was reflected as an increase to additional&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; paid-in capital, all of which was employee related. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended December 31, 2022 and 2021, compensation of $1.4 million and $1.4 million, respectively, was reflected as an increase to additional&lt;/span&gt; paid-in capital, all of which was employee related.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i319cb485eedd404a8b0525a42c144e5e_I20061121"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzA1_1436d8ac-40da-4bf8-86d8-27476842ae80"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i124fe5e6230a4630a62ed6b5b04e0d66_I20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfODI1_21a94945-655e-4ec5-8d37-e85efb772f0c"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="id39f56f005d149c1b465694988b14646_D20170216-20170216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODI0MDMy_b577e3df-8301-4e30-927f-80dc03b42ed7"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ie686cd256ac841c290a740d58fa0128c_D20180202-20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjExMg_7928ee0d-89d1-425f-8d39-7ec82eb46282"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="if3d44ad1e2f441659ef97e1de7898de2_D20181115-20181115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjEyMw_6f4a20d9-1596-41b0-984d-ab66d1c5d017"
      unitRef="shares">715000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i14171336bf9443a9a4f5906ebea800a2_D20201112-20201112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjEzNw_a19bb705-2bd3-43d4-bab6-6a534fa2ba2d"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ia799876fcd8d48f3a197ae9951a5a93f_D20201110-20201110"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODk3_6be6f900-93e7-4070-b42d-226df9752c8c"
      unitRef="shares">1052000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjI4OQ_1a837753-a89a-4a53-a1fa-8e7e30729b20"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i3924c2c406d347e5ba4fdff4f8a7dadc_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjQ0MA_4c3708bd-da97-466c-9918-5726ec01a4b6"
      unitRef="shares">3492000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1a9535be90b54a28934aa4096ffa89cc_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjQ2NQ_8222ba5f-57b7-415f-a610-77447de7f21a"
      unitRef="shares">475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMjczNA_3620bce6-e134-4da9-bf13-d4a9195db174"
      unitRef="usdPerShare">4.44</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="if84a6b9c61ff454ea30977fdf0b8c64f_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzNg_eb73d0c9-aa4d-44ef-9f53-67e89b944092">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm
      contextRef="i1c455728e942439eb75adbf84a5525ff_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzMjA4_7bc4f3cd-a60e-4856-a039-577a1fb9303c">P10Y</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1aba86ab020d4e54b00e5504a42bf7a1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzE3NA_85c993cc-e3c7-4610-8ee4-8652f6801044"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzU0OQ_a4bb425b-c7b4-4d5e-946e-82f1f5516af9"
      unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzYxOA_e7a6f7b6-82e2-4d4e-a01f-5b9899361c26"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfMzk3Mg_49bc45e2-31d3-4cf0-bcac-2273a4cd90b9"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDE0OA_7b51f8f8-64aa-4199-bed2-0d9984ccf75d"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDIyMg_edfa94fa-eefe-4517-add8-a6b8a5b686b1"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted
      contextRef="i2a2bf424c72e488582d382f0dd0a0b89_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNDQzOA_e1055c4b-dad1-43b1-bd4f-05c385760391"
      unitRef="usd">25000</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="i7a27e6fa8a8f4ff8aac04adf3ffd196b_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTIzMA_fe9e9500-56da-4520-a8e9-35805f10aaf1">P6M</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODM4_09955f39-ec33-41f4-9317-65bddaaed97f"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODIzODU0_c2f4e9af-da19-43d5-a69e-42e962713d8d"
      unitRef="shares">27000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i521dab2d24b34aebb658e4110516048b_D20221001-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5Mjg4_829f8437-2061-4739-b865-39237ca5cafa"
      unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i7a9e791f15644f42bb2a535f075ea4b7_D20211001-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5MTcx_5d700bcc-58f5-462b-8dee-277a47e33fe6"
      unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5Mjk2_88ee42a0-043c-4876-9b33-9a86c3264b1c"
      unitRef="usd">1400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i74717441bd5c4de4aefb5a956e836b87_D20210701-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF81OC9mcmFnOmRjZGJiM2RjNWI1MzQ4NjU4OWE5MGEzMmNjNzc5ZDI5L3RleHRyZWdpb246ZGNkYmIzZGM1YjUzNDg2NTg5YTkwYTMyY2M3NzlkMjlfNTQ5NzU1ODE5MzA0_fe484e63-fca7-4fdd-ac7c-73a68fe73bc0"
      unitRef="usd">1400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:LossContingencyDisclosures
      contextRef="i8d21455c9aa149998ae44b714c894031_D20220701-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfODQ2Ng_75d7d1aa-8aa0-46ed-b7fa-46c21b76234e">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  December&#160;31, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class Action Lawsuit (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Smith v. LifeVantage Corp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#x2019;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#x2019; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#x2019; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#x2019; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#x2019;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#x2019; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#x2019; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#x2019;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#x2019;s motion for class certification. On December 15, 2022, the case was dismissed with prejudice, which concluded litigation.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;    &lt;/span&gt;In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfNTQyMw_a9b96643-428b-4593-943a-f46084740d8d"
      unitRef="claim">3</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iab9abce091734ee090f3cba6def7ace7_I20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmI0ZTc2NjI1YWE2ZjQzNzY5NjJhNDgwMjZjMzQ2MjU0L3NlYzpiNGU3NjYyNWFhNmY0Mzc2OTYyYTQ4MDI2YzM0NjI1NF82MS9mcmFnOjFjNjE1MDBhZWM1ZTQ4NjY4MjA4MjNjMzkwMTUwNzAzL3RleHRyZWdpb246MWM2MTUwMGFlYzVlNDg2NjgyMDgyM2MzOTAxNTA3MDNfNTQ0NQ_83e8d92c-579a-43eb-94c4-ecbc8ba11f6c"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>41
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M2C<9^3#2?2 ($Z#WIYRKEXGI-,K.TOL+4$L#!!0    ( +6 0E:Z6B^(UP8
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MOAD?M.6B 9&'CX?Z;<(>W]E)*$F J@F4FNJD! [!_P,X!.V(8&+OF+/%4.
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M\]O%\4-5;"Y[]1S\CZ*JBM7^QT66UK/?ID']]YNBJ+Y^&-3Z=\7VXS[&U?\
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M XT'J)O[)BG?RN.X]878/57>\IRR;0KF9=*'!W"SV="P4-]7E#5&P/KH*'E
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MU_,<V/Z14* M./TH]6*PSK8O6QQ,8W'N*9O#,53I#C;>XL#X';N81B]A68(
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MOZ#;+(T3B_G48(&UZ%77T ?MY;*-:4 DW$TZS*_Y'/$<.[2A7 5^3VX2<SE
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M145P]22"X [!1(!L0Y0'(2C9" HL$@N-#,/ !1Q/'G"@!]7B,,*,#&(ZQUX
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M+Y5&'P3A4K1_/)."(8;:;$NS5ZI_L2$D[OY4 ]5[Q8AFR0@W)*:QGR"M3]<
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M#<'6\;("A.38 ..EA=)V-[Q _PGJXO]02P,$%     @ M8!"5B;T4<Z\ P
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M6A ZJM\I>$#G8? &N47%1&92)Y8D,R:=%MS)=^YJLKP_H?LA+-NV K+T-8E
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MU:LIL.W0FK*0Q@EAR>?M\6TGQFE;WHH2>'H:O2L8'OUDO*+$;K?5:0:F<%%
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M<>B:3%($6).2R"";2#J&(5I\-H8G((EWQ((,\77U_ _@8UM^400!/"-OYY)
M;W813;0"9/%<6X-:R ZNH5[(MF$&LI:J5%;FB+U'OR"'GZ+T/3'N\?R?D#PF
M&=7%=X@A_";\43-:+JU: N:T)QE-OJKL,$-%YA4\]HK;;7-D*/P2'.WU%$B
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M=_DX[MP6%\HN^4Z<&!GY"Q?'S6IS[7X=;IO;[>'.'@6$HG(B5PL<349G)X/
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M[TW+'Q$G^(\6X/G2&)\NZ(#\^Y/+_P%02P,$%     @ M8!"5EP1]!C&%
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MZI4JJTPNEW7- EF.9UQ5<2?LT.X<G.;%)3%L?+R+<^G"C]R>$V]0"Y+GWIA
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MDY]#V-Y06LRFPG,9B[Q['0<8J&4BO-_%+N$>=_9.[\MAJ*..72(;BB"S*J6
M5C42;P>OYH3D$1>C76_)T?:Y-\/>E!23>YPONY:N7"+KPJ8]9""2P@17\&Q<
MW18Z2":>1+!15;SL#@_+ X;O<C@+EX!@* N/@5P0,L%=+K-D'+U,/5^TQ@K,
MQCD>Y$,/G#^1,?+I21B].CA,FU8"O?*V@01W*=E*43[JZM[4='VN76EH7_K9
M!J!@[(L8S\;/G<9NLR^-83[)B1"-\S&,<)'(2<^XW02 E6$J\2GH[>S\T0UB
M:/FDY"48S  KID2JZ-I,^*TLDPI 60CD>E/1Z)"8SJI3@-56$YY<<3<@E4K9
M%3I=VND5-[L(C&3@0# T3850PS!!OL\[0Y?>J)-K5=*OJ>_8#RV$[?);P[6]
M=]9NQ+;*P!8,(F:8W)NDY')P79.&-_=2W06HV":TH0<@F2(X_?(#8+SX+QLR
MH1OLH[;<,PS<)-R5UD&(*?=:;NQ["Z43=ROD2T*'IN*8.W#V;)9-#=2[.?:\
M1[K@]J>M4(\1J/6*S.83)!K6E*A9BK2$K"1Y:4!&-D@A#![X^7N]<!WU#XB#
M.#)"X]4],D1HW47H]SK3 DSZWYX]GYV>GNY=D"6)SZ>&2,[Z6:BSZ6&H&QJ)
M.9:[QJML &LTR?ECI/;RC^#,7J9Q1F:_J+,K;=&(O2E_CNT[::XYRH<=!_4,
MYE?D7:*)O&\K2@S3/NH>*=-^8O0O&9OQM1U-KU%^FN(/]+?4AH(!\I8$1#(V
M2+%>HZ2U.ZWWARJWSE)W-IYJI#^HA=%9-IGE=-^Q5#Y,Q8"F1ZV:*,611:I/
MF4(P9T&"<+*\"*=D*0[JY0)/+.P#\<&M^;&HEETZ.\]QY>,&%$KX3JAWQL_@
M3@IU*,,O38QR[VK4VL<WY9H&&D. Z0<2";:(J<Z+S*+:T@59;Q^L]A0,N>&Z
MW:\W>X0^/SW[IG@?5<NV7UQW*$G(N:\!%L)=3"-47N\/]XV[@$L9HM7[EQM_
M#389VTHT35HT'>.!#%/&^\%L0C1THNDFR5+G@+!FUG]9FR72=^J''2]IZ(-'
MMR$=29SBL%TI<\I\BU#YD50LFRK@6U!N;HF,H_>.\#&D3ZP\5D!RE1"MAGIF
MQ09D/72&)!82;<((N5V1"<7^:<A^"X>$@!DX@OLE%B5I"NH;\"D\##5*5"$3
M6BC/,B;Y 1LQ +.5RCUIZ.XM1U4?EL2A9T$Y]J;ATX^T5NR,K@^#W0!Y)8M<
M[L'& 5^,V2#=.DBB*JDAQ+C@U#HEA(<(4'ZXH/;4V@ &'O%(20/]+U[F+&+$
MI!$ G29'.4@_'AT5-^&[M]%32E$-&O7T_$@_D'DV/3+Y0<:F/]']S&CX_/SE
MQ8?!"/:C%EX/2*&XR*8F=F%09(Z<(<8*]3 UM9OA>C3\4-S00BJ?X8J:+QE5
M*YTGT:\-\^_RVT*W]SKT\4;F\7DF1BK>?@R_GP ^P)[TQ.%<V>PG<;60]@*#
M="JYJ*D?Y]7[ZP:W.\:QV)X_7R;I^E=N;.D4'<_1T[HXO1S!P1)XA*L3]1 N
M;EF! ;MVF@:@T_VXW/Q!+,AV*4O,I2C7<CWEA>CGCB,J7Q.V=*$X0_DH'0V$
MXD;K*BBO["L*F#?1;W7/LWB8EE<U*%_]#&EPHT %PGR@)(%A3H"?AJ<.*9!T
MWR-&M(D!4F7^#H?L<!"H:-M!G\=!-HU>\JPZ\TAME5@!Q3</PKSI,F 3CR34
MYE:3MK ?%VL]3L5%$9D\UQ0\U<-7&?I!I5B^8%M@V^V@T#":,,!WF8V@V$AO
MXO1O6!E$IG#0<,.<WV3SBR6+4'?SE4>;.7=_[,<%]X(N&>^X9O2($#0)Y.28
MJGAQ^N]R<+.V4 HX66BYN*$IM'17P]9%[CJ)B?V<\=GT='# L6OP<4.O>HSB
MXI>1H,%(5+5/R-N?1HO;TL2CW6SXNDG)[ -A?A>2*0Z&,2&A+'ZX/*1;C]XA
MZ'.LG+B\AL'WN*"8O30D!C^3L-SQS"M?_>YE RIBD:F9OS]XE,\_QI!Y>3&G
MU?$6MR(VR!D'NV93U-E<8NL8%W?A)"'23)E*/V9]-CT9?:-7'"8^]&VZ46OY
M8BH#0)%H$=KJ!9VKSKMV/BQ?[+*[M3"PD-^0#R]GXO2#:B2I%(2 VT-%]#ZS
M#.D=NK64OEC&EE!9.89W9$VH_03A0I[(G5WZ-*=C;8 FJ6+)FH3#=V7&>E<!
M6V(7CHS,\;Q,!.2,^%:9-,%[Z"A#Z)9)!&G6IC>:^M'G17B"^U%,] L%M]>[
M-UZM5E1CMKH?2Z% =&]1/EM(<XO82U4HG>=;/F!X0=*';]. Q:!])A,=[SL4
M!SH\.&KP)]G[VZ"[XK?4^3W!II57N=.WZ4WX2WG_NW]<7J/_.S1#MRRU7F+I
MZ?SK%T=R@Q#_:.V6WP9?V!9FR!_76B$GI ?P^]+"O\,?M$'Z_P=X^[]02P,$
M%     @ M8!"5@/HKK!I!0  / X  !D   !X;"]W;W)K<VAE971S+W-H965T
M,38N>&ULO5=9<]LV$/XK.XJ;VC.,Q/OPH1DY1YM,DO%83OO0Z0-$0A+&),$"
MH&7_^^Z"$BTG"L=I.WTAL2!V]\.W!X'SC52W>LVY@?NJK/7%:&U,<SJ9Z'S-
M*Z;'LN$U?EE*53&#HEI-=*,X*ZQ254Y\UXTG%1/U:'INYZ[4]%RVIA0UOU*@
MVZIBZN&2EW)S,?)&NXEKL5H;FIA,SQNVXG-NOC17"J5);Z40%:^UD#4HOKP8
MS;S3RX36VP6_";[1>V.@G2RDO"7A?7$Q<@D0+WENR +#UQU_S<N2#"&,O[8V
M1[U+4MP?[ZR_LWO'O2R8YJ]E^;LHS/IBE(Z@X$O6EN9:;G[EV_U$9"^7I;9/
MV'1KHW@$>:N-K+;*B* 2=?=F]UL>]A12]SL*_E;!M[@[1Q;E&V;8]%S)#2A:
MC=9H8+=JM1&<J"DH<Z/PJT ],YUWP0"YA+E8U6(I<E8;F.6Y;&LCZA5<R5+D
M@FLXOF&+DNN3\XE!QZ0^R;=.+CLG_G><Q/!)UF:MX6U=\.*I_@0!]ZC]'>I+
M?]#@&YZ/(? <\%W?'[ 7]"P$UE[P'7N'MOO';*&-PJSY\]"&.WOA87M42:>Z
M83F_&&&I:*[N^&CZ\H47NV<#:,,>;3AD?3K'RBS:DE/07LNJD36OC2;I?7V'
M0ZD>#D$>-CJS!I!87BVXZLD%5A?PH:TY!&XWXX#8>8%<8G5JPPO2/18UF+5L
M-:KHD].GMGH3[T0M,%T+6$E9:#@"+W;",('4'4?P$\F^$R<A)/$X0_F:;3#=
M#5>"E1H")TM3\#*[-'"2+ 4_&'LHW$C#RCUD1XC5"8,(/-<=NYUA=)3XNXF!
M.$1]'*(?BD-KF.TT*'[&=GK\46I]@C')9<7A"HF8KYGBAT(SZ.=P-MVL.2QE
MB4V5LE9H8-@C,1ZY*$4/HR88I84A.A@-PM $PP;6H)&-;5R\>,7NN,(^C$&M
M*E2WJS I6J,-KB4O^ ^ IE6-U-QF2VXW35^P,8K<FBQ$V5)"D.MO?#Y)$0?X
M?<X;LX^IHC*DY+E9*\Z?M(VG^307]P-?;>;BP]L;?6XKW!\FQVD7G2>T',&Q
MY[A1>H*C)",Q#*T0.$$6H?%:8O/MM"_M7G^ -LSH* S "QP/;9'DNB3Y60AO
METO\/Q&9ECC\0X'F>:N$P1YT"G,C\UM@&Z:P5HA>V5!L-;Q\D?J>?P:9VP]C
MQ+DE_Q^!\]-]<$&4'>"I#Y6S#3DRA>5DJ<*WMY7#3O;C81.[7!DV$L% K<9]
MK<;/KM5KCEVBY<B69JN5XBM&(!8/\ N7*\6:->[KFJ^(YT/%.NCH.<5JZ#\*
M]BOU;2I":A^L?OA98Q%WX(JOP>$RS<%L)*P>8:H.YC>]][\OGQE6#YX-J&,'
MF9.X$0U"'*14,K'C8L_&@>=X40(S+=CDBN5TG("7K&K.X&VK\"1)F97A B]Q
MPA3-9TX0^V3'Q\FNA^\(.((H<&+\B@/?\5*J2L^-L*G'NY$7PJPH!%6$;?[=
M&=4>]I!6N<^L+9+D[)'?I9(55A.U!,N@)9!#);4!O7<2>B0;76#6HF5LMAK3
M&KV9-2SH7/L_\/^E%I0(<_S'<!N$Q,D2(B?PG31+B'O\<08N#N+$-IH/##=.
M\\@Q12MSLHQJRXN<* AHD#EI$ Y55])75_+LZOHHZ]6K$AM9@6F /.FO*FM&
M'!ZJJT$7_[JNRD=8K(-%?S.![X&0X]%#W=+:YYUMOHX1'D'BP.^83K!3[R+B
M8?*[]IW&V4'^)WLG>BR\E;VW:+"GU.YPW\_V5Z-9=R-X7-[=JSXQM1*8X"5?
MHJH[3O"PH;J[2B<8V=C[P4(:O&W8X1JO=US1 OR^E-+L!'+07QBG?P-02P,$
M%     @ M8!"5BHEL-8D P  @@<  !D   !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&ULC55M;],P$/XKIX#0)E7+2Y-NE+;2-D" F)CH "'$!S>Y-!:.'6QG
MW?X]9Z?+.A$BI,@YVW>/GWOQ>;%3^I>I$"W<U4*:95!9V\S#T.05ULR<J 8E
M[91*U\S25&]#TVADA3>J19A$T2RL&9?!:N'7KO5JH5HKN,1K#::M:Z;O+U"H
MW3*(@X>%SWQ;6;<0KA8-V^(:[9?F6M,L[%$*7J,T7$G06"Z#\WA^D3E]K_"5
MX\X<R. \V2CURTW>%\L@<H108&X= J/?+5ZB$ Z(:/S>8P;]D<[P4'Y ?^M]
M)U\VS."E$M]X8:ME<!9 @25KA?VL=N]P[X\GF"MA_ B[3C=- LA;8U6]-R8&
M-9?=G]WMXW!@<!;]PR#9&R2>=W>09_F:6;9::+4#[;0)S0G>56]-Y+AT25E;
M3;N<[.SJ(Y)+!HYNV$:@.5Z$ED#=5ICO 2XZ@.0? #.X4M)6!M[( HNG]B&1
MZ1DE#XPNDE' UYB?P#2>0!(ER0C>M/=PZO&FXQ[^.-\8JZD(?@[YV$&DPQ#N
M8LQ-PW)<!E3Y!O4M!JL7S^)9]&J$8-H33,?05VNZ:$4K$%0)GNP$+I6Q0S1'
M@89IKMNF$4C7R#(!.3,5E'01@<ON0G=W2S"+!5@%=-DU+<HMB"YL.V: OE()
MLJ(ZX1)LI5K#9&&.YW!3:<0G%0"4/ZPWJ'T.U_QN9-=EV WQ@?2I9^#)4A\I
M_<FE5O7?])[#:9;1F"4IC?$DBV;^'V4IC*0FZU.3_7=JKIAM-;?W?9K@(V<;
M+KCE:(:2-0H]G*S#,[R'(![/ &8'PL<TCB7H.S(-Z$/_H94(TV@"Y[5JI77F
M4SC2Z%JW"ZFA7-5=KLC K?063O78!S:-4C=+27R9S)R8D3B+O#AS8NK%4R>>
MG5*!(+T5I27*9Y.8#KQ1KA#CV63Z,J$X&C,'7C>MJS\N20V-A:-D$D?1,5R[
MP!#36R9:'(X)<4HG"4$-93L\Z(LUZJWO_@9RYW[7(OO5_H$Y[_KJHWKW.ETQ
MO>72$(.23*.34\JN[CI^-[&J\5UVHRSU;"]6]$BB=@JT7RIE'R;N@/[97?T!
M4$L#!!0    ( +6 0E8E+W4ZE <  )@X   9    >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;+6;:V_;-A2&_PKA#4,*M+5%WY(L,=!8EV9HNZ!!MP_#/C R
M;1.11(^D<AGVXT=*LF79-"T7I_W06/;A<RB]1[R\MJZ>N7B42TH5>DF33%YW
MEDJM+KM=&2]I2N1[OJ*9_F3.14J4/A2+KEP)2F9%HS3IXEYOU$T)RSJ3J^*]
M.S&YXKE*6$;O!))YFA+Q>D,3_GS=\3KK-[ZRQ5*9-[J3JQ59T'NJOJWNA#[J
M;B@SEM),,IXA0>?7G0_>983/38,BX@]&G^76:V1.Y8'S1W-P.[ON]$R/:$)C
M91!$_WFB4YHDAJ3[\4\%[6QRFH;;K]?TL#AY?3(/1-(I3_YD,[6\[IQWT(S.
M29ZHK_SY(ZU.:&AX,4]D\3]ZKF)['13G4O&T:JQ[D+*L_$M>J@NQU0#C PUP
MU0"W;="O&O1W&UP<:#"H&@S:-AA6#88[#0:# PU&58-1VPSCJL&X$*N\NH4T
M/E%D<B7X,Q(F6M/,BT+?HK56A&6F%.^5T)\RW4Y-[LL21'R.[MDB8W,6DTRA
M#W',\TRQ;('N>,)B1B5ZA[X0(8@I'73F4T58(M\@N21"?\@R])DEB:XN>=55
MNF,&WXVK3OAE)_"!3O319YZII41!-J,S2_O0W7[D:-_5%V1S5?#ZJMQ@)]"G
M\7O4]]XBW,,8?;OWT=G/;RS]FKHQO^69QO2.8OSOZ$UUX2VTH#W-.TX+OZMO
M=*&'*Z7'JH49;P["(ZBN-E3N;VJ_7^#[!_!3GL6ZEZ:D=2>_,OF(_OJD8]"M
MHJG\V]+?FQ(XL /-M'$I5R2FUQT]+T@JGFAG\LM/WJCWJZUX(&$^)"R A(60
ML @(UJB7P:9>!B[Z1,]]>F;+]+ L!,WB5Z1+)Y.DG%,7>MI'9PF7\LU;7?<D
M8?]:A[(;9XY32P@2YI>P40$S2YBGB5[0Z']7W:?MXM@/>^=9XD)+7-\2%QV/
M:Z@UW*@U=*KE4\&>RMF*95*)W(Q(LM8&&:UL CFQIPH$"?-+V'#K2NUJLQ_1
M'^PK ]FI:#^EYU!OM%%OY%3OALSTBO)!(?JB5]W2.GO<.!&G*@4)\T='E3H:
M$1Z-B%P1C:L^WESUL?.JWV9/^B;A>CWX1)*\G!>KL[4*,-Z[=3W;D#&UQ-F&
M K\E+W">Q:GS4\ND$5#2AC#G&V'.G<+H]2U]U7NN^!$M<J*G'44I6ND1CEOG
M&"?LU!L#$N9#P@)(6.@6H-]#,_)J7<,"]:)1%Q>;NKAP=NLK5;G(JDI <R[,
M[4H2\I!01+*9.5(\?BR.BU6MK5J<*4ZM%DB8#PD+(&&A6Q8/H[38D=KJ!:@?
MC7KQ>O5^OW>D8N:Y+@Q=,6;O\[TE4R6YV!XT=\9\=S].K83C"0/0A.'QA!%4
MPJ:26\Z-YU3RHU8K,0[-EFKF<$[IV[6^9$'1&9&(K-^PV0\W5:+M<^V]W]/3
MV9N3]6R1,@!-&;9)&4&E;&J*:TUQF_$\8>2!)4R]KE=?5M5PJ_W:M(ISK- K
M2=KQ O<IG*Q*NZP15-:F,+55Y#F=!2V,I$3$R^)FF]$GFO"5V5!:A0%UB4!I
M?D4;'A6Y75QHB;-N\BUQ \<VT:L]&<]MRMR9D]83F=FP4&-C)Y1(NKF#F'WC
M4D$;]\0 7V#+W0-JL;3.&X#F#5OGC:#R-N6L31O/[=I\XE(BO>N,N3%F8X44
M%2G+BJVH54A0MP:4YGO[ULC >J]!9@U;9HV@LC:%KOT=SVWPW&8Q3RE2Y&5M
M\5CE!;5X0&E^16L:H6.+O):XX7@_,+0$8CRT*+<?-^Q?'!Y+:_?'<]L_'S+%
M9BS)"]-4TC@7Q0"J!8J3?$;U!E/P% 5W]R@F29PGI4%TQM;?\+Q!_QW^KN?&
MG?QD+2%I?D4S*_JMQ2'>5=(:Y>W*:(T:[(IX)&-3PMHG\MP^Q9<\?:#"S(,+
MRA>"K)8L7G\=)[4\Y3=R5GE 32-0F@]*"T!I845KK)1VM?X1%I%7>T2>VXVH
M:X+K72 IOM7?*HGJI;4F0*TA4)H/2@M :6%%:RRW=FOB1]A N+:!L-L&NE_R
M9\&YW=UQMSU5=E":#TH+0&DA*"V"HC4KI+:7L ?]ZP@,Z==,06D^*"T I86@
MM B*UJR;VL+";@OK^S;D>-^DLGQS/77G/KDF]KTG2]( -&G8+FD$E;2I8NUW
M8;??-25RB4CY*T")EC29H95@*1$L>45$H=_U0!#J?7D6,Y*@VTPJIO)#FW1W
MKI/'!5!##)06@-)"4%H$16M65&W4X0'X? +Z6RE0F@]*"T!I(2@M@J(UZZ9V
M!+';$6S6C9Y/8D%G3"&A*\A:-)8?)&&; S:U10YMD;Z[BR>+#>KW@=(B*%I3
M[-H5Q&Y7L)AV++.-6NH-K'6^L:\F0&U#4)H/2@M :2$H+8*B-6NI=C/Q&'S"
M ;4H06D^*"T I86@M B*UJR;VD+%;@OUY GG?-^.[UGGF_W P;EUN@&U.T%I
M(2@M@J*54G>WGH-*J5@4C[A)5&QBRL="-N]N'J/[4#P\MO.^[UT&GN7]T+N,
MRH?D:GSYS-YG(A8LDWJS.]>I>N_'>AX5Y6-PY8'BJ^(IK >N%$^+ETM*9E28
M /WYG'.U/C )-@\C3OX'4$L#!!0    ( +6 0E8'Z9R(Z0(  )\(   9
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M)^@(48[N-J)2F"_5R-5@UDSIYJVQR\98\(:Q*<G/4.B?HL + @M]<IC^I>)
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MM>-0A9-H?A5)<_D'8>P3^%RFI$#@$5&PVD**P&6,.,2Y&+H&3ZL87%Y\ A?
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M)/*?UA7.NL%)I0ILSX1S4JC/+8(9HG*"&%\3PM\:4D!;9Y[_!U!+ P04
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M&JS>Z&T*6:B="J7Y4%H I8506H2BF>)IW5G/[F@>\K#6CCI8,./]'"L?FC:
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M.^P:#2>CHR>1)C2KU9)555H>@-K0M Z4YD)I'I3FHVA-Z6FU]+0/9C\3GM&
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ M8!"5KB?TQ,: P  _Q,   \
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MBYHQ(,]DW!^,LT&?N+-L,AKVNS-7N.V.NN/>@'B0*0*9'A'R,?4@SQ#(LZ-
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M0JY)@->$8), L0G))@%F$Z)- M0F9)L$N$T(-PF0FY!N$F W(=XD0&]&O5F
MWHQZLP"]^>5E6X#>C'JS +T9]68!>C/JS0+T9M2;!>C-J#<+T)M1;Q:@-Z/>
M_$Z]G;^WQBT]CS5^8+^3:C_=:Y;'S\O')N*<S#AK^-US_ 502P,$%     @
MM8!"5E8,451_ 0  PQ(  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS9C+3L,P
M$$5_)<JV:EP;* ^UW0!;Z((?,,FDL>J7;+>T?\\D?4B@$E$5B=G$2CQS[[5'
M.HM,WK8>8K8QVL9IWJ3D'QB+90-&QL)YL+A3NV!DPM>P8%Z62[D )D:C,2N=
M36#3,+4:^6SR!+5<Z90];_!S5,Y.\P ZYMGCKK#UFN;2>ZU*F7"?K6WUS66X
M=RBPLZN)C?)Q@ 4Y.^G0[OQLL.][74,(JH)L+D-ZD0:KV$:SF+8:8M$O<2*C
MJVM50N7*E<&6(OH LHH-0#*ZV(D.^IT3WC#LGOQB_TZFSQ KY\'YB!,+<+[=
M821M]]"C$(2D^H]X=$3IB\\'[;0KJ'[IC=?[X<*RFT=DW7+Y'7^=\5'_S!R"
M2(XK(CFNB>2X(9)C3"3'+9$<=T1RW!/)P4=4@E A*J>"5$Z%J9P*5#D5JG(J
M6.54N,JI@)53(:N@0E9!A:R""ED%%;(**F055,@JJ)!54"&KH$)6\9]D?7=N
M^=>_5=JU,%+9@S_K_EW-/@%02P$"% ,4    " "U@$)6!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M +6 0E8Q6FG][@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( +6 0E:97)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ M8!"5CN7
M[.O?!0  HA\  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( +6 0E:["('9E08  ($;   8
M  " @2(.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "U
M@$)69-EGG@H#  !E"@  &               @('M%   >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ M8!"5KI:+XC7!@  5B(  !@
M         ("!+1@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( +6 0E;SS>&\-@T  ,2$   8              " @3H?  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "U@$)6DM_..EX'  "6'P
M&               @(&F+   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ M8!"5@?(!A/4!@  H!   !@              ("!.C0  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( +6 0E:1;DL/'QH
M /U/   8              " @40[  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " "U@$)6.I[4K)\'  ".$@  &               @(&9
M50  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ M8!"5B;T
M4<Z\ P  ZP@  !D              ("!;ET  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " "U@$)6_,%JZPL)  "N&P  &0
M    @(%A80  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M +6 0E:,4#]LM@8  !X4   9              " @:-J  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ M8!"5A-</SZ$"   F!@  !D
M             ("!D'$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " "U@$)6*&=)4)4,  "+(@  &0              @(%+>@  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( +6 0E9<$?08QA0
M "M    9              " @1>'  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ M8!"5@/HKK!I!0  / X  !D              ("!
M%)P  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "U@$)6
M*B6PUB0#  ""!P  &0              @(&TH0  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( +6 0E8E+W4ZE <  )@X   9
M      " @0^E  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ M8!"5@?IG(CI @  GP@  !D              ("!VJP  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "U@$)6O0,*8'L$  !S%@
M&0              @('ZKP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( +6 0E:K17F(Z 0  $,@   9              " @:RT  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ M8!"5GNN+H>@
M P  71   !D              ("!R[D  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " "U@$)6_*Q3]*X#  "R$P  &0
M@(&BO0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( +6
M0E;:1]\TGP(  -8'   9              " @8?!  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ M8!"5L_MS5/- @  Z@<  !D
M         ("!7<0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " "U@$)6UU=BM,@&  !/.P  &0              @(%AQP  >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( +6 0E9>+^E1=08  +LX
M   9              " @6#.  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ M8!"5INP HJ]"0  /W(  !D              ("!#-4
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " "U@$)6>%)6
MP0\"  "4!   &0              @($ WP  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( +6 0E:_!XRH20,  ,P4   -
M  "  4;A  !X;"]S='EL97,N>&UL4$L! A0#%     @ M8!"5I>*NQS
M$P(   L              ( !NN0  %]R96QS+RYR96QS4$L! A0#%     @
MM8!"5KB?TQ,: P  _Q,   \              ( !H^4  'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( +6 0E;:L 5M4@$  /X1   :              "
M >KH  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( +6
M0E96#%%4?P$  ,,2   3              "  73J  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     E "4 ^@D  "3L      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>126</ContextCount>
  <ElementCount>232</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>27</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OrganizationandBasisofPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Gig Economy Group Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestment</Role>
      <ShortName>Gig Economy Group Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/Leases</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Components of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Gig Economy Group Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails</Role>
      <ShortName>Gig Economy Group Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/GigEconomyGroupInvestment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebtDetails</Role>
      <ShortName>Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/LongTermDebt</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lfvn-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:LesseeOperatingLeaseTermOfContract, us-gaap:NumberOfOperatingSegments -  lfvn-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="lfvn-20221231.htm">lfvn-20221231.htm</File>
    <File>lfvn-20221231.xsd</File>
    <File>lfvn-20221231_cal.xml</File>
    <File>lfvn-20221231_def.xml</File>
    <File>lfvn-20221231_lab.xml</File>
    <File>lfvn-20221231_pre.xml</File>
    <File>lfvn_123122xex311.htm</File>
    <File>lfvn_123122xex312.htm</File>
    <File>lfvn_123122xex321.htm</File>
    <File>lfvn_123122xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="517">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>47
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lfvn-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 517,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 126,
   "dts": {
    "calculationLink": {
     "local": [
      "lfvn-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfvn-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lfvn-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lfvn-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfvn-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lfvn-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 333,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 23,
   "keyStandard": 209,
   "memberCustom": 11,
   "memberStandard": 14,
   "nsprefix": "lfvn",
   "nsuri": "http://www.lifevantage.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.lifevantage.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.lifevantage.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.lifevantage.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.lifevantage.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.lifevantage.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.lifevantage.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "15",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "16",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "17",
     "role": "http://www.lifevantage.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "18",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "menuCat": "Details",
     "order": "19",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails",
     "shortName": "Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details)",
     "menuCat": "Details",
     "order": "20",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Computation of Net (Loss) Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "ib97c9bdb37f9443998ba3b10ca21301b_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "idbccf873afec4cdb9617f979dc003b3a_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Gig Economy Group Investment (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
     "shortName": "Gig Economy Group Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "idbccf873afec4cdb9617f979dc003b3a_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.lifevantage.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails",
     "shortName": "Leases - Schedule of Lease, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails",
     "shortName": "Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i6986876bbd06457a874cb6f112493823_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Long-Term Debt (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.lifevantage.com/role/LongTermDebtDetails",
     "shortName": "Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i6986876bbd06457a874cb6f112493823_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stockholders' Equity (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.lifevantage.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "ic4aee92a781f4df9a6fc3d60ebecbf20_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Stock-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.lifevantage.com/role/StockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Commitment and Contingencies (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.lifevantage.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i0a3f6a0b75c14110b02ada2017e58d06_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i41ae61d037b64e21a0009d260cbf079c_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i521dab2d24b34aebb658e4110516048b_D20221001-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i5a0c5debcdaa46d09da95435056b3e42_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i2e78919c31bd44d69859fb3ece814814_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Organization and Basis of Presentation",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.lifevantage.com/role/OrganizationandBasisofPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Gig Economy Group Investment",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestment",
     "shortName": "Gig Economy Group Investment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20221231.htm",
      "contextRef": "i8d21455c9aa149998ae44b714c894031_D20220701-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 27,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lfvn_AsiaPacificAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific And Europe [Member]",
        "label": "Asia Pacific And Europe [Member]",
        "terseLabel": "Asia/Pacific &amp; Europe"
       }
      }
     },
     "localname": "AsiaPacificAndEuropeMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "label": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "terseLabel": "Cash accounts held primarily at One Financial Institution"
       }
      }
     },
     "localname": "CashAccountsHeldPrimarilyAtFinancialInstitutionMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held At Other Financial Institutions [Member]",
        "label": "Cash Accounts Held at Other Financial Institutions [Member]",
        "terseLabel": "Cash held primarily at Other Financial Institutions"
       }
      }
     },
     "localname": "CashAccountsHeldatOtherFinancialInstitutionsMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CommissionAndIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards",
        "label": "Commission And Incentives",
        "terseLabel": "Commissions and incentives"
       }
      }
     },
     "localname": "CommissionAndIncentives",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts With Customers, Refund Percent For Resalable And Restockable Items",
        "label": "Contracts With Customers, Refund Percent For Resalable And Restockable Items",
        "terseLabel": "Refund percent for resalable and restockable Items"
       }
      }
     },
     "localname": "ContractsWithCustomersRefundPercentForResalableAndRestockableItems",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts With Customers, Return Period For Resalable And Restockable Items",
        "label": "Contracts With Customers, Return Period For Resalable And Restockable Items",
        "terseLabel": "Return period for resalable and restockable Items"
       }
      }
     },
     "localname": "ContractsWithCustomersReturnPeriodForResalableAndRestockableItems",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "label": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "terseLabel": "Debt instrument, covenant, fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFixedChargeCoverageRatio",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentCovenantMaximumAllowedDividends": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Allowed Dividends",
        "label": "Debt Instrument, Covenant, Maximum Allowed Dividends",
        "terseLabel": "Debt instrument, covenant, maximum allowed dividends"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumAllowedDividends",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "label": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "terseLabel": "Debt instrument, covenant, required minimum working capital"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRequiredMinimumWorkingCapital",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "label": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "terseLabel": "Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentFloorInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Floor Interest Rate",
        "label": "Debt Instrument, Floor Interest Rate",
        "terseLabel": "Floor interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentFloorInterestRate",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_DebtInstrumentTrailingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Trailing Period",
        "label": "Debt Instrument, Trailing Period",
        "terseLabel": "Trailing period"
       }
      }
     },
     "localname": "DebtInstrumentTrailingPeriod",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_HandlingAndRestockingFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Handling and Restocking Fee, Percentage",
        "label": "Handling and Restocking Fee, Percentage",
        "terseLabel": "Handling and restocking fee, percentage (as a percent)"
       }
      }
     },
     "localname": "HandlingAndRestockingFeePercentage",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_IncreaseDecreaseInLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Lease Liabilities",
        "label": "Increase (Decrease) In Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiabilities",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_InventoryFinishedGoodsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Finished Goods, Percent Of Total Inventory",
        "label": "Inventory, Finished Goods, Percent Of Total Inventory",
        "terseLabel": "Finished goods, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryFinishedGoodsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_InventoryPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Percent Of Total Inventory",
        "label": "Inventory, Percent Of Total Inventory",
        "totalLabel": "Percent of total inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_March2016RevolvingLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Revolving Loan [Member]",
        "label": "March 2016 Revolving Loan [Member]",
        "terseLabel": "March 2016 Revolving Loan"
       }
      }
     },
     "localname": "March2016RevolvingLoanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_March2016TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Term Loan [Member]",
        "label": "March 2016 Term Loan [Member]",
        "terseLabel": "March 2016 Term Loan"
       }
      }
     },
     "localname": "March2016TermLoanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_MoneyBackGuaranteePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money back guarantee period.",
        "label": "Money Back Guarantee Period",
        "terseLabel": "Money back guarantee period"
       }
      }
     },
     "localname": "MoneyBackGuaranteePeriod",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_NotesReceivableRelatedPartyMaximumCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Related Party, Maximum Commitment",
        "label": "Notes Receivable, Related Party, Maximum Commitment",
        "terseLabel": "Notes receivable, related party, maximum commitment"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartyMaximumCommitment",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_NumberOfGeographicSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of geographic segments.",
        "label": "Number Of Geographic Segments",
        "terseLabel": "Number of geographic segments"
       }
      }
     },
     "localname": "NumberOfGeographicSegments",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "label": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "terseLabel": "Proceeds from common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_RawMaterialsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raw Materials, Percent Of Total Inventory",
        "label": "Raw Materials, Percent Of Total Inventory",
        "terseLabel": "Raw materials, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "RawMaterialsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_ReturnLiabilityReserve": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Liability Reserve",
        "label": "Return Liability Reserve",
        "terseLabel": "Return liability reserve"
       }
      }
     },
     "localname": "ReturnLiabilityReserve",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "terseLabel": "Amount in excess of fair market value of stock for option not to be granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "terseLabel": "Contractual term of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_ShowroomsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Showrooms",
        "label": "Showrooms [Member]",
        "terseLabel": "Showrooms"
       }
      }
     },
     "localname": "ShowroomsMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandAndSevenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and seven long term incentive plan.",
        "label": "Two Thousand And Seven Long Term Incentive Plan [Member]",
        "terseLabel": "2007 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndSevenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and ten long term incentive plan.",
        "label": "Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20221231",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r455",
      "r523",
      "r560",
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "GEG"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r322",
      "r413",
      "r437",
      "r456",
      "r457",
      "r473",
      "r475",
      "r481",
      "r521",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r322",
      "r413",
      "r437",
      "r456",
      "r457",
      "r473",
      "r475",
      "r481",
      "r521",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r320",
      "r322",
      "r353",
      "r354",
      "r355",
      "r412",
      "r413",
      "r437",
      "r456",
      "r457",
      "r473",
      "r475",
      "r481",
      "r516",
      "r521",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r253",
      "r320",
      "r322",
      "r353",
      "r354",
      "r355",
      "r412",
      "r413",
      "r437",
      "r456",
      "r457",
      "r473",
      "r475",
      "r481",
      "r516",
      "r521",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r235",
      "r236",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r474",
      "r480",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r235",
      "r236",
      "r444",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r474",
      "r480",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r15",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r238",
      "r239"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r18",
      "r460"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions payable"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r152",
      "r433",
      "r442",
      "r443"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r27",
      "r30",
      "r101",
      "r409",
      "r438",
      "r439",
      "r492",
      "r493",
      "r494",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r7"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r501",
      "r502",
      "r503",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Stock based compensation reflected in additional paid in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r92",
      "r93",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from EPS calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r119",
      "r132",
      "r148",
      "r176",
      "r219",
      "r228",
      "r232",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r381",
      "r383",
      "r389",
      "r479",
      "r519",
      "r520",
      "r563"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r144",
      "r155",
      "r176",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r381",
      "r383",
      "r389",
      "r479",
      "r519",
      "r520",
      "r563"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r44",
      "r50",
      "r55"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents \u2014 end of period",
        "periodStartLabel": "Cash and Cash Equivalents \u2014 beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r44",
      "r115"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in Cash and Cash Equivalents:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r176",
      "r195",
      "r199",
      "r201",
      "r203",
      "r208",
      "r209",
      "r241",
      "r257",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r292",
      "r293",
      "r296",
      "r300",
      "r307",
      "r389",
      "r458",
      "r488",
      "r497",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r23",
      "r125",
      "r137"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies - Note 8"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividend paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividend, common stock declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r501",
      "r502",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r6",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2014 par value $0.0001 per share, 40,000 shares authorized and 12,707 and 12,493 issued and outstanding as of December 31, 2022 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r31",
      "r158",
      "r160",
      "r165",
      "r429",
      "r434"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive (loss) income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r60",
      "r61",
      "r111",
      "r112",
      "r237",
      "r445",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r130",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Concentration of credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r62",
      "r111",
      "r114",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r60",
      "r61",
      "r111",
      "r112",
      "r237",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r99",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r36",
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt conversion, converted instrument, amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt conversion, converted instrument, shares issued (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Interest Rate of Debt",
        "terseLabel": "Debt conversion, original debt, interest rate of debt (as a percent)"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtInterestRateOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r174",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r282",
      "r289",
      "r290",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r120",
      "r122",
      "r131",
      "r179",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r398",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r179",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r278",
      "r279",
      "r280",
      "r281",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r398",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Quarterly installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r367",
      "r368"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r48",
      "r95",
      "r373",
      "r378",
      "r379",
      "r500"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r48",
      "r217"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r107",
      "r550"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "negatedLabel": "Derivative instruments, realized loss"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r106",
      "r108",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r327",
      "r357",
      "r358",
      "r359",
      "r364",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r88",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "terseLabel": "Dividends, common stock, cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net (loss) income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r166",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r195",
      "r201",
      "r202",
      "r203",
      "r205",
      "r387",
      "r388",
      "r430",
      "r435",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share, basic (in USD per share)",
        "verboseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r166",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r195",
      "r201",
      "r202",
      "r203",
      "r205",
      "r387",
      "r388",
      "r430",
      "r435",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share, diluted (in USD per share)",
        "verboseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Foreign Currency Effect on Cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r81",
      "r142",
      "r162",
      "r163",
      "r164",
      "r180",
      "r181",
      "r182",
      "r184",
      "r190",
      "r192",
      "r207",
      "r242",
      "r308",
      "r360",
      "r361",
      "r362",
      "r375",
      "r376",
      "r386",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r409",
      "r438",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]",
        "terseLabel": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]",
        "terseLabel": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities held without readily determinable value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "terseLabel": "Foreign currency transaction gain (loss), realized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedTerseLabel": "Loss on disposal of assets"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r35",
      "r176",
      "r219",
      "r227",
      "r231",
      "r233",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r389",
      "r467",
      "r519"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r33",
      "r118",
      "r126",
      "r140",
      "r219",
      "r227",
      "r231",
      "r233",
      "r431",
      "r467"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "(Loss) income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r177",
      "r191",
      "r192",
      "r218",
      "r369",
      "r377",
      "r380",
      "r436"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit (expense)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r161",
      "r365",
      "r366",
      "r370",
      "r371",
      "r372",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r45",
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r124",
      "r138",
      "r489"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r495"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r203",
      "r326"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock awards and options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r72",
      "r73"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r169",
      "r171",
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r71",
      "r461"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r154",
      "r459",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r146",
      "r153",
      "r206",
      "r244",
      "r245",
      "r246",
      "r415",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r71",
      "r490"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r70",
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r511",
      "r512",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Gig Economy Group Investment"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r559"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining six months ending June 30, 2023)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r407"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r17",
      "r176",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r382",
      "r383",
      "r384",
      "r389",
      "r466",
      "r519",
      "r563",
      "r564"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r123",
      "r135",
      "r479",
      "r499",
      "r513",
      "r553"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r145",
      "r176",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r382",
      "r383",
      "r384",
      "r389",
      "r479",
      "r519",
      "r563",
      "r564"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum capacity on draw"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r16",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Fixed rate interest on debt (as a percent)"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r247",
      "r248",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnContractTermination": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The loss recognized on termination of a contract.",
        "label": "Loss on Contract Termination",
        "terseLabel": "Loss on contract termination"
       }
      }
     },
     "localname": "LossOnContractTermination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r170"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used in Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r44",
      "r46",
      "r49"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash (Used in) Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r34",
      "r49",
      "r127",
      "r139",
      "r143",
      "r156",
      "r159",
      "r164",
      "r176",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r200",
      "r219",
      "r227",
      "r231",
      "r233",
      "r241",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r388",
      "r389",
      "r467",
      "r519"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income",
        "totalLabel": "Net (loss) income",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r219",
      "r227",
      "r231",
      "r233",
      "r467"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r401",
      "r404"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r399"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r496"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r406",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r405",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/OrganizationandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r97",
      "r98",
      "r100"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive gain (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r97",
      "r98",
      "r100",
      "r157",
      "r160"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive gain (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of company stock",
        "terseLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Payment of cash dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r5",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r5",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock \u2014 par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r491"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r91"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r75",
      "r136",
      "r432",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r167",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r507",
      "r508",
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r321",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r321",
      "r410",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Payment of cash dividends"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r94",
      "r141",
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r88",
      "r134",
      "r441",
      "r443",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r142",
      "r180",
      "r181",
      "r182",
      "r184",
      "r190",
      "r192",
      "r242",
      "r360",
      "r361",
      "r362",
      "r375",
      "r376",
      "r386",
      "r438",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r215",
      "r216",
      "r226",
      "r229",
      "r230",
      "r234",
      "r235",
      "r237",
      "r317",
      "r318",
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r319",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition &amp; Shipping and Handling"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue Disaggregated by Geographic Regions"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Net (Loss) Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r12",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r32",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r323",
      "r325",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r149",
      "r150",
      "r151",
      "r208",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300",
      "r305",
      "r307",
      "r473",
      "r488",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share based payment award, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the ESPP (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Options outstanding, net of awards expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued under equity award plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r331",
      "r350",
      "r351",
      "r352",
      "r353",
      "r356",
      "r363",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other (in shares)",
        "terseLabel": "Shares canceled or surrendered as payment of tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r56",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r176",
      "r195",
      "r199",
      "r201",
      "r203",
      "r208",
      "r209",
      "r241",
      "r257",
      "r259",
      "r260",
      "r261",
      "r264",
      "r265",
      "r292",
      "r293",
      "r296",
      "r300",
      "r307",
      "r389",
      "r458",
      "r488",
      "r497",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r25",
      "r81",
      "r142",
      "r162",
      "r163",
      "r164",
      "r180",
      "r181",
      "r182",
      "r184",
      "r190",
      "r192",
      "r207",
      "r242",
      "r308",
      "r360",
      "r361",
      "r362",
      "r375",
      "r376",
      "r386",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r409",
      "r438",
      "r439",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r207",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r81",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r81",
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Repurchase common stock amount authorized (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of company stock (in shares)",
        "terseLabel": "Stock repurchase program shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r5",
      "r6",
      "r81",
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r69",
      "r479",
      "r499",
      "r513",
      "r553"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r175",
      "r293",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r308",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r3",
      "r121",
      "r133"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UsTreasuryUstInterestRateMember": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on direct treasury obligation of U.S. government (UST).",
        "label": "US Treasury (UST) Interest Rate [Member]",
        "terseLabel": "US Treasury (UST) Interest Rate"
       }
      }
     },
     "localname": "UsTreasuryUstInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r63",
      "r64",
      "r65",
      "r210",
      "r211",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r194",
      "r203"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r193",
      "r203"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMELOSSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetLossIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "275",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938061&loc=d3e54681-109401",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r482": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r483": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r484": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r485": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r486": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r487": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0000849146-23-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000849146-23-000015-xbrl.zip
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M3 B:&*EP9#YJ(Z*C7J!@@[.1H-&>*8(7; 5(X@$\C14P)O4'TP@!'S"BF*+
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M?=ZB]8T6S&@3-T@C3V!AKW6+@==,4,(TSYSP-&-8N"P50662" 8J07)$Q,C
MLV4W\,V=]<;N5F',1Q;^_<>=W8_KC6:MN5W9^>_8^2LK-S+T;W:VZ[7QE&<_
MM'*%?'#=GDGZX]6P Z8H7968.1%M]O^>WVJLK"4&KJAQ&S6^%^_3"R1J:4MU
MWD])OEK, 6-UAD7J[PFM\&:1+'D#+VL4[WJ6YO6GT?$Y/.^+Q3$2*W46J+=9
M:HB=:6UC)KW 1ED2A(\I]80SR@6352CP@?.]+5$URV4BY%[K].1"MA,.\OX
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ME A,07@B H<; ]PWSH5,<&%%:@09C%E94PPQNCAYE!^"N#)\.R)Q@N3'/1#
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M%%U96Y\T=,]U8]J-_,1=0COJ+#B5#3Z+)[Z-VP#5_&E8Z=SOS6JW!).EE;Q
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MX!EO@NT-3>]L5-U0= ZG13YOQ/!OBMP9/#.=(%:P>SF8E>LBH+T&0L"_$>;
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M]3F V\ J]L.5@:^.2C;SSDFW=0(H,>]_[1?O&\)"]-+TTZ-7T^(D?P$L*/@
M904(N K'\-5HI>$1@Y0G*3ZGRI=!6MB#T9Y#6+;"YL+=H,GZ><H9Q^%@V$O
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MLN@J)-'-O7PW==S#-=JTPD85\STOYJ.-@R_"<JE3T(E1F<)/5F?*N @&EMN
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M^1IF,Q<D+]R/5I#\0$B>=JAYR4CP@!%S(B35.FJD>&0(6+*VA;$&FQRXYYL
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M+\^Y4K"^**Q/^U5P]$ZQ*! AQ"&P@)%E'E RJ7F@6"0E+$^ENJ:9?"E=>[)
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M/(K%ZEHXS:@AOI:@AF<_E!Z&HFS<BXWV:LI&L$1BGV3D#0\(N")(6>40LYZ
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M3\70%F(VLK)-/09K0IN*,3:TV(PFPY!^!.9ZWUI3;YZ>G9@!_.+X8SN;<]
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M><$.G&O]A!V[ZTRB;>"$A@D^3#L#[]:M($-G6>2_D"7@EO7'MM=LK;FT7KO
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MB0W)E13@Q+&4B"2-80>E2Z1RL8R3E7V[CWN-AQT+VJ7;'9P (D7A'N%P9"L
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M"S A 5<W05$^H#.2]FRWA:(+3;Q<%SS.C:!YP1.$(6EL3/&^DBI81EL3[P%
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M/(O#7^W>=LS6/E5GJ!'<6XK7"+&GAM0_NJ='GJ]TZJK,B5./.RR,%)@-H#<
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MDBT ;*NIW2UC*\:\=]^JVC4BQ4^:VZVKQ+4\[L9XW*)_+?"B+ 5P.:Z0KL.
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M4W$:9*X71($227;I=JLM\*\'?'_OXQ%W$Q8$J7+B*)4."SAW1.!R1[$P2R5
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M.$RT&AG.57#G$\9VQD9C.Z=C9:EQ+O(ZZ,4\KB-/N4$L(J9]CX-*E2H_<J4
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MNQH0C&C\V66<093V@%8$/^%YCZ-Y@EFX=7W>C$$YX[H^OWB67\-YR05/(BX
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M.F&$'4Y"WW5XHE,G"!,WS#R74PUS;0\L9!7,VP=;EA=8Y.EB(PED&<0I -&
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M\XL6G!7$GFQ"[2>D@E$^UI\-MAOI^PG86G= *[;Y'^<+6ECW1Y<=)7Z:)2S
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MMSI96?0I/YB*B."_6TU!-#>VMQJX(WL\[\.7<1"O2>!O<KX>7;DQG6DD+[5
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M%24"&.'8]G"H:E%IA%&8QDU@6'T9NZ:0O=!@7A5QS+ -6S%'S3=/<GUZ(?\
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MF&Y9IH[ ]'.ILMJJYEO4-VS+,M&MCIT'*D$MJ89N]HM";7>^C.H9-:8U>VM
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M8_^][=7S1Z_?8>'>D[R6MKJ% R'%P$ES9=H<VIY]HS'L%VYDQ_QDFJW:EB)
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MXG?PUABV^RW-Y94?RMA_9DKK(E>Y%YCOIXD*J5M%*B-J#/(>>=1)N[&@E<(
M@,;]+("N>IWWNXD=OX7_RD$;N,"V$2,Z%CXP$<>P*A_07'<MP2,B9!&99/Z
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M4S&?'&<26P]J=MXL'Q$#E41YMOR1N5%TSY]N27!IM:O@L/\[3LUJIJ!5G Q
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MS4I)),6U%^>MO;AF6:*UWN(.X.PO;!"Q9C$#HK5IHF6@VK.)U 8J:2OBEHI
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M-.M9TVT*ZI8D-[7^@;B6Q9/(NRW25.@^8$F,U>H@^%+)7P$J-64S%!* ]P_
M6"[J4C2AP]4\#DW;+/214S@1_L]<>0'ZA'6N6377K%/GFJT%,#!?V!D#F*:%
M(-('MT*PI'8D?X96GP50()0J1)&1X&3+Z&("8[20]Q 025:4%!TA<U%NH@#D
M.'UY8U4S=I?$X/BQ\DN5<)_P07E@_"4_-VOK+BCHOJX/,%5U8&E+?QP#Q$?D
M$T^+OD&[*5#7E#J+(HP')&ULZ\CKLNF+',C8YH)U. $ZFR5K_O?_.FNUFN\)
M-K_A]7-SG:YX[X_97#:Q9M+7K4@NR@"R&$"?BR4K9X5T6O!6MKYTM0BHG4X
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M9$F]]\Z6\MI)$F [3U9114E .I5MHC6.)=DOSI$FLG.\D:CRCZ3A>"5]S5Q
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M=*Y?R6FF*Z.*7)5'Y1B="E8]!1IUM+<BBI(;$Q#0801N#P6VG$G6 -EDPGI
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M::L5GGN#2C 8321G]7W%D!F#9(%^E";$8"=Q%D'(.54RD31V13/^XMDH\4E
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M@'!SO_K!4.LRK*M.PC@W.C)_@<TDDIUDVFDT3W!H %CTR&-<P/8)CM<P X*
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M4O=QR:N 21VT&] L0+$-E:ZG0D,3/U8<28E%)F/,&@Y>9MC3K.C">@50:S%
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M;'_VH&)[(D\1VG5Z]_HQ.%'"5.5:*E%$<)Z6<-Z8U$#OW4]D.V^0[]WDG!\
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M/':52 46WM^,)=?IBP!;@,""J$<U54-QLRY,$$5VE@QGI_G@FT<R!HD168M
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M$)A[A^0)#8!I2P9''$A,TJE1"91Q1M?>-OI HVAUJ<HJM=&7#9B[TW(" 09
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MQE.T.B$HFYD 4NXN)[*L';..:2(UU4R+D'/U"V_6;76N/SR.9[L1R\0&[KV
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M#^AWV:S8A%O]FW/%\+A\OWP)B.&WG_X/4$L#!!0    ( +: 0E8*I^5_CB8
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M6S^(Q0J\RP59"0Z^9ZM[\ <7Q9] YLL'\,<R_S-[(A#^:_G2N^7C<Y[=W:^
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M![%,11Q!$82A6D5$"A.<>#"D?J#WNAX/(BOOJ^-]36UN5Z)>-,D&6^*";Z7
MEKO=+IC-IKXC\ 8F@C-PLW?).HV(*Y^LCI[&=<HZK?*>5Y;!*SUSZRQ6&<_F
M:UT@]*M@Z[QT_;KZP>9K+KB^Z]6>INMJIW$MKTBN8\ V9:\O'W0NQYGP/<EB
M9:5ZJ:],55\9#XD?"QC',2)>A(@45F?M3J2:&AVUE0+%1BL@:K4J_X>KFZ^
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MJT,-@*N<<*[%&S=GW$#@[N64&ZH?NP5"5[N_E#*;9WK?57D_U37N8L:HQ(A
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M$0K)(.*QA%@$'*:)3&&<^*E0/P_2Q"@5[@BR3HU<?.3%8)M2;2,QT"*#C8I
M/8>./F=AK S\)1A8B],9WZ$O%KXO02,WV*A:#B(X,(@7K='>>57IK)X__N+I
MO>[HGX&%O3N=SV$D6WDZGX6=U3W.0'5:[ .+,)ZU/PZ6.SN%D;KL&:0Q)T5Q
M+<OL_Y^RA?BX$@_%3" 6TY@(R!+JZYV&@!1A K$7DHC0-$D]JY)N!WN9FD%0
M"EFF\"F+@GS3@H)24ML8C8.8FEV8G8W4P$MK'Y#L0S2Z0' 5H7&PCW$#-+K4
MW(O/Z'S81=VTC=/SC*9ADJ"8P"AF <2,,9A&J4ZWG$@4^%[D)U;3_T@_4R.
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M'',4X20RLNI-.YS:RJ1$!@^-S)LX,\TW62,R>),M6@%H-B%G)B/0O; ,@>O
M:X&&]+<MI+7 NNY/*3+8R.P82 L_7,> CN1,>SZP=DZP%BAU>K*:M#.>.ZJ%
M5CL^I3;O]=O@J.6@6DFTQ73Y1+)YM1*HM>9AN6COJW1V$K8Y$& 4QR%B H9A
MH(/4@A@F<>S!F!(<$B9C8I;/Z4PYID;MG]6<S/7W;7F<VW<8S'8((X [,+]K
M>WS'M@<;-;0I7BD"VII<E.ETV" G.6?BZ<CF[BO%J-;SF5"]M(//;:XW2;XC
MQ?U-OGS*N.!OGW\O=#&7.@O+XNY26=Q/5>D/+@*42"H@BW0^3<X(I%A0Z-/
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MAK.=WM&.1M[CG5)X?W=W\HUSHH)*U_!M'S/L$^)[6%.#ET",10*3D!(HHC1
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M[DLN./V"_2GBN^63R T_V;WG)_2)EG(Y_2J/:MOK*&NWI=$.L XJT#ZV.OQ
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M<<&E,_>D<X#Q$DI<[#C)$G%Z(&QW^9JO;+G:>M=AJJX2T&I&"PBE4 7 -!,
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M;H#";3ZY%^HQ3 ]J-?,V>Z6;/Q\6._'F]6:9@F8<R0QC"D&)J *(DA)01C-
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M.K/^FT$%1 HQ($*D7!&&L]2+6V) 7:?FW!N-K=/@>YU; OCC!C7!M/!#3OO
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MP&<A!;H-P#6.((<GG[=HX1NOYO;58Q3]DWEV,X.XU$S@ @B1F6,Y(APP3 C
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MW]5I_D;A?VRK=;71'_7J6R5U0X#W0<OEIT4]XJP4C B%S)E99BE E!: <BJ
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MXCDZ*!R1H,,5FU@4'#?EC4NRX6K^&8V&\X-^?F:]VLP^V)UK75'!"R%(F4$
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M5*.BKW>\B;*K$XR)W>"^KE$VV6F;O#A&LE7X>MY2@#-S12>:S[HI<&37Y K
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MX-7OB8SWLK]N?*3U?D' J O]NH%/5WC')WO&W=Z5'S=+^7=;<6,64\/:<SC
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M7'M1'L_76_/3?_[3[C?F/Y:^Z#__Z?\#4$L#!!0    ( +: 0E9"M-3NJE(
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MT,[Z\$R4PBCJ"U?G W'#1*EOHP/(:GR115_N;4MR>'[[.D7C9HT& E5#)?0
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M0Q57#J^P#L["1S$Y"3QEK9V"S)0"91,C<<H(GF7T66.(MG63T4<1..[9^02
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MK?OM[$7H^$\KQ\9K0T5V@-;GTZ_3C/.\>A96GR?D]7HFN09,QM2Z'3H@ HO
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M3],97F'OX^*QDDW<4\B<+,G3\]-29)43R(C)1G(F3//[WZ%Y&GFTYM.BNRN
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M3_W!<CYC*[P#$WP0L]MF^#>+ -+LI/KNE\6Z%?6$&<Z=SQ8D9Z4./\\0:S6
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M^HY-SJ8QP5X>T.G?;&5,;B.DD>78?O0Y$CPJ7UPMK$:[N<%$<,)Z$!&]"8X
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MW4W-N(9M.,S<2"ZUT4?')FJW2^SA;^5'NIT?ZY;>!"5KV08H7@0HE^EP15'
M*JF5I%/.B];Y[N%NZ:]4MVP^_/O%46Y%EC$3I\)KXE1LAT!B?>_'1"J:J^;-
M7N^CI]L;^<<@XL:;AE8*Z* 6^/?:O^G%:CT])D]Q-5&V.&6$!</JFVBR*^!J
MPH^S0DYHM@9-ZP?!5RD8>0+\,( Y0,@=0.3E8HEDU)]M>F83U)>!PHNTZ>U
M_L#FR]E&0ZOK>T'F1 =30<A"95 RT:&M,4+14DB)@NOFQ5%[$SOR%/=A@/<T
MJNL H\]Q.?U*G'S%&YPH;[P47%(TZR.H8B+XP!AX:06C8#Q;W;I:[6YJ1A[
M/@S*&@F_ QB=/DB\_D+\&E/>.R5=$"!#K0QVM05\#!(RUR$)RS+#(9Y$/TC8
MR+/3!W*VFJND!YPMYHG86&ZS=-/5/YX1#=-U_=,D:+*M*GE D<GR(D71@14'
MIO@2O99&NP$\^+O(&7FZ^6 .?!/Q=X"DBVG"-_:$E<'&7,<S15W',VD.] U5
MGYAI)R/G[;-W=U,S[O/V@7#42/@=P.AL7/#W&X8U)RZ"\F V?F!V"-%*!4(C
MUT2KM!=C@AJ6U]Y&R[COT@>"4!/!=P"@EV&Z_/<P.\%+[ZM>S4E )\<7Y_6$
M.$HJY (\>5&OY\D=E+41E4RQ&#JH16AMDG8B;-QY;$,%?\U5T@'.WB/MEQ.L
M32;K34$54NW'^^QDM5X<X_+Z+A(V>OJ'@;7U5C5) 4'72U;O.>?"LV);=P5]
M'(4C3V(;[& <3$M=8'"%1$ -2YX3H[/%9B3-Z0CTLVV%*JLZ^1R9H\#7>0M!
M1 8A2R9DR<&+UNU==B!K-[3]:/GXUOKH &+;,OMM=?WUW5*B1N6] 2-EH-U"
MQMHG$R$ISFV*K/H'@SQNN)6<W2#UHV7L6\F_ RC=WJ!^VYR9=LRK32@\_;II
M"W[F%,1 $8M6#G3PQ*(N$5SB$G+6R@3/"^>MC\T]R-P->C]:SGYH?74 R?-F
M.->W5K#):;/96B0R55L41HD.G-):(!J=7?OF5;?3LANX?K14?1/)=X"@%V$Y
M)]G4YJV;_7*='<-M9LDF\%CO'9)2X 1G($,1/OH0F6]MP!X@:3<\_6C9^99Z
MZ !6'_!3=1W?XY?%\EQ6-U(SN@A6HJ@/HLB-5")4-W+SF#I3S*QE8:IU%F,G
MPG:#V(^6K&^ODQ^^/O#C)N4\7'7@Z><_;6W@;4P-7QD812HU^4">$QJ")P9P
M5I&]<H(%KE04S7ME#-B_)WW&?#+#M^4\K;PM_5AOA'OI=@*M#DI9$"::FG")
M$+&. 9!9^Z*,3:GUD]Y=:>NV8O Q2+EAPX903 _GY3E?UQV!VD@QU83,='92
M!Z==95-FZ:WU"6RH?9V1*7(0K*&@)1J/)<CV#T3W)+7;>L0V<!Q.;1V@\U(6
M^@4=),MYF)UEH%>_?/\5%Y^6X<MGXK=.?+C&:K3):N0)<JSB]4F"#U* +%XX
MDFZ=]3S<Q<%CR>VV>/$0E#Z5^CI :FWM\7KZ%?/1:H7K![GCW@B*IR1@H-VG
M'+'H/'<09+:2?&I95.N>5X^CL-LRQT/P.*"2.HY(3CO\[!UQ7/G[;3ME#1@Q
M7.N8%#2/2OD,%*GF.I%.0109(7'/M74^J>[[9=&GU7? UT]TYD2PW ,:5>_\
MZX -%@LXE9 +(R7:UH' ':1TU2'K,?J^>75TN*A[.))N:?3U>AKB=#9=?_\M
MK$^6]-]K+&H7K.:%_$-3WWXR*2%P'@"C)]<0$T_%-D?3H\D<UZ5OBK1A5=3Q
MJ;1;2NE-6"XW[Q*>XSI,9P-FS&ZL]+2YL_L9'3Z+ACD&[1D'OFDKF!CY.@PM
M,(RQ9,F\:3[_=M#WM5>KPS=;:"*\PY1H:XI:-Z*(87 \%. 49F@=@D'6?*#8
MK91TFR%[# H>+,E_O- [.#1O</'+]X_T5X^^35<35 ;1UJZ8RB0*/>KH5:8X
M:.U*"89G^O?0^+D@9^R6$H=K^R$ [2GZ'E%4&7F^. [3^01I1[&4,VAE:8]%
M)VJ#,P\IU\JCPNA$;]^2Y4YR.D/1OBI_T!;M)_\1H53]F.W3N:VY7OT-9_G=
M<DJ^Q'3V_6A]I2!\NCZIG/Z&QQ&7D\2*LZ8^I5/U)M6*#$Z+ #H:'AA+LCC_
MD-.T__*=(6I?S2^>5 V] 2VL-SWH;^-N=<J>4U'F*#QQ5LL"DC 0HXM@I9+2
M"R^+,GNA[.&UQXW_G@1BC170P9GX;KF@.'?]O58]KH_FN;X%WI1Y7[+Y)20?
MR;Y#U*407RI 0*6 21.*L0PY;]V+=0>R>H/;P9Y6:U7TC*Y+FY,5F[4N"31*
MVC69?(OHG86@%5<:$T9LG0/>@:QQS\OF4-@5:GOJ9>R#\L/GQ1_+Q>+XS B;
M8'3(M.]2$?5"W;#:]%-!Q-JH. 85C-WI%+SVP9VB8E^M+1J)L -+<\,>OY[.
M\=4:CU<34Y(*B8O:-%'31J'#.!BU;788G5?%AM9/QNZF9MR*@J?(#^PG^ X@
M='=3IU]I9]4>FN\QS*;_A7FBR;QB\1KH#ZE6Q0:(3+LZ $H4YKTIHG7.:7?J
M.@OU]L3#SAVW#E).!["[Z/)TZ1'YF\7Z.:Z(X=IG^HABC_QI.O]TZ1?.N*YC
MTH-.TF2&P"P9?B4Y^029\[J;A1(E:^5:H_%@HCOSWMN ]&E5^7CL^BUVY_BI
MTC)TQZ5;FB/\%KY-CT^.7WS[LFD_/"G%B2*$!>=L)A%C)F^%OHP4E$LT1K+2
M^CG1001W=GJW0>W3J; #:TL^]-?IBABE ^7YXB2NR\GL+,,S06F-\#6OC9&<
M9V7)YXU"@&:6.\Q>:-7:4[R/GG&K_09"6S,%= "F\T<'M1W,Z62(%2Z_(D7G
MTD3M10 4,8!BSD,,(@//S'@7O96V]7W2W=2,V\!P(" U$O[8J8O?%G/\_DM(
M__CU))!3NT9\1U[$(D^\8@J%3&#(F07%601?L@"/)"?.94%WK4/8'3F,NU88
MMP5A8U2TD^78@#AK[+.ZW-F'HIOUR7*^98<L)T$]S&KL?C3/].<Z+:I^M96?
M=R4DH0U8(HZXI<#>Z6*!96%)K#SRL%OVZV!2QNU.. 3$GE8[O6*QG,PS<5NE
M^Q"[BJ+N>O,%9'=K863(X),+(%"7.C<;_?6#\)%@W)V6<1L=/B4:!]+/V'#\
M6YAG^L&G"S[HBY<;*U]9#9]P$F*VUA@'F06L$],5A2-9@J:#WPG/DTIY)[@]
MO-:XS0V'@%-C^8X-EZU5/J_</G4/)U(5EZ.6P+ X$DJP$!1N'A#Q$*1(-O*=
M('+[YX_<>7 (7#009 ?1VKWM["8\&U:XCU!4E9#@!5SM5&V#LUYCUD:TGJEQ
M+T$CMQ0<*&AKIX,. '7'"Y%)<L@#%Q1TDG"V)68AY028F)0F)!:Q]62,.T@9
MN8G@0"!J(?<.X%-S_F_G9R[<1UP>3^<;24V",LE1)%!;:090KK*$.D*4 G-A
MTKK0NCGXG<2,W QP( BUD7T'(#IO/'=J0W_!.9;I>I**C*IFY U/DH13 O@B
M$5(PJ3#AL[?M^\O?2LK(#?\&RSX>+O<.X',T7T]S[4DR_8H?,-67C5-<O?B6
M9B<9\[;/]/&7DZV^;K8U.3JN>?L)2A&Y\@F,BZGN&0?.D%_H4I*6<R-";OT^
MM0GA(_<.' B:3Z_3L0.]-R>U9.UMN6@<<=K<;C61,2%R4T"R3#Z!L4B&W7NP
M#%,. ;5)NZ6?[EYCY/: 0P1\C03:@8$[X^3<9SQG1.NDO-<!K#-8\[ 2(L\"
MM.4%DXK!^-9O:^\D9C<(_2B)\K:R_^%?RU=KNYA7OA<7;>H&?SE_[ZI/^XI^
M=P$,_Z+>!Y)D)G]>L%IF4&K'U*0]:/3**\128G-79; 7]1?"O#DOGAME6)82
MN."U?CL4B!0#0TF)Y6A8O88:J@#A)CG=OJU_#![NK$ X4/P=')/GK+R<SJ>K
MSYA_72QRK4A\6\ZK*B2/UE2/D$M.1P&G?SE3W[@YF;C5*>GFPPMV(&M<9#6#
MP%W0:J2/GB#V/OSQ6Z#/G899G9;\X>3+EUGMM7*%.>U2]HZXD4D78LYS<+(H
MB(D)EY2V++9^%?8H L>M7QX<=LUUU!, :Z%US0>3+!1P;V0=H&R!_D![J0C&
MK5(<5>L<_>7UQRTD'AP^CY7P_NA8K,/L\ 3"[>;V]-K[;?E85SG_G4GF/ 9)
M,8OT65$D5&IV6"/PF*.*S/N8=ZO,>]2RXU8#MX;,P&(?.R-UV7[>Q8\.T6-6
M=&I;67OIUD(P%NO+39,S5T;GM!N,=EALW K@0<#36L1C0^9B8NT=S!A)-C.9
M#**(^M+"1@@Q.G ZU2R,+,P_TNP< I;!\IG#6IH6PFUV6HV5D3K_K4L7 8M"
MAW:]%MW>;)W=!@R>I]J#EJ?-7ATJK.%S6E(%E%IGR+*0E2LZ@5,R0*UXD(7;
MVAG[A\EID6"W0JWB/?I*\MPT6EV0](\7\P^U*/'S8I9KK_K-3(4S(9"5#X7\
M ;+M@H2060;GG0/CF.)!&,RY=>_V/4GM-A?V&!S=R/4_@=HZB"&OL#E!)7Q)
M%/8&BW1HI)J!"4%#0:_1>ELLMLZ(72%@7"0]B<KO@]FCY-\!>/Z.TT^?ZR/P
MK[BD@^CL>FQS=*S>GJQ7ZS#/M#&OB2M+DRF2!LM-!!5K14D6"H2P4H;DLL36
M]Y1[$=KM1)]#S-KP*ML;ET117(R!S$D(:!6S%H2/Y(5+25%5;;M?4@[(@[/9
MMBZ5?A2!XYK%)X#,(2!]E/9Z-9JG8[1N<'B4_^_):EUK#"Z:9ROIG)<6$O.E
M3DKUX 5)-Y!(BS,FJ-3:.3Z0Y&Z'3C4WI .IL0/4DI.RQ,I F)VZ0QL>C];K
MY312$+EQE"XFDK\+WS?<+I=A_@FW-3)$5I0NV3H%3I";)!QXK37D[$,V7FF/
MK0.:PZGNT/0.!;*;!<%/J?$.,'['L7.7O"=(YXVRAHR&=1:4T9X.'N; :D'?
MI<-/AM:#'AY)8K?CU09P89NH:<1[NS/V;IVT.=$2A7;,@S3UD;UU=:)F)N_*
M2U8B+P)=ZY;%MQ(R[KW+0(@Z7.0=6*_K3)SNAXDWWG)M)!C/ZL!S2XZXE@9D
MCIH5R8NRK4?HWD'*N-<P3X2=?<3^PU<$G]9!OYJ7Q?)XL^SPURQW+OG$MRF[
ML3[\I8FH#XICJ;G'6MB>O(90M ">BPLRNJ*;S]1[B@'UI\-]5[=.]SV:YVO#
M5K?]?[7Q/"HKH7 1:A%L 5^*A>*3E5J2-XJM:X4/H[C;*Y3'H.KNZ>&#*W'$
M\W>U7$\^D*XV,<_%^Z(PVXX7PNS(S31@B2I03&APC!<H)BH=9=0I[%261ZM<
M0B%]=8' >PD8%UA/B8!%:W6,C:GMP7*9A=.6^"I')HHCGU2S6C2"$B)3"=!8
M6Y*-5IB=$BD/8>HN L;!5$/%+EI+>62H'-$F(LK/)AT(Q@W&G,&K7 =I(((+
MR8,M*AKT02O<Z3KC 7Q<775$4+11X:*)/,<NNCM:3<.[D*J[6@=JG-0)&Z=L
M*,9U1F_ <<WJ/8FDB"1H8"86DH\4AKF'?/,'UACGRK0]"%J*<D1$;+RZY??)
M[Q\F+G/RU+@$P7D=<^@4!%E/5A29X,V92/?9A!6F/W]:?/WY]!.W9N'TBPNK
M<+'>.%<^[8&PIP0[T/G_>#<1R))5A-*07&589(B!N#9!),NL0I5<,YW_CW?C
M))N'T_DC)=A!"O"13O;K\T?Q21.CKA3 $"G*BY+XM)D [E)4+IE@\3ZD[-<K
M;C]:QZW*&2&@>5+E]@/B;5N7;3NKR\U@MVU?ZG4GL4G_Y(_AVT2R@%9D#2*(
M2.=Q1(C<.+"U,;%B6MC2^FIY#S+'C<6?!C^W@W8P97: US>+>=H,<5IO!3?Q
M,G-N3 $=E  53(3H>";QT9^U,+)]1X;K-(QK)$=!VD%JZ/@"YM?IIQ=I,5\<
M?_]UN3CY4A_X;(L\#KAA>? S6UVA/([X1G<D%ZNLCF:SS7SCR]\ZRVRG(*27
MAB*WC([.XNKEH=%@-7F%19CD?>O9.+M1UO+N9%;G8KT+R_7E 7.K7[Y?^<G&
M->$\J!*R!&4$A3>!)0IOI *TR:0DA"B#7IGL3.CX[3$:8^N^6Y-AU-?!H;D;
M:YO,KI-H2D &VM?IA[7W9(RUD%CG8$.,TC<?I[P[=?U<KPP$E1O^W"!ZZPR1
MI\D#)Y0MF -PENICZVC!,V,@)N-XR(J\B-;U?3>I&#MH&$;?]\!J#^&/??U2
MRG0VK0R\F*^GZ^]GUP;H"FHOH28':9]I";$H"QA-%H5QBV&GQW0/7</<NGH_
ML-E'GXNFPNW NM3)YNOOK^;TB>0LO%JM3C"_7=;_5I/\R_<Z\'RSBZ23CCQU
M!2S7R=6.G(88G0'GG#5&AFR:=TK?E;9^,F]/<]8-HK/NL5BY.MVRV@;/ A:@
M>)FVK,FQSI<K8$FF3OJ0BBU/BL4+VL8U;\,@XU'PVU--'<#OTFOJ4UM.(5'P
MFBE(AFTF%-3[%EN TS>YI5WJ=.O0\P81/0-J7UW?&(M\B. [0,X=AO\B?V@,
MMS%P"3H14RJ40NY%"36):)QQ+!;6^F7Y0S2-^_:QFP!Q/QV-74SS9K'&U7M,
M./U:!7.9M].IX75/33?)GTG4@02'NM:$D-2BR."BL: =X\[S:# _F)A]]*K]
MN/F'*WOQ%)+OP(P]Q[A^MIA_I0^L\RJ6TT_3>9C5[YX= .^)V;>E?F=B6/$<
ME8*@ZA/*.K4BN*0A^QQR+,F:TKHUP6/H&_NB:0#\#:ZF[B"X_1,)\M5\M5Z>
MU#VU?46Y=40X'0C*8N$::ML&4"($\,('8+S$@($IQULGPAY'X;BG[!/"L*FJ
M?@0@;H?W\-K.4-DZIX/\7U,KL1Q$DQRP%)7UQJ$(K=^_[DK;N(^LQP7?/NKI
M ';;>.MBEE2M25F<K-]CR--9G>2QG9]'GL?+,%W^>YB=G$V18B$Q5@I)DVL'
MBA/+/M-.RZZ4@,XQ>;U5<J.<R![$COM6>U!@/HT".RX+V4P*7;T)RSJ(Z.LA
M74WO^*16)2"[$-JH\&.[U$5O7<V,X[7$,C+2=+0)O L<F/$E1!.":3YQX2H%
M!\]3K25QN/G,Y[A*R^F7JH%MC&YSMHGE0 8W>3*XB?XDT8$HT63NDJ(@O3ES
M=Y(S;AAZ@-YOC%%M)/*1;R3?UQX\FPRTB9I3<"P .=D\%2R#* ,#XL58%J*7
M9J?N#P]<0IXO.#82&JEO<:@L>P# :9979BX-VK@=/:[$9@"PH<.662$#;0^;
M6CP7O;3D>&\!]U36=77O(;F1%?[;=%ZS8J>$:^5<%F3]6,8(BM&?@M(2BI9&
M)9,=-SM%2P^H_,JB(RM]'Y4M6LAO;,5OTZ&GA*? LV)1@&.*@4J6UXGQY.)R
MG;E@W@;?XNGOE47'>_391/%[RZ^#./;V\^XBQ I<R9 +<6)J/^E8JV1DBE"L
M1&VLY^;ZA(V!O,3'W8<-EC!N[1\,H8=N8'4^Y7;#UT>*J-^6LT<\DY*]B#9D
M2+INE/HF/JCH(:&(Q5K#E&G]R.5AJGIT/O<$P:T :Z:1#C!VE9=K/1W?8ZUV
MN,PHGT0CN*CY;*ZJ0Y<$@Q#H8#9!"(91JQQ:7^X_EL8>C5L;_ VJK=[16.<V
MU=QAO>\[';=4^V)9J\D]R)R1A^@2!^^%A2(3SRF7Y$7K<8N/I7'<2['1T'BH
MMKI#XXMO7W"^PHDH,FJ,"4*.Q(2NXP(M*@B1>\Y,D::TO@*[E9!Q[[N>#E?[
MR+W[&X.SBK!%V7S];+$ZY"'I@Y_9]A9A5^*'N4^046;+*"Q(7!&RLF'@@BK
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M_P77O%3B'$B%D4AT+F<NA)W!09/SV!OH].8P33&X.4<W1B;+[6EX6S \^:/
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M>C9+S0_<W'2A$ZRWPC[?Y;F/8I[]0*C\#9\K^0^G+OX#4$L#!!0    ( +:
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MK;Z2=GA\[D2P_\\/HG?VPUX7L/2_*Z]SY^C;PM\JJ%85/;A+_*$3F9G^RLF
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M#;9J&O-8:21H>WQ2=GL4YMO'/?N2F+*'\W,IKKGYHL$BMU/G;:9L.#81<U/
MRK8#)3V<<U<U2P'?\N$C@6.?@:8F":QS?&-L9>HKY>_!64LNBL.FGF0I,4%]
M=/IR1U(V9/[=$C)'IEKKIY<\]87_Y%%.>2T.ENP1U_&_4$L#!!0    ( +:
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M'Y'<YZR3?P%02P$"% ,4    " "V@$)6L<L6J26  0"NFA  $0
M    @ $     ;&9V;BTR,#(R,3(S,2YH=&U02P$"% ,4    " "V@$)6XE%.
M*<,*   @80  $0              @ %4@ $ ;&9V;BTR,#(R,3(S,2YX<V10
M2P$"% ,4    " "V@$)6S^^,Y:\7  #PV@  %0              @ %&BP$
M;&9V;BTR,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ MH!"5@JGY7^.)@
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M;E\Q,C,Q,C)X97@S,C$N:'1M4$L! A0#%     @ MH!"5I_C[Y=4!0  *1,
M !4              ( !C\L" &QF=FY?,3(S,3(R>&5X,S(R+FAT;5!+!08
1    "@ * )8"   6T0(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
